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Disease induced changes to subcellular components leads to measurable changes in whole cell 
deformability. Thus, mechanical phenotyping offers potential as a diagnostic tool. Cells 
undergo physical and biological changes during cancer progression and understanding these 
changes is a major challenge in developing new diagnosis and treatment methods. 
High-throughput mechanophenotyping methods are required to account for cell heterogeneity, 
which arise due to cell-cycle stage and biological noise. Here, a high-throughput microfluidic 
technique called deformation cytometry was used to deform cells in an extensional flow using 
a cross-slot geometry. Cells are viscoelastic and their mechanical response to an applied stress 
depends on the magnitude and timescale of application. Two distinct flow regimes were 
studied where either shear or inertial forces dominated the system. In the inertia-dominant 
regime cell response showed yield stress behaviour and subsequent cell structural failure at 
high stresses, whilst the shear-dominant regime required lower applied stress to achieve high 
cell strains. The different regimes proved able to expose subtle changes attributed to specific 
subcellular changes, tested by treating cells with drugs to disrupt the actin, microtubule, and 
nuclear structure. Deformation and recovery were tracked as a function of time, with various 
deformation and relaxation parameters found to be useful markers to distinguish cell types. 
Deformation cytometry was also applied to studying colorectal cancer progression. Colorectal 
cancer is the third most common cancer in the UK and the five year survival rate drops from 
~93% with early stage diagnosis to ~7% for late stage diagnosis. The deformability of three 
colorectal cancer cell lines was investigated using both flow regimes. SW480, HT29 and 
SW620 cell lines offered a model of metastatic progression from primary to metastatic and 
were compared to the leukaemia cell line HL60. Results indicated increased deformability 
associated with metastatic progression, and relaxation parameters showed significant changes 
between different cell types. Additional work showed that hydrodynamic deformation can be 
used to increase non-endocytic uptake of quantum dots into cells, due to the applied shear 
force forming transient pores in the cell membrane. Successful delivery of quantum dots into 
the cytosol will allow them to be used to measure the cell redox environment, which is a 
marker of disease state including metastatic progression.  
Results showed the potential for deformation cytometry as a cell mechanophenotying tool 
with high sensitivity, including multiparameter characterisation for improved accuracy in 
detecting disease stage. This work shows that mechanical measurements on a single cell level 
offer insight into heterogeneity, allowing distinctions to be made between different 
phenotypes. Future work could use the method for detection of rare events or subpopulations, 






List of Abbreviations  
AFM Atomic Force Microscopy OT Optical Tweezers 
CA4 Combretastatin A4 PBS Phosphate Buffered Saline 
CRC Colorectal cancer PBS-MC PBS with Methyl Cellulose 
CytoD Cytochalasin D PCA Principal Component Analysis 
CV Coefficient of Variation PDMS Polydimethyl Siloxane 
DC Circularity QD Quantum Dot 
DC Deformation Cytometry RBC Red Blood Cell 
DEP Dielectrophoresis Re Reynolds number 
DI Deformation Index RS Raman Spectroscopy 
DMEM Dulbecco’s Modified Eagle Medium RT-DC Real time deformation cytometry 
DMSO Dimethyl sulfoxide SD Standard Deviation 
DNA Deoxyribonucleic acid SE Standard Error 
E Elastic Modulus TSA Trichostatin A 
ECM Extracellular matrix ε Strain 
EMT Epithelial-to-Mesenchymal transition ε0 Initial strain 
FBS Foetal Bovine Serum ε∞ Final strain 
FC Compressive force εmax Maximum strain 
FS Shear force σ Stress 
FT Total force τd Deformation time 
FWHM Full width half maximum τr Relaxation time 
IPA Isopropanol 
 
LatA Latrunculin A 
 
LDA Linear Discriminant Analysis 
 
MA Micropipette Aspiration 
 
MC Methyl Cellulose 
 






Table of Contents 
Acknowledgments .................................................................................................................. v 
Abstract ................................................................................................................................. vii 
List of Abbreviations ............................................................................................................ ix 
List of Figures ...................................................................................................................... xiv 
List of Tables ........................................................................................................................ xx 
1 Introduction .................................................................................................................... 1 
1.1 Overview ................................................................................................................. 1 
1.2 Background: Mechano-phenotyping and Single Cell Analysis .......................... 1 
1.3 Biophysical characterisation techniques .............................................................. 2 
1.3.1 Overview .......................................................................................................... 2 
1.3.2 Microfluidics .................................................................................................... 5 
1.4 Deformation Cytometry Applications ................................................................ 10 
1.4.1 Detecting diseased states ................................................................................ 10 
1.4.2 Sensitivity to subcellular changes .................................................................. 11 
1.4.3 DC for non-endocytic uptake of nanoparticles .............................................. 12 
1.4.4 Combining DC and fluorescence measurements ........................................... 14 
1.5 Scope of project and thesis outline ..................................................................... 15 
2 Theory and Background .............................................................................................. 17 
2.1 Cell Structure ....................................................................................................... 17 
2.1.1 Overview ........................................................................................................ 17 
2.1.2 The Cell Membrane ....................................................................................... 18 
2.1.3 The Cytoskeleton ........................................................................................... 18 
2.1.4 The Nucleus ................................................................................................... 22 
2.1.5 The Cell Cycle ............................................................................................... 23 
2.2 Cancer cell progression and mechanical changes ............................................. 26 
2.2.1 Cancer and Metastasis .................................................................................... 26 
2.2.2 Colorectal Cancer ........................................................................................... 26 
2.2.3 Model System ................................................................................................ 28 
2.2.4 Mechanical phenotype of malignant cells ...................................................... 29 
2.3 Biomechanics of Cells .......................................................................................... 31 
2.3.1 Viscoelasticity ................................................................................................ 31 
2.3.2 Linear-Spring and Dashpot models ................................................................ 33 
2.3.3 Overview of Models of Cell Mechanics ........................................................ 36 
2.3.4 Kelvin-Voigt Model ....................................................................................... 39 
2.3.5 Cell Plasticity ................................................................................................. 40 
2.4 Microfluidics Background ................................................................................... 42 
xi 
 
2.4.1 Navier-Stokes equation .................................................................................. 42 
2.4.2 Reynolds number ........................................................................................... 43 
2.4.3 Flow Resistance ............................................................................................. 44 
2.5 Microfluidic Cell Deformation ............................................................................ 45 
2.5.1 Structure induced deformation ....................................................................... 45 
2.5.2 Flow induced deformation ............................................................................. 45 
2.5.3 Shear and Inertial Forces ................................................................................ 47 
3 Experimental Methods ................................................................................................ 50 
3.1 Microfluidic Device Fabrication ......................................................................... 50 
3.1.1 Master Fabrication ......................................................................................... 50 
3.1.2 PDMS Device Fabrication ............................................................................. 51 
3.2 Device designs ....................................................................................................... 52 
3.2.1 Cross-slot ....................................................................................................... 52 
3.2.2 Serpentine ...................................................................................................... 53 
3.3 Deformation Cytometry Procedure .................................................................... 54 
3.4 Microscopy Techniques ....................................................................................... 55 
3.4.1 Bright Field Microscopy ................................................................................ 55 
3.4.2 High Speed Microscopy ................................................................................. 55 
3.4.3 Phase Contrast Microscopy ............................................................................ 56 
3.4.4 Confocal Fluorescence Microscopy ............................................................... 57 
3.5 Automated Image Analysis ................................................................................. 58 
3.5.1 ImageJ particle tracking ................................................................................. 58 
3.5.2 Matlab particle tracking ................................................................................. 61 
3.5.3 Parameter definitions ..................................................................................... 63 
3.6 Cell Culture .......................................................................................................... 65 
3.6.1 HL60 .............................................................................................................. 65 
3.6.2 Colorectal Cancer Cell Lines ......................................................................... 65 
3.6.3 MCF-7 ............................................................................................................ 66 
3.6.4 HEK-293 T-REx and Piezo1 T-REx .............................................................. 66 
3.6.5 Concentration and Viability Measurements ................................................... 68 
3.7 QD uptake in Cells ............................................................................................... 68 
3.7.1 Quantum Dots ................................................................................................ 68 
3.7.2 Microfluidic Uptake Protocol ........................................................................ 69 
3.7.3 Analysis of QD uptake ................................................................................... 69 
4 Cell deformation in shear and inertial flows ............................................................. 70 
4.1 Cross-slot optimisation ........................................................................................ 70 
4.1.1 Tracking particles in flow .............................................................................. 70 
xii 
 
4.1.2 Varying Flow Rate ......................................................................................... 73 
4.1.3 Varying Velocity Threshold ........................................................................... 75 
4.1.4 Varying Channel Dimensions ........................................................................ 77 
4.2 Cell deformation across flow regimes ................................................................ 81 
4.2.1 Varying suspension buffer viscosity .............................................................. 81 
4.2.2 Inertial Regime ............................................................................................... 83 
4.2.3 Deformation as a function of force ................................................................ 84 
4.3 Cell viability after deformation .......................................................................... 85 
4.3.1 Shear Regime ................................................................................................. 85 
4.3.2 Inertial Regime ............................................................................................... 86 
4.4 Tracking cell deformation and recovery ............................................................ 88 
4.4.1 Single cell tracking in the shear regime ......................................................... 88 
4.4.2 High strain recovery in the shear regime ....................................................... 93 
4.4.3 High strain recovery in the inertial regime .................................................... 97 
4.4.4 Summary of section 4.4 ............................................................................... 100 
4.5 Discussion............................................................................................................ 101 
5 The sensitivity of DC to subcellular alterations ...................................................... 105 
5.1 Treating cells with Latrunculin A .................................................................... 105 
5.1.1 Drug treatment and observations ................................................................. 106 
5.1.2 Deformation Cytometry in the shear regime ................................................ 110 
5.1.3 Deformation Cytometry in the inertial regime ............................................. 114 
5.1.4 Deformation traces and SCA ....................................................................... 116 
5.1.5 Discussion .................................................................................................... 120 
5.2 Treating cells with Combretastatin A4 ............................................................ 122 
5.2.1 Drug treatment and observations ................................................................. 123 
5.2.2 Deformation Cytometry in the shear regime ................................................ 127 
5.2.3 Deformation Cytometry in the inertial regime ............................................. 130 
5.2.4 Viability Assays ........................................................................................... 132 
5.2.5 Deformation traces and SCA ....................................................................... 137 
5.2.6 Discussion .................................................................................................... 141 
5.3 Treating cells with Trichostatin A .................................................................... 145 
5.3.1 Drug treatment and observations ................................................................. 145 
5.3.2 Deformation Cytometry in the shear regime ................................................ 147 
5.3.3 Deformation Cytometry in the inertial regime ............................................. 148 
5.3.4 Discussion .................................................................................................... 150 
5.4 Chapter Overview .............................................................................................. 152 
6 Changes to mechanical phenotype with colorectal cancer progression ................ 154 
xiii 
 
6.1 Colorectal cancer cell lines ................................................................................ 154 
6.1.1 Initial morphology........................................................................................ 154 
6.1.2 Nucleus size ................................................................................................. 155 
6.2 Deformation Cytometry .................................................................................... 157 
6.2.1 Shear-dominant regime ................................................................................ 157 
6.2.2 Inertia-dominant regime ............................................................................... 161 
6.2.3 Cell width and height ................................................................................... 164 
6.3 Deformation and Recovery ............................................................................... 167 
6.3.1 Strain trace multiparameter analysis ............................................................ 167 
6.3.2 Single Cell Analysis ..................................................................................... 170 
6.3.3 Linear Discriminant Analysis ...................................................................... 172 
6.4 Discussion and Chapter Overview .................................................................... 174 
7 Other applications of Deformation Cytometry ....................................................... 179 
7.1 Non-Endocytic uptake of Quantum Dots ......................................................... 179 
7.1.1 Shear Regime ............................................................................................... 180 
7.1.2 Inertial Regime ............................................................................................. 183 
7.1.3 Constriction channel control ........................................................................ 186 
7.1.4 Uptake by incubation ................................................................................... 189 
7.1.5 Discussion .................................................................................................... 192 
7.2 DC for probing the mechanoresponse of Piezo1.............................................. 195 
7.2.1 Yoda1 activation .......................................................................................... 197 
7.2.2 Shear Regime Deformation .......................................................................... 199 
7.2.3 Strain Traces ................................................................................................ 202 
7.2.4 Discussion .................................................................................................... 206 
8 Conclusions and Future Work .................................................................................. 210 
8.1 Chapter by Chapter Overview .......................................................................... 210 
8.2 MRC Project ....................................................................................................... 215 
8.3 Next Steps ........................................................................................................... 216 
8.3.1 Further optimisation ..................................................................................... 216 
8.3.2 DC to study other subcellular alterations ..................................................... 217 
8.3.3 DC for studying Piezo1 ................................................................................ 218 
8.3.4 DC and high speed fluorescence .................................................................. 219 
Appendix ............................................................................................................................. 221 





List of Figures 
Figure 1.1 Schematic representations of the types of experimental techniques used for biomechanical 
characterisation of cells. ......................................................................................................................... 4 
Figure 1.2 The typical ranges of forces (a) and displacements (b) probed by various biomechanical 
assays ...................................................................................................................................................... 5 
Figure 1.3 A graphical representation of the “precision” of different biomechanical methods for probing 
cells compared to the “speed” (i.e. throughput) ...................................................................................... 6 
Figure 1.4 The principles of deformability cytometry. ........................................................................... 8 
Figure 1.5 (a) An example scatter plot of deformation against initial size (cross sectional area) for a 
HL60 cell sample. ................................................................................................................................... 9 
Figure 1.6 Constriction microfluidics for increased QD uptake in cells. .............................................. 13 
Figure 1.7 Details of the inertial microfluidic cell hydroporator for intracellular delivery of 
nanoparticles ......................................................................................................................................... 14 
Figure 2.1 A fluorescent image of a cell with labelled cytoskeletal filaments ..................................... 18 
Figure 2.2 A simplified schematic of the structure of the three cytoskeletal filaments: actin filaments, 
microtubules and intermediate filaments .............................................................................................. 19 
Figure 2.3 Schematic showing the main structure of the eukaryotic cell nucleus ................................ 22 
Figure 2.4 (a) A simplified schematic of the four main phases of the cell cycle. ................................. 24 
Figure 2.5 Schematic describing progression from normal epithelial crypts through to colorectal 
adenocarcinoma to metastasis ............................................................................................................... 27 
Figure 2.6 A schematic outlining the model system for CRC progression ........................................... 29 
Figure 2.7 Graphical schematic of the stress-strain loading and unloading curves of an elastic vs a 
viscoelastic material. ............................................................................................................................ 32 
Figure 2.8. Schematic describing the three simplest spring-dashpot models and their responses over 
time to a step-wise applied stress σ and strain ε ................................................................................... 34 
Figure 2.9 Simplified schematics showing some of the main conceptual models of cell mechanics. .. 38 
Figure 2.10: (a) Cross-slot velocity profile found using COMSOL ..................................................... 39 
Figure 2.11 A schematic showing the different microfluidic geometries that can be used to deform 
single cells ............................................................................................................................................ 46 
Figure 2.12: Variation of Reynolds number with flow rate in a cross-slot device for two viscosities . 48 
Figure 2.13: Plots of equations  2.23 and 2.24 as a function of flow rate. Changing the viscosity µ of 
the fluid determines whether the system is inertia or shear dominant. ................................................. 49 
Figure 3.1. Schematic summarising the production steps for fabrication of an SU-8-silicon master ... 51 
Figure 3.2. Schematic summarising the production steps for fabrication of microdevices using PDMS
 .............................................................................................................................................................. 52 
Figure 3.3. (a) Cross-slot device designed using AutoCAD, with inlets and outlets labelled and arrows 
used to show the direction of flow ........................................................................................................ 53 
Figure 3.4. Serpentine device designed using AutoCAD, with inlets and outlets labelled and arrows 
used to show the direction of flow ........................................................................................................ 54 
Figure 3.5. (a) Schematic of the microfluidic apparatus used for deformation cytometry. .................. 55 
Figure 3.6 Simplified schematic of the optical set-up of a phase contrast microscope......................... 56 
Figure 3.7  Simplified schematic of a confocal microscope. ................................................................ 57 
Figure 3.8. An example image of a cell deforming at the stagnation point of a microfluidic device. .. 60 
xv 
 
Figure 3.9. An example of particle tracking used to analyse the deformation of a HL60 cell deformation 
in a cross-slot device ............................................................................................................................ 61 
Figure 3.10. Example of precision particle tracking using Matlab. The code is used to track the position 
and shape of a cell passing through an extensional flow junction. ....................................................... 63 
Figure 3.11. Schematic describing how the deformation parameters DI, ɛ and DC change when a cell 
begins to deviate from a perfect circle (Shape A). ............................................................................... 64 
Figure 4.1 Comparison of the trajectory of a cell in a cross-slot microfluidic device compared to a 
polystyrene bead................................................................................................................................... 71 
Figure 4.2 COMSOL simulations of flow in a cross-slot microfluidic device. .................................... 72 
Figure 4.3 The velocity (m/s) as a function of flow rate (µl/min) of polystyrene beads and HL60 cells 
travelling through a rectangular channel. ............................................................................................. 73 
Figure 4.4 Density scatter plots of DI as a function of initial diameter of HL60 cells deformed at various 
flow rates .............................................................................................................................................. 74 
Figure 4.5: A plot of the average DI±SE of HL60 cells deformed over a range of flow rates in a shear-
dominant flow regime (μ ≅ 33 cP). ..................................................................................................... 74 
Figure 4.6 The velocity profile of a HL60 cell as it passes through the extensional flow junction of a 
cross-slot microfluidic device .............................................................................................................. 75 
Figure 4.7 (a) The average DI±SE of HL60 deformed at 40 µl/min in 0.24% methyl cellulose buffer, as 
a function of Δv threshold. ................................................................................................................... 77 
Figure 4.8 Bright field images of HL60 cells deforming at DI ≅ DImax in a shear-dominant flow regime 
(μ ≅ 33 cP). ......................................................................................................................................... 78 
Figure 4.9 HL60 cells were deformed in microfluidic cross-slot devices at a range of flow rate. The 
flow regime was shear-dominant (µ≈33 cP) and device dimensions are labels channel width W by 
channel height H (W x H µm). ............................................................................................................. 79 
Figure 4.10 A plot of DImax±SE of HL60 cells deformed in microfluidic cross-slot devices with different 
channel dimensions. ............................................................................................................................. 80 
Figure 4.11 Bar graphs showing the percentage number of cell events with ∆v > 0.75 when HL60 cells 
were deformed microfluidically at a range of flow rates, for different channel dimensions. ............... 81 
Figure 4.12 DI as a function of Q for HL60 cells in four different suspension buffers with viscosity 
ranging from 1 to 33 cP. ....................................................................................................................... 82 
Figure 4.13 A graph of the extrapolated value DImax associated with the deformability of HL60 cells as 
a function of flow rate for four different viscosities of suspension buffer. .......................................... 83 
Figure 4.14 The average DI±SE of HL60 cells versus Q, in an inertial-dominant flow regime (µ= 1 cP).
.............................................................................................................................................................. 84 
Figure 4.15 The DI of HL60 cells as a function of applied force (µN), where FT is the sum of the shear 
force (Fs) and inertial force (FC). ........................................................................................................ 85 
Figure 4.16 The viability of HL60 cells after being deformed on-chip over a range of flow rates, where 
the flow regime was shear dominant (μ ≅ 33 cP)................................................................................ 86 
Figure 4.17 The viability of HL60 cells after microfluidic deformation at a range of flow rates Q (blue) 
in the inertial regime (µ=1 cP) ............................................................................................................. 87 
Figure 4.18 Shape analysis of HL60 post-deformation. ....................................................................... 88 
Figure 4.19 (a) Strain, ε, as a function of time, averaged over 50 HL60 cells, with the standard error 
shown in gray. Q was fixed at 5 µl/min, and the suspension medium viscosity was 33 cP. ................ 89 
Figure 4.20 (a) The average velocity profile of N=50 HL60 cells as they pass through the SP of the 
cross flow. ............................................................................................................................................ 90 
Figure 4.21 Examples of 4 strain traces of HL60 cells deforming in the extensional flow junction of a 
microfluidic cross-slot device. ............................................................................................................. 91 
xvi 
 
Figure 4.22 Histograms of the single cell parameters extracted from strain traces of N=50 HL60 cells
 .............................................................................................................................................................. 93 
Figure 4.23 Schematic and bright field images of cell recovery after deformation at the SP of a cross-
slot device. ............................................................................................................................................ 94 
Figure 4.24 The DI±SE of HL60 cells as a function of position in a cross-slot device (μ ≅ 33 cP) ... 95 
Figure 4.25 Histograms of the DI of HL60 cells at various positions in a cross-slot microfluidic device 
which were deformed in a shear-dominant regime (μ ≅ 33 cP) .......................................................... 97 
Figure 4.26 Example bright field images of cells in the cross-slot device at the different positions, where 
the flow rate was 600 µl/min and the flow regime was inertia-dominant (µ≈1 cP). ............................. 98 
Figure 4.27 The DI±SE of HL60 cells as a function of position in a cross-slot device (μ ≅ 1cP) ...... 99 
Figure 4.28 Histograms of the DI of HL60 cells at various positions in a cross-slot microfluidic device 
which were deformed in a inertia-dominant regime (μ ≅ 1 cP) ......................................................... 100 
Figure 4.29 The DI±SE of HL60 cells as a function of time in a cross-slot device as cells recover through 
the outlet after deformation at the SP ................................................................................................. 101 
Figure 5.1 Measurement of the size and shape of HL60 cells compared to those treated with 1 µM of 
LatA: ................................................................................................................................................... 106 
Figure 5.2 Measurement of the size and shape of SW480 cells compared to those treated with 1 µM of 
LatA: ................................................................................................................................................... 107 
Figure 5.3 Confocal fluorescence images of control HL60 cells and HL60 treated with 0.01 µM, 0.1 
µM and 1 µM of LatA, stained for actin (red) and DNA (blue). ........................................................ 108 
Figure 5.4 Confocal fluorescence images of control SW480 cells and SW480 treated with 0.01 µM, 0.1 
µM and 1 µM of LatA. ....................................................................................................................... 109 
Figure 5.5 Confocal fluorescence images of control SW480 cells and SW480 treated with 0.01 µM, 0.1 
µM and 1 µM of LatA. ....................................................................................................................... 109 
Figure 5.6 The nuclear diameter of HL60 and SW480 cells was measured using confocal fluorescence 
images with DNA staining.................................................................................................................. 110 
Figure 5.7 (a) The deformation index DI of HL60 cells treated with 1 µM of LatA as a function of flow 
rate, compared to a control sample. Cells were deformed in a shear-dominant regime where μ ≅ 33 cP.
 ............................................................................................................................................................ 111 
Figure 5.8 (a) The deformation index DI of SW480 cells treated with 1 µM of LatA as a function of 
flow rate, compared to an untreated sample. Cells were deformed in a shear-dominant regime where 
μ ≅ 33 cP. .......................................................................................................................................... 112 
Figure 5.9  Histograms of the DI of SW480 treated with 1 µM of LatA compared to an untreated sample.
 ............................................................................................................................................................ 113 
Figure 5.10 (a) The deformation index DI of HL60 cells treated with 1 µM of LatA as a function of 
flow rate, compared to a control sample. Cells were deformed in an inertia-dominant regime where μ ≅
1 cP. .................................................................................................................................................... 114 
Figure 5.11 (a) The deformation index DI of SW480 cells treated with 1 µM of LatA as a function of 
flow rate, compared to an untreated sample. Cells were deformed in an inertia-dominant regime where 
μ ≅ 1 cP.............................................................................................................................................. 115 
Figure 5.12 The averaged strain trace for SW480 (N = 56) and SW480 treated with 1 µM LatA ..... 117 
Figure 5.13 Strain traces of SW480 and SW480 treated with LatA fitted with the Kelvin voigt model, 
accompanied by velocity profiles fitted with a sine function. ............................................................ 117 
Figure 5.14 SCA was performed on strain traces of SW480 treated with LatA and a control sample to 
extract multiple parameters................................................................................................................. 119 
Figure 5.15 Histograms showing the maximum strain εmax, final strain ε∞ and relaxation time τr of 
SW480 treated with LatA (N=30), compared to an untreated control sample (N=56). ...................... 120 
xvii 
 
Figure 5.16 Measurement of the size and morphology of HL60 treated with 100 nM of CA4, compared 
to a control sample ............................................................................................................................. 124 
Figure 5.17 Measurement of the size and morphology of SW480 cells treated with 100 nM of CA4, 
compared to a control sample ............................................................................................................. 125 
Figure 5.18 Confocal fluorescence images of control HL60 cells and HL60 treated with 10 nM, 50 nM 
and 100 nM of CA4, stained for tubulin (red) and DNA (blue). ........................................................ 126 
Figure 5.19 Confocal fluorescence images of control SW480 cells and SW480 treated with 10 nM, 50 
nM and 100 nM of CA4 ..................................................................................................................... 126 
Figure 5.20 DNA stained images were used to measure the nuclear diameter of HL60 and SW480 
treated with CA4 ................................................................................................................................ 127 
Figure 5.21 (a) The deformation index DI of HL60 cells treated with 100 nM of CA4 as a function of 
flow rate, compared to a control sample. Cells were deformed in a shear-dominant regime where μ ≅
33 cP. ................................................................................................................................................. 128 
Figure 5.22 Histograms of the DI of HL60 treated with 100nM of CA4 (N=890) and a control sample 
(N=853), cells were deformed at 60 µl/min in a shear dominant regime (μ ≅ 33 cP). ...................... 129 
Figure 5.23 (a) The deformation index DI of SW480 cells treated with 100 nM of CA4 as a function of 
flow rate, compared to a control sample. Cells were deformed in a shear-dominant regime where μ ≅
33 cP. ................................................................................................................................................. 130 
Figure 5.24 (a) The deformation index DI of HL60 cells treated with 100 nM of CA4 as a function of 
flow rate, compared to untreated cells. Cells were deformed in an inertia-dominant regime where μ ≅
1 cP. ................................................................................................................................................... 131 
Figure 5.25(a) The deformation index DI of SW480 cells treated with 100 nM of CA4 as a function of 
flow rate, compared to untreated cells. ............................................................................................... 132 
Figure 5.26 The viability of HL60 cells treated with CA4 was tested up to 48 hr of incubation with the 
drug. ................................................................................................................................................... 133 
Figure 5.27 The circularity of HL60 cells treated with CA4 was measured using Dc up to 48 hr of 
incubation with the drug. .................................................................................................................... 135 
Figure 5.28 (a) The viability of SW480 cells after incubation with 100 nM of CA4 for 2 hr and 48 hr 
was measured using a Trypan blue assay. .......................................................................................... 136 
Figure 5.29 The normalised fluorescence intensity of SW480 and HL60 using an AlamarBlue assay 
after 4 hr incubation with different concentrations of CA4. ............................................................... 137 
Figure 5.30 The averaged strain trace for HL60 (N = 50) and HL60 treated with 100 nM LatA (N = 30) 
as a function of time ........................................................................................................................... 138 
Figure 5.31 The averaged strain trace of N=38 HL60 cells treated with CA4, the Kelvin-Voigt model 
was fitted, shown in red. The average velocity profile of the same 38 cells is shown and fitted with a 
sine function, shown in red. ............................................................................................................... 139 
Figure 5.32 SCA performed on strain traces of HL60 treated with CA4 and a control sample. ........ 140 
Figure 5.33 Histograms showing the maximum strain εmax, relaxation time τr and final strain ε∞ of 
HL60 treated with CA4 (N=38), compared to an untreated control sample (N=50). ......................... 141 
Figure 5.34 Confocal fluorescence images of control HL60 cells and HL60 treated with 100 nM of CA4
............................................................................................................................................................ 144 
Figure 5.35 Measurement of the size and shape of HL60 cells compared to those treated with 1 µM of 
TSA .................................................................................................................................................... 146 
Figure 5.36 Confocal fluorescence images of control HL60 cells and HL60 cells treated with 0.1 µM 
and 1 µM of TSA ............................................................................................................................... 147 
Figure 5.37(a) The deformation index DI of HL60 cells treated with 1 µM of TSA as a function of flow 




Figure 5.38 (a) The deformation index DI of HL60 cells treated with 1 µM of TSA as a function of flow 
rate, compared to untreated cells. Cells were deformed in a inertia-dominant regime where μ ≅ 1 cP.
 ............................................................................................................................................................ 149 
Figure 5.39 Histograms of DI of HL60 at various flow rates, comparing cells treated with 1 µM of TSA 
to a control sample. ............................................................................................................................. 150 
Figure 6.1 Phase contrast images of HL60, SW480, HT29 and SW620 ............................................ 154 
Figure 6.2 Confocal fluorescence images of detached (a) SW480, (b) HT29 and (c) SW620 cells ... 156 
Figure 6.3 Bar graph showing the Nuclear Ratio of HL60, SW480 and SW620 cells ....................... 157 
Figure 6.4 DI of SW480, HT29 and SW620 cell lines over a range of flow rates Q (µl/min). The flow 
regime was shear dominant (µ≈33 cP). .............................................................................................. 158 
Figure 6.5 Histograms of the DI of the CRC cells lines deformed at 5 µl/min in a shear-dominant regime 
(µ≈33 cP). ........................................................................................................................................... 159 
Figure 6.6 Histograms of the DI of the CRC cells lines deformed at 80 µl/min in a shear-dominant 
regime (µ≈33 cP). ............................................................................................................................... 160 
Figure 6.7 The initial size normalised deformation index DI/A of three colorectal cancer cell lines over 
a range of flow rates Q (µl/min), ........................................................................................................ 161 
Figure 6.8 DI of SW480, HT29 and SW620 cell lines over a range of  flow rates Q (µl/min). The flow 
regime was inertia dominant ( µ≈1 cP). .............................................................................................. 162 
Figure 6.9 Histograms of the DI of the CRC cells lines deformed at 300 µl/min in the inertia-dominant 
regime (µ≈1 cP). ................................................................................................................................. 163 
Figure 6.10 Histograms of the DI of the CRC cells lines deformed at 600 µl/min in the inertia-dominant 
regime (µ≈1 cP). ................................................................................................................................. 163 
Figure 6.11 DI/A of three colorectal cancer cell lines over a range of flow rates (µl/min), in an inertia 
dominant regime (µ≈1 cP). ................................................................................................................. 164 
Figure 6.12 Cells were deformed at the SP of a cross-slot device, the width (W) and (height) of the cell 
were measured at their maximum deformed state at the SP (µ≈ 33 cP). ............................................ 165 
Figure 6.13 Cell were deformed at the SP of a cross-slot device, the width (W) and (height) of the cell 
were measured at their maximum deformed state at the SP (µ≈ 1 cP). .............................................. 166 
Figure 6.14 Strain ε was tracked for SW480, HT29 and SW620 cells as a function of time ............. 168 
Figure 6.15 The average strain trace of  SW480, HT29 and SW620 cells fitted with the Kelvin-Voigt 
function accompanied by the velocity profile fitted with a sine function (shown in red). .................. 169 
Figure 6.16 A bar graph of the Elastic moduli of HL60, SW480, HT29 and SW620 cells. ............... 170 
Figure 6.17 Multiparameter analysis of HL60, SW480, SW620 and HT29 cell populations using 
statistical t-tests .................................................................................................................................. 171 
Figure 6.18 Linear discriminant analysis of 5 parameter datasets for HL60, SW480, HT29 and SW620
 ............................................................................................................................................................ 173 
Figure 7.1 Schematic describing the passive diffusion of quantum dots through transient membrane 
pores in cells, due to deformation at the stagnation point of a cross-slot microfluidic device. .......... 180 
Figure 7.2 The deformation index DI of MCF7 cells as a function of flow rate in a shear-dominant 
regime (μ ≅ 33 cP) ............................................................................................................................ 181 
Figure 7.3 QD uptake analysis of MCF7 cells microfluidically deformation whilst suspended with 100 
nM of QDs in a shear-dominant regime (µ≈33 cP). ........................................................................... 182 
Figure 7.4 Confocal fluorescence images of MCF7 cells with QD uptake, showing ......................... 183 
Figure 7.5 The deformation index DI of MCF7 cells as a function of flow rate. Cells were deformed in 
an inertia-dominant regime where μ~1 cP. ........................................................................................ 184 
Figure 7.6 Uptake of QDs in MCF7 cells deformed in a cross-slot device whilst suspended in media 
(µ~1 cP) with 100 nM QDs ................................................................................................................ 185 
xix 
 
Figure 7.7 Analysis of uptake of MCF7 cells deformed in a cross-slot whilst suspended with 100 nM 
of QDs (µ≈1 cP). ................................................................................................................................ 186 
Figure 7.8 Shape analysis of cells deformed in a constriction channel. ............................................. 187 
Figure 7.9 Uptake of QDs into MCF7 cells deformed in a constriction channel ............................... 188 
Figure 7.10 Analysis of uptake of QDs in MCF7 cells deformed in a constriction channel whilst 
suspended with 100 nM of QDs ......................................................................................................... 189 
Figure 7.11 Confocal images of QD uptake in MCF7 cells of the inertial and shear controls ........... 190 
Figure 7.12 (a) Histograms of the fluorescence per cell for the inertial control and the shear control, 
showing the distribution of QD uptake in MCF7 cells. ...................................................................... 191 
Figure 7.13 Simplified shematic showing the mechanosensitive ion channel Piezo1 which resides in the 
cell membrane. ................................................................................................................................... 196 
Figure 7.14 (a) Phase contrast images of HEK293 T-REx and Piezo1 T-REx cell lines adhered to a 
culture flask, scale bars are 20 µm. .................................................................................................... 197 
Figure 7.15 The drug Yoda1 was used to activate the mechanosensitive ion channel Piezo1. .......... 199 
Figure 7.16 The deformation index DI of HEK293 T-REx and Piezo1 T-REx as a function of flow rate.
............................................................................................................................................................ 200 
Figure 7.17 (a) The fluorescence intensity Lm1/Lm2 of HEK293 T-REx and Piezo1 T-REx cell lines 
as a function of flow rate through a cross-slot microfluidic device.................................................... 201 
Figure 7.18 The averaged strain trace for HEK293 T-REx (N = 95) and Piezo1 T-REx (N=60) as a 
function of time .................................................................................................................................. 203 
Figure 7.19 Averaged strain traces and velocity profiles of (a) N=95 HEK293 T-Rex cells and (b) N=60 
Piezo1 T-Rex cells ............................................................................................................................. 203 
Figure 7.20 SCA was performed on individual strain traces of HEK293 T-Rex and Piezo1 T-REx. 205 
Figure 7.21 Histograms showing the final strain ε∞ of HEK293 T-REx (N=95) and of Piezo1 T-Rex 
(N=60). ............................................................................................................................................... 206 
Figure 8.1 Schematic showing structural information that could be gained from combining deformation 
















List of Tables 
Table 4.1 Multiple characteristic parameters extracted from the strain traces of N=50 cells. .............. 91 
Table 4.2 A summary of the strain rate and relaxation time of HL60 cells after deformation at the SP of 
an extensional flow ............................................................................................................................. 101 
Table 4.3 A table summarising the different values of elastic modulus reported for HL60 cells using a 
range of techniques. ............................................................................................................................ 103 
Table 5.1 Multiple characteristic parameters extracted from the strain traces of N=56 SW480 cells and 
N=30 SW480 cells treated with LatA. ................................................................................................ 118 
Table 5.2 Multiple characteristic parameters extracted from the strain traces of N=50 HL60 cells and 
N=38 HL60 cells treated with CA4. ................................................................................................... 140 
Table 5.3 Summary of DI results w between untreated HL60 cells and those treated with TSA. ...... 150 
Table 6.1 The average nuclear diameter of HL60, SW480, HT29 and SW620 cells (measured using 
confocal images), and the nuclear ratio of each cell line (Anucleus/Acell). ............................................. 157 
Table 6.2 Summary of parameters associated with cell width W and H during deformation at the SP 
over a range of flow rates. .................................................................................................................. 166 
Table 6.3 Multiple characteristic parameters extracted from the strain traces of N=56 SW480 cells, 
N=49 HT29 and N=50 SW620 cells. .................................................................................................. 169 
Table 6.4 Characteristic parameters of HL60, SW480, HT29 and SW620 cell lines, found using single 
cell analysis ........................................................................................................................................ 170 
Table 6.5 Summary of p-values comparing properties of HL60, SW480, SW620 and HT29 cell 
populations ......................................................................................................................................... 172 
Table 6.6 k-fold validation tests to classify the four cell lines (5-fold). ............................................. 174 
Table 7.1 Multiple characteristic parameters extracted from the strain traces of N=95 HEK293 T-REx 
cells and N=60 Piezo1 T-REx cells .................................................................................................... 204 



















This PhD project was part of a larger collaboration to design a microfluidic platform with 
combined assays to mechanically, chemically and electrically phenotype single cells. The 
proposed assays were Deformation Cytometry (DC) for mechanical phenotyping, Surface 
Acoustic Wave (SAW) dielectrophloresis (DEP) for electrical phenotyping and Raman 
Spectroscopy for biochemical phenotyping.  The main application of the platform would be 
to distinguish between healthy and diseased cells within a population, in a non-destructive 
manner. Traditional genomic and transcriptomic analytical methods are costly and time-
consuming, as well as being inherently destructive, making it impossible to determine both a 
cells mutational load, its biological behaviour and therapeutic response. The integrated 
microfluidic platform, indicated above, would provide a unique cell characterisation system 
capable of discerning between normal and pathological states on a single-cell level. The on-
chip measurements leave the cells viable, permitting subsequent destructive genetic 
sequencing. Further, the platform could aid understanding of disease progression and with 
assessment of treatment success. The three assays were to be first developed and optimised 
separately; this project worked towards development of DC to mechanically phenotype single 
cells using a microfluidic device. 
1.2 Background: Mechano-phenotyping and Single Cell Analysis 
The deformability of a cell is the result of a complex interplay between its biological 
constituents at the subcellular level. Disease can induce changes to subcellular constituents 
(including the cytoskeleton, nucleus and cytoplasm), making cell deformability a biophysical 
marker for disease. The aim of the project is to mechanically phenotype cells in order to 
identify diseased populations in a sample and understand how the mechanical phenotype 
changes with disease progression.  
The mechanical properties of biological materials can be measured on various length scales, 
including submicron protein filaments and micron ranging single cells, scaling up to tumours 
or entire organs. A challenge in cancer research is understanding how biological changes relate 
to pathology, hindered by finding appropriate methods to map tumours across all length scales. 
Comparisons between cell genotype and phenotype commonly come from averaged 
measurements of a population of cells. These measurements are useful, however cell 
populations are heterogeneous and averaging cannot assess individual responses. Cell 
heterogeneity derives from the active nature of cells, which involves biochemical reactions 
driving processes such as the cell-cycle, signalling, motility and differentiation. Further, 




environment, show stochastic gene expression resulting in phenotypic changes. Detailed 
reviews of biological noise can be found [3], [4]. Thus, an average study may show significant 
changes between two populations, however a single-cell analysis may produce further 
information on heterogeneity as well as sub-populations in mixed samples. For example, a 
study on mechanical changes induced by a drug treatment may only affect a small fraction of 
the cells which would not be deduced by averaging. Therefore, to properly characterise a 
system the individual components much be understood. 
Common downfalls of single-cell analysis techniques are that they are time-consuming and 
require large numbers of cells to gain statistical significance. Flow cytometry is a high-
throughput technique, able to analyse thousands of cells per second, to measure physical and 
chemical properties of cells [5]. Cells flow single file through a laser beam, scattered light is 
collected and used to infer information about the cells. Physical properties such as size and 
morphology can be deduced from scattering without fluorescent labelling, however 
fluorescent labelling is required for study of the chemical content (e.g. DNA stain to study cell 
cycle stage). Traditional flow cytometry offers no mechanical information, and thus current 
methods do not combine mechanical and chemical phenotyping at the single-cell level.  
Many techniques exist for mechanical phenotyping of single cells (described in more detail in 
the next section), but are often plagued by being time-consuming and low-throughput. 
Microfluidics offers a high-throughput alternative for biophysical characterisation. 
Microfluidics constrains fluid flow to the micronscale, and involves flow through channels 
with dimensions on the 10s of microns scale. Fluids can be carefully manipulated with devices 
requiring low-volume of sample (picolitres to nanolitres). Advantages of microfluidic 
techniques include; low reagent, low cost, biocompatibility, integration capability and high-
throughput potential. Additionally, on-chip measurements leave the cells viable and permits 
subsequent destructive genetic sequencing. 
1.3 Biophysical characterisation techniques 
1.3.1 Overview 
Many experimental techniques have been developed for studying the mechanical properties 
of cells, these are summarised by schematics in Figure 1.1, and can be separated into three 
types; localized probing which deforms a small area of the cell, whole cell deformations, and 
simultaneously applying stress to a population of cells (102-104 cells) [6].  
Localized deformation techniques include atomic force microscopy (AFM) and magnetic 
twisting cytometry (MT). In AFM, a local deformation is induced on the surface of cell 
through contact with a sharp tip at the end of a flexible cantilever (Figure 1.1a). The deflection 




range in AFM is 10-12-10-6N, and capable of small displacements less than 1 nm [7]. This 
technique has been used to explore elastic deformation of cells and their subcellular 
components, such as the cytoskeleton, but is limited to measurements on cells that can adhere 
tightly to a substrate. Mechanical measurements are not optical and thus its combination with 
fluorescent labelling and chemical disruption of cytoskeletal filaments was used to show that 
actin filaments contribute more to cell stiffness than microtubules [8]. AFM data analysis 
requires application of elastic models, commonly the Hertz model, which rely on assumptions 
that do not account for the time-dependent and non-linear behaviour seen in cell mechanics. 
A more thorough review of the use of AFM for cell biomechanics can be found in Kumar et 
al. 2012 [9]. Magnetic twisting cytometry (MT) involves functionalised attachment of 
magnetic beads to the cell surface, a magnetic field is then applied to deform the cell via a 
twisting moment (Figure 1.1d). The applied forces and displacement are similarly small like 
in AFM (10-12-10-6N, <1 nm) [7], with bead diameters of 250 nm to 5 µm [10]. This method 
was first developed by Crick et al. (1949), and has since been used to study the cytoplasm, 
cell membrane and cytoskeleton [11]. MT has been used to study cyclic loading experiments, 
frequency range 0.2-400 Hz [12], to develop further insight into cell viscoelasticity. 
Whole cell deformations can be induced by Optical Trapping (OT) and micropipette aspiration 
(MA). Optical tweezers (laser trapping) involves aiming a laser beam at a dielectric bead of 
high refractive index attached to a cell, an attractive force between the bead and laser beam 
pulls the bead to the focal point of the trap (Figure 1.1c). For cell deformations, two variations 
of OT exist. First, two beads can be attached to opposite ends of a cell and trapped by two 
laser beams which induces cell stretching. Second, a single bead can be trapped at one end of 
the cell whilst the other end of the cell is attached to a glass plate. Induced forces are typically 
on the 10s to 100s of pN range [7]. Biological objects probed by this method must be 
sufficiently compliant that the required laser power is enough to deform the object without 
imparting radiation damage, thus OT is typically limited to cells in fluid suspension (e.g. blood 
cells). Also, non-uniform stress distributions arise from the inherent point loading at the bead 
attachment area which creates challenges when calculating mechanical parameters. An 
advancement of traditional OT is the optical stretcher OS which does not require cells to be 
attached to beads or glass [13]. Here, two lasers are diametrically shone on opposite sides of 
the cell. The laser spots are unfocused in this plane, thus high laser powers can be used without 





Figure 1.1 Schematic representations of the types of experimental techniques used for biomechanical 
characterisation of cells. Including atomic force microscopy (a), micropipette aspiration (b), optical 
trapping (c), magnetic twisting (d), shear-flow (e) and substrate stretching (f).  
Micropipette aspiration (MA) uses extracellular pressure for time-dependent studies of cell 
deformation (Figure 1.1b). An aspiration pressure (suction) is used to draw a cell into a glass 
tube (micropipette), with an inner diameter smaller than the initial cell diameter [14]. Applied 
aspiration pressure typically ranges 0.1-1000 Pa [15]. The micropipette is coated with 1% agar 
to prevent cell adhesion and pressure is maintained over a specific time period and 
deformation is monitored by optical microscopy. Models can be applied to obtain mechanical 
parameters such as elastic modulus, apparent viscosity and relaxation constants. However, the 
values derived of these parameters are very model dependent. 
The biomechanics of a population of cells can be simultaneously studied using shear-flow 
(Figure 1.1e) and substrate stretching (Figure 1.1f). Shear-flow is used to monitor the 
biomechanical response of cells by their resistance to fluid flow. This is conducted using either 
a cone-and-plate viscometer (a stationary flat plate below an inverted cone where laminar and 
turbulent flows are applied), or by parallel-plate flow where laminar flow is applied [16]. 
Substrate stretching involves adhering cells to polymeric substrates through focal adhesion 
complexes, the compliant substrate can be deformed and cell spreading, deformation and 
migration can be studied [17]. Here, forces are on the 10-100 nN range and displacements can 
be up to the mm range [7]. Additionally, the effect of changing the mechanical properties of 
the substrate on the cell response can be studied. A downfall of cell population studies, 
including shear-flow and substrate stretching, is that cell heterogeneity is largely unaccounted 




A more in-depth description of these biomechanical techniques can be found in these review 
papers [6], [7], [10]. Figure 1.2 shows a representation of the range of forces and 
displacements cells are exposed to using the previously discussed techniques, and also 
provides comparison to relevant biological processes. The forces ranges from 10-14 to ~10-7N, 
with the lowest forces imparted using optical tweezers and largest forces via substrate 
deformation. The displacement ranges from 10-10 to ~10-3 m, with AFM nanoindentation 
resulting in the smallest displacement and substrate stretching the largest displacement.  
 
Figure 1.2 The typical ranges of forces (a) and displacements (b) probed by various biomechanical 
assays, compared to biological cell and molecular interactions and length-scales. Included are; atomic 
force microscopy (AFM), optical tweezers (OT), optical stretching (OS), magnetic twisting cytometry 
(MTC), micropipette aspiration (MA) and substrate deformation (SD). Figure taken from Suresh et al. 
2007 [7].  
1.3.2 Microfluidics 
The previously discussed biomechanical techniques are often limited by being low-
throughput, where measurements are performed one cell at a time which can be time-
consuming, often resulting in a small number of cells being probed. Commonly used 
techniques such as AFM, MA and OT are well established and offer high precision 
measurements, however higher “speed” techniques are required for accurate characterisation 




flow (using microfluidics) allows for automated event capture (no preselection) and improved 
measurement throughput. Figure 1.3, taken from a review by Wyss 2015 [18], shows a 
graphical summary of biomechanical methods based on their “precision” and “speed”. 
 
Figure 1.3 A graphical representation of the “precision” of different biomechanical methods for 
probing cells compared to the “speed” (i.e. throughput). Figures (e)-(f) depict microfluidic methods 
where the arrows indicate the direction of flow. Figure taken from Wyss 2015 [18].  
Cell deformation using microfluidic techniques can be categorised as either: structure-induced 
deformation or fluid-induced deformation [19]. Structure-induced deformation involves 
passing a cell through a constriction channel with a width W smaller than the cell diameter D 
(W<D) (Figure 1.3e). From this, parameters such as cell elongation, transit time and recovery 
can be used to quantify cell stiffness. Structure-induced deformation is particularly useful for 
the study of red blood cells (RBCs) as the constriction channels mimic in vivo capillaries. 
Shelby et al. 2003 first used constriction (W<D) channels to deform malaria infected RBCs 
[20]. These type of devices can also be paired with impedance measurements, first 
demonstrated by Zheng et al. 2012 [21], eliminating the need for image analysis and instead 
using electric signals to infer mechanical properties. This allowed improved throughputs of 
~100 cells/s and parameters such as transit time, impedance amplitude ratio and impedance 
phase increase were found. Abkarian et al. 2006 correlated pressure drop due to the presence 
of a cell in a constriction channel to its stiffness by measuring the fluid-fluid interface 
displacement downstream. Measurement throughput using constriction channels (W<D) has 




adhesion between the cell membrane and channel walls. Larger and stickier cells will have a 
longer transit time, making it difficult to infer changes to stiffness. Additionally, the small 
channel diameters in such devices makes them susceptible to clogging which limits 
experimental throughput. 
Fluid-induced deformation occurs when cells are deformed by a shear or extensional 
hydrodynamic force rather than by structural confinement [23], [24], which is not affected by 
friction or adhesion between the cell and channel walls. Constriction channels with widths 
slightly larger than the cells diameter (W>D) can be used to induce shear fluid stress (Figure 
1.3g). Zheng et al. 2013 used a straight channel with W>D to deform RBCs and found shear 
fluid stress can cause stretching, tumbling and recoiling [25], showing that chemically fixed 
RBCs are less deformable. Functionally, RBCs are required to squeeze through narrow 
capillaries in the body so are naturally highly deformable. Therefore, fluid-induced shear 
stress is often not enough to deform other cell types in these geometries. Lee et al. 2009 
showed that extensional flow was more efficient for deforming cells than shear flow [26]. 
Extensional flow is due to a velocity gradient between a larger chamber and a contraction area 
in a microfluidic device. RBCs were deformed using a hyperbolic converging channel to 
create an extensional flow, they found that the same stress in extensional flow induced a higher 
degree of deformation compared to purely shear flow. 
Extensional flow deformation can also be achieved using a cross-slot geometry, consisting of 
a junction with two opposing inlets and outlets (Figure 1.3g). An extensional flow is generated 
and cells are hydrodynamically deformed at the stagnation point (SP) at the centre of the 
junction. This geometry can be used to induce high strains on cells (>50%) [27]. This method 
often requires cells to be focused to a central streamline before entering the junction, to ensure 
they are exposed to the same stress field. This can be achieved via inertial focusing [28] or 
viscoelastic focusing [29]. A technique called Deformability Cytometry (DC) has been 
developed by the Di Carlo group, utilising inertial focusing and a cross-slot geometry to 
mechanically phenotype cells, first introduced in Gossett et al. 2012 [27]. The experimental 
set-up, cell deformation and analysis of the technique is summarised by Figure 1.4. This 
technique showed a significant increase in throughput in continuous mechanical phenotyping, 
the largest reported as 20,000 cells/s [30], [31]. The applied stress field is also dependent on 
initial cell size and shape, thus initial cell size and deformability are measured independently 
and used for classification [32]. They defined deformability as a simple ratio of the major (a) 
and minor (b) axis (Figure 1.4e), density scatter plots of deformability vs initial size were used 





Figure 1.4 The principles of deformability cytometry. (a) Image of the device set up. (b) Schematic of 
the cross-slot device with inertial focusers. (c) A schematic of deformation at the stagnation point (SP) 
of the cross-slot. (d) Example high-speed image of a deformation event. (e) Definition of shape 
parameters for measuring deformability. (f) Example density scatter plot of deformability 
measurements. Reprinted  from Gossett et al. 2012 with permission from PNAS [27].  
Microfluidics techniques such as DC use high speed imaging to collect 1000s of cell 
deformation events, which in turn generates large amounts of data. This can require significant 
computational time between data collection and finished analysis. Real-Time Deformability 
Cytometry (RT-DC) was developed by the Guck group (first published in [33]), where 
microfluidic deformations are acquired continuously and analysis occurs in real-time. 
Comparatively, DC requires ~15 mins before results are available. RT-DC uses constriction 
deformations (W>D) where cells are suspended in high viscosity suspension buffers to 
increase the wall proximity induced shear forces. Cells deform to a bullet-like shape due to 
the strong velocity gradient within the channel. The throughput of RT-DC is 100 cells/s, 
however RT-DC has analysed total populations of >100,000 cells whereas DC only a few 
thousand despite the faster rate [19]. The deformations in RT-DC are relatively low compared 
to DC and are antisymmetric making the shape harder to characterise. 
RT-DC operates in the laminar flow regime where the Reynolds number 𝑅𝑒 ≈ 0.1. To find 
the associated flow fields in this system the Navier-Stokes equation must be solved, at 𝑅𝑒 ≪
1 the inertial terms can be ignored making the problem linear and time-independent. 
Comparatively, DC operates in a regime of 𝑅𝑒 ≈ 50, here inertia has a significant effect and 
flow field calculation is a challenging non-linear and time dependant problem [34]. Mietke et 
al. 2015 produced an analytical model of RT-DC and related elastic parameters back to cell 




measured under a steady state, the surface stresses on an isotropic and incompressible sphere 
in a cylindrical channel were found and used as a boundary condition to solve linear elasticity 
theory. Results agreed well with experiments using a rectangular channel (common for 
microfluidic fabrication) with identical channel pressure drop, and cells were modelled as an 
elastic sphere, a sphere with a thin elastic shell, and with added surface tension.  
They were able to calculate the elastic modulus E of cells, decoupling size from deformation. 
However, the model is only valid for small deformations. Figure 1.5 shows an example density 
scatter plot of deformability against initial size for a given cell line, overlaid isoelasticity lines 
on the scatter plot are used to divide it into areas of equal stiffness. The model was in good 
agreement with experiments on agar beads of known stiffness, however the elastic modulus 
of HL60 measured using RT-DC was 𝐸 = 1.48 ± 0.51 𝑘𝑃𝑎 which is ~9 fold bigger than using 
AFM. They discussed that the shorter timescale of RT-DC (~1 ms) was responsible for the 
difference, or that the shell properties (membrane and cytoskeletal cortex) dominate the 
system. This work shows progress in using high-speed techniques whilst also improving 
measurement precision by extracting known mechanical properties. 
 
Figure 1.5 (a) An example scatter plot of deformation against initial size (cross sectional area) for a 
HL60 cell sample. (b) Isoelasticity lines can be used to divide the scatter plot into areas of identical 
stiffness as multiples of Elastic Modulus 𝐸0. Figure taken from Otto et al. 2015 [33].  
Guillou et al. 2016 used a cross-slot device to deform cells at low strain (0.01<ε<0.18, where 
ε is the strain defined in section 3.5.3) and at low Reynolds number (Re<0.2), allowing them 
to apply an analytical model to extract mechanical parameters [35]. A viscoelastic two-
parameter power law model was used to predict the shear modulus of cells, results were further 
validated using micropipette aspiration and by comparing to dextran particles. Here, cells were 
small compared to channel size and the model was only valid for small deformations. Cells 
which did not pass through the stagnation point of the device were discarded, resulting in low 




Integration of traditional “precise” techniques with microfluidics may be capable of producing 
a system that is high-throughput and outputs mechanical properties. For instance, Guck et al. 
2005 combined continuous flow of cells through a microchannel with optical stretching 
measurements [36]. The trapping and stretching of cells using this method requires precise 
alignment of two laser fibres on each side of the microchannel, adding complexity to this 
method. Micropipette aspiration also lends itself to integration with microfluidics as a way to 
increase throughput and extract properties such as elastic modulus [37]. However, 
microchannels are commonly rectangular in shape which may reduce the validity of applying 
traditional MA models. Additionally, throughput is limited compared to other microfluidic 
techniques (such as DC and RT-DC). More detailed reviews discussing the advantages and 
disadvantages of different biomechanical assays can be found in [18], [19], [31], [38]. 
1.4 Deformation Cytometry Applications 
1.4.1 Detecting diseased states 
A principal application of mechanical phenotyping is disease diagnostics, i.e. identifying 
diseased cells based on their mechanical properties. Deformability changes have been 
identified in diseases such as cancer, sepsis [39], malaria [40], diabetes [41] and sickle cell 
anaemia [42]. Cancer is a common target of investigation as studies repeatedly show that 
malignant phenotypes are have reduced stiffness than their healthy counterparts [7]. This is 
thought to be caused by a more disorganised cytoskeletal so that cancerous cells can more 
easily invade surrounding tissue and metastasise. The stiffness/softness of cells can be 
quantified in a number of ways such as measuring strains induced by an applied force, to 
extracting mechanical parameters such as elastic modulus (where a reduced modulus indicates 
cell softening). Cross et al. 2007 showed that malignant cells were >70% softer than cells from 
normal tissue by using AFM to extract single cell elastic moduli [43]. Often, diseased cells 
can equate to a small population of a sample and thus high-throughput screening is require for 
mechanical phenotyping. Microfluidic mechanical phenotyping has been able to distinguish 
cells with a variety of diseases. 
Tse et al. 2013 used DC to identify disseminated tumour cells in pleural effusion samples from 
patients. Scatter plots of initial diameter against deformability showed two distinct regions 
corresponding to healthy leukocytes and malignant pleural cells. From these plots, a diagnostic 
scoring system was developed to categorise deformability. Cells were allocated a number from 
1-10 based on their position on the graph, 1 indicates least likely to be malignant and 10 
indicates most likely to be malignant. Regions 1-6 and 9-10 contained 63% of the cell 
population and identified the cell type with 100% accuracy, cells in region 7-8 were more 




et al. 2017 combined microfluidic vortex trapping and DC to isolate and characterise rare 
circulating tumours cells (CTCs) from patient blood samples. Compared to samples from 
healthy patients, cancerous samples showed a cell population with increased size and 
deformability confirmed as CTCs by immunofluorescence. 
Microfluidic studies have also been used to identify differences in deformability of malignant 
cell lines and those from different stages of cancer progression. This includes; breast cancer 
cell lines [36], [44], prostate cancer cell lines [44], pancreatic cancer cell lines [45], bone 
cancer [46] and brain cancer cells [47]. 
1.4.2 Sensitivity to subcellular changes 
The sensitivity of DC has been tested by using various drugs to alter the internal structure of 
the cell, which includes destabilising or enhancing various cytoskeletal filaments, disrupting 
nuclear structure and inhibiting motor proteins. Microfluidic techniques have been used to 
probe the effect of deformability due to changes in; actin [27], [35], [48]–[50], microtubules 
[27], [50], intermediate filaments [27], [30], nuclear chromatin [48], [49], [51], and inhibition 
of motor proteins including Myosin II [27], [32], [50], [52]. 
Some studies were able to detect specific subcellular changes whereas some were not, showing 
that different microfluidic assays may be more/less sensitive to specific internal changes. 
Gossett et al. 2012 used DC (inertia-dominant and high strain deformations) to show 
deformability increases due to lymphocyte activation and stem cell pluripotency, states that 
are characterised by loose open chromatin structures [27]. However, no changes in 
deformability were detected due to treatment with several cytoskeletal altering drugs. Guillou 
et al. 2016 also used a cross-slot device but in a shear-dominant and low strain regime. This 
regime was able to detect increased cell deformability due to actin destabilisation using the 
drug cytochalasin D [35]. Otto et al. 2015 used RT-DC (shear-dominant and low strain) 
constriction induced deformations (W>D) and found significant deformability changes due to 
cytoskeletal alterations [33]. They also saw no significant changes in deformability due to 
nuclear structural changes. Thus, the sensitivity of microfluidic deformation cytometry is 
highly dependent on the device geometry used and the flow regime utilised. 
Previous works limit the measurement range to either low or high relative strains, or apply 
stresses dominated by either shear force or inertial force [29], [35], [53], [54]. The scope of 
this thesis investigates the sensitivity of DC from low to high strain in shear and inertial flows 
using a single device geometry [1]. Compared to previous microfluidics assays, by probing 
over a wide range of conditions we could infer more physical understanding of how 
subcellular changes are coupled to whole cell mechanics. This would identify which 




being tailored towards their application. The shear-regime was also used to introduce new 
parameters to describe cell response, allowing improved multiparameter characterisation on a 
single-cell level which can infer heterogeneous responses. 
1.4.3 DC for non-endocytic uptake of nanoparticles 
Cell deformation may also affect the cell membrane such that stretching can induce transient 
membrane pores, allowing materials to flow in and out of the cell. This phenomenon can be 
utilised for intracellular delivery of macromolecules and nanoparticles (NPs). This has a range 
of applications, including; RNA and DNA delivery for gene therapy [55], protein delivery 
[56], various NPs for cancer therapies [57], intracellular labelling [58], [59], and single-
molecule tracking [60]. For example, Quantum Dots (QDs) are colloidal semiconducting 
nanoparticles with a range of uses in the fields of bioimaging and biosensing. Their size-
tuneable broad absorption spectra, narrow emission profiles, photostability and brightness 
compared to traditional fluorophores, makes them appealing. However, usually the cell 
membrane is mostly impermeable to nanoparticles and their uptake into cells occurs 
predominantly via endocytosis.  
Methods exist to either release QDs from enclosed endosomes, or to deliver them directly to 
the cytosol. Labelling QDs with cell-penetrating peptides can facilitate direct uptake [61], 
however this requires successful dual conjugation. Electroporation involves exposing cells to 
an electric field to increase membrane permeability, and has shown cytosolic uptake of QDs 
[62]. However, the electric field can cause QDs to aggregate and reduce cell viability. 
Sonoporation is a similar technique utilising ultrasound instead of electric fields, and has been 
used for macromolecule and nanoparticle delivery [63]. Microinjection can directly deliver 
QDs to the cytoplasm, however this technique is extremely low throughput [64]. 
More recently, various types of microfluidic DC assays have achieved non-endocytic 
macromolecule and NP uptake. Langer and Jensen pioneered this technique, first using 
microfluidic constriction channels (W<D) to achieve cytosolic delivery of QDs to cells [65]. 
This cell squeezing method creates transient membrane pores which facilitate passive 
diffusion, the initial study found ~35% delivery efficiency whilst maintaining 80-90% cell 
viability. Figure 1.6 shows their experimental set-up and initial results for increased QD 
uptake for smaller constriction channels. They have since used this method to deliver a range 
of materials into 11 cell types [66], [67], including carbon nanotubes, proteins and siRNA. 
Sharei et al. 2013 showed increased delivery efficiency with increased cell speeds, reduced 
constriction dimensions, and increased number of constrictions. Additionally, 3kDa dextran 
beads were added at varying time points after microfluidic treatment showing that 70-90% of 





Figure 1.6 Constriction microfluidics for increased QD uptake in cells. (a) Schematic of the device. (b) 
Schematic of theorised method of uptake due to transient pore formation. (c) Confocal fluorescence 
images of cells deformed through different microfluidic constrictions with QDs. Reprinted from. 
Reprinted with permission from Lee et al. 2012 [65]. Copyright (2019) American Chemical Society. 
Chung’s group adapted their inertial microfluidic cell stretcher (iMCS) for intracellular 
delivery, here cells are deformed by contact with the device wall at a T-junction in an inertial  
flow regime (Re>100) [54]. A sharp tip was added to the contact area of the T-junction wall, 
to increase the uptake efficiency [68]. Figure 1.7 shows images of the microfluidic device and 
results for increased uptake of 3 kDa dextran particles using the iMCS. Uptake of 3kDa and 
70kDa beads was successfully demonstrated to mimic protein delivery. They also showed 
successful cytosolic uptake of various DNA origami structures achieving between 30% and 
55% delivery efficiencies. More recently, this group have opted to use a cross-slot device in 
an inertial flow regime (similar to DC by the Di Carlo group) which they refer to as a 
Hydroporator. They achieved delivery of many macromolecules to 10 cell types, with up to 
90% delivery efficiency and a throughput >1.6 million cells/min. This included testing various 
sizes of Dextran beads and achieving ~60% delivery efficiency even at 2000 kDa (~50 nm). 
DNA origami structures were successfully delivered and maintained structural integrity for 
~1 hr afterwards.  
Deformation cytometry can achieve cytosolic uptake of macromolecules and nanoparticles of 
various shapes and sizes. The advantages of deformation cytometry include; high-throughput, 







Figure 1.7 Details of the inertial microfluidic cell hydroporator for intracellular delivery of 
nanoparticles (a) Schematic of the T-junction chip design. (b) Bright field image of a cell deforming in 
the device. (c) Successful delivery of fluorescent dextran into cells using the system. Figure taken from. 
Reprinted with permission from Deng et al. 2018 [68]. Copyright (2019) American Chemical Society. 
1.4.4 Combining DC and fluorescence measurements 
DC has shown high-throughput and sensitivity to subcellular and pathological changes. 
However, using bright-field imaging alone does not provide the same specificity as traditional 
flow cytometers which can detect specific molecular markers using fluorescent labelling. 
Recent studies are working to combine mechanical phenotyping using DC with fluorescence 
measurements to identify how substructure affects whole cell deformation, and for improved 
classification rates by multiparameter analysis [69]. 
Hodgson et al. 2017 combined constriction channel deformation (W<D) with nuclear staining 
to study the nuclear deformability of embryonic stem cells [49]. Cells were imaged before, 
during and after compression using frame rates of 30-100 fps, and the traverse and axial strain 
of the cell nucleus was found. They also studied changes in nuclear deformability due to 
treatment with actin depolymeriser Cytochalasin D (CytoD) and chromatin decondenser 
Trichostatin A (TSA). The Guck group recently combined RT-DC with 1D imaging-
fluorescence (RT-FDC) [69]. Lasers excite in a light sheet perpendicular to the channel axis 
such that cells pass through the light-sheet at constant speed, this allows measure of subcellular 
distribution of fluorophores in the direction of flow in the channel. Cells deform through a 
constriction (W>D) and pass through a 3 µm wide light sheet at constant speed, being excited 
by three lasers with photodiodes to measure fluorescence. This method allows identification 
of subpopulations, such as mitotic cells, and direct correlation to deformability. This method 
only measured fluorescence in 1D and no 2D or 3D (z-stack) fluorescence image accompanies 
the bright field image. Recently, the Goda research group have made progress in combining 
high speed confocal and light-sheet fluorescence of cells travelling up to >1 m/s [70], [71]. 
Confocal fluorescence imaging cytometry has been demonstrated for cells travelling up to 2 
m/s, with two fluorescent channels including a DNA stain [70]. This allows multiple parameter 




Traditional imaging flow cytometers have much lower throughput than non-imaging, using 
light-sheet excitation they improved fluorescence intensity 10 fold and achieved throughput 
of ~10,000 cells/s [71]. However, these techniques are yet to incorporate deformation studies 
which would elucidate further biomechanical information and potentially improve 
classification rates. 
1.5 Scope of project and thesis outline 
The scope of the project was to investigate the use of deformation cytometry using a cross-
slot device for characterisation of cell mechanical properties in shear and inertial flow regimes. 
This included assays on cells treated with various drugs to alter the substructure and a 
colorectal cancer model system. Additional applications were also explored, such as the ability 
of DC for cytosolic uptake of quantum dots into cells.  
Chapter 2 of this thesis includes theoretical background and Chapter 3 the methodologies 
used to undertake the research. The deformation cytometry results are next reported in 
Chapters 4 to 7. Finally, Chapter 8 provides a conclusion and discusses future work such as 
integration of DC with other phenotyping techniques. This includes a comparison of Raman 
Spectroscopy data performed on the same CRC model system. Below is a short description of 
each results chapter. 
Chapter 4 describes the optimisation of the cross-slot device, including defining shear and 
inertial regime deformations using HL60 (human leukaemia) cells. Cell deformations were 
tracked as a function of time allowing multiple deformation and relaxation parameters to be 
extracted. A Kelvin-Voigt model was fitted to the strain curve to extract an elastic modulus. 
The advantages of bulk-averaging vs single cell analysis are also explored using the 
multiparameter dataset. 
Chapter 5 involves probing mechanical changes due to subcellular alterations in the shear 
and inertial regimes. This includes; actin destabilisation using Latrunculin A (LatA), 
microtubule destabilisation using Combretastatin A4 (CA4), and chromatin decondensation 
using Trichostatin A (TSA). Deformation tracking and single cell analysis optimised in 
Chapter 4 were also applied to the datasets. 
Chapter 6 focuses on mechanical changes due to colorectal cancer progression. This is done 
using a model system of three CRC cell lines (SW480, HT29 and SW620) representing 
different stages of disease progression. Deformation cytometry assays were performed in 
shear and inertial regimes, and deformation tracking was used for single-cell multiparameter 





Chapter 7 explores other applications of microfluidic cell deformation. Firstly, cytosolic 
uptake of quantum dots (QDs) into MCF7 cells is probed as a function of flow rate in shear 
and inertial flow regimes. Secondly, preliminary results are presented for using microfluidic 





























2 Theory and Background 
In this thesis, deformation cytometry is used primarily for mechanical phenotyping of single 
cells. This includes studying the effects of subcellular perturbations to whole cell mechanical 
response, and mechanical changes as a function of colorectal cancer progression. The 
introduction chapter provided a general introduction to advantages of microfluidics for 
mechanical phenotyping compared to other techniques, as well as a literature review on the 
diagnostic applications of mechanical phenotyping. 
This chapter includes a deeper background into subcellular structure and metastatic 
progression, and how these relate to mechanical phenotype. The principles and main equations 
relating to microfluidics are also described. Finally, an overview of models of cell mechanics 
is provided as well as details of the Kelvin-Voigt model used throughout the thesis. 
2.1 Cell Structure 
2.1.1 Overview 
The cell is considered the basic biological unit which makes up all living organisms. The two 
main types of cell are prokaryotic and eukaryotic. Prokaryotes are usually single living cells 
and have the simplest internal structure. They are thought to have been the oldest living 
organisms, the two types of prokaryote are archaea and bacteria which are usually between 1 
µm and 10 µm in size. Eukaryotic cells are vastly more complex, generally bigger, capable of 
forming multicellular organisms (unlike most prokaryotes) and include fungi, plant and animal 
cells. For example, the human body is made up of ~37.2 trillion cells of ~200 different kinds 
of cells. Individually many cell types have a size of ~10-20 µm, however can be even smaller 
such as red blood cells 6-8 µm, and much larger such as female egg cells (oocytes) ≈120 µm. 
All cells are enclosed by the cell membrane, which keeps the key cellular components 
internalised. The cell membrane consists of a lipid bilayer with embedded membrane proteins, 
and controls movement of ions and molecules in and out of the cell. Eukaryote structure is 
more complex due to the presence of additional internal lipid membranes which enclose 
“organelles” from the rest of the internal cytoplasm. Additionally, eukaryotes contain a 
nucleus where DNA is contained and arranged into chromosomes. The material contained 
within a cell, apart from the nucleus, is referred to as the cytoplasm. The aqueous component 
of the cytoplasm, where all the organelles are suspended, is referred to as the cytosol. 
Prokaryotes do not contain a nucleus or enclosed organelles, any DNA and proteins are found 
within the cytosol and contained by the cell membrane. The other main organelles within 




2.1.2 The Cell Membrane 
Cell membranes mainly consist of a phospholipid bilayer typically ~7 nm thick, held together 
mainly by non-covalent interactions and are dynamic fluid structures with the lipids able to 
diffuse freely within the plane of the membrane. The other main components of the membrane 
are various lipids, cholesterol and embedded proteins. The three main types of membrane 
protein are: integral proteins, peripheral proteins, and lipid-anchored proteins, which are 
important for a variety of biological activities [72]. Integral proteins span the membrane and 
are anchored within it, one example of a function of integral proteins are ion channels which 
can be chemically or mechanically triggered to allow ions to cross the membrane. Lipid 
anchored proteins are covalently bonded to lipid molecules which anchor the protein and are 
located on either side of the membrane surface. Peripheral proteins are attached to integral 
membrane proteins or the lipid bilayer periphery but interactions are temporary. 
Through membrane proteins, the cell membrane anchors to the cytoskeleton which provides 
cell shape and integrity, and also attaches cells to the extracellular matrix (ECM) and other 
cells to form tissues. The membrane itself is a viscous fluid-like substance contributing to cell 
viscosity, bending resistance and incompressibility. However, as discussed in the next section 
the cytoskeleton is thought to be the main contributor to cell mechanics [73]. 
2.1.3 The Cytoskeleton 
 
Figure 2.1 A fluorescent image of a cell with labelled cytoskeletal filaments: actin filaments (blue), 
microtubules (green) and intermediate filaments (red), Scale bar 10 µm. Image taken from [74].  
The cell membrane alone does not provide enough structural integrity to maintain cell shape 




the cytoplasm, known as “the cytoskeleton”, are responsible for maintaining cell shape, 
internalised organisation of organelles, cell division and cell movement. 
The cytoskeleton is highly dynamic and constantly reorganises itself to change the shape and 
arrangement of the cell. This depends on the environment; various signalling pathways can 
trigger restructure of the cytoskeleton. An example of this is the continuous cell cycle in which 
DNA is replicated and cells divide. The cytoskeleton also plays a key role in cell movement, 
vital for tissue development and wound healing. Until recently it was thought that the 
cytoskeleton was only present in eukaryotic cells, however some bacteria have been found to 
have primitive cytoskeletal components [75]. The cytoskeleton of eukaryotic cells consists of 
three types of filament; microtubules, intermediate filaments and actin filaments. Figure 2.1 
shows an example fluorescent image of the three filaments. The three filaments play different 
mechanical and functional roles within the cell, discussed in the following sections. 
 
Figure 2.2 A simplified schematic of the structure of the three cytoskeletal filaments: actin filaments, 
microtubules and intermediate filaments. Image taken from [76] under the Creative Commons 
Attribution License.  
Microfilaments 
Microfilaments are also referred to as actin filaments of F-actin, they have a diameter of 7-10 
nm, which is the smallest of the three cytoskeletal filaments in eukaryotic cells. Actin 
filaments are formed by polymerisation of actin monomers (G-actin which is ~42 kDa) which 




is shown by Figure 2.2a). Actin filaments have polarity, the two ends of a filament are labelled 
the barbed (or +) and pointed (or -) ends. The barbed end has preferential addition of G-actin 
and the pointed end preferential dissociation [77]. When the rate of polymerisation at the 
barbed end matches the rate of depolymerisation at the pointed end, the filaments are referred 
to as “treadmilling” with the appearance of moving forward. 
The persistence length 𝑙𝑝 is used to define the stiffness of cytoskeletal polymer filaments. If 
the filament has a length below the 𝑙𝑝 it can be modelled as a flexible/elastic rod, whereas if 
the length is above the 𝑙𝑝 it can only be modelled statistically as a 3D random walk. The 
persistence length of F-actin is 𝑙𝑝 = 3 − 17 μ𝑚, which is more than for intermediate filaments 
(200 nm-1 µm) and less than for microtubules (4-8 mm) [78]. However, microfilaments form 
bundles and networks which help to regulate cell shape and give cells structural rigidity. Many 
types of actin binding cross-linkers facilitate the orientation and spacing of bundles and 
networks, mainly found at the cell periphery (Figure 2.1). Myosin motor proteins are ATP 
dependent and move along actin filaments, they are able to exert tension in the cell and 
transport intracellular vesicles. For instance, stress fibers are actin bundles with a highly 
regulated acto-myosin structure able to provide contractile forces for functions such as cell 
adhesion, motility and morphogenesis. 
Actin microfilaments also form a cortex at the cell periphery, referred to as the cell cortex or 
actin cortex, which is ~100 nm thick [79]. The cortex consists of a network of microfilaments 
and myosin motors which are attached to the lipid membrane via membrane-anchoring 
proteins. This structure is mechanically rigid and provides cell shape, however the membrane 
fluidity results in rapid turnover of protein constituents so the cortex is also plastic in nature. 
Thus, the lipid membrane composition and microfilaments are coupled and changes to either 
can result in whole cell mechanical changes. 
Microtubules 
Microtubules have a diameter of 25 nm and their length can vary from 0.2 µm to 25 µm, they 
have the largest diameter of the three cytoskeletal filaments. These filaments consist of α and 
β tubulin dimers which polymerise end-to-end to form a helical filament structure, with a pitch 
of approximately 13 dimers [80]. Figure 2.2b shows a schematic of a microtubule where 
protofilaments self-assemble to form the cylindrical filament.  
Figure 2.1b shows that microtubules radiate away from the cellular nucleus, this helps 
maintain cellular structure and provides transport mechanisms from the nucleus to the rest of 
the cell. An organelle called the centrosome is the primary microtubule organising centre, 




mainly by two motor proteins: kinesin and dynein [81]. Both motor proteins can only move 
along the filament in one direction. The direction is inherently controlled by filament polarity, 
the ends of each protofilament have either α or β subunits. 
Microtubules are the stiffest of the three cytoskeletal filaments, with 𝑙𝑝 = 4 − 8 𝑚𝑚 [78]. 
However, they are still thought to be less important to whole cell mechanics compared to 
microfilaments. Microtubules are individually stiffer, but microfilaments can be highly cross-
linked providing more mechanical rigidity. 
Intermediate Filaments 
Intermediate filaments have a diameter of 10-24 nm (“intermediate” in size compared to the 
other two cytoskeletal filaments). Microfilaments and microtubules consist of single types of 
proteins (G-actin and tubulin), whereas 70 different genes have been identified for coding 
various intermediate filament proteins. Six subcategories of intermediate filaments exist based 
on their amino acid sequence and protein structure. Their final structure consists of eight 
protofilaments arranged in a rope-like structure (Figure 2.2c). They are assembled to form 
antiparallel tetramers, resulting in them not having distinct plus and minus ends (unlike 
microfilaments and microtubules which are highly polar).  
Intermediate filaments are less dynamic than microfilaments and microtubules and do not 
illustrate “treadmilling”, they are generally more stable and uninvolved in cell motility. 
However, phosphorylation regulates their assembly and disassembly. They have various roles 
within the cell including supporting the cell membrane and fixing organelles in place within 
the cytosol. Vimentin and keratin are examples of cytoplasmic intermediate filaments. Lamin 
is an example of a nuclear dwelling intermediate filament, a fibrous protein which provides 
the nucleus with structure and mechanical rigidity. These filaments are disassembled and 
reorganised during mitosis. 
The persistence length of intermediate filaments in 𝑙𝑝 = 200 𝑛𝑚 − 1 𝜇𝑚, the lowest of all the 
cytoskeletal filaments [78]. However, microfilaments and microtubules are more brittle and 
rupture under strains ~10% whereas intermediate filaments can withstand strains of ~200% 
[82]. This behaviour is attributed to the hierarchical structure of intermediate filaments that 
permits unfolding of subunits without rupturing the filament. Figure 2.1 shows that actin 
filaments are located at the cell periphery forming a cortex, which is mainly responsible for 
resisting stresses, the nature of the cortex allows cytoplasmic flow above a critical strain. 
Intermediate filaments maintain cell integrity in such cases by being sufficiently flexible to 
allow deformations without making the cytoskeleton too rigid or brittle, whilst still preventing 




2.1.4 The Nucleus 
Most eukaryotic cells have a nucleus containing nearly all of the cells’ genetic material, a 
small amount is contained in the mitochondria. The nucleus is the largest organelle and its 
mechanical properties can influence measurements of whole cell stiffness. The diameter of 
most mono-nucleated mammalian cells is 5-20 µm [84]. The nucleus is bound by two lipid 
bilayers, known as the nuclear envelope. The space between the layers is ~20-40 nm and 
known as the perinuclear space. The nuclear envelope isolates the contained genetic material 
from the cytoplasm and prevents passage of large molecules. Nuclear pores are embedded 
across both membranes and regulate transport of molecules across the envelope. The nuclear 
lamina is a fibrous network containing lamins (an intermediate filament) and membrane 
proteins, located on the inner surface of the inner nuclear membrane. An internal network 
provides the nucleus with mechanical support and helps to regulate DNA replication and 
mitosis. A looser external network forms outside of the nuclear envelope, providing additional 
support by binding to the cytoskeleton. The nuclear lamina is part of the nuclear matrix, which 
is the network within the nucleus which is comparable to the whole cell cytoskeleton. 
 
Figure 2.3 Schematic showing the main structure of the eukaryotic cell nucleus. Taken from [85].  
Chromosomes are organised as DNA-protein complexes called chromatin. There are two types 
of chromatin: euchromatin which is less compact and contains frequently used genes, and 
hetero chromatin which is denser and contains infrequently transcribed genes. Nuclear 
stiffness is known to be mostly dependent on the structure of nuclear lamins and chromatin. 
Many membraneless structures also reside within the nucleus, called nuclear bodies, the 
largest being the nucleolus which synthesises rRNA and assembles ribosomes.  
The mechanical properties of cells is dominated by the nucleus during physiological 
deformations, such as cell migration and movement through narrow capillaries. The nuclear 




bodies) all affect the stiffness. For example, during differentiation stem cells increase 
expression of proteins in the nuclear envelope and modify chromatin structure leading to 
increased stiffness [86]. Also, drugs such as Trichostatin A lead to decondensed chromatin 
which softens the nucleus [49], [87], [88]. The structure of the nucleus is also coupled to the 
cytoskeleton, loss of nuclear lamins has led to changes in cytoskeletal structure and reduced 
stiffness [89]. During interphase the nucleus can be 2-10 fold stiffer than the cytoplasmic areas 
of the cell, with measured elastic moduli between ~1-10 kPa (values vary due to cell type and 
experimental technique) [90], [91]. Under an applied stress, nuclear stiffness is mediated by 
the structure of lamins (generally closer to nuclear periphery) and the nuclear interior 
(chromatin structure and nuclear matrix). The nuclear lamina behaves like an active element 
whereas the nuclear interior a compressible viscoelastic material, also exhibiting strain-
stiffening under compression [92].  
The main techniques used to probe nuclear stiffness are atomic force microscopy (AFM), 
micropipette aspiration (MA) and microrheology [93], [94]. Both AFM and MA can be 
performed on isolated nuclei although the structure can be damaged during the initial isolation 
process. The techniques can also be performed on intact cells, however results can be skewed 
by the surrounding cytoplasm. Intact cells can also be used with a disrupted cytoskeleton to 
more accurately capture nuclear properties [92]. Tensile forces can transmit stress onto the 
nucleus via the cytoskeleton so this method loses that information. Comparatively, 
microrheology can be used to study local properties from within the nuclear interior. Active 
measurements involved inserting ~500-1000 nm magnetic beads into the nucleus, then 
applying a controlled force and inferring properties from the bead displacement. Downsides 
of this are that microinjection of these relatively large beads can disrupt the nuclear structure. 
Passive measurements use smaller beads (~100 nm) to compensate this, and measure the 
Brownian motion of the beads due to thermal fluctuations to infer stiffness. The smaller beads 
are less disruptive, however measurements are highly subject to local variations (i.e. a bead 
less embedded in the matrix will move more). 
2.1.5 The Cell Cycle 
The cell cycle is the process within a cell where DNA is replicated and the cell contents are 
divided onto two daughter cells. The cell cycle of eukaryotic cells has two basic parts called 
mitosis and interphase [95]. Mitosis is the process of nuclear division and eventual cell 
division (known as cytokinesis), interphase is the period between mitosis events where cell 
growth and DNA replication occur. A complete cell cycle is typically 24 hr (depending on cell 
type) and the mitosis phase ~1 hr, meaning dividing cells are in interphase 95% of the time. 




synthesis occurs during one portion of interphase, meaning the cell cycle can be described by 
four distinct phases, summarised by the schematic in Figure 2.4a. 
 
Figure 2.4 (a) A simplified schematic of the four main phases of the cell cycle. (b) A schematic of the 
subphases during mitosis which results in cell division (cytokinesis).  
G1 (gap 1) phase is the gap between cytokinesis (end of mitosis phase) and the beginning of 
DNA replication, however the cell remains metabolically active and growth occurs. Next is 
the S (synthesis) phase, this is when DNA replication occurs. The G2 (gap 2 ) phase signals 
the completion of DNA synthesis, the cell continues to grow and proteins are synthesised in 
preparation for mitosis. G1, S and G2 occur during interphase and the time spent in each phase 
is cell dependent. The M phase (mitosis) is described by subphases, summarised by the 
schematic in Figure 2.4b. Immediately after interphase ends, the cell enters prophase and 




down allowing microtubules to invade the nuclear space and form the mitotic spindle. The 
mitotic spindle is a cytoskeletal structure (composed mostly of microtubules and other 
proteins) which works to separate sister chromatids (identical copies of chromosomes). The 
cell then enters metaphase, the two centrosomes (locates at opposite ends of the spindle) work 
to pull the chromosomes to opposite ends of the cell. The chromosomes align along the 
“metaphase plate” at the midline of the cell. Anaphase then results in the chromatids being 
cleaved and separated so that a copy of each chromosome is at opposite ends of the cell, 
Telophase then signals the nuclear membrane to reform into two nuclei within the cell. Finally, 
cytokinesis occurs via Myosin II and actin forming a ring which contracts to cleave the cell 
into two daughter cells. 
Many adult eukaryotic cells cease division (e.g. nerve cells) or divide occasionally via 
signalling pathways when new cells are required to replace lost or damaged cells (e.g. skin 
fibroblasts).  These cells exit the G1 phase and enter the G0 phase, which is a quiescent 
(dormant) stage where cells remain metabolically active but do not proliferate. The cell cycle 
is regulated by extracellular growth factors as opposed to availability of nutrients. 
Figure 2.4 shows that the subcellular structure of cells is altered greatly throughout the cell 
cycle, particularly during mitosis. This results in changes in cell stiffness depending on cell 
cycle phase. Otto et al. 2015 chemically synthesised HL60 cells at the four phases and used 
microfluidic RT-DC to measure the cell deformability [96]. They found that cell size and 
deformability could distinguish the four phases, particularly cells in G2 had increased 
deformability compared to M. Similar deformability’s were found for M, G1 and S, with M 
being the stiffest, however the cell size halves after mitosis (M-S) and then increases again 
(SG1). Fluorescence-activated cell sorting (FACs) has traditionally been unable to separate 
G2 and M as it relies on DNA stain, and both phases have the same total DNA content. 
Therefore, deformation cytometry shows promise as a label free method for studying the cell 
cycle.  
Discussion of the cell cycle often focuses on structural changes in microtubules (mitotic 
spindle formation) and nucleus (condensing chromatin and nuclear division), however the 
actin structure also changes significantly. Actin has a key role in early mitosis, it initiates cell 
rounding by forming a cortex (adherent cells must become rounded in order to divide during 
cytokinesis) [97].  Also, Matze et al. 2001 used AFM to study the actin stiffness before and 
after formation of the cleavage furrow, the actin-Myosin II contractile ring which forms to 
cleave the cell during cytokinesis. They showed a significance increase of actin in this region 





2.2 Cancer cell progression and mechanical changes 
2.2.1 Cancer and Metastasis 
The staple of a cancerous cell is uncontrolled continuous proliferation, whereas a normal cell 
has controlled proliferation. This continuous proliferation arises due to mutations in genes, 
however multiple specific mutations are required for a cell to become cancerous. Two basic 
types of mutation are required, firstly in systems which promote cell growth and secondly in 
safeguarding systems preventing unwanted cell growth. During mitosis DNA is replicated and 
mistakes naturally occur, causing mutations. However, the relative number of mistakes is 
extremely low and cells have safeguarding mechanisms to repair DNA. Usually, if cell DNA 
is irreparably damaged then cell death is triggered (apoptosis). Environmental factors 
(carcinogens) and genetic factors cause mutations. Hence, the likelihood of the multiple 
mutations required for cancer increases with age. 
Once mutations occur in multiple genes associated with cell growth and multiple genes 
associated with safeguarding genes, which would usually induce apoptosis, a cancerous 
growth (primary tumour) will occur. Another requirement for tumour growth, is access to a 
blood supply. For a mass of cancer cells to continue growing, additional mutations must occur 
to promote the growth of new blood vessels or else the cells will starve (necrosis). Cancer next 
becomes metastatic when cells from the primary tumour are able to enter the blood stream or 
the lymphatic system. This leads to secondary cancerous growths in other regions of the body. 
For metastases to occur, a cancerous cell must be able to break away from the primary tumour 
and move into a blood vessel or lymph node. This process is not well understood, theory 
suggests the cells may begin to produce an enzyme that destroys surrounding membranes and 
structures separating the tumour from the blood and lymph. Additionally, for cancerous cells 
to move to new locations their mechanical structure may change to increase their 
deformability. Therefore, cell deformability is a marker for cancer cell progression. 
2.2.2 Colorectal Cancer  
Colorectal cancer (CRC) is the third most common in the UK for both males and females, 
there are around 41,700 new cases each year in the UK [98], [99]. The five year survival rate 
for early stage diagnosis (where the primary tumour is contained within the bowel lining) is 
93.2%, this drops drastically to 6.6% for late stage diagnosis when the tumour has metastasised 
to different parts of the body [100]. Therefore, improvements are needed for ensuring early 
stage diagnosis and also for treatment of advanced stages of CRC. This section will detail how 




The interior of the colon is covered in “crypts”. The surface is covered by a single layer of 
epithelial cells that facilities salt and water absorption. Epithelial stem cells reside at the 
bottom of the crypts, these cells proliferate in a controlled way and move toward the colon 
surface to replenish cells at the surface when they die. When mutations occur the epithelial 
cells may begin to proliferate continuously and form a mass called a polyp which protrudes 
into the interior of the colon. Most colon cancers originate from cells in polyps. 
The majority of progressed colon cancers show examples of multiple mutations in genes 
associated with promotion of cell growth and safeguarding methods to prevent cell growth. 
The earliest mutations are found in both copies of the gene APC [101]. APC is responsible for 
a growth factor pathway, when both copies are mutated the APC proteins turn on growth 
factors even when no signalling occurs to signal proliferation being required. Cells in the 
epithelial lining begin to proliferate, forming a “nest” of pre-cancerous cells. Cells lacking 
APC protein also show many more mistakes being made during mitosis, therefore APC 
mutations lead to both growth advantage and an increase in subsequent genetic mutations. 
However, APC mutation alone is not enough to lead to cancer metastasis due to additional 
safeguarding systems. In half of polyps a second mutation called KRAS was responsible for 
progression from cell nest to polyp [102]. This mutation can cause growth factor pathways to 
be permanently on. Mutations in two APC genes and one KRAS can form a polyp. A polyp is 
still termed pre-cancerous and further mutations are required for tumour progression and 
metastasis. At least 7 mutations are required for most colon epithelial cancers to progress to a 
metastatic stage [103]. Figure 2.5 shows a schematic outlining the genetic mutations which 
can result in a pre-cancerous polyp developing into an adenocarcinoma and then 
metastasising. 
 
Figure 2.5 Schematic describing progression from normal epithelial crypts through to colorectal 
adenocarcinoma to metastasis, including common genetic mutations towards promotion of cell growth 
and loss of safeguarding methods which lead to CRC progression. Image taken from [104]. 
Colon cancer progression is described by the Dukes system, different stages are identified by 




tumour cells have entered the lymphatic system. Staging helps to determine what treatment is 
suitable i.e. surgical methods for polyp removal, chemotherapy and/or radiotherapy. The 
stages range from a polyp (Duke’s stage A), to detectable metastasis stage (Duke’s stage D). 
The most common location for a secondary metastatic tumour is the liver. Chemotherapy and 
radiotherapy are widely used for treating advanced cancerous tumours, however the rapid 
mutations in cancer cells render some of them resistant to these treatments [105]. They do this 
by: blocking entry of a drug into the cell, enhancing systems that repair DNA damage and 
disabling enzymes required to activate the therapeutic drugs. 
2.2.3 Model System 
Three colorectal cancer cell lines, originating from different tumour stages, were chosen to 
study changes in cell deformability due to CRC progression. Traditionally, the Duke’s staging 
system is used to classify CRC stages but the TNM cancer staging system is used more widely 
for all cancer types. TNM provides three numbers to classify the stage: T refers to the size of 
the primary tumour, N the number of nearby cancerous lymph nodes and M the amount of 
metastasis. SW480 cells derive from a primary adenocarcinoma corresponding to Duke’s 
stage B, which is equivalent to T2-3 N0 M0. SW620 cells derive from a secondary tumour 
from the lymph node of the same patient (Duke’s stage C and T2-4 N1 M0). The SW480 cells 
were isolated in 1976 from the colon of a 50 year old male, with the SW620 cells isolated 
from the secondary lymph node tumour a year later [106]–[108]. These two cell lines are an 
ideal model of progression as they derive from one patient, eliminating any metastasis 
variability due to variations between patients. 
HT29 was the third CRC cell line studied, it is a Duke’s stage C human colon adenocarcinoma 
(T2-3 N1 M0) from a 44 year old female isolated in 1964 [109]. This cell line represents an 
intermediate stage between primary SW480 cells and the secondary SW620 cells, so the three 
together are ideal for studying progression. Ahmed et al. 2015 has a comprehensive study of 
the genetics and epigenetics of CRC cell lines, including those of SW480, SW620 and HT29 
[110].  Figure 2.6 shows a schematic outlining the Duke’s stages of the CRC adenocarcinoma 
model system. 
Several works report that the secondary SW620 cells have up-regulated genes associated with 
cytoskeletal changes, which accompanied increased motility, enhanced invasion potential, 
reduced adhesion and higher proliferation compared to the primary SW480 [111]–[115]. 
Tsikritis et al. 2015 [116] and Palmieri et al. 2015 [117] both used AFM to study the 
mechanical properties of SW480 and SW620. They found that the progressed SW620 cells 
were softer and insinuated this may be due to changes in the actin cytoskeleton. Gala de Pablo 




the three for the model system studied here [2]. They found a correlation with stage 
advancement and lower lipid content and higher lactate content. To the best of our knowledge 
microfluidic deformation assays have not been previously used to mechanically phenotype 
SW480, HT29 and SW620 cells. 
 
Figure 2.6 A schematic outlining the model system for CRC progression, which includes SW480, 
HT29 and SW260 cells.  
2.2.4 Mechanical phenotype of malignant cells 
A primary tumour is exposed to different types of mechanical interactions, including cell-cell 
and cell-ECM (extracellular matrix) interactions. The three types of mechanical stress include 
tensile stresses due to actomyosin contractibility in response to the ECM stiffness, 
compressive forces due to rapid expansion caused by proliferation in a confined space, and 
shear stresses due to blood and interstitial flow. Mechanotransduction is the biochemical 
response of cells due to a mechanical stimulus. These same mechanical stimuli can elicit 
increased actomyosin contractility and ECM stiffening in transformed cancerous cells, which 
aids tumour progression [118], [119]. Further, the alteration of protein structures as cells 
become cancerous leads to changes in cell shape, stiffness and adhesion to the extracellular 
matrix. This results in enhanced motility of cancerous cells, which in turn allows them to 
escape the primary tumour and migrate to secondary sites. Generally, studies have shown a 
correlation between cell deformability and malignancy [7], [120], [121]. Specifically, changes 
to cytoskeletal structure have been noted in the Epithelial-to-Mesenchymal transition (EMT), 
associated with metastatic progression [122]. This transition involves cell phenotype changing 
from epithelial to mesenchymal and is known to facilitate metastasis by disrupting cell 
polarity, cell-cell adhesion and transforming well-organised cytoskeletal networks into 
fragmented arrangement. These changes aid migration and invasiveness of cells. Nuclear 
morphological changes have also been noted in cancer cells, including disrupted chromatin 




Guck et al. 2005 used a microfluidic optical stretcher to deform various breast cancer cell lines 
representative of different stages of metastatic progression: MCF10 (benign). MCF7 (primary 
adenocarcinoma) and modified MCF7 to increase invasiveness (metastasis) [36]. They found 
a correlation between increased deformability and disease progression, which they also related 
to an associated drop of ~30% in F-actin. Cross et al. 2007 used AFM to study metastatic cells 
from pleural fluids of patients with lung, breast and pancreas cancer [43]. They showed that 
metastatic cells are ~70% softer from different cancer origins. Metastatic cells had a common 
stiffness and their properties were less heterogeneous than benign cells. Xu et al. 2012 used 
AFM to study deformability as a function of ovarian cancer progression [124]. They showed 
that highly metastatic ovarian cells are softer (HEY A8) compared to the less invasive ovarian 
cancer cell (HEY), and further correlated metastatic potential to increased invasiveness. Gene 
expression analysis of the two cell lines indicates that stiffness reduction is related to changes 
in the actin cytoskeleton, a correlation was found between F-actin coalignment and Young’s 
modulus with softer cells showing less organised F-actin arrangements. Additionally, Lekka 
et al. 1999 found decreased stiffness in cancerous bladder cells using AFM and suggested 
cytoskeletal reorganisation due to oncogenic transformation as the cause for this. It should be 
noted that these techniques (AFM and optical stretching) are low strain and mostly sensitive 
to cytoskeletal properties, other mechanical changes in the nucleus likely play a key role in 
cancer progression [118]. As the largest and stiffest organelle, a compliant nucleus coupled 
with contractile forces enables cells to squeeze through the vasculature to aid metastatic 
progression. 
More recent studies have shown that correlation between metastatic progression and 
deformability may be dependent on cancer type. Ahmmed et al. 2018 used a microfluidic 
channel to deform cells under shear stress, and studied deformability changes of breast and 
prostate cancer cell lines at different stages of disease progression [44]. They found that 
strongly metastatic breast cancer cells had increased deformability, similar to the results by 
Guck et al 2005 [36]. However, they found that prostate cells showed decreased stiffness with 
metastatic potential. Nguyen et al. 2016 studied the mechanical properties and invasiveness 
of pancreatic cancer cell lines using deformability cytometry, AFM and parallel 
microfiltration [45]. They showed that metastatic potential correlated with passive 
deformations using microfiltration, which is representative of invasiveness. However, AFM 
showed increased Young’s modulus with metastatic potential. Cell transit time through a 
microfluidic constriction channel was weakly correlated to invasiveness. The use of AFM and 
microfluidics to deform cells in both adhered and suspended states shows how morphology 
can affect mechanical response. RNA sequencing was also performed and showed that Lamin 




compared to F-actin. Zhan et al. 2013 used a microfluidic constriction channel to study benign 
and cancerous brain cells [47]. They found that the cell types were indistinguishable using cell 
elongation, transit speed. They also measured the associated pressure drop due to passage of 
cells through the microchannel. Entry time into the microchannel was more sensitive than 
pressure drop when distinguishing the cell types. The cancerous cells took longer to squeeze 
into the constriction suggesting that cancerous cells have increased stiffness. 
The general consensus suggests that cancerous cells tend to become softer to aid migration 
and invasiveness, however this may depend on cancer type. Mechanical properties have been 
shown to successfully distinguish cells based on disease state. However, different techniques 
and measured properties can be more/less sensitive to these changes, which shows that 
multiple parameter analysis offer a wider understanding of disease induced changes to 
mechanophenotype. 
2.3 Biomechanics of Cells 
Cells display viscoelastic response to an applied stress when probed using multiple techniques 
ranging across forces (10−14 − 10−6 𝑁) and length scales (~10−10 − 10−4 𝑚) [125]. Many 
models exist which try to encompass the complex behaviour of cells and extract fundamental 
parameters. The elastic modulus is often used, which is a measure of the cells resistance to 
elastic deformation due to an applied stress (with units of Pa). However, reported values for 
the elastic moduli for the same cell type can vary by an order of magnitude depending on 
model and technique used. This section of the thesis gives an overview of the complexity of 
cell viscoelasticity, the main models used in cell mechanics and the model that was adapted 
toward the original work in this thesis. 
2.3.1 Viscoelasticity 
A viscoelastic material exhibits behaviour somewhere between an ideal solid and an ideal 
liquid. A purely elastic material does not dissipate energy when a stress is applied and 
removed. However, materials have a characteristic “yield stress”. Below the yield stress the 
deformation is termed reversible and once the stress is removed the material returns to its 
original shape (elastic deformation). Above the yield stress, the material undergoes a 
permanent deformation known as plastic deformation which results in energy loss. A 
viscoelastic material also loses energy when a stress is applied. 
An ideal solid is modelled as a linear spring described by Hooke’s law (equation 2.1). The 
strain ε (amount that the spring stretches from equilibrium) is linearly proportional to the 
applied stress σ, where E is the elastic modulus which characterises the spring’s stiffness. 
Purely elastic materials are time independent, when stress is applied the strain is immediate 




an ideal liquid is modelled by a dashpot where a plunger moves through a viscous Newtonian 
fluid. Equation 2.2 describes this behaviour, where the applied stress σ is proportional to strain 
rate 𝜀̇ with a constant of proportionality η, which is the fluid viscosity. The material deforms 
at a constant rate until stress is removed, i.e. the material “flows”. The energy required to 
deform the material is dissipated and the strain is permanent (time dependent). 
 𝜎(𝑡) = 𝐸𝜀(𝑡) 2.1 
 𝜎(𝑡) = 𝜂𝜀̇(𝑡) 2.2 
For a material to be deemed viscoelastic it must have three properties: hysteresis in its stress-
strain curve, exhibit stress relaxation and exhibit creep behaviour. Unlike an elastic material, 
a viscoelastic stress-strain curve will show hysteresis with the area of the loop equal to the 
energy loss during the loading-unloading cycle (Figure 2.7). This is due to it taking more 
energy to displace the material from equilibrium than to return it to its original shape, the 
energy consumed during loading is due to heat dissipation or molecular rearrangement. Stress 
relaxation is the reduction of stress as a function of time in a material which is undergoing a 
constant strain. Contrasting this, creep behaviour is the tendency of a material to continue 
deforming when a continuous stress is applied, the strain increases until the material reaches 
an equilibrium and the strain is constant.  
 
Figure 2.7 Graphical schematic of the stress-strain loading and unloading curves of an elastic vs a 
viscoelastic material. Where a viscoelastic material shows hysteresis where the area of the loop is 
equivalent to energy loss.  
These characteristic viscoelastic behaviours can be modelled by arrangement of spring and 
dashpots as equivalent circuits [126]. Here, stress is equivalent to voltage and strain rate is 
equivalent to current. The elastic modulus of the spring corresponds to the capacitance as it 
stores energy, and the viscosity of the dashpot corresponds to the resistance because it 
dissipates energy. The next section discussed the different circuit arrangements and their 





2.3.2 Linear-Spring and Dashpot models 
Viscoelastic materials can be modelled by a circuit arrangement of linear springs and dashpots, 
and are often used to model cell mechanics [127]–[136]. The two simplest arrangements are 
the Maxwell model and the Kelvin-Voigt model. The Maxwell model consists of spring and 
dashpot arranged in series (Figure 2.8ai), governed by equation 2.3. Where 𝜎(𝑡) is the applied 
stress, 𝜀(𝑡) is the strain, E is the elastic modulus associated with the linear spring and η is the 
viscosity associated with the dashpot. If a material is subjected to an instantaneous force 𝜎0, 
the solution of equation 2.3 is shown by equation 2.4. There is an instantaneous elastic 
deformation governed by E, and viscous flow deforming at constant rate governed by η (Figure 
2.8aii). When the force is removed at time t, the elastic deformation recovers instantly whereas 
the deformation of the viscous element is permanent. The Maxwell model can predict stress 
relaxation (Figure 2.8aiii) but not creep behaviour, this model is often used to model 
viscoelastic liquids. 
The Kelvin-Voigt model consists of a spring and dashpot arranged in parallel (Figure 2.8bi), 
governed by equation 2.5. If an instantaneous force is applied (𝜎0) the solution to equation 2.5 
is shown by equation 2.6. Here, the strain response develops over time as the dashpot retards 
the response of the spring. The system initially behaves like a viscous liquid, over longer 
timescales the behaviour becomes more elastic as the spring stretches. Under constant stress 




characteristic creep behaviour (Figure 2.8bii). When the material is freed at time t, the spring 
retards the material back to its original shape with no deformation.  The Kelvin-Voigt model 
successfully predicts creep behaviour, lending itself as a suitable model for viscoelastic solids, 
but not stress relaxation (Figure 2.8biii). It has been used to model the behaviour of cells [137], 
[138], however resolution was limited in early experiments and since then more complex 



































Figure 2.8. Schematic describing the three simplest spring-dashpot models and their responses over 
time to a step-wise applied stress σ and strain ε: (a) Maxwell Model consisting of a spring and dashpot 
in series (b) Kelvin-Voigt Model consisting of a spring and dashpot in parallel and (c) Standard Linear 
Model consisting of a Maxwell body in parallel with another spring.  
Two principal phenomena seen in viscoelastic materials are creep/recovery and stress 
relaxation. The Maxwell model predicts stress relaxation but not creep behaviour, and vice 
versa the Kelvin-Voigt model predicts creep behaviour but not stress relaxation. The simplest 
spring-dashpot circuit model to predict both phenomena is the Standard Linear Solid (SLS) 
Model [134], consisting of a Maxwell body in parallel with a second spring Figure 2.8ci 
(modelled by equation 2.7). Figure 2.8cii shows the creep behaviour of this system which 
combines the responses of the Maxwell and Kelvin-Voigt Models. When an instantaneous 
stress (𝜎0) is applied there is an instantaneous elastic deformation similar to a Maxwell body 
and due to the stretching of spring with 𝐸2, followed by a response similar to the Kelvin-Voigt 
model where the dashpot (η) retards the stretching of the second spring 𝐸1. Similarly, when 
the stress is removed instantaneously there is an associated instantaneous decrease in strain 
followed by a slower recovery. Figure 2.8ciii shows stress relaxation of the system under a 




deformation remains. Overall, this model can accurately predict the shape of curves for many 














Heterogeneous materials such as cells can have multiple associated relaxations, which are not 
predicted by the SLS model. A commonly used model which can predict creep behaviour, 
stress relaxation and multiexponent decays is the Generalised Maxwell model (GMM) [128], 
[133], [136], [141], [142]. GMM is an expansion of the SLS model and consists of N number 
of Maxwell bodys in parallel with an additional linear spring, also in parallel. The model 
accounts for the fact different subcellular components have different mechanical properties 
with varying relaxation times, more Maxwell body elements can be added to represent more 
complex distributions. However, as additional elements are added to spring-dashpot circuits 
they become less useful for extracting numerical values corresponding to real life parameters. 
Therefore, depending on experimental technique some still prefer to use the simpler Maxwell 
and Kelvin-Voigt models. For example, AFM used to perform stress relaxation measurements 
shows good agreement with Maxwell models and GMM [134], [136], [141], [142]. Whereas, 
techniques where the timescale of applied force is much less than the cell relaxation time show 
that Kelvin-Voigt is a suitable model [129]–[132], [134]. A simplified GMM model called the 
Zener mode, consisting two Maxwell body’s in parallel with a linear spring, also shows good 
agreement with stress relaxation AFM measurements [128]. 
Bausch et al. 1998 used magnetic twisting microrheometry to apply 1 𝑠 pulses of force 
(500−2500) 𝑝𝑁 to cells, and a model consisting of  the SLS Body in series with a dashpot was 
found to fit their experimental data [127]. This model shows a three phase response to an 
instantaneous force: an initial elastic response, a relaxation regime and viscous flow. This 
behaviour suggests at least two components of the cell exhibit an elastic response and at least 
two a viscous response. Once again, a downfall of this model is that it tells us nothing about 
which components of the cell are responsible for these responses. This model has a large 
number of parameters which are impossible to equate to real cellular components which makes 
the model ambiguous [126].  
Overall, circuit arrangements of linear springs and viscous dashpots have been used to model 
the mechanical response of cells across a wide range of techniques. More simplistic models 
are more useful for extraction of viscoelastic parameters; however they do not account for cell 
heterogeneity and multiple relaxation times. More complex models have shown to accurately 




mechanical responses of different subcellular components. Other mechanical models, 
discussed in the next section, have been developed to compensate these issues. 
2.3.3 Overview of Models of Cell Mechanics 
Early cell mechanics experiments had limited resolution and simple spring-dashpot models 
were sufficient to model viscoelastic creep and stress relaxation. As a wider range of 
timescales and frequencies were probed at improved resolutions, additional spring-dashpot 
elements were required to sufficiently fit data. The increasing number of model fit parameters 
made their mechanistic meaning ambiguous. The exponential relaxation behaviour modelled 
by linear viscoelasticity was previously favoured over power-law stress relaxation because it 
was seen as more intuitive [143]. However, a weak power-law dependence has now been 
found for a large number of cell types, using different experimental techniques and timescales 
[137], [144]–[146]. Cell rheology is typically characterised by sinusoidal deformations at a 
given frequency (𝜔), using the frequency-dependent complex shear modulus 𝐺∗(𝜔). The 
complex shear modulus of cells can be described using equation 2.8, validated across many 
studies [145]. Where 𝐺′(𝜔) is the storage modulus, 𝐺′′(𝜔) is the loss modulus and β is the 
power law exponent. 
 

















 |𝐺∗(𝜔)|2 = 𝐺′(𝜔)2 + 𝐺′′(𝜔)2 2.8 
Equation 2.9 describes power-law behaviour from a creep experiment where a constant force 
𝐹 is applied to a material at 𝑡 = 0, the material deformation over time is recorded where 𝐽(𝑡) =
𝑑(𝑡)/𝐹 is known as the creep function. The power law exponent 𝛽 describes the viscoelastic 
behaviour of the material. For a given system such as a cell type, 𝑗0 and 𝜏0 are constants. The 
constant 𝑗0 characterises the materials compliance, and 𝜏0 is an arbitrary timescale which does 
not affect 𝛽. This makes the behaviour timescale invariant.  Power-law rheology manages to 
display cell responses to force with just one parameter. As β tends to 0, equation 2.9 reduces 
to Hooke’s law (equation 2.1) and the material behaves elastically. As β tends to 1 equation 
2.9 reduced to equation 2.2 and the material behaves as a viscous liquid. For cells, β commonly 











The downfall of this is that cell behaviour is highly non-linear and power-law rheology offers 




behaviour of the cytoskeleton makes cells inherently different from non-living material. 
Various cell types both stiffen and fluidize when undergoing an applied stress, known as the 
stiffening-softening paradox in cell mechanics [147]. Currently no model combines this stress-
dependant cell response and weak power-law rheology, and no synthetic materials exhibit both 
of these behaviours. Thus, mechanistic values such as elastic modulus vary between 
experimental techniques making it difficult to compare between studies. 
Several conceptual models have been suggested to explain the unique mechanical behaviour 
of cells. The “Sol-gel” model treats the cell like a gel, where polymer filaments pervade a fluid 
cytosol [148]. The filament lengths and amount of cross-linking proteins determines whether 
the response to stress is fluid-like (Sol-state) or solid-like (gel-state). More recently, data 
suggests that the cytoskeleton is better modelled as a glassy material. The Soft-glassy rheology 
(SGR) model describes a material existing close to a glass transition where disorder and 
metastability govern the mechanical response. This theory does well to explain the weak 
power-law behaviour of cells but does not explain the phenomenon of stress-induced 
stiffening [149]. The tensegrity model operates under the assumption that cell stiffness is 
proportional to intracellular stresses [150]. The cell is a prestressed structure with evidence 
suggesting that actin filaments are responsible for tensional forces and microtubules for 
compressional forces. This theory links the active and dynamic nature of a cell with its 
mechanical response, however it does not predict power-law rheology [151].  
Linear-Viscoelasticity, Tensegrity and SGR are examples of “top-down” approaches, where 
the main principles are valid independently of microscopic substructure. “Bottom-up” models 
can be used instead which explain bulk properties of a system from its individual constituents. 
One examples is the Glassy Worm-Like (GWLC) chain model, which combines the worm-
like (WLC) chain model from polymer physics with the SGR model. WLC describes polymer 
segments (in this case cytoskeletal filaments) as semi-flexible rods with successive segments 
pointing in roughly the same direction. Stretching of curved individual filaments reduced the 
number of available conformations, reducing entropy and generating prestress. SGR is 
combined with WLC by adding “sticky” interactions between filaments, retarding filament 
relaxation. GWLC can explain weak power-law behaviour and stress stiffening. However, 
“bottom-up” descriptions do not offer a quantitative cell shear modulus because the mesh size 





Figure 2.9 Simplified schematics showing some of the main conceptual models of cell mechanics. 
None of these models account for dilatational (volume) changes in the cytoplasm. Living cells 
are constantly undergoing biochemical processes to remodel their internal structure. They can 
change their shape and volume without an external force. Examples include cell oscillations, 
blebbing and cell movement [152]. To have a complete understanding of cell rheology, shear 
and dilatational effects should be accounted for. Moeendarbary et al. 2013 introduced the 
poroelastic model of the cell cytoplasm, where a porous elastic solid meshwork (the 
cytoskeleton, organelles and macromolecules) is immersed in the fluid cytosol. The rate of 
deformation is governed by the rate at which the cytosol can pass through the holes in the 
porous meshwork [153]. Using AFM they found force-relaxation to be poroelastic at short 
timescales. Poroelastic behaviour can be characterised by the diffusion constant 𝐷𝑝. This is 
shown in Equation 2.10 where 𝐸 is the elastic modulus, 𝜁 is the pore radius, and 𝜇 is the 
cytosol viscosity. Equation 2.11 shows the timescale 𝑡𝑝 for water movement through the pores, 
where 𝐿 is a length scale associated with the amount of indentation. If the force application 
time 𝑡𝑟 is shorter than the timescale for water movement (𝑡𝑟 ≪ 𝑡𝑝) then poroelastic relaxation 














Overall, the mechanical response of a cell is dependent on; the magnitude of the load, 
technique of application and the timescale. Different theories capture different aspects of cell 
mechanical behaviour and produce scaling laws which fit well to experimental data. A 
universal model does not currently exist and a complete understanding of the physical 




2.3.4 Kelvin-Voigt Model 
The Kelvin-Voigt model was introduced in section 2.3.2 as a simple model for a viscoelastic 
solid, and has been used widely in the field of cell mechanics. This model was used as it is 
applicable to measurements of whole-cell deformations and known to fit viscoelastic solid 
behaviour well. Equations 2.6 shows the solution to the differential equation 2.5 when an 
instantaneous step force is used. The work in this thesis used a cross-slot microfluidic device 
to deform cells at the SP of an extensional flow. Here, the force is not applied in a step-like 
fashion and is instead ramped from 0 to a maximum value occurring at the SP. In a shear 
dominant flow regime velocity scales linearly with force (equation 2.24). Calculation of the 
flow profile in the cross-slot device was used to characterise how the stress on a cell deforming 
at the SP varies with time. 
The velocity profile in a shear-dominant regime was simulated using the finite element 
software COMSOL Multiphysics, with the fluid properties 𝜇 = 33 𝑐𝑃 and 𝜌 = 1005 𝑘𝑔/𝑚3. 
The simulation was 3D and the geometry mimicked the cross-slot geometry used 
experimentally, the channel widths were 35 µm and channel height was 25 µm. A single-phase 
laminar flow model was used with the initial condition of incompressible fluid behaviour. The 
boundary conditions were inlet laminar inflow at a flow rate of 5 µl/min, and at the outlet 
pressure of 0. An “extremely fine mesh” was used when running the simulation. Figure 2.10 
shows the variation of flow velocity for an ideal cell deformation event, following a central 
path through the inlet/outlet and travelling through the SP. The position (-40-0) µm is the inlet, 
position 0 is the stagnation point and (0-40) µm is the outlet.  
 
Figure 2.10: (a) Cross-slot velocity profile found using COMSOL where position 0 is the stagnation 
point of the cross-flow. The volumetric flow rate used was 5 µl/min. (b) A velocity magnitude image 
generated by COMSOL.  
The velocity profile shows an initial linear velocity in the inlet corresponding to the volumetric 




sine function is fitted to the velocity profile, shown in red (𝑅2 = 0.99). This suggests that 
𝜎(𝑡) varies approximately as a sine function, for a period 𝑇 (where ω =
2π
T
). Equation 2.12 
shows the sine-varying stress σ(t) as a function of time which is used to solve equation 2.5. 
The analytical solution is shown by equation 2.13. Here 𝜎0 is the peak value of the sine wave 
corresponding to the SP position, which was found by calculating the pressure drag and shear 
stress on a cell at the SP (described in section 2.5.2).   








𝜂 − 𝐸𝜂𝜔 cos(𝜔𝑡)
+ 𝜔2𝜂2 + 𝐸2 sin(𝜔𝑡) + 𝐸2) 
2.13 
This model is used throughout the thesis to fit data for cell deformation dynamics and extract 
an elastic modulus for various cell types. The addition of multiple spring and dashpot elements 
was considered, however the simpler Kelvin-Voigt fit well to experimental data. Multiple 
elements also produce more fitting parameters which cannot be correlated to specific 
responses, whereas Kelvin-Voigt produces an elastic modulus which can be easily compared 
to other studies.  
2.3.5 Cell Plasticity 
After a cell is deformed due to mechanical stress, the cell shape recovers. Studies have shown 
that this recovery is not always to the original undeformed shape, some cells do not recovery 
fully and show an apparent “permanent deformation”. Cells show viscoelastic behaviour, an 
elastic deformation would result in complete recovery (i.e. linear spring) whereas a viscous 
deformation would result in no recovery after stress removal (i.e. dashpot). However, “plastic” 
deformations can occur due to bond ruptures occurring within the cytoskeleton resulting in 
incomplete recovery, referred to as cell plasticity. The majority of cell mechanics research 
focuses on cell deformation due to an applied stress, with less focus on the cell-shape recovery 
once stress is removed [154]. However, incomplete shape recovery is an adaptive cell property 
as it reduces mechanical stress during cyclic deformations which can protect the cell from 
mechanical damage [155]. 
Bonakdar et al. 2016 used a multidirectional magnetic tweezer device to investigate the 
reversibility of deformation in cells, and found cells did not recover their initial shape [155]. 
Additionally, they used cyclic loading and showed that the magnitude of incomplete recovery 
increased with each cycle of force application and followed weak power law behaviour. They 
discussed that under cyclic loading tensed fibers become permanently stretched and 





developmental “plasticity” of the nuclei human embryonic stem cells compared to 
differentiated cells [86]. Developmental “plasticity” refers to the ability of cells to modulate 
their gene expression, but evidence of physical plasticity was seen in the undifferentiated stem 
cells. Micropipette aspiration showed that stem cells were ~6 fold softer than differentiated 
cells, and also did not recover their original shape after being deformed. Undifferentiated cells 
showed negligible traces of Lamin A/C and also decondensed chromatin. Fluidisation of 
chromatin and lack of Lamin A/C was attributated to the plasticity of stem cells. 
Ho et al. 2018 devised a microfluidic device to impart cyclic deformations on cells, to test 
whether compression loading and unloading lead to plastic deformations [156] (as opposed to 
tensile or shear). They found no plasticity in MCF10A cells after 0.5 Hz cyclic compression 
for 6 min. These results show that plastic deformations are dependent on loading frequency, 





2.4 Microfluidics Background 
Microfluidics is defined as the manipulation of fluid flows on the microscale. This scale offers 
many advantages due to the precise-control over the fluid compared to macroscopic scales due 
to the presence of laminar flow.  This technology, known as lab-on-a-chip [157], utilises a 
device made of small channels typically etched into glass or a polymer. Microfluidic device 
fabrication is discussed in section 3.1. 
The main advantages of microfluidics are the low volumes required, reducing the amount of 
reagents needed and thus the production cost. The scaled down systems also readily allow 
automation, device multiplexing, and high-throughput measurements. This section will give 
an overview of the governing equations which determine the nature of flow in microfluidic 
devices, and its interaction with suspended particles. 
2.4.1 Navier-Stokes equation 
The Navier-Stokes equation govern the motion of viscous fluid substances. An application of 
the equations is to model fluid flow in a pipe, including predicting flow behaviour in 
microfluidic devices. Equation 2.14 denotes the Navier-Stokes equation in the case of an 
incompressible and Newtonian fluid [158]. Where v is the fluid velocity, µ is the fluid 
viscosity, ρ is the fluid density and p is the fluid pressure. The different terms correspond to 
different force contributions, a is the inertial forces due to fluid acceleration. Term b is the 
pressure term representing the external pressure applied to the fluid, where fluid flows in the 
direction of the largest pressure change. Term c is the viscous forces, increasing viscosity acts 
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2.15 
Here, the Navier-Stokes equation represents the conservation of momentum. It is solved 
together with the continuity equation 2.15 which represents the conservation of mass. Under 
the assumption of fluid incompressibility, fluid density is assumed to be constant. Therefore, 
equation 2.15 reduces to ∇ ∙ 𝑣 = 0. The Navier-Stokes equation can be simplified for certain 
flow regimes, whereas for others additional equations may be required. Flow regime can be 





2.4.2 Reynolds number 
The behaviour of fluid flows can be characterised by the Reynolds Number (𝑅𝑒) shown by 
equation 2.16 [159]. 𝑅𝑒 is the ratio of inertial to viscous forces, quantifying the relative 
importance of each force for given flow conditions. The hydraulic diameter 𝐷𝐻 is dependent 
on the cross-sectional geometry of the channel the fluid flows through, the equation for a 
rectangular channel is given by equation 2.17 [160]. Where A is the cross-sectional area of the 

















At  low Re viscous forces dominate which is known as laminar flow, where fluid follows 
smooth continuous streamlines and particle velocity is not a random function of time [161]. 
As Re increases inertial forces begin to dominate and flow transitions from laminar to where 
the flow is chaotic and instabilities such as eddy currents and vortices will occur, making it 
impossible to predict the position of a particle in flow as a function of time [162]. This 
transition occurs at a critical Reynolds number. For flow in a pipe a critical value of 𝑅𝑒 =
2300 is often quoted in the literature, where flows with 𝑅𝑒 < 2300 remain laminar even with 
system disturbances such as surface roughness, vibration and heat transfer. The critical value 
changes for different geometries such as square or rectangular channels. Thus, the “transitional 
flow” regime between wholly laminar and turbulent flows is often quoted as occurring 
between 2300 < 𝑅𝑒 < 4000 [163]. 
Equation 2.16 shows that a low Re requires a combination of low velocities, high viscosities 
and small length scales. Hence, microfluidic systems almost always operate in the laminar 
flow regime due to the microscale dimensions of the channels (usually 10’s of micrometres). 
In many cases, microfluidics achieves 𝑅𝑒 ≪ 1, known as Stokes or creeping flow, where 
inertial effects are considered negligible [159]. Here, the inertial term can be removed from 
the Navier-Stokes (equation 2.14), and assuming no external forces, the equation simplifies to 
𝜇∇2𝑣 − ∇𝑝 = 0. The problem then becomes linear and time-independent, and the associated 
flow fields can be solved. Comparatively, at higher Re the inertial term cannot be ignored and 
the flow field calculation becomes more challenging due to non-linearity and time 
dependence. An intermediate regime exists (~1 < 𝑅𝑒 < ~100) where inertia still has a notable 
effect and can be used to manipulate particle positions in flow [164]–[166]. 
Microfluidic systems often involve fluid flow with suspended particles, which are subject to 





flow of particles through a channel. The channel Reynolds number 𝑅𝑐 (equation 2.18) 




𝑅𝑐, whereas the particle Reynolds number 𝑅𝑝 (equation 2.19) has an additional 
dependence on the size of particle within the channel [167]. Where 𝑣𝑚𝑎𝑥 is the maximal fluid 
velocity and a is the particle size. Particle flow is dominated by viscous forces at low particle 
Reynolds number (𝑅𝑝 ≪ 1). Here, particles travel at the local fluid velocity due to viscous 
drag. Under these conditions neutrally buoyant particles do not migrate across streamlines and 
particle distribution is conserved. With increasing 𝑅𝑝 (𝑅𝑝 > 1) particles become increasingly 
subject to “the wall effect” and “shear-induced” lift forces leading to migration across 
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2.4.3 Flow Resistance 
Flow resistance must also be considered when designing microfluidic channels. This is 
calculated using equation 2.20, where ΔP is the pressure difference across a channel, Q is the 
volumetric flow rate and 𝑅ɸ is the channel resistance. Microfluidics commonly uses 
volumetric flow rates Q (m3/s) instead of linear velocity (m/s), as this value remains constant 
throughout the device whereas v changes with channel dimensions. 
 ∆𝑃 = 𝑄𝑅ɸ 2.20 
The fluid flow in a rectangular microchannel can be defined by equation 2.21 [168]. Where w 
is the channel width, h is the channel height, L is the length of the channel and µ is the fluid 
viscosity. β is the aspect of the channel (β=h/w), such that 0 < 𝛽 < 1 where β=1 represents a 
square channel. The function 𝑓(𝛽) (equation 2.22) shows a known polynomial of the aspect 
ratio β, which simplifies significantly for high aspect ratios (β tending toward 0) where the 


















2.5 Microfluidic Cell Deformation 
Microfluidics is an appealing technique for cells studies due to: small sample volume, low 
cost, biocompatibility, integration capability and potential for high throughput measurements. 
Cell deformation using microfluidics can be categorised as either: structure induced 
deformation or fluid induced deformation. Figure 2.11 summarises the different channel 
geometries that can be used to hydrodynamically deform single cells. 
2.5.1 Structure induced deformation 
Structure induced deformation involves passing cells through a channel which has at least one 
channel dimension that is smaller than the cell diameter (Figure 2.11a). Confinement by the 
channel walls requires the cells to deform as they are pushed through the channel at a set flow 
rate. Parameters such as cell elongation, transit time and recovery are used to quantify cell 
deformability [19]. Structure induced deformation is particularly useful for studying red blood 
cells (RBC) because the channels mimic in vivo capillaries [20], [22]. However, constriction-
induced deformation is also affected by cell volume and adhesion between the cell membrane 
and channel walls. This means that larger and stickier cells will have a longer transit time. 
Additionally, the small diameters of constriction channels make them susceptible to clogging 
which limits experimental throughput. 
2.5.2 Flow induced deformation 
Fluid-induced deformation is where the cell is deformed by a shear or extensional force rather 
than by confinement structures [38]. Fluid-induced deformation is not affected by adhesion 
between the cell and the channel walls, and cell strain can be adjusted as a function of flow 
rate.  Several geometries can be utilised for fluid-induced deformations (and are shown in 
Figure 2.11).  
Channels with a diameter slightly larger than the cells diameter can be used to induce shear 
fluid stress, where the cells deform to a bullet-like shape due to the strong velocity gradient 
within the channel (b) [19], [34], [46], [52], [96], [169]. Here, the magnitude of shear stress is 
relatively small and only able to induce smaller strains. The entrance or exit of a constriction 
channel can also be used to generate an extensional flow, often more efficient for deforming 
cells [26]. Extensional flow is caused by a velocity gradient between a larger chamber and an 
area of contraction in a microfluidic device, a hyperbolic converging channel to deform cells 






Figure 2.11 A schematic showing the different microfluidic geometries that can be used to deform 
single cells in a high-throughput and automated manner.  
Figure 2.11 a-c show microfluidic geometries comprising of single channels which expand 
and contract to induce extensional or shear forces, geometries d-f have more than one channel. 
An extensional flow can also be generated using a cross-slot geometry (d). Cells are delivered 
to a junction of two orthogonal channels at a set flow rate Q, an extensional flow is generated 
due to the flow decelerating to 𝑄 ≅ 0 at the stagnation point (SP) at the centre of the junction 
[27], [29], [32], [35], [48], [170], [171]. This geometry is capable of inducing high-strain cell 
deformations. However, unlike the single channel geometries (a-c) the cells need to be focused 
to the centre of inlet square/rectangular channels in order to deform at the SP. This requires 
an additional on-chip particle focusing mechanism, such as sheath or inertial focusing, which 
can be difficult to design and implement. Alternatively, particle tracking software can be used 
to only analyse the deformations of cells which passed through the SP and discarding cells 
which were close to channel walls. 
A cell travelling down a straight channel can be hydrodynamically stretched by a pinched flow 
(d), where the cell is squeezed by the introduction of two opposite and perpendicular channels 
[30]. A T-Junction design combines fluid and structure induced deformation (f) [54]. Cells are 
delivered to a T-Junction where they collide with the channel wall, resulting in high-strain 
deformation. Similar to cross-slot channels, pinch-flow and T-junction deformations are also 
dependent on the cells position within the channel. Adding complexity to either device design 











2.5.3 Shear and Inertial Forces 
Hydrodynamic cell stretching is due to a combination of shear and inertial forces. The 
Reynolds number determines whether the regime is shear-dominant or inertia-dominant. The 
different regimes depend on device geometry, cell suspension viscosity and flow rate. 
The majority of the studies in the thesis use a cross-slot geometry (Figure 2.11d), a geometry 
first designed to study extensional rheology of polymer solutions [172], [173]. This geometry 
was chosen as it can be used to induce low and high strains at a range of flow conditions. The 
shear and compressive force’s acting on a cell deforming at the SP of a cross-slot device can 
be estimated using equations  2.23 and 2.24. The compressive force 𝐹𝐶, is due to the inertia of 
the fluid and the fact the cell is decelerating at it moves towards the SP, can be calculated 
using  2.23 [174].  Where 𝜌 is the density of the suspension media, U is the fluid velocity, 𝐴𝑝 
is the cross sectional area of the cell and 𝐶𝐷 is the drag coefficient. 𝐶𝐷 is highly dependent on 
Re (equation 2.16), and was calculated using equation 2.25 which is the four-parameter drag 
correlation equation proposed by Brown et al. 2003 [175]. This equation was correlated to a 
480 point data set of measured values of 𝐶𝐷, using the terminal velocity of falling spheres, 
over a large range of Re. The given equation best correlated the experimental data for 𝑅𝑒 <
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The shear force 𝐹𝑆, due to the viscosity of the suspension fluid imparting a frictional force on 
the cell, was determined by 2.24, where 𝜇 is the viscosity of the suspension media, r is the cell 
radius and ?̇? is the strain rate [35], [174]. Flow rate and viscosity can be tailored to achieve a 
shear or inertia-dominant flow regime. This can be demonstrated by calculating Re (equation 
2.16) for a range of flow rates and suspension medium viscosities. Figure 2.12 is a plot of Re 
as a function of flow rate at two viscosities of suspension medium, 1 cP (the same as water) 
and a high viscosity 33 cP. Where the unit cP (centipoise) is equivalent to 1 mPa-s. 
Calculations were done for devices with channel width of 35 µm and a height of 25 µm, 
matching the dimensions of the design most used in this thesis (described further in section 
3.2). Figure 2.12 shows a linear increase of Re as a function of flow rate, and that increasing 






Re between 20-40, therefore 𝑅𝑒 = 40 was used as a boundary for the inertial regime [30], 
[176], [177]. For a solution with a viscosity of 1 cP, Re>40 for flow rates ≥11 µl/min. 
Therefore, low viscosities and high flow rates ensure an inertia-dominant regime. For 𝜇 =
33 𝑐𝑃, the Reynolds number is low (𝑅𝑒 < 6) for the entire range of flow rates used in the 
body of work, a high viscosity and low flow rate are ideal for a shear-dominant regime. 
 
Figure 2.12: Variation of Reynolds number with flow rate in a cross-slot device for two viscosities, µ=1 
cP and µ=33 cP. The dashed line at Re=40 represents the flow regime being defined as either shear- 
or inertia-dominant.  
The total force 𝐹𝑇 is the sum of the two force components, 𝐹𝑇 = 𝐹𝑆 + 𝐹𝐶. Figure 2.13 further 
describes the separate contributions to 𝐹𝑇 by 𝐹𝑆 and 𝐹𝐶 as a function of flow rate and Reynolds 
number. Figure 2.13a shows plots of equations  2.23 and 2.24 as a function of flow rate for a 
suspension viscosity of µ=1 cP . 𝐹𝐶 is proportional to 𝑈
2 compared to 𝐹𝑆 which is proportional 
to 𝑈. For flow rates ~40 µl/min the compressive contribution 𝐹𝐶 begins to surpass the shear 
contribution 𝐹𝑆. Here, Re>40 which corroborates that at these flow conditions inertial effects 
are significant. Thus,  𝐹𝑇 is dominated by 𝐹𝐶 at low viscosity and high flow rates. Throughout 
the thesis inertia-dominant flow measurements are taken for flow rates ≥ 50 𝜇𝑙/𝑚𝑖𝑛 in a low 
viscosity buffer (PBS or DMEM media ~1 cP).  Figure 2.13b shows the force contributions as 
a function of flow rate for a suspension viscosity of µ=33 cP. 𝐹𝐶 increases with density 
whereas 𝐹𝑆 increases with viscosity. Methyl cellulose (MC) was used to increase the viscosity 
of PBS from ~1 cP to ~33 cP, comparatively changes to density were small (0.5% methyl 
cellulose). This results in 𝐹𝑇 being dominated by 𝐹𝑆 up to flow rates of 200 µl/min, Re<11 for 
the entire range shown in Figure 2.13b. Additionally, for flow rates <18 µl/min the Reynolds 






Figure 2.13: Plots of equations  2.23 and 2.24 as a function of flow rate. Changing the viscosity µ of 
the fluid determines whether the system is inertia or shear dominant. (a) For µ=1 cP, at flow rates 
above ~40 µl/min the compressive force contribution 𝐹𝑐 begins to surpass the shear contribution 𝐹𝑆. (b) 
For µ=33 cP the shear force has a larger contribution that the compressive force 𝐹𝑐 for the entire range 

















3 Experimental Methods 
3.1 Microfluidic Device Fabrication 
Fabrication of microfluidic devices involves three steps: designing the device geometry using 
the software AutoCAD, creating a master of the device, and using soft lithography to create 
devices from the master. The methods below detail the protocol of master fabrication and 
micro-device fabrication. The master fabrication process is summarised in Figure 3.1 and 
PDMS microdevice fabrication summarised in Figure 3.2. Specific device designs are 
discussed in Section 3.2. 
3.1.1 Master Fabrication 
Device masters were fabricated using 3-inch Silicon wafers and the negative photoresist SU-
8 2025 (Microchem, Warickshire, UK). Wafers were cleaned using piranha wet etch (using 
H2SO4 & H2O2) at >80 ⁰C for 30 mins and then rinsed and stored in deionised water (Figure 
3.1 a). Before use, wafers were dried using a nitrogen gun and placed in an oven at 180 ⁰C for 
~20 mins. Room temperature wafers were placed on a spin coater (EMS 6000) and coated 
with SU-8, and then the acceleration, speed and spin times were set to achieve the desired 
photoresist thickness (Figure 3.1 b).   
A soft bake then solidified the SU-8 layer by evaporating the solvent in the SU-8. Wafers were 
placed on a room temperature hot plate (EMS 1000-1, Salisbury, UK) which was then set to 
55 oC (it took ~5 min for the hot plate to heat to 55 oC). Wafers were left at 55 oC for 30 mins 
before turning the hot plate off and waiting for them to cool to room temperature (Figure 3.1 
c), which took ~1 hr 30 min. Direct-write laser lithography was used to etch the microdevice 
designs into the SU-8 using a 2 μm laser of wavelength 375 nm (MicroWriter ML™, Durham 
Magneto Optics) (Figure 3.1 d). SU-8 2025 is a negative photoresist, the areas of the wafers 
exposed to the UV laser became crosslinked whereas the rest of the SU-8 remained soluble. 
The dose was optimised for device design, lower doses can achieve better resolution for small 
features but lead to adhesion problems between the SU-8 and wafer. High doses can cause 
overexposure, reducing resolution and creating “bell-shaped” channels wider than desired. A 
dose of 400 mJ/cm2 was optimal for designs in this thesis (smallest channels of ~35 µm width). 
A post-exposure bake then completed the polymerisation step, the same temperature ramping 
procedure as the soft bake was used (Figure 3.1e). Wafers were developed in ethyl lactate 
(C5H10O3) solvent (EC solvent) for ~2 mins to remove the uncrosslinked SU-8, then washed 
in isopropanol (CH3CHOHCH3) for ~1 min (Figure 3.1 f). The previous baking steps can cause 
stress on the SU-8 layer and cause cracking. A hard bake at 180 °𝐶, slightly below SU-8 glass 




8 (Figure 3.1 g). The completed master was then usable for PDMS microdevice fabrication 
(Figure 3.1 h).  
The height of the SU-8 channels was confirmed using a Stylus Profiler (Bruker Dektak). Stylus 
profilers use a mechanical probe to acquire surface topography, the probe scans across a 
surface whilst a feedback loop monitors the force from the sample. The probe performs a line 
scan across an SU-8 channel to provide a height profile and give the step-height of the channel.  
 
Figure 3.1. Schematic summarising the production steps for fabrication of an SU-8-silicon master, the 
main steps of the protocol are shown in order (a-h).  
3.1.2 PDMS Device Fabrication 
Microfluidic device channels were formed in the polymer PDMS (polydimethylsiloxane), 
using the master as a mould to create a negative replica of the SU-8 structures in the PDMS. 
A mixture of liquid PDMS and a cross-linking agent (SYLGARD 184) at a ratio of 1:10 was 
prepared and centrifuged at 14,000 rpm for 4 mins to remove bubbles. The mix was then 
poured over the master in a petri dish (Figure 3.2 a) and left under soft vacuum for ~1 hr to 
remove any remaining gas dissolved in the PDMS. The PDMS was then cured in an oven at 
75 oC for ~1hr, becoming a hydrophobic elastomer. The now solid PDMS layer was then 
peeled away from the master (Figure 3.2 b), and the fluid inlet and outlet access holes were 
punched using a 1 mm diameter Biopsy Puncher (Figure 3.2 c). PDMS moulding creates 3 out 
of the 4 walls required for an enclosed channel.  
The PDMS was sealed to either a glass slide or cover slip by oxygen plasma treatment, creating 
the fourth wall. The PDMS and glass were placed inside a plasma-cleaning chamber (Zepto, 
Diener electronics, Germany), and were plasma treated for 1 min, at 0.8-1 mbar of O2 (Figure 
3.2 d). Plasma treatment involves oxidation of the PDMS and glass substrates. Treatment with 
the reactive gases replaces hydrocarbon groups present in both PDMS and glass, increasing 
the number of surface hydroxyl groups (-Si-O-H-). The PDMS and glass were then brought 
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bonds form between the substrates [178]. Finally, the bonded microfluidic devices were baked 
at 75 °C for 30 min (Figure 3.2 e). 
 
Figure 3.2. Schematic summarising the production steps for fabrication of microdevices using PDMS, 
the main steps of the protocol are shown in order (a-e).  
3.2 Device designs 
3.2.1 Cross-slot 
Cross-slot microfluidic devices are commonly used to generate an extensional flow, which is 
used throughout this thesis to deform single cells over a range of flow conditions. Figure 3.3a 
shows the cross-slot device used in the thesis, designed using AutoCAD, which was used to 
fabricate devices for deformation cytometry. 
A single-cell suspension was flowed through the inlet port (Figure 3.3a). Samples were first 
passed through an on-chip filter (Figure 3.3ai). This is shown in further detail by Figure 3.3b, 
an array of filtering pillars with minimum spacing of 50 µm were used to prevent blockages 
occurring down-stream due to cell debris and cell clumps. The filtered sample was then 
separated on-chip into two equally sized channels. These channels were redirected to a 
junction of two opposite inflowing channels and two orthogonal outflowing channels (Figure 
3.3aii). This area will be referred to as the extensional-flow junction and is shown in further 
detail by the schematic in Figure 3.3c. This is where the cross-slot design generates the 
extensional flow, causing cell deformation at the stagnation point at the centre of the junction. 
Unless stated otherwise, the channels at the extensional-flow junction had a width of 35 µm 
and a height of 25 µm. The sample then leaves the device through either of the outlet ports.  
PDMS
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Figure 3.3. (a) Cross-slot device designed using AutoCAD, with inlets and outlets labelled and arrows 
used to show the direction of flow. Highlighted areas include (i) an on-chip filter and (ii) the 
extensional-flow junction. (b) A schematic of the on-chip filter placed after the inlet in order to prevent 
larger particles causing blockages down-stream. (c) A of the extensional-flow junction, the feature of 
the cross-slot device where cell deformation occurs.  
3.2.2 Serpentine  
Another application of deformation cytometry is that it can induce transient membrane pores 
which allows increased uptake of nanoparticles into cells, discussed in section 1.4.3. Other 
microfluidic geometries have been used to increase uptake of nanoparticles into cells [54], 
[65], [67], [179]. 
In the cross-slot devices in the shear-dominant regime the cells undergo small deformations 
due to confinement in the channel (discussed in section 4.1.4). Therefore, a control was needed 
to ensure that the QD uptake was improved using a cross-slot device compared to just shearing 
effects due to channel confinement. A serpentine device, shown in the schematic in Figure 3.4, 
was used to do this. The serpentine region has the same width and height as the inlet and outlet 
channels of the cross-slot (35x25 µm), the length of the serpentine equates to the length of the 
inlet and outlets in the cross flow. Therefore, passing a cell through the serpentine at the same 
flow rate is equivalent to the shear confinement forces in the cross-slot but removes the 

























Figure 3.4. Serpentine device designed using AutoCAD, with inlets and outlets labelled and arrows 
used to show the direction of flow. Highlighted area shows a serpentine channel with a width of 35 µm, 
devices were fabricated to a height of 25 µm, and the channel length matched the length a cell would 
travel down the inlet and outlet of a cross-slot device (Figure 3.3) at these confined dimensions.  
3.3 Deformation Cytometry Procedure  
The apparatus for deformation cytometry is summarised in Figure 3.5a, using the microfluidic 
device previously described in Section 3.2.1. A 1ml glass syringe was cleaned with ethanol 
and deionised water before being loaded with a cell sample. Fine Bore Polythene tubing 
(Smiths MedicalTM , Kent, UK), 0.36mm ID and 1.09 mm OD, was connected from the syringe 
to a microdevice. The tubing was fitted directly into 1 mm diameter punctured PDMS inlets 
and outlets. The syringe was then loaded into a syringe driver (WPI, Hertfordshire, UK), 
which was used to set a volumetric flow rate (µl/min) to flow samples through the devices. 
Tubing was also connected from the device outlets into a glass vial or microcentrifuge tube to 
collect the sample. Microdevices were mounted above an inverted bright field microscope 
(Figure 3.5b), a 10x objective was used to capture cell deformation events with an additional 
1.5x magnification for flow rates 𝑄 < 200µ𝑙/𝑚𝑖𝑛. 
High speed microscopy was used to capture cell deformation events, the high speed camera 
(Photron, Fastcam SA-X) was operated at frame rates of (7000-260,000) f𝑝𝑠 and exposure 
times of (0.37-6.67) 𝜇𝑠. An external light source was mounted over the set-up (Figure 3.5c), 
this additional light allowed image capture at higher frame rates and reduced exposure times 






Figure 3.5. (a) Schematic of the microfluidic apparatus used for deformation cytometry. (b) Image of a 
PDMS device mounted into a holder for high-speed microscopy of cell deformation, with inlet and 
outlet tubing inserted. (c) Image showing how the device is held between a standard inverted bright 
field microscope and an additional light source which enhances image intensity.  
3.4 Microscopy Techniques 
3.4.1 Bright Field Microscopy 
The microscope used for deformation cytometry was an inverted microscope (Eclipse Ti-U, 
Nikon, Japan) utilising reflection bright-field microscopy, which shines white light onto a 
sample and collects the reflected light. Contrast is achieved by absorbance of the light by the 
sample. This form of microscopy typically has low contrast when viewing biological samples. 
Mammalian cells are usually optically transparent and colourless, and bright field images 
show low definition and little structural detail. High contrast bright field images of cells can 
only be achieved on samples which are stained, which often requires fixing the sample (i.e. 
not applicable for imaging of live cells in suspension). 
3.4.2 High Speed Microscopy 
A camera is high speed if the frame rate exceeds 250 frames per second (fps) with an exposure 
time less than 1 ms. In this body of work cells were deformed microfluidically, and these 
deformations and recoveries can occur in less than a millisecond. Therefore, high speed 
























The determining properties of a high speed camera are; the image resolution, the frame rate, 
the exposure time and the data rate. The resolution needs to be high enough so that the field-
of-view can capture the cell before, during and after it deforms. Frame rates should be high 
enough to ensure that the maximum cell deformation will be captured, if the frame rate is too 
low this information could be missed. The exposure time should be short enough that images 
do not have motion blur. Here, high speed microscopy was performed using the FASTCAM 
SA-X camera (Photron). Each acquired pixel has an image sensor, this system uses a CMOS 
(metal–oxide–semiconductor) sensor. This camera has a maximum resolution of 1024 X 1024 
pixels which can be maintained for frame rates ≤12,500 fps. At higher frame rates the 
resolution is limited by the data rate, thus as frame rate increases the field of view decreases. 
An ISO value is used to measure a cameras ability to capture the light which falls onto the 
image sensor, a higher ISO allows for lower exposure times. The SA-X camera has an ISO 
value of 25,000, allowing for a minimum exposure time of 293 ns. 
In this body of work, frame rates of ≤ 230,000 frames per second and exposure times ≤ 293 
ns were achieved. At the highest frame rate the maximum resolution was 128x128 pixels. 
3.4.3 Phase Contrast Microscopy 
 
Figure 3.6 Simplified schematic of the optical set-up of a phase contrast microscope. The condenser 
annulus and 1/4 wavelength phase plate are used to convert phase shifts into amplitude.  
Bright field microscopy relies on absorption of light to see contrast in samples, however 
absorption is not the only way that light interacts with a sample. Other forms of microscopy 
utilise polarization or phase shift to see better contrast in sample. The eye is only sensitive to 
changes in amplitude or colour, however phase contrast microscopy converts differences in 
phase into amplitude, allowing improved contrast in biological samples. 
Different cellular components have different refractive indices. When light is shone on a 
sample the different optical path length cause a change in phase but not in amplitude. The 
















compared to the background (direct) light. Objects will show excellent contrast when the 
phase difference between the diffracted and direct light is a ½ wavelength, due to destructive 
interference. Therefore, phase contrast microscopy works to advance the direct light by a ¼ 
wavelength. 
Figure 3.6 shows a schematic of a phase contrast microscope. Two components are required to 
transform a bright field microscope to a phase contrast microscope. The condenser annulus is 
a mainly opaque ring with a clear ring, whose purpose is to produce a circle of light onto the 
front of the condenser. The condenser subsequently focuses a hollow cone of light onto the 
sample plane. The phase plate is a circular shaped clear plate with a ring in it, with equal 
dimensions to the circular annulus. Most commonly, the ring is made of an optically thinner 
material to the rest of the plate. When the ring of light hits the sample, some of the light is 
diffracted and some is not (direct light). The direct light passes through the optically thinner 
ring of the phase plate, which advances the phase of the direct light by ¼ relative to the 
diffracted light. As the phase of the diffracted light was retarded by ¼ wavelength by the 
sample, the phase difference between direct and diffracted light is now ½ wavelength. This 
cause’s destructive interference, leading to the sample appearing dark compared to a light 
background, this is known as dark/positive phase contrast. A phase plate can also be used to 
achieve constructive interference, where the sample appears bright compared to the 
background (bright/negative phase contrast).  
3.4.4 Confocal Fluorescence Microscopy 
 
Figure 3.7  Simplified schematic of a confocal microscope. Light from the focal plane (red) is focussed 
through the pinhole whereas light from other depths within the specimen (orange) is blocked. This 
results in acquiring fluorescence from a defined depth, reducing background fluorescence.  
Fluorescence microscopy uses the detection of light emitted from fluorophores to generate an 
image and can be performed together with bright field microscopy. In this work, fluorescent 




Confocal microscopy is a fluorescence imaging technique with improved resolution over 
traditional epifluorescence microscopy. In epifluorescence microscopy, light emitted 
throughout the depth of the sample is detected. Therefore, some of the detected light will be 
out of focus (more prominent for high magnification objectives) which limits resolution. In 
confocal microscopy a pin-hole is used to block out light emitted from regions other than the 
focal plane, this results in a small depth of field and reduced background fluorescence (Figure 
3.7). High resolution in x and y is achieved by raster scanning the excitation laser spot over a 
sample. Samples can also be mapped in 3D, known as a z-stack, where a series of 2D images 
are collected at varying depths and then stacked. 
Confocal microscopy was performed on samples of cells using a Leica DMi8, which allows 
simultaneous capture of bright field images and fluorescent images using either 488 nm, 552 
nm and 638 nm excitation lasers. The microscope was equipped with 2.5×, 10×, 40x 
objectives, and also 60×, 100× oil immersion objectives. Cytoskeletal imaging was done using 
a live cell fluorogenic labelling probe based on Silicon-Rhodamine (Sir) (Spirochrome, 
Cytoskeleton Inc.) to stain F-actin or tubulin, using a 638 nm excitation laser. Adjustable 
emission filters were used to accommodate the spectra of these dyes. Hoechst 33342 (Thermo 
Fisher Scientific) was used to stain cell DNA, using laser excitation at 488 nm, imaged 
simultaneously with either SiR actin or tubulin staining. Confocal fluorescence was also 
performed on cells incubated with Quantum Dots (QDs), using laser excitation at 488 nm. The 
confocality was used to collect Z-stacks of the incubated cells to visualise whether quantum 
dot uptake was endocytic or non-endocytic.  
Samples were imaged in transparent chambers (Lab-Tek II), where each chamber held 0.2-0.5 
ml of sample. Each chamber had 8 identical wells, which allowed multiple samples to be 
prepared and imaged with ease. The thickness of the bottom was the same as glass coverslips. 
The wells were pre-treated with poly-L-lysine, which facilitated cell attachment to the surface 
of the well before imaging. 
3.5 Automated Image Analysis 
Automated image analysis was performed offline using ImageJ and MatLab, the position and 
the shape of each cell event was tracked and parameters such as initial size, velocity, 
circularity and maximum deformation index (𝐷𝐼 = 𝐻/𝑊) were extracted.  
3.5.1 ImageJ particle tracking  
The scientific image analysis software ImageJ was used to track the size, shape and velocity 
of cells deforming in microfluidic devices. Figure 3.8 outlines the series of steps performed on 
a raw image (a) of a deformed cell, to convert the image to binary in order to perform the 




removes smooth continuous backgrounds based on the “rolling ball” algorithm [180]. Next, 
the brightness and contrast of the subtracted image is adjusted, to increase the contrast between 
the dark outline of the cell and the light background (c). From this, the “Make Binary” 
command is used (d), where image pixels are converted to either black or white. This 
procedure divides an image into objects (i.e. a cell or channel wall) and background by taking 
a threshold, above which the pixel is converted to black and below which the pixel is converted 
to white. ImageJ thresholding uses an iterative algorithm to convert images to binary 
[181].The subsequent image shows a black cell outline and black device walls with a white 
background. The “Fill Holes” command then fills the cell which is shown as an ellipse shape 
(e). This set of commands was applied to image stacks containing multiple cell deformation 
events. 
The ImageJ “DropletTracker” plugin (created by Travis Geis in 2013) was then used to 
analyse and track cell shape and movement [182]. A minimum and maximum particle size 
was defined, only objects within this range were detected and tracked. This was chosen to 
encapsulate the range of cell sizes for each particular cell line. The channel walls were 
excluded from tracking as these objects exceeded the maximum size. Additionally, any clumps 
of multiple cells passing through the device were discarded as they tended to exceed the 
maximum size. A nearest-neighbour approach was used to track objects across stacked frames. 
A user-specified maximum “velocity” in pixels/frame was used. If an object in two successive 
frames moved a distance less than that specified by this “velocity” it was considered the same 
object, objects above the “velocity” were considered separate.  As one frame could contain 
multiple single cells, the frame rates used were chosen so that the space between cells was 
large compared to the distance travelled by a cell between two subsequent frames. A minimum 
track length was also defined and events were only included in the outputted data if they were 
tracked for at least this number of subsequent frames (between 6 and 30 frames dependent on 
field of view). This helped to remove noise from the data, for instance if a frame contained 
noise within the particle size range but only for one frame it would be discarded. 
DropletTracker could be run on stacks of up to 30,000 images depending on image resolution. 
It outputs a spreadsheet which contains the position, shape and size of each cell event as a 
function of time. Each detected object is assigned a “particle number” as each event spans 
multiple rows of the spreadsheet corresponding to each frame in which the object appears, a 
corresponding “frame number” tells you which objects appeared in a specific frame.  For each 
object in each frame, the centroid position (x, y), area, perimeter and various deformation 
parameters are found (using object width and height, section 3.5.3). Additionally, velocity 




(m/s) via the frame rate (fps) used during high speed imaging and knowing the pixel 
conversion to meters.  
 
Figure 3.8. An example image of a cell deforming at the stagnation point of a microfluidic device. Steps 
(a-f) show the process of converting the raw image to a binary image which was then analysed to find 
the cell size and shape.  
The data was processed using Matlab and code was written to extract the parameters of interest 
and compile each individual event. Various plots were generated to check the ImageJ analysis 
was robust. Figure 3.9 shows example plots for N=387 HL60 cells deformed at 40 µl/min in a 
cross-slot device (Figure 3.9 d) in a shear-dominant regime (µ= 33 cP), each individual event 
is colour coded with adjoining lines to help guide the eye. Figure 3.9a shows the X and Y 
centroid position of each cell event, tracking the position of the particles across each frame 
they are present. This clearly shows cells following the expected path through the cross-slot 
geometry, and that different cells entered from either inlet and exited from either outlet which 
validates the system symmetry. The velocity profiles are plotted in Figure 3.9 b, which shows 
the cell events have similar incoming velocities which decrease to near 0 corresponding to 
being at/near the stagnation point. Figure 3.9 c is a plot of the ratio of cell height to width 
(DI=H/W) as a function of frame number, showing that cells have initial deformation of ~1 
(undeformed/circular), which increases as they pass through the stagnation point before 
decreasing as the cells enter the outlet channel. Finally, a scatter plot of the maximum 
deformation DI of the cells as a function of initial diameter A is shown (Figure 3.9 e). This 
verified that an appropriate particle size detection range was chosen. 
This analysis method was used throughout the thesis for bulk analysis measurements of the 
maximum cell deformation and initial cell diameter (A). The velocity profiles were also used 
to threshold the data, discarding any cell events which did not pass through or close to the 
stagnation point. This thresholding is discussed in section 4.1.3. 
(a) Raw image (b) Subtract Background (c) Enhance contrast





Figure 3.9. An example of particle tracking used to analyse the deformation of a HL60 cell deformation 
in a cross-slot device (Q=40 µl/min, µ= 33 cP). (a) The X and Y centroid position of each cell event. 
(b) The cell velocity (pixels/s) as a function of frame number. (c) The deformation ratio H/W as a 
function of frame number. (d) An overlayed imaged of a cell deforming at the SP of a cross-slot device. 
(d) A density scatter plot of the maximum DI=H/W of each cell at/near to the SP as a function of initial 
cell diameter (µm), the dashed lines represent the mean values.  
3.5.2 Matlab particle tracking 
The previously described image analysis method was used mainly for bulk measurements of 
the DI of 100 s-1000 s of cells at a range of flow conditions. However, some of the work in 
the thesis required tracking the deformation and recovery of cells deforming in a cross-slot, 
allowing for multiparameter analysis (i.e. not just the maximum DI at the SP). For more 
precise tracking and visualisation of each event a mathematical image processing algorithm, 
written by Dr. Hermes Gadêlha (University of York), adapted from flagellar image tracking 
was used [38].  
Each frame of a video, containing multiple cell events, is loaded and read individually. Firstly, 
2D adaptive noise removal filtering is used to improve image quality (matlab function 
weiner2). This type of filtering works best for images where noise is constant (Gaussian 
noise), looks at the statistical variance of pixel intensity compared to local neighbourhood. A 
large variance leads to little smoothing and a small variance leads to more smoothing. 
Thresholding is then used to convert the grayscale video into a binary video and create a mask, 
with a white background and a black foreground (which should only include any cells present 









































the value of 1 (white) and below the set level to a value of 0 (black). The range is relative to 
the signals in the loaded image, i.e. a set level of 0.5 corresponds to the half level intensity 
between the minimum and maximum in that image. After achieving a successful binarized 
image, a minimum and maximum object size (black pixel area) is set to encapsulate the size 
range of cells to be detected. Figure 3.10a shows a display screen which is used to check that 
the filtering and tracking is adequate for image analysis of single cells. This includes filtering 
the original image, binarizing to create a mask, and filtering by size to leave only objects of 
interest.  
For object tracking, two parameters are defined. The “maximum distance” between objects in 
subsequent frames is defined. If the distance between two objects is below this, the code 
recognises this as a single cell event and tracks its movement. If the distance between two 
objects in subsequent frames is above the “maximum distance” the code recognises these as 
two separate cell events. The “minimum track length” is also measured and this can be used 
to filter out cell events which do not pass through or near to the SP (their track length will be 
shorter). Images of successful tracking are shown by Figure 3.10b and c, where the red line 
outlines the detected cell contour, the blue dot tracks the cells centroid position, and the black 
line represents the path of the cell.  
Finally, colour contour plots of each detected cell in the video are displayed (Figure 3.10 d). 
These show superimposed traces of the cell shape as a function of time, starting with dark blue 
as the cell approaches the SP to red as the cell recovers in the outlet channel. The display of 
individual objects is a useful check to see if any unwanted objects were detected, which can 
easily be filtered out from subsequent analysis. The information gathered from these videos is 
used for multiparameter analysis of cell deformation and recovery of different cell types, and 





Figure 3.10. Example of precision particle tracking using Matlab. The code is used to track the position 
and shape of a cell passing through an extensional flow junction. (a) A cell deforming at the SP, the 
blue dot shows the detected centroid position, the red line shows the detected contour and the black 
line tracks the path of the object. (b) The same cell as it has traversed further into the outlet. (c) 
Superimposed colour contour plots that show how the cell shape changes as a function of time, ranging 
from dark blue where the cell approaches the cross-flow junction to red when the cell reaches the end 
of the outlet channel.  
3.5.3 Parameter definitions 
Several parameters were used to measure cell shape and define the deviation in shape due to 
deformation. Firstly, the deformation index DI is defined by equation (3.1), where H is the 
height of the cell and W is the width of the cell. Another definition is the Taylor strain 
parameter, which will be referred to as the cells’ strain ɛ and is defined in equation (3.2). 
Finally, the circularity c can be used to describe how much the shape deviates from a perfect 
circle. This is calculated using equation (3.3), where S is the 2D projected surface area and P 
is the perimeter.  A perfect circle has 𝑐 = 1 and for a deformation 𝑐 < 1. The deformation is 
defined as 𝐷C = 1−𝑐, for ease 𝐷C will be referred to as circularity throughout the thesis, 




















Throughout the thesis these three parameters are used to define cell shape and the usefulness 
of the parameters for different assays can be described by the schematic in Figure 3.11. Shape 
A in Figure 3.11 shows a circle, where W=H and circularity is 1. Shape B shows an irregular 
shape which deviates from a perfect circle. If a bounding rectangle is applied the width and 
height are still equal to each other. Therefore, DI and ɛ have the same values compared to 
shape A whereas 𝐷𝐶 has increased because the shape perimeter and surface area have changed 
compared to a circle. Shape C is closer to an ellipsoid, here the width, height, perimeter and 
surface area have all changed compared to shape A and therefore DI, ɛ and 𝐷𝑐 would all 
increase. 
An undeformed cell under flow has a DI~1 and a circular morphology. This parameter is 
intuitive for characterising the change in cell shape from circular to ellipsoidal due to on-chip 
deformation at the stagnation point (DI>1). Similarly, the strain ɛ also uses the height and 
width to characterise deformation. This parameter can be used in the Kelvin-Voigt model to 
calculate cell elastic modulus (section 2.3.4). These parameters are directional, i.e. dependent 
on the orientation of the cell, whereas 𝐷𝑐 is independent of orientation. When measuring cell 
morphology off-chip an image may contain 10 s to 100 s of cells all at different orientations, 
here 𝐷𝑐 is a more suitable measure of cell shape compared to DI or ɛ.  
 
Figure 3.11. Schematic describing how the deformation parameters DI, ɛ and 𝐷𝐶  change when a cell 








3.6 Cell Culture 
This section describes the culturing procedure for the different cell lines used within this 
project. Cells were stored in a moisture-controlled incubator at 37 °C with a 5% CO2 
atmosphere and cultured in either 25 cm2 flasks or 75 cm2 flasks. Culturing was performed 
inside a Class II A1 Biosafety Cabinet.  
3.6.1 HL60 
The HL-60 (Human promyelocytic leukemia) cell line is a non-adherent cell line with a usual 
doubling time of 36-48 hrs [183], [184]. HL60 are often used in microfluidics as they naturally 
reside in single cell suspension, without need for trypsinisation or resuspension in an EDTA 
(Ethylenediaminetetraacetic acid) based anti-clumping buffer.  
HL-60 were purchased as a frozen stock European Collection of Authenticated Cell Cultures 
(ECACC 98070106) and kept in liquid nitrogen in the presence of the cryoprotectant Dimethyl 
sulfoxide (DMSO) (typically 10% DMSO and 90% Fetal Bovine Serum). The cells were 
revived by quickly thawing them in a water bath at 37 oC  and immediately adding them to 4 
ml of RPMI media with 20% Fetal Bovine Serum (FBS), 2 mM Glutamine (Gln) and Penicillin 
100 units/ml Streptomycin 100 µg/ml (Sigma). Penicillin and streptomycin are added to 
prevent bacterial infections, the combination acts against both gram-positive and gram-
negative bacteria. Centrifuging at 100 g for 4 mins was sufficient to visibly pellet the cells, 
they were then resuspended in 10 ml fresh media in a culture flask. Resuspension is necessary 
to remove DMSO, which is damaging to cells at high concentration and can cause 
differentiation. Aseptic technique was used for all cell culturing to prevent contamination.  
The cells were then split every 2-3 days to ensure the cell concentration did not exceed 1∙106 
𝑐𝑒𝑙𝑙𝑠/𝑚𝑙. After 2 passages after revival, RPMI media with 10% FBS, 2 mM Gln and Penicillin 
100 units/ml Streptomycin 100 µg/ml (Sigma) was used for continued culturing. Once cell 
passage number exceeded 50 the cells were disposed of and replaced with a frozen vial of 
lower passage. 
3.6.2 Colorectal Cancer Cell Lines 
The SW480, SW620 and HT29 colorectal cancer cell lines were provided by St James’s 
University Hospital and cultured in Dulbecco’s Modified Eagle Medium (DMEM F-12, 
Glibco) supplemented with 10% Fetal Bovine Serum (Sigma), 2 mM Glutamax (Thermo 
Fisher Scientific) and Penicillin 100 units/ml Streptomycin 100 µg/ml (Sigma). All three are 
adherent cell lines and were subcultured when reaching 70-80 % confluency, which occurred 
every 3-4 days. This was achieved by washing with Dulbecco’s phosphate buffered saline 




Scientific) and incubating for 5 mins. One fifth of the resulting suspension was then diluted in 
growth media, and transferred to a new flask. 
3.6.3 MCF-7 
MCF-7 are an adherent breast cancer cell line, they were obtained from ECACC (European 
Collection of Authenticated Cell Cultures) as frozen stock, and subsequently cultured in 
DMEM (Sigma) with 10% FBS (Sigma), 20 mM GlutaMAX (Sigma) and Penicillin 100 
units/ml Streptomycin 100 µg/ml (Sigma). The cells were subcultured every 3-4 days. This 
was achieved by washing with Dulbecco’s phosphate buffered saline (DPBS), before being 
detached by applying TrypLE dissociation reagent. One fifth of the resulting cell suspension 
was then diluted in growth media, then transferred to a new flask.  
3.6.4 HEK-293 T-REx and Piezo1 T-REx 
Ion channels are cell membrane proteins which under certain stimuli form pores which allow 
ions to pass through the channel. One such stimuli is mechanical deformation. 
Mechanosensitive ion channels (MSCs) will activate when the membrane deforms under 
stress, due to changes in membrane tension or curvature. An example of a MSCs protein is 
Piezo1. Results section 7.2 discusses whether Piezo1 can be activated in HEK292 cells using 
shear-dominant deformation in a cross-slot microfluidic device. Here, we cover the culturing 
of HEK293 with and without Piezo1 expression, how Piezo1 can be activated, and how 
fluorescence measurements can be used to detect Piezo1 activation. 
Culturing HEK293 T-REx and Piezo1 T-REx Cells 
To test the activation of the MSC Piezo1, two cell lines were used; control HEK293 T-REx 
and Piezo1 T-REx. HEK293 is an adherent human embryonic kidney cell and T-REx cell lines 
stably express the tetracycline repressor protein (TetR). Here, expression of Piezo1 can be 
turned on or off by using the antibiotic tetracycline [185].  
HEK293 T-REx and Piezo1 T-REx were provided by the Faculty of Biological Sciences at 
the University of Leeds as frozen stocks, and subsequently cultured in DMEM (Sigma) with 
10% FBS (Sigma), 20 mM GlutaMAX (Sigma) and Penicillin 100 units/ml Streptomycin 100 
µg/ml (Sigma). The cells were subcultured every 3-4 days, once cells had reach 70-80% 
confluency. This was achieved by washing with Dulbecco’s phosphate buffered saline 
(DPBS), before being detached by applying TrypLE dissociation reagent. HEK293 T-REx 
required a 1:9 dilution and Piezo1 T-REx required a 1:5 dilution.  Passage numbers for both 





The antibiotic blasticidin was added to both cell lines whilst in culture (5 µg/ml). As both cell 
lines contain a plasmid (pc/DNA6/TR©) which encodes TetR, they should have blasticidin 
resistance. Adding blasticidin ensures any cells that are not resistant to TetR will die. The 
antiobiotic zeocin is also added to the Piezo1 T-REx cell line (400 µg/ml). Only cells resistant 
to zeocin should express Piezo1.  These cells express two tet operator (TetO2) sequences which 
serve as binding sites for two TetR proteins. These repress Piezo1 transcription, addition of 
tetracycline induces transcription (activation) of Piezo1 by binding to the TetR proteins 
instead and preventing the TetO2 from binding [186]. 
Activating Piezo1 
Before cells were deformed microfluidically, both cell lines were incubated with tetracycline 
for 24 hr at a final concentration of 0.1 µg/ml. This should activate Piezo1 expression only in 
the Piezo1 T-Rex cell line. Next, the cells were loaded with the fluorescent dye Fura-2-
acetoxymethyl ester (Fura-2AM). Fura-2AM is used to measure cellular calcium 
concentrations using fluorescence intensity. It can initially cross the cell membrane, once 
inside removal of the acetoxymethyl groups occurs by cellular esterases generating “Fura-2” 
which can no longer cross back out through the cell membrane. Cells were resuspended in a 
mix of the buffer SBS (Standard Barths Solution) with 1:10 of 10% pluronic acid in DMSO 
(acting as a dispersing agent) and 2 µM of Fura2-AM. Cells were incubated at 37oC in this 
mix for 1 hr. The mix was then removed and replaced with SBS buffer for 30 minutes at room 
temperature in a dark room, this allowed time for esterase’s to cleave AM. 
Cells were then detached into a single cell suspension (as previously described), and 
resuspended in either SBS or SBS with 0.5% methyl cellulose at a final cell concentration of 
5 ∙ 105 𝑐𝑒𝑙𝑙𝑠/𝑚𝑙. SBS contains calcium, if Piezo1 is activated calcium can pass through the 
ion channels into the cell. Fura-2 emits at two wavelengths, unbound Fura-1 emits at 380 nm 
and Fura-2 bound to calcium emits at 340 nm. Both excitation wavelengths have an emission 
of 510 nm. When Piezo1 is activated and calcium enters the cell the emission at 340 nm 
increases and the emission at 380 nm decreases. Therefore, the fluorescence ratio can be used 
to study Piezo1 activation. 
Microfluidic Deformation and Fluorescence Measurements 
HEK293 T-REx and Piezo1 T-REx which had been successfully incubated with tetracycline 
for 24hr and loaded with the calcium indicator Fura-2, were then deformed microfluidically 
to study Piezo1 activation by mechanical stress. Cells were deformed at the SP of a cross-slot 
microfluidic device at a range of flow rates. After deformation, samples were collected and 




each flow condition were measured in a 96 well plate (Costar 96 clear U bottom) with 100 µl 
of sample in each well (~ 50,000 cells per well). Fluorescence was measured at Lm1=340/520 
nm (excitation/emission) and Lm2= 380/520 nm. The ratio Lm1/Lm2 was used to quantify if 
deformation lead to an increase in Fura-2 binding to calcium, which is indicative of Piezo1 
activation. 
3.6.5 Concentration and Viability Measurements 
The concentration of single cell suspensions was counted using a haemocytometer. This is a 
specialised counting chamber of known volume. An engraved grid on the surface of the 
counting chamber allows the number of cells in a defined volume to be counted. Deformation 
Cytometry experiments were performed using concentrations or 1 − 2 ∙ 106 𝑐𝑒𝑙𝑙𝑠/𝑚𝑙 
(Section 3.3).  
Cell viability was measured using Trypan blue (Thermo Fisher Scientific). In a viable cell, the 
dye is unable to pass through the membrane and is not absorbed. However, in a dead cell 
where the membrane is compromised the dye is absorbed into the cell. Therefore, dead cells 
appear blue under a microscope and alive cells do not. Live cells are excluded from staining 
and this is known as a dye exclusion method. Viability is quantified using equation (3.4). All 
samples used throughout the thesis had viability≥ 95%. 
 
% 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠 =
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑎𝑙𝑖𝑣𝑒 𝑐𝑒𝑙𝑙𝑠
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙𝑠
∙ 100 (3.4) 
An Alamar Blue assay was also used for cell viability measurements. Healthy living cells 
maintain a reducing state within their cytosol. The “reducing potential” of cells converts 
alamarBlue® reagent (BIO-RAD) into a detectable fluorescent (or absorbent) product. The 
blue indicator dye Resazurin, is irreversibly reduced to the pink coloured and highly red 
fluorescent resorufin. Metabolic reduction is indicative of cell death, thus fluorescence is 
proportional to the number of living cells. 
For the assay, cells were seeded at a density of 1x105 cells/ml in phenol red free media and 
then seeded in a 96 well plate with 100 µl per well, 10 µl of alamarBlue reagent was added 
and incubated for 1 hr. Fluorescence measurements were taken using a plate reader 
(SpectraMax® M2) with excitation at 560 nm and emission at 590 nm. 
3.7 QD uptake in Cells 
3.7.1 Quantum Dots 
Quantum dots had a Cadmium telluride (CdTe) core and a Cadmium Sulfide (CdS) shell, these 




3.7.2 Microfluidic Uptake Protocol 
Cells were detached into a single cell suspension, their suspension buffer was either DMEM 
media of PBS with 0.5% methyl cellulose. Quantum dots were added to the cells to achieve a 
final QD concentration of 100 nM. The sample was separated into two, the first half was set 
aside as a control to observe QD uptake in cells purely from incubation and via endocytosis. 
The second half of the sample was loaded into a 1 ml glass syringe to perform deformation 
cytometry, as described in section 3.3. 
Cells were deformed at a range of flow rates and collected in Eppendorfs. After cell 
deformation, all samples were incubated for ~20 mins. Deformation caused pores to form in 
the cell membrane, this incubation time allowed time for the QDs to get inside the cells via a 
non-endocytic route. Cells were then centrifuged at 100 G for 5 mins, the supernatant was 
removed and replaced with PBS. This process was repeated once more with PBS and a final 
time to re-suspend cells in DMEM. The washing steps were to ensure any free QDs in the 
solution were removed, only QDs inside the cells should remain afterwards. Samples were 
then imaged using confocal fluorescence microscopy as described in section 3.4.4. 
3.7.3 Analysis of QD uptake 
Matlab was used to analyse confocal fluorescence images of cells containing QDs. Images 
were taken using a 10 x objective, and each fluorescent image was accompanied by a bright 
field image. The matlab function “imfindcircles” was used on the BF image, this function 
automatically detects circular objects in an image. The circles detected from the BF image 
were then overlayed onto the FL image. This allowed single cell measurement of the 
fluorescence intensity of each single cell in the image. For each flow condition, images of 
N>1000 cells were used to quantify the fluorescence due to QD uptake. Average fluorescent 






4 Cell deformation in shear and inertial flows 
This chapter contains the optimisation of cross-slot devices for measuring cell deformation at 
the stagnation point (SP) of an extensional flow junction, and the characterisation of the 
deformability of HL60 cells under different flow conditions. Cell deformability was measured 
as a function of flow rate using two distinct flow regimes, a shear-dominant regime and an 
inertia-dominant regime. Additionally, cell deformation and recovery were tracked as a 
function of time in order to extract multiple distinguishing parameters including an elastic 
modulus. This also allowed further investigation into the use of bulk averaging compared to 
single cell analysis (SCA) for measuring the mechanical properties of heterogeneous samples. 
The deformability assays described in this chapter were subsequently used to probe cells 
treated with drugs to alter their cytoskeletal structure (chapter 5), and to investigate 
mechanical changes during colorectal cancer progression (chapter 6). 
4.1 Cross-slot optimisation 
4.1.1 Tracking particles in flow 
The cross-slot microfluidic devices were first tested using suspensions containing 15 µm 
polystyrene microspheres (Thermo Fisher), the beads were suspended in PBS with 0.5% 
methyl cellulose resulting in a shear-dominant flow regime (with a viscosity of 𝜇 ≅ 33 𝑐𝑃). 
Figure 4.1a shows a superimposed bright field image of a bead passing through the device at 
a flow rate of 50 µl/min, a frame rate of 42,000 fps was used with an exposure time of ~6.8 
µs. The bead showed no deformation and was used as a control to compare to deformable 
objects (i.e. cells). HL60 (human leukaemia) cells were next deformed under the same flow 
conditions, Figure 4.1 is a superimposed bright field image of a cell passing through the 
device. The image shows that the cells undergo a maximum deformation at the SP of the 
extensional flow. 
The deformation index DI (DI=H/W, equation (3.1)) was used to characterise deformability 
of the beads and HL60 cells at the SP. Figure 4.1c shows histograms of the DI of 205 beads 
and 2653 cells. Results showed a sharp peak at DI=1 for the beads (shown in blue), with the 
average being 𝐷𝐼 ≅ 1.04. This confirmed the monodispersity of the sample and that they are 
an undeformable solid, this also confirmed that the high speed camera settings were 
satisfactory and no motion blur distorted the images which would lead to a skewed 
measurement of DI. The DI of HL60 cells showed a normal distribution (shown in red), which 
was fitted with a Log-normal function with a peak value of 𝑏 = 2.16 ± 0.01 and a FWHM of 




conditions and also shows the heterogeneity of cells resulting in a range of deformability (from 
DI=1 - 4.5).  
 
Figure 4.1 Comparison of the trajectory of a cell in a cross-slot microfluidic device compared to a 
polystyrene bead. (a) Bright field superimposed image of a ~15 µm diameter bead passing through the 
extensional flow junction. The flow rate was 50 µl/min and the beads were suspended in PBS with 0.5% 
(w/v) methyl cellulose (µ≈33 cP). (b) A bright-field image of a HL60 cell passing through a device with 
identical geometry and flow conditions. (c) A histogram of the DI of N=2653 HL60 cells deformed at 
𝑄 = 50 𝜇𝑙/𝑚𝑖𝑛 (shown in red), the data is fitted with a Lognormal function. As a comparison a 
histogram of N=205 beads is overlayed (shown in blue), with the same bin size as the cell data.   
The applied stress leading to deformation at the SP was proportional to the linear velocity of 
particles under flow (equation 2.24). The volumetric flow rate in m3/s can be converted to 
linear velocity in m/s by dividing by  the device channel dimensions, where the linear velocity 
will be a constant value in the inlet and outlet channels (where 𝑣𝑖𝑛𝑙𝑒𝑡 = 𝑣𝑜𝑢𝑡𝑙𝑒𝑡 ) with the 
velocity dropping to ~0 at the SP. The linear velocity of the beads and cells was measured and 
compared to the theoretical values.  
COMSOL Multiphysics was used to model flow in the inlet channel at a range of flow rates 
(5 µl/min to 80 µl/min), details of the model can be found in the appendix. Figure 4.2a shows 
the velocity magnitude through the channel cross-section in the y-z plane, for a volumetric 
flow rate of 5 µl/min where red is the highest velocity and blue the lowest velocity. This shows 
that flow is fastest at the channel centre and 0 at the channel walls. Figure 4.2b shows the 
velocity profile in the x-y plane of the extensional flow junction, including the stagnation point 
where the velocity is 0. The velocity profile across the mid-section of the channel is plotted in 
Figure 4.2c for a range of volumetric flow rates, showing a characteristic parabolic profile. 
From this, the maximum velocity 𝑣𝑚𝑎𝑥 at the channel centre and the average velocity 𝑣𝑎𝑣𝑔 in 
the channel were plotted as a function of volumetric flow rate (µl/min) (Figure 4.3). The linear 




tracking of high-speed videos (described in section 3.4). Figure 4.3, compares the linear 
velocity of beads and HL60 to theoretical values as a function of flow rate, with each dataset 
showing the expected linear relationship (all have 𝑅2 = 0.99). Results show that the velocity 
of HL60 cells as a function of flow rate is the same as the average flow velocity found using 
simulations. This shows that not all cells pass through the centre of the channel, hence why 
𝑣𝐻𝐿60 < 𝑣𝑚𝑎𝑥. For Q>20 µl/min, the polystyrene beads travelled faster than HL60 and 𝑣𝑎𝑣𝑔. 
This may be because the beads are much stiffer (non-deformable) and will be more focused 
toward the channel centre, increasing their average velocity. 
 
Figure 4.2 COMSOL simulations of flow in a cross-slot microfluidic device. (a) A y-z cross-section of 
a microfluidic channel of width 35 µm and height 25µm showing the velocity magnitude when flow 
through the channel is at a rate of 5 µl/min. (b) An x-y cross-section of the extensional flow junction 
showing the velocity magnitude when flow through the inlet and outlet channels and around the 
stagnation point. (c) The parabolic velocity profile through the middle of the channel in the y direction. 





Figure 4.3 The velocity (m/s) as a function of flow rate (µl/min) of polystyrene beads and HL60 cells 
travelling through a rectangular channel. This is compared to simulations used to calculate the fluid 
velocity in the channel, including the maximum velocity down the centre and the average velocity across 
the channel in the y-direction.  
4.1.2 Varying Flow Rate 
Deformability as a function of flow rate was investigated using HL60 cells and 15 µm 
polystyrene beads. Both were suspended in PBS with 0.5% methyl cellulose (shear-dominant 
𝜇 ≅ 33 𝑐𝑃) and the flow rate range was 5 ≤ 𝑄 ≤ 80 𝜇𝑙/𝑚𝑖𝑛. Figure 4.4 shows density scatter 
plots of DI as a function of initial diameter of 1279<n<2653 HL60 cells deformed at different 
flow rates, where red represents the highest density area and dark blue the lowest density area. 
The plots also include the DI of 55<n<507 beads as a function of initial diameter, shown in 
magenta. The mean average DI of cells and beads are marked by dashed lines. Results show 
that the DI of cells increases with flow rate whereas the DI of the rigid beads does not. 
Figure 4.5 shows a graph of average 𝐷𝐼 ± 𝑆𝐸 of cells and beads as a function of flow rate. 
This shows that HL60 deformation increases with flow rate with the trend showing logarithmic 
growth. Do due their inverse relation, this trend can be fitted with an exponential decay 
function (𝑦 = 𝐴𝑒−𝜏𝑥 + 𝑦0) shown in red with 𝑅
2 = 0.99. The DI of beads does not increase 
with flow rates and is ~1 for all flow rates, this dataset is fitted with a linear fit with a fixed 





Figure 4.4 Density scatter plots of DI as a function of initial diameter of HL60 cells deformed at various 
flow rates whilst suspended in PBS with 0.5% (w/v) methyl cellulose. Where red shows the most densely 
populated areas and dark blur the least populated, a dashed line is used to show the average DI. As a 
comparison the DI as a function of initial diameter of ~15.5 µm beads is shown in magenta. The beads 
were passed through the device under the same flow condition, the average DI of the beads is also 
shown with a dashed line. For (a) Q=5 µl/min, (b) Q=20 µl/min, (c) Q=50 µl/min and (d) Q=80 µl/min.  
 
Figure 4.5: A plot of the average DI±SE of HL60 cells deformed over a range of flow rates in a shear-
dominant flow regime (𝜇 ≅ 33 𝑐𝑃). This is fitted with an exponential decay  function, shown in red. As 




4.1.3 Varying Velocity Threshold 
Cells passing through a cross-slot microfluidic device experience a different applied stress 
dependant on their initial position as they traverse the inlet before entering the extensional 
flow junction. An ideal cell would travel at a velocity (vinlet) centrally through the inlet before 
entering the junction and decelerating to a velocity of 0 at the SP, before accelerating into the 
outlet channel and returning to its initial velocity (vinlet=voutlet). However, many cells are not 
central in the channel when entering the extensional flow junction and therefore do not pass 
through the SP. Here, the closer their proximity to the SP the bigger the velocity drop and the 
larger the applied stress on the cell. Cells must be selected which undergo the same applied 
stress, in order to compare measurements made between samples. This can be achieved by 
looking at the velocity profile of each cell traversing the extensional flow junction. 
 
Figure 4.6 The velocity profile of a HL60 cell as it passes through the extensional flow junction of a 
cross-slot microfluidic device, where the volumetric flow rate was 5 µl/min. The cells inlet velocity, 
before it reaches the extensional flow junction, is marked with a dashed line where vinlet=0.127 m/s. The 
cells minimum velocity where it is closest to the SP is marked with a dashed line where vmin=0.007 m/s.  
Figure 4.6 shows an example velocity profile of a cell travelling through the extensional flow 
junction at 5 µl/min, a sine function is fitted (shown in red). The initial velocity of the cell is 
𝑣𝑖𝑛𝑙𝑒𝑡 = 0.127 𝑚/𝑠, which drops to a minimum velocity of 𝑣𝑚𝑖𝑛 = 0.007 𝑚/𝑠 when the cell 
is closest to the SP. The velocity threshold ∆𝑣 is defined by equation 4.1, where ∆𝑣 = 1 
represents cells which decelerate to a velocity of 0 at the SP and ∆𝑣 = 0 represents a cell 









As ∆𝑣 is proportional to applied stress, cells deformed at higher ∆𝑣 deform more and DI 
increases. Figure 4.7 shows an example dataset of the average 𝐷𝐼 ± 𝑆𝐸 as a function of ∆𝑣, 
where only cells deformed with ∆𝑣 greater than this threshold were used for each average. 
The dataset is fitted with a dose-response function (shown in red). For a threshold of ∆𝑣 =
0.50 the average is 𝐷𝐼 = 1.33 ± 0.02. As ∆𝑣 is increased further there is a step increase in DI 
which plateaus at a value ~1.41 (found from the fit), which is significantly larger than 
thresholds of ∆𝑣 < 0.60 and outside the range of error. For thresholds ∆𝑣 > 0.8 the error 
begins to significantly increase due to the reduction of cell deformation events included 
towards the average, without a significant change to the average DI. A threshold of ∆𝑣 =
0.75 was found to be sufficient for distinguishing cells deformed at or near to the SP which 
undergo the same applied stress. Evan through Figure 4.7 shows the plateau region was 
reached at ∆𝑣 = 0.65, adding a 10% increase to  ∆𝑣 = 0.75 ensured measured DI was within 
the plateau region across multiple datasets. Figure 4.7b shows a scatter graph of DI as a 
function of ∆𝑣 for the same dataset, which also demonstrates the general increase in DI as a 
function of ∆𝑣. In this example, the total number of cells was N=433, with a velocity threshold 
of ∆𝑣 = 0.75  the sample size was reduced to N=77 cells (~20%). Only 11 cells had ∆𝑣 >
0.9, which would only leave ~2.5% of the total number of events. 
Throughout the thesis the DI index of different cell samples was measured across flow 
conditions, unless stated otherwise a velocity threshold of ∆𝑣 = 0.75 was used to find the 






Figure 4.7 (a) The average DI±SE of HL60 deformed at 40 µl/min in 0.24% methyl cellulose buffer, as 
a function of Δv threshold. When no threshold is applied the average DI was taken of the entire dataset 
N=433, when using a velocity threshold of Δv the average DI was taken of the remaining cells. (b) A 
scatter graph the DI of the HL60 cells as a function of Δv. The shows a general step increase in DI as 
Δv increases. The threshold chosen as Δv>0.75, which is marked by the dashed line.  
4.1.4 Varying Channel Dimensions 
The channel dimensions of the microfluidic device were varied in order to investigate the 
effect on cell deformation. This was done by changing the height H of the channels and the 
width W of the inlet and outlet channels. Figure 4.8  shows the four device geometries tested 
and includes bright field images of a cell before deformation (in the inlet) and deforming at 
the SP. The device shown by Figure 4.8a has the smallest channel dimensions, where H=25 
µm and W=35 µm. The three other devices have H=35 µm and increasingly wider channel 
widths, the widest being W=65 µm (Figure 4.8d).  
Images for each geometry were taken at flow rate corresponding to deformations occurring at 




as the channel dimensions become more comparable to the size of the cell, there is some 
deformation seen in the inlet channel and cells appears more “bullet-shaped” instead of 
circular. This is the same deformation described by Otto et al. (2015) and is due to shear 
viscous forces acting due to proximity to the channel wall [96]. Previous works have shown 
that deforming cells multiple times can lead to a change in cell deformability [187]. Varying 
channel dimensions allowed investigation into whether any shear-stresses due to confinement 
may change the measured deformability at the SP.  
 
Figure 4.8 Bright field images of HL60 cells deforming at 𝐷𝐼 ≅ 𝐷𝐼𝑚𝑎𝑥 in a shear-dominant flow regime 
(𝜇 ≅ 33 𝑐𝑃).  Cells were deformed in different channel geometries with a given width W and height H, 
where (a) had W=35 µm and H=25 µm, (b) had W=35 µm and H=35 µm, (c) had W=50 µm and H=35 
µm and (d) had W=65 µm and H=35 µm. Scale bars are 20 µm.  
HL60 cells were deformed over a range of flow rates in a shear-dominant flow regime (𝜇 =
33 𝑐𝑃), this was repeated using the four device dimensions described by Figure 4.8. Figure 
4.9a shows a plot of the average DI of HL60 as a function of flow rate for the different datasets, 
which are fitted with an exponential function. To more accurately compare deformability, the 
data was plotted as a function of flow velocity as opposed to flow rate (Figure 4.9b). In the 
shear-regime linear velocity is proportional to applied stress (equation 2.24), so this allowed 
comparison of cell deformability when applying the same stress in different channel 
dimensions. Results show mostly no significant changes in measured deformability due to 
device dimensions. No discernible change or trend could be seen for these geometries; (35 x 
25) µm, (35 x 35) µm and (50 x 35) µm. The largest channel width used (W=65 µm) showed 
some increase in DI for 𝑣 < 0.6 𝑚/𝑠. 
The exponential decay function fitted to each dataset in Figure 4.9 was used to find the 
extrapolated value 𝐷𝐼𝑚𝑎𝑥. Where the trend tends asymptotically towards a maximum value 
𝐷𝐼𝑚𝑎𝑥. Figure 4.10 shows the values of 𝐷𝐼𝑚𝑎𝑥 found for each channel geometry, the averaged 




𝐷𝐼𝑚𝑎𝑥 are within error of each other, and that channel geometry had no effect on the maximum 
cell deformation. Overall, results show that no trend can be seen between increasing channel 
dimensions and changes in measured DI at a set applied stress. This suggests that any initial 
viscous stresses due to channel confinement do not alter the mechanical properties in a way 
that measured DI at the SP is affected. 
 
Figure 4.9 HL60 cells were deformed in microfluidic cross-slot devices at a range of flow rate. The 
flow regime was shear-dominant (µ≈33 cP) and device dimensions are labels channel width W by 
channel height H (W x H µm). (a) A plot of the average DI±SE of HL60 cells as a function of flow rate 
in different device geometries. (b) A plot of the average DI±SE of HL60 cells as a function of flow 





Figure 4.10 A plot of DImax±SE of HL60 cells deformed in microfluidic cross-slot devices with different 
channel dimensions. The dashed line shows the average of the four values, with the SE of the average 
highlighted in grey. This shows all values of DImax are within error of each other.  
Section 4.1.3 described the use of a velocity threshold of ∆𝑣 > 0.75 to discard events which 
do not deform at or near the SP. This thresholding was used for determining the values of DI 
in Figure 4.9 as a function of flow rate. Figure 4.11 shows bar graphs of the percentage of 
events collected which had ∆𝑣 > 0.75 as a function of flow rate for the four geometries. 
Figure 4.11a shows that using the smallest channel dimensions (35 x 25) µm, resulting in 40-
70% of the collected events being included in the calculated of DI. For Q>40 µl/min, >60% 
of events were above the velocity threshold. Figure 4.11b shows that increased channel height 
from 25 µm to 35 µm resulting in <50% of events being above the velocity threshold for all 
flow rates. Here, 30-50% of collected events were included in the calculation of DI. 
Subsequent increases in channel width also led to a general reduction in the % of cells included 
in calculation of DI. Figure 4.11 shows that for the largest channel dimensions (65 x 25) µm, 
<50% of events were above the velocity threshold for all flow rates. Particularly, for Q<60 
µl/min less than 20% of values were above the velocity threshold. 
 In summary, results showed that even if cells experience an increased viscous-shear force due 
to channel confinement, there is no change to measured deformability at the SP when the same 
stress is applied. Figure 4.11 showed that by reducing the channel height and width a higher 
percentage of cells passing through the device are above the velocity threshold (∆𝑣 > 0.75). 
This is expected as increased channel confinement will increase wall effects on the cells. 
Therefore, by using the geometry (35 x 25) µm an increased measurement throughput can be 
achieved. Unless stated otherwise, this is the geometry used for subsequent deformation 





Figure 4.11 Bar graphs showing the percentage number of cell events with ∆𝑣 > 0.75 when HL60 cells 
were deformed microfluidically at a range of flow rates, for different channel dimensions. Cell events 
with ∆𝑣 < 0.75  were discarded and not used for calculating DI. This was calculated for channels of 
(a) (35x25) µm, (b) (35x35) µm, (c) (50x25) µm and (d) (65x25) µm.  
4.2 Cell deformation across flow regimes 
4.2.1 Varying suspension buffer viscosity 
HL60 cells were deformed in a cross-slot microfluidic device as the SP of an extensional flow 
junction. Their deformability was measured using the deformation index DI when the cell is 
at or near the SP. A range of stresses were applied to the cells by changing the cell velocity 
and the viscosity of the buffer the cells were suspended in. 
Figure 4.12a shows DI as a function of flow rate Q for four viscosities of suspension buffer 
which were; PBS (1 cP), PBS with 0.24% methyl cellulose (11.1 ± 0.1 𝑐𝑃), PBS with 0.35% 
methyl cellulose (23.8 ± 0.1 𝑐𝑃) and PBS with 0.5% methyl cellulose (33.4 ± 0.3 𝑐𝑃). A 
rheometer was used to measure the viscosities, this data can be found in the appendix (Figure 
S1). Here, the range of Q was 0-400 µl/min for the lowest viscosity suspension buffer. At 
higher viscosities the maximum Q was limited, the back pressure in the channels increased 
with viscosity which lead to device failure (leakages or device delamination) at higher flow 
rates. For each dataset, DI increases asymptotically toward a maximal deformation value 




fitting had an 𝑅2 ≥ 0.98. Figure 4.12b shows an image of cell deforming at ~𝐷𝐼𝑚𝑎𝑥 for each 
dataset, accompanied by a superimposed colour contour plot. This shows how deformation 
varies as a function of time, going from blue where the cell approaches the extensional flow 
junction to red where deformation occurs at the SP. 
 
Figure 4.12 DI as a function of Q for HL60 cells in four different suspension buffers with viscosity 
ranging from 1 to 33 cP.  𝐷𝐼 ± 𝑆𝐸 was averaged from multiple cell events combined from N=3 repeats; 
each data point includes 30 > n > 500 cell events. Each data set is fitted with an exponential decay 
function. (b) Images of a cell deformation for each flow condition where 𝐷𝐼 ≅ 𝐷𝐼𝑚𝑎𝑥. They are 
accompanied by superimposed color contour plots that show how the cell shape changes as a function 
of time.  
Section 2.5.3 discussed how two distinct flow regimes, shear and inertial, can be defined. 
Where 𝑅𝑒 > 40 defines the beginning of the inertial regime. This shows that the low viscosity 
dataset (1 cP) occurs in the inertial regime, whereas the other three datasets move increasingly 
into the shear regime as viscosity is increased. In the inertia-dominant regime (𝜇 = 1 𝑐𝑃), the 
Reynolds number is 𝑅𝑒 > 40 for 𝑄 > 11 μ𝑙/𝑚𝑖𝑛. In the most shear-dominant regime (𝜇 =
33.4 𝑐𝑃), the Reynolds number is 𝑅𝑒 < 6 for the entire range of flow rates. Supporting video 
1 shows examples of HL60 deforming in this regime at Q=80 µl/min. Figure 4.13 shows that 
𝐷𝐼𝑚𝑎𝑥 increased linearly as a function of suspension buffer viscosity. This indicates that as 
the flow regime becomes more shear dominant, higher cell deformations can be achieved for 
lower flow rates. Additionally, Figure 4.12b shows that as flow regime becomes more shear 
dominant the cell shape at maximal deformation changes from elliptical at low viscosity to 





The low Reynolds number and increasingly shear-dominant regime is indicative of the 
observed change in shape. 
 
Figure 4.13 A graph of the extrapolated value DImax associated with the deformability of HL60 cells as 
a function of flow rate for four different viscosities of suspension buffer. DImax varies linearly as a 
function of viscosity.  
4.2.2 Inertial Regime 
Measurements of DI in the inertial regime (µ= 1 cP) were extended to Q=600 µl/min, shown 
by Figure 4.14. As discussed in the previous section, for Q≤400 µl/min the DI tended towards 
a plateau value DImax. For Q≥400 µl/min, DI increased nonlinearly until Q=600 µl/min. For 
Q>600 µl/min the cells begin to rupture and visibly break apart at the extensional flow 
junction, and DI could no longer be measured. Figure 4.14 includes example images of cells 
deforming at the SP at different flow rates. The deformations at 50 µl/min and 300 µl/min are 
both relatively low and show an ellipsoidal shape which is characteristic of an inertia-
dominant regime. Comparatively, the cell is highly strained at 600 µl/min and shows sharply 
pointed ends. This is further indication of the change in trend seen for flow rates above and 
below 𝑄 = 400 𝜇𝑙/𝑚𝑖𝑛. 
The stress corresponding to a flow rate of 400 µl/min was thus defined as the yield stress of 
the cell. The yield stress is thought to be associated with the breakdown of the cells internal 
structure (such as actin depolymerisation), leading to the sudden nonlinear increase in 
deformation at higher applied stresses. Supporting videos 2-4 show examples of HL60 
deforming at flow rates below the yield stress (Q=200 µl/min), at the yield stress (Q=400 
µl/min) and above the yield stress (Q=600 µl/min). The flow rate Q=600 µl/min was defined 
as the cell’s failure point which has an associated maximum strain of the cell before rupture, 




point are suggestive of the ability of cells to recovery post deformation, and their subsequent 
viability. These values may also be useful parameters for distinguishing between cell types.  
 
Figure 4.14 The average DI±SE of HL60 cells versus Q, in an inertial-dominant flow regime (µ= 1 cP).  
DI was averaged from multiple cell events combined from N=3 repeats; each data point includes 30 > 
n > 500 cell events. For Q≤400 µl/min the dataset was fitted with an exponential decay function, to 
extrapolate the value DImax, shown by the dashed line. The entire dataset is fitted with a third order 
polynomial function, shown by the black line.  
4.2.3 Deformation as a function of force 
Figure 4.12 and Figure 4.13 introduced four datasets of HL60 cells deformed over a range of 
flow rates suspending in four different viscosities of suspension buffer. These results showed 
that lower flow rates can be used to achieve higher strains when the regime is more shear-
dominant (i.e. high viscosity and low Re). However, an inertia-dominant regime showed a 
unique behaviour where high-strain deformations can be achieved above an associated yield 
stress of the cell.  
The different mechanical responses of cells dependent on flow regime was further investigated 
by plotting DI as a function of force instead of flow rate (Figure 4.15). The total force on the 
cell (FT) was calculated using equations 2.23 and 2.24 which sums the shear and inertial 
contributions of force. Figure 4.15 shows that for the same total force, FT, the cells were 
generally more deformable in a shear-dominant regime. As the regime becomes more shear-
dominant the same force can be applied at lower flow rates, thus the magnitude of the force is 
the same but the time over which the stress is applied increases (lower strain rate). Therefore, 
the cells show a stiffening behaviour which means that if the same force is applied more 
quickly the subsequent strain is lower. Cells are inherently viscoelastic and are known to 










However, this strain-stiffening is only observed for forces below the previously defined yield 
stress behaviour seen in the inertia-dominant regime. The yield stress is equivalent to 𝐹𝑇 =
0.58 𝜇𝑁, below this DI is greater in the shear-regime at the same applied force. For 𝐹𝑇 >
0.58 𝜇𝑁, the DI begins to surpass that of the shear regime. This coincides with the sub-
structural breakdown, leading to softening of the cells. 
 
Figure 4.15 The DI of HL60 cells as a function of applied force (µN), where 𝐹𝑇 is the sum of the shear 
force (𝐹𝑠) and inertial force (𝐹𝐶). The four datasets vary the viscosity of the cell suspension buffer, 
ranging from 1 cP (where the inertial force dominates (𝐹𝑇) to 33 cP (where the shear force 
dominates 𝐹𝑇). DI was averaged from multiple cell events combined from N=3 repeats, each data point 
includes 30 > n > 500 cell events.  
4.3 Cell viability after deformation 
4.3.1 Shear Regime 
The viability of cells was measured post-deformation at the SP of a cross-slot microfluidic 
device. HL60 cells were deformed in a shear-dominant flow regime (using PBS with 0.5% 
w/v of methyl cellulose (𝜇 = 33 𝑐𝑃) over a range of flow rates Q.  
Samples were collected off-chip and a trypan blue viability assay was performed (described 
in section 3.6.5). Before performing the assay, cells were centrifuged to a pellet at 100 g for 5 
mins and resuspended in PBS. Each deformed sample was accompanied by a control sample, 
which derived from the same initial sample but did not undergo any microfluidic deformation. 
Controls were outside of the incubator for the same time period as deformed samples and went 
through the same centrifugation and resuspension steps. This was to ensure that any observed 
viability drop was due only to microfluidic deformations, and not due to stresses associated 
with resuspending cells in a buffer of higher viscosity. Results are summarised by Figure 4.16, 




in this regime over the entire range of flow conditions. The viability remained >95% for the 
range of flow rates, which encompass the flow rates used for measuring DI in the shear-
dominant regime throughout the thesis.  
 
Figure 4.16 The viability of HL60 cells after being deformed on-chip over a range of flow rates, where 
the flow regime was shear dominant (𝜇 ≅ 33 𝑐𝑃). Here, the viability of the deformed sample is 
normalised to a control sample which was not deformed to ensure any changes were only due to 
microfluidic deformation. Results show that the viability did not drop significantly and was >95% for 
the entire range of flow rates.  
4.3.2 Inertial Regime 
Cell viability was measured post-deformation at the SP of a cross-slot microfluidic device, 
where HL60 cells were deformed in an inertia-dominant flow regime (suspended in PBS, 𝜇 =
1 𝑐𝑃) over a range of flow rates Q. Trypan blue viability assays were performed on samples 
collected off-chip. A control sample accompanied each deformed sample, the control sample 
derived from the same initial sample and was out of the incubator for the same time period 
but was not deformed on-chip. Figure 4.17 shows that there was no significant change in 
viability for 𝑄 ≤ 600 μ𝑙/𝑚𝑖𝑛, where viability remained >90% for this range of flow rates. 
For 𝑄 > 600 μ𝑙/𝑚𝑖𝑛,  the viability dropped to <50%. This substantial viability drop occurs 
for flow rates above the failure point where cell rupture was observed during microfluidic 
deformation. 
Figure 4.18a shows phase contrast images of HL60 cells collected after deformation at 600 
µl/min and 800 µl/min and a sample which was not deformed. The control and 600 µl/min 
sample show a similar rounded morphology, whereas the 800 µl/min sample shows a 
significant reduction in rounded cells and an increase in cell debris, potentially from internal 




post-deformation was measured from these images by calculation of the circularity DC (using 
equation (3.3 shown by Figure 4.18b). A perfect circle has 𝐷𝐶 = 0, and shapes which deviate 
from a perfect circle have 𝐷𝐶 > 0. The control and 600 µl/min samples have relatively low 
values of DC with average values of 𝐷𝐶 = 0.18 ± 0.08 and 𝐷𝐶 = 0.17 ± 0.09. The 800 µl/min 
sample shows a general increase in scatter of Dc with a population remaining similar to the 
control and a second population with 𝐷𝐶 > 0.2 corresponding to the increase in cell debris. 
These results validate that for 𝑄 > 600 𝜇𝑙/𝑚𝑖𝑛 a drop in viability is associated with on-chip 
cell destruction leading to some cells not recovering their original shape. 
The failure point of HL60 cells (𝑄 = 600 𝜇𝑙/min ) represents a limit below which live cells 
could be mechanically phenotyped by on-chip deformation and then collected for potential 
further studies, such as chemical phenotyping via Raman spectroscopy [2] or gene sequencing. 
 
Figure 4.17 The viability of HL60 cells after microfluidic deformation at a range of flow rates Q (blue) 
in the inertial regime (µ=1 cP), compared to a control which was not deformed (red). The viability 






Figure 4.18 Shape analysis of HL60 post-deformation. (a) Phase contrast images of HL60 cells post-
deformation in the inertial regime (µ= 1 cP). Scale bar 40 µm. (b) Density scatter plots of HL60 cell 
shape, using Dc as a function of diameter, comparing cells which were not deformed to those which 
were deformed at 600 µl/min and 800 µl/min.  
4.4 Tracking cell deformation and recovery 
4.4.1 Single cell tracking in the shear regime 
The on-chip deformation and recovery of HL60 cells was tracked as cells passed through the 
SP of an extensional flow junction. Here, cell shape was measured using strain 𝜀 = (𝐻 −
𝑊)/(𝐻 +𝑊), where H is the height of the cell and W is the width of the cell, introduced in 
section 3.4 by equation (3.2).  
Figure 4.19a shows the average ɛ of N=50 cells as a function of time, deformed at a flow rate 
of 5 µl/min in a shear dominant regime (µ=33 cP). A low-velocity and shear-dominant regime 
was chosen for tracking deformation and recovery, as this allowed a reduced frame rate (7000 
fps) and a maximized field of view for operation of the high-speed camera (discussed in 
section 3.4.2). Supporting video 5 shows examples of HL60 deforming under these conditions. 
The sign of the strain value describes the cell direction, which changes as the cell moves from 
the inlet to the outlet as they are perpendicular to each other, whereas magnitude describes the 
amount the cell is strained.  
Figure 4.19b shows a superimposed bright field image of a cell as it moves through the inlet 
channel, deforms at the SP, and then recovers to its original shape in the outlet channel. The 
strain trace in Figure 4.19a shows that as cells traversed from the inlet to the SP there was an 
increase in ɛ; this was fitted with an exponential decay function with an associated deformation 
time 𝜏𝑑. The strain ɛ continued to increase as the cell moved from the SP to the outlet, reaching 

























decreased exponentially with a relaxation time 𝜏𝑟. The initial strain (before the cell entered 
the extensional flow junction) 𝜀0 was also found and compared to the final strain 𝜀∞, found 
by extrapolation of the exponential function fitted to the relaxation. 
 
Figure 4.19 (a) Strain, ε, as a function of time, averaged over 50 HL60 cells, with the standard error 
shown in gray. Q was fixed at 5 µl/min, and the suspension medium viscosity was 33 cP. The exponential 
fits shown in red were used to quantify the deformation and relaxation of the cells. (b) A superimposed 
brightfield image of a cell as it deforms and relaxes at 5 µl/min (µ≈33 cP) is shown. Scale bars, 30 µm. 
The arrows indicate the direction of cell motion.  
Figure 4.20 compares the average strain profile to the velocity profile of the cells. The velocity 
profile can be approximated as a single period of a sine wave, as discussed in section 4.1.3, 
which is fitted in red to Figure 4.20a with 𝑅2 = 0.99. A cell is closest to the SP when the 
velocity profile is at a minimum, occurring here at ∆v ≅ 0.025 m/s. Figure 4.20b shows that 
the sine-oscillating Kelvin-Voigt model (equation 2.13) can be fitted to the strain trace, this 
shown in red and 𝑅2 = 0.98. The sine-oscillating Kelvin-Voigt model (discussed in section 
2.3.4) was equated to find the elastic modulus of HL60 to be 𝐸 = (0.30 ± 0.03) 𝑘𝑃𝑎. 





Figure 4.20 (a) The average velocity profile of N=50 HL60 cells as they pass through the SP of the 
cross flow. A sine function is fitted, shown in red. (b) The strain profile of the same 50 cells, the Kelvin-
Voigt model was fitted, both shown in red. Q was 5 µl/min and viscosity was µ=33 cP.  
Multiple parameters were extracted from the average strain trace shown by Figure 4.19, these 
are summarised in Table 4.1. However, cells are known to be heterogeneous and their 
mechanical properties may change depending on their stage in the cell cycle. Bulk 
measurements, using averaging, on heterogeneous samples often miss any subpopulations 
within a large sample. Also, bulk measurements cannot make correlations between specific 
parameters (e.g. whether larger cells have a larger maximum strain). Therefore, single cell 
analysis (SCA) was also performed on the N=50 HL60 strain traces to elucidate any 
advantages of SCA compared to bulk averaging. Appendix Figure S2 shows the raw data of 
the N=50 HL60 strain traces. 
Figure 4.21 shows example of four individual strain traces of HL60 cells, these were used to 
perform single cell analysis. A Sativsky-Golay filter was applied to each strain trace, shown 
by the black line of the traces, this was used to remove noise from the signal and to find a 
more accurate value of 𝜀𝑚𝑎𝑥. An exponential decay function was fitted to the trace, from 5 
data points after 𝜀𝑚𝑎𝑥 occurred until the last datapoint. The fit was used to extract 𝜏𝑟 and 𝜀∞ 
for each cell. The initial strain 𝜀0 of each cell was found by averaging the first 5 datapoints, 






diameter A of each cell was also found, by averaging the cell diameter for the first 5 datapoints 
of each trace (before any deformation occurred). 
 
Figure 4.21 Examples of 4 strain traces of HL60 cells deforming in the extensional flow junction of a 
microfluidic cross-slot device. Sativsky-Golay filtering was applied to the datasets (shown by the black 
line) and used to find the maximum strain 𝜀𝑚𝑎𝑥. An exponential function was fitted to the strain recovery 
and using to find the relaxation time 𝜏𝑟 and final strain 𝜀∞.  
Table 4.1 Multiple characteristic parameters extracted from the strain traces of N=50 cells. Including 
the initial cell diameter A, the initial strain ε0, the final strain ε∞, the maximum strain εmax, the 
deformation time τd, the relaxation time τd and the elastic modulus E. Two analysis methods were used 
and the resulting values were compared: 1. the N=50 strain traces were averaged and values were 
extracted, “Averaged Strain Trace” and 2. values were separately found from individual traces and 
then averaged with ±SE, “Single Cell Analysis”.
 Averaged Strain Trace Single Cell Analysis 
A (µm) n/a 12.3±0.2 
ε0 -0.012±0.004 -0.012±0.005 
ε∞ 0.030±0.009 0.030±0.004 
εmax 0.18±0.01 0.18±0.01 
τr (ms) 3.52±0.14 3.04±0.15 
τd (ms) 1.04±0.05 n/a 
E (Pa) 301±29 n/a 
The values for 𝜀𝑚𝑎𝑥, 𝜀0, 𝜀∞ and 𝜏𝑟 using SCA were compared to those found from the 
averaged strain trace, summarised in Table 4.1. This shows that the extracted values from both 




calculated from the averaged strain trace compared to SCA. Four of the individual traces could 
not be fitted sufficiently with an exponential, which may account for the small difference seen 
in 𝜏𝑟. 
Figure 4.22 shows histograms of the values found for 5 single cell parameters extracted from 
the individual strain traces of HL60 cells. A normal distribution is seen for: A, 𝜀𝑚𝑎𝑥, 𝜀0 and 
𝜏𝑟, and these were fitted with a Gaussian function (shown in black) with 0.85 > 𝑅
2 > 0.94. 
The average 𝜀0 using SCA has a magnitude of 0.012, likely due to some shear confinement 
between the cell and the channel walls, this relatively small compared to 𝜀𝑚𝑎𝑥 which is ~15 
times smaller than 𝜀0. An elastic material would recover fully after stress is removed and 
have 𝜀∞ = 𝜀0, however HL60 are shown to have a final strain of 0.030 which is more than 
double the initial strain. The fact the cells do not fully recover suggests either a viscoelastic 
effect where subsequent relaxations occur over timescales not within our field of view, or that 
the applied stress results in a permanent strain due to cell plasticity. Additionally, the 
histogram shown by Figure 4.22e may offer more insight into shape recovery. Unlike the other 
parameters, 𝜀∞ does not show a normal distribution and cannot be fitted with a Gaussian. 
Here, the majority of values fall in the 0-0.02 range, which is the same for the 𝜀0 histogram 
(Figure 4.22b). Figure 4.22e suggests smaller populations of cells do not recover and undergo 
some permanent strain.  
These results show the potential advantages of using SCA analysis for elucidating the 
mechanical response of cells to applied force. Histograms of the single cell properties allow 
visualisation of the sample heterogeneity and whether the parameters follow a normal 
distribution, information not provided by bulk analysis. For example, (a) to (d) follow a normal 
distribution which would allow extraction of the Gaussian peak value, standard deviation and 
coefficient of variation (𝐶𝑉 = 𝑆𝐷/𝑚𝑒𝑎𝑛). Further, increased sample sizes may allow 






Figure 4.22 Histograms of the single cell parameters extracted from strain traces of N=50 HL60 cells 
deformed in the shear-dominant regime (𝜇 = 33 𝑐𝑃) at a flow rate of 5 µl/min. Fitted Gaussian 
functions are shown in black. Where (a) shows the initial diameter A, (b) the initial strains 𝜀0, (c) the 
maximum strain 𝜀𝑚𝑎𝑥, (d) the relaxation time 𝜏𝑟 and (e) the final strain 𝜀∞.  
4.4.2 High strain recovery in the shear regime 
The previous section discussed the deformation and recovery of HL60 in a cross-slot 
microfluidic device, in a low-velocity (5 µl/min) and high viscosity (33 cP) flow regime. This 
resulted in generally low maximum strains being applied to the cells (𝜀𝑚𝑎𝑥 ≅ 0.18 𝑎𝑛𝑑 𝐷𝐼 ≅
1.61). Figure 4.12 and Figure 4.14 showed that the trend in mechanical response can change 
between a low-strain and high-strain regime. To elucidate this, the recovery of HL60 cells 
deformed in a high-strain regime was also studied. Here, a higher flow rate of 150 µl/min was 
used in a suspension buffer viscosity of 𝜇 ≅ 33 𝑐𝑃. This required capturing videos at a frame 
rate of 150,000 fps at a resolution of 320 x 192 pixels. This field of view was not enough for 
capturing both deformation and recovery. Therefore, instead of acquiring single cell strain 









Figure 4.23 Schematic and bright field images of cell recovery after deformation at the SP of a cross-
slot device. (a) A schematic showing the different positions at which the DI of cells was measured. This 
includes the inlet (before deformation), the stagnation point SP (where maximum stress is applied due 
to extensional flow), and various positions along the outlet (to track recovery) which were labelled 
positions 1-18. The maximum distance down the outlet where the cells DI was measured (P18) was 
~2500 µm from the SP. (b) Example bright field images of cells at the different positions, where the 
flow rate was 150 µl/min and the flow regime was shear-dominant (µ≈33 cP). Scale bars 20 µm.  
Figure 4.23a shows a schematic which highlights the various positions that deformation was 
measured on-chip, including the inlet (before deformation), at the SP, and various positions 
down the outlet. The outlet had equally spaced positions labelled number 1-18, which were a 
design feature to allow capture of DI at known distances from the SP. Figure 4.23b shows 
example images of cells captured at the different positions. At the inlet cells underwent a 
relatively small bullet-like deformation due to confinement, at the SP the cells experienced a 
high-strain and became tear-drop shaped, and through the outlet the amount of strain decreases 
with distance from the SP. The DI of 100s-1000s of cells was measured at each of these 
positions, the averaged value of DI as a function of position are shown in Figure 4.24. Here, 
no velocity thresholding was applied and all cells which passed through the device were 
included in the final averages. This was because thresholding could not be applied to bulk DI 
measurements collected after the SP, as this requires single-cell velocity profiles in the 
extensional flow junction. 
 Results show that the initial deformation in the inlet (before the cell enters the extensional 
flow junction) was 𝐷𝐼0 = 1.34 ± 0.02 and the maximum deformation at the SP was 𝐷𝐼 =
2.14 ± 0.08. The recovery of the cell as it moves through the outlet (positions 1-18) was fitted 
with an exponential function (shown in red), the full distance which was tracked was ~2556 




shape recovered fully then 𝐷𝐼∞ = 𝐷𝐼0. Here, 𝐷𝐼∞ > 𝐷𝐼0 suggesting some permanent strain 
due to the applied stress at the SP.  
Low-strain and high-strain recovery both showed a permanent strain due to the applied stress 
(Figure 4.20 and Figure 4.24). This allowed comparison of the change in initial and final 
strains after low-strain recovery and high-strain recovery. The strain change was defined by 
normalising the change between final and initial strain by the maximum strain ∆𝜀 = (|𝜀∞| −
|𝜀0|)/𝜀𝑚𝑎𝑥. After low-strain recovery the strain change was ∆𝜀 = 0.10 ± 0.05, and after 
high-strain recovery it was ∆𝜀 = 0.14 ± 0.01. These values are within error of each other 
suggesting that applying both low and high-strains to cells in the shear-dominant regime 
results in a characteristic strain change representative of plasticity after deformation. The 
histogram of 𝜀∞ values after low-strain recovery (Figure 4.22e) showed that most cells recover 
back to their initial strain 𝜀0 with a smaller population not recovering, resulting in an average 
value with 𝜀∞ > 𝜀0. This highlights the importance of single-cell analysis vs bulk averaging, 
as averaging suggests all cells do not recover. This was investigated after high-strain recovery 
by plotting histograms of DI at various positions to see if recovery followed a normal 
distribution. 
 
Figure 4.24 The DI±SE of HL60 cells as a function of position in a cross-slot device (𝜇 ≅ 33 𝑐𝑃), 
averaged from multiple cell events combined from N=3 repeats; Where the flow rate was 150 µl/min 
and flow was shear-dominant.  
Figure 4.25 shows histograms of the DI of HL60 cells deformed at different positions in the 
device. Each dataset was expected to show a normal distribution and was fitted with a 
Gaussian function, which allowed calculation of the position at the centre of the peak b and 




(b) the SP, (c) position1 and (d) at position 18. For each position, the experiment was repeated 
three times and each dataset is shown. The FWHM of the curves fitted to the inlet datasets 
(Figure 4.25a) is 𝑤 = 0.23 ± 0.01. Comparatively, at the SP 𝑤 = 0.80 ± 0.03 which is a ~3.5 
fold increase. This is expected as cells are inherently heterogeneous, and have different 
deformability’s depending on their initial size and stage in the cell cycle. At P18 (~2500µm) 
from the SP into the inlet channel, 𝑤 = 0.31 ± 0.05 suggesting the cells are near to full 
recovery. 
Figure 4.25b shows that for two of the repeats there was a smaller peak at DI~1 as well as the 
larger peak at DI>1.5. This could be due to the fact that no velocity threshold was used here, 
and this peak could represent cells which did not pass near to the SP and thus did not deform. 
It could also suggest a small population of cells were less deformable. For example, apoptotic 
cells are known to be less deformable and therefore these could be cells in early stages of 
apoptosis [188], [189]. Finally, all the values of the peak centres b shown in Figure 4.25 are 
less than the averaged DI values shown in Figure 4.24. The reason for this is apparent in the 
histograms. Even though a Gaussian function is fitted, many of the datasets show a log normal 
distribution. Thus, even though the majority of cell DI’s occur at b, the skew to the right of b 






Figure 4.25 Histograms of the DI of HL60 cells at various positions in a cross-slot microfluidic device 
which were deformed in a shear-dominant regime (𝜇 ≅ 33 𝑐𝑃) at 150 µl/min, each dataset shows a 
normal distribution and is fitted with a Gaussian function, where b is the position at the centre of the 
Gaussian peak and w is the full width at half maximum. For each position, the experiment was repeated 
three times, where (a) is the DI at the inlet position, (b) the SP, (c) at position 1 which was ~140 µm 
into the outlet channel and (d) at position 18 which was ~2500 µm into the outlet channel.  
4.4.3 High strain recovery in the inertial regime 
The recovery of HL60 cells has been discussed after low-strain and high-strain deformations 
in a shear-dominant regime. Figure 4.15 showed that high-strains can also be achieved in an 
inertia-dominant regime, and that this regime seems to show yield stress behaviour (not seen 
in the shear-regime). This may indicate that cells deformed to high-strains in an inertia-





To investigate high-strain recovery in the inertia-dominant regime, cells were deformed at 600 
µl/min whilst suspended in PBS buffer (𝜇 ≅ 1 𝑐𝑃). The average DI of 100s-1000s of cell was 
measured at different positions, including the inlet, SP and outlet (as described in section 
4.4.2). Figure 4.26 shows example images of cells deforming at the inlet (before the applied 
stress), at the SP (where maximum applied stress occurs) and at various positions through the 
outlet (after the applied stress is removed). Images show that the cell is relatively undeformed 
in the inlet, incurs a high-strain at the SP and P1, then the strain begins to decrease at positions 
further from the SP. 
 
Figure 4.26 Example bright field images of cells in the cross-slot device at the different positions, where 
the flow rate was 600 µl/min and the flow regime was inertia-dominant (µ≈1 cP).  
Figure 4.27 shows the 𝐷𝐼 as a function of these positions. The cell recovery at different 
positions through the outlet was fitted with an exponential decay function (shown in red), 
which is similar to the results for the shear-dominant regime (Figure 4.24). Here, the initial 
deformation was 𝐷𝐼0 = 1.17 ± 0.02, the final deformation was 𝐷𝐼∞ = 1.46 ± 0.04 and the 
deformation at the SP was 𝐷𝐼𝑆𝑃 = 1.81 ± 0.07. As with the low-strain and high-strain shear-
dominant regimes, this also showed some permanent strain (𝐷𝐼∞ > 𝐷𝐼0). Interestingly, in this 
regime the maximum deformation occurred after the SP and at position 1 (𝐷𝐼𝑃1 = 2.15 ±
0.30) and also showed a ~4 fold increase in the standard error compared to the 𝐷𝐼𝑆𝑃. This 
behaviour may be indicative of this deformation occurring above the yield stress. Cells are 
known to be viscoelastic, and if destruction of the subcellular structure has occurred the cell 
may begin to behave more like a viscoelastic liquid resulting in the material “flowing” even 
after the applied stress is reduced.  
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Figure 4.27 The DI±SE of HL60 cells as a function of position in a cross-slot device (𝜇 ≅ 1𝑐𝑃), 
averaged from multiple cell events combined from N=3 repeats; Where the flow rate was 600 µl/min 
and flow was inertia-dominant.  
Figure 4.28 shows histograms of the DI of HL60 cells deformed at 600 µl/min in the inertia-
dominant regime as different positions in the device. Each dataset was fitted with a Gaussian 
function which was used to find the position of the peak centre b and the FWHM w. The 
experiment was repeated three times and all datasets are shown for each position, where: (a) 
is the inlet position, (b) the SP, (c) position 1 and (d) position 18 which was ~2500 µm from 
the SP into the outlet. The average FWHM of the curves for the inlet datasets (Figure 4.28a) 
was 𝑤 = 0.14 ± 0.02, which increase ~5 fold at the SP (Figure 4.28b) where 𝑤 = 0.75 ±
0.22. The spread of data at position 1 was similar to the SP 𝑤 = 0.78 ± 0.23, and at position 
18 𝑤 = 0.23 ± 0.04 showing that cells were near to recovery.  
Similar to behaviour in high-strain recovery in the shear-dominant regime (Figure 4.25), some 
of the average values of the peak centre b were less than the mean averaged DI shown in Figure 
4.27. For the inlet, 𝑏 = ±1.17 ± 0.01 which is within error of the average DI at this position 
𝐷𝐼0 = 1.17 ± 0.02. At the SP the average  𝑏 = ±1.52 ± 0.01 is significantly less than the 
average 𝐷𝐼𝑆𝑃 = 1.81 ± 0.07. Once again, Figure 4.28b shows a skewed distribution which 
may be better represented by log normal than a Gaussian function. This shows that even 
though the majority of cells deform with DI=b, more than 50% of cells have DI>b resulting 
in the mean average being 𝐷𝐼𝑆𝑃 > 𝑏. Figure 4.28d shows that at position 18 𝑏 = 1.25 ± 0.04 
which is also significantly different to the mean average 𝐷𝐼∞ = 1.46 ± 0.04. The histograms 
show that the majority of cells recover to their initial shape (DI~1.17), however, some cells 
remain deformed 2-3 times as much as this. This suggests that a small population of cells 
undergo a permanent strain after applied stress. As measurements are done by bulk averaging 




underwent the highest deformations at the SP. This regime occurs above the yield stress and 
before the failure point which suggests that even though these cells show permanent strains, 
they are able to recover over longer time periods and no viability drop was detected using a 
trypan blue viability assay (Figure 4.17). 
 
Figure 4.28 Histograms of the DI of HL60 cells at various positions in a cross-slot microfluidic device 
which were deformed in a inertia-dominant regime (𝜇 ≅ 1 𝑐𝑃) at 600 µl/min, each dataset shows a 
normal distribution and is fitted with a Gaussian function, where b is the position at the centre of the 
Gaussian peak and w is the full width at half maximum. For each position, the experiment was repeated 
three times, where (a) is the DI at the inlet position, (b) the SP, (c) at position 1 which was ~140 µm 
into the outlet channel and (d) at position 18 which was ~2500 µm into the outlet channel.  
4.4.4 Summary of section 4.4 
Figure 4.29 shows the summarised data from Figure 4.24 and Figure 4.27, showing the DI of 
the cells replotted as a function of time as they recover whilst travelling down the outlet. Here, 




other. The graph shows that the cells in the shear regime relax at a slower rate than the inertial 
regime, and their final deformation 𝐷𝐼∞ is larger than the inertial regime. 
As the flow rate in the inertial-regime was 4 times faster than the shear regime, the strain-rate 
and relaxation times should reflect this. Table 4.2 confirms that the strain-rate in the inertial 
regime was ~ 4 times that of the shear regime. However, the relaxation time in the inertial 
regime was ~6 times quicker than that of the shear regime. The slower relative relaxation time 
in the shear-regime may be indicative of the viscous element of cells (known to be 
viscoelastic) which may also explain why the cells do not recover their original shape as much 
as in the inertial regime. Quicker strain-rates are likely probing the cell elasticity whereas 
slower strain-rates may lead to some viscous flow. 
 
Figure 4.29 The DI±SE of HL60 cells as a function of time in a cross-slot device as cells recover through 
the outlet after deformation at the SP, averaged from multiple cell events combined from N=3 repeats. 
Comparing deformation in an inertia-dominant regime (Q= 600 µl/min and 𝜇 ≅ 1 𝑐𝑃) to a shear-
dominant regime (Q= 150 µl/min and 𝜇 ≅ 33 𝑐𝑃).  
Table 4.2 A summary of the strain rate and relaxation time of HL60 cells after deformation at the SP 
of an extensional flow, in the shear-dominant regime (Q= 150 µl/min and 𝜇 ≅ 33 𝑐𝑃)  and the inertia-
dominant regime (Q= 600 µl/min and 𝜇 ≅ 1 𝑐𝑃).
 Regime Strain Rate x105 (s-1) 𝜏𝑟 x10
-4 (s) 
Shear 1.63 1.51±0.35  
Inertial 6.53 0.25±0.08 
4.5 Discussion 
The aim of this chapter was to show that a microfluidic cross-slot device could be used to 
measure the deformation properties of HL60 cells over a wide-range of flow conditions in two 
flow regimes, showing the method has potential for the mechanical phenotyping of cells and 




Cells were deformed in two distinct flow regimes: a shear-dominant regime working at low 
Re, low Q, and increased suspension buffer viscosity µ, and an inertia-dominant regime 
working at Re>40, high Q and low µ. Results showed that using a shear-dominant regime 
could achieve higher cell deformations for the same applied force (showing cell viscoelastic 
stiffening behaviour). The inertia-dominant regime also showed a non-linear increase in 
deformation at Q>400 µl/min, which was defined as the cell yield stress and is associated to 
sub-structural breakdown. Further, the failure point of HL60 cells was found to be 600 µl/min 
as it resulted in on-chip cell destruction and a drop in subsequent viability. Comparatively, in 
both flow regimes cells remained viable after deformation (even above the yield stress but 
before the failure point). 
A low-strain shear-dominant regime was used to capture “strain traces” of HL60 cells, which 
showed the variation in cell shape from steady-state in the inlet to passing through the SP and 
relaxation through the outlet channel. Figure 4.19 showed strain as a function of time which 
was used to find multiple characteristic mechanical cell parameters. Particularly, the elastic 
modulus of HL60 was found to be 𝐸 = 0.30 ± 0.03 𝑘𝑃𝑎 using an adapted Kelvin-Voigt 
model. Table 4.3 shows a summary of other values of E reported for HL60 using a variety of 
techniques utilising different applied stresses and strain rates [1], [34], [190]–[192].  
Mietke et al. 2015 measured the modulus of HL60 using both AFM and microfluidics by 
shear-confinement, their value using microfluidics was ~8 times larger than for AFM [34]. 
They attributed this to the shorter timescales used to apply strain in microfluidics (~1 ms), 
compared to AFM, inducing a stiffening response in the cells. However, our result found using 
extensional flow microfluidics is closer to the reported AFM value even though the strain-rate 
was closer to that of shear-confinement (~2 ms). This suggests that strain-rate is not the only 
factor responsible for differences in measured elastic modulus.  Additionally, Rosenbluth et 
al. (2006) also used AFM to measure elastic modulus and this value is ~5 times greater than 
the value reported by Mietke et al. (2015) using the same technique [190]. Overall, the 
difference between the stiffest and softest reported values is ~16. This showed that the applied 
stress, strain, technique and applied model had a huge effect on measured elastic modulus. 
The values in Table 4.3 show a range of sample sizes used to find the average elastic modulus 
of HL60, the highest was N=281, using microfluidics, and the lowest was 12, using optical 
tweezers [34], [192]. The value we found using microfluidic extensional flow, was averaged 
from a sample size of 50. This is relatively low compared to the other microfluidic values 
reported. However, the throughput of the experiment was still higher than using AFM or 
optical tweezers (~1 cell/min). Here, the cell deformation rate was ~800 cells/s which is 2 




factor resulting in the lower sample size is the processing times of saving large files containing 
the high-speed videos. In conclusion, microfluidic extensional flow was used to measure the 
elastic modulus of HL60 using an adapted Kelvin-Voigt model and resulting in a value 
comparable to previous reported results. This method increases measurement throughput and 
shows proof of concept, performing real-time analysis of deformation would be necessary to 
utilise this throughput and achieve higher sample sizes (100s-1000s of cells). 
Table 4.3 A table summarising the different values of elastic modulus reported for HL60 cells using a 
range of techniques. 













>200 (Nyberg et al. 2017) 
0.90±0.08 AFM 60 (Rosenbluth et al. 2006)  
0.17±0.01 AFM 169 (Mietke et al. 2015) 
~0.09 Optical Trap 12 (Zhou et al. 2014) 
 
The strain traces of n=50 HL60 cells was also used to find multiple characteristic parameters; 
the initial diameter A, relaxation time 𝜏𝑟, initial strain 𝜀0, maximum strain 𝜀𝑚𝑎𝑥 and the final 
strain 𝜀∞. These were found from both the averaged strain trace and single cell analysis (SCA) 
of individual cell traces. This showed that the two sets of analysis were comparable to each 
other, however SCA offered more insight into the distribution of parameters. Particularly 
showing that most cells recover their original strain (|𝜀0| = |𝜀∞|) and a smaller population do 
not recover ( |𝜀0| < |𝜀∞|). Permanent deformations have been seen after applied stress is 
removed, particularly using cyclic loading, and attributed to a plastic element due to 
subcellular disruption [86], [155], [156]. These deformations are known to depend on loading 
frequency, applied stress, technique used and potentially an inherent property of specific cell 
phenotypes. Thus, the final strain 𝜀∞ acquired from strain traces may be a measure of plasticity 
and useful for distinguishing phenotypes or identifying sub-populations. 
Overall, a microfluidic cross-slot device was successfully used to measure the deformation 
properties of HL60 cells in two distinct flow regimes. The shear and inertia-dominant flow 
regimes revealed different behaviours allowing more mechanical information to be obtained. 
The shear-dominant regime can achieve higher strains for lower applied stresses, and the 
inertia-dominant regime shows yield stress behaviour and an apparent failure point where cell 




fluidisation [83]. This was corroborated by high-strain deformations occurring above the 
yield-stress showing subpopulations of cells not recovering initial shape which is indicative 
of a plastic (i.e. permanent) deformation. Strain traces allowed multiparameter single cell 
measurements to be collected for HL60 including initial shape and strain, maximum strain and 
relaxation properties. An elastic modulus value was also found which is within the range of 
values reported in the literature. The method shows promise for improving the sensitivity of 
microfluidic mechanophenotyping by probing a range of forces and strains and extracting 




5 The sensitivity of DC to subcellular alterations 
This chapter covers the use of DC to probe the mechanical properties of cells treated with 
various drugs to alter subcellular components. Latrunculin A (LatA) was used to prevent 
polymerisation of F-actin, Combretastatin (CA4) was used to disassemble microtubules and 
Trichostatin A (TSA) was used to decondense chromatin. Deformation Cytometry was used 
in the shear-dominant and inertia-dominant flow regimes to deform cells at low and high 
strains. This was to investigate whether certain strains and strain-rates are more sensitive to 
specific subcellular structural changes induced by the drugs. Multiparameter single cell 
analysis was also used to track the deformation and recovery as a function of time. This 
allowed further insight into whether subcellular changes also affect the relaxation process, and 
if the response to drug was heterogeneous across the sample.  
5.1 Treating cells with Latrunculin A 
Latrunculins are a family of products known to affect the polymerisation of actin filaments. 
They do this by binding to actin monomers and preventing further polymerisation [193]. 
Latrunculin A (LatA) binds to G-actin monomers near the nucleotide binding cleft with a 1:1 
molar complex [194]. This sequesters the monomers from polymerisation, thus growth from 
the barbed end of microfilaments ceases but dissociation from the pointed end continues 
resulting in eventual depolymerisation. As discussed in section 2.1.3, actin is a major 
component of the cell cytoskeleton responsible for giving cells structure and rigidity. Here, 
cells are treated with LatA and deformed microfluidically, using DC, in both shear and inertia-
dominant flow regimes.  
Different cell types may respond differently to treatment with LatA and may require different 
concentrations to inhibit polymerisation. Mouse neuroblastoma clone NII-115 cells required 
90 nM of LatA, whereas Swiss 3T3 mouse fibroblasts required 900 nM to show the same 
effects. Additionally, LatA was shown to disrupt actin organisation after 1 hr of incubation 
and the effects were fully reversible within 1 hr of removing the drug [194].  
In this study, the deformability of two cell lines treated with LatA was measured. Continuing 
from the results in chapter 4, HL60 cells were used to study the effects of LatA on non-
adherent leukaemia cells. The colorectal cancer cell line SW480 was also studied to allow 
comparison of cells derived from a primary tumour and represent an adherent cell line. The 
differing functions and initial morphology of these states means that HL60 are known to be 
more deformable than SW480, suggesting their cytoskeletons differ significantly. Therefore, 
probing the effect of both cell types to LatA could offer further insight into the sensitivity and 




5.1.1 Drug treatment and observations 
Both cell lines were treated with LatA and imaged using phase contrast and confocal 
fluorescence microscopy. This was to show whether the drug altered cell morphology and also 
to visualise the actin disruption. 
HL60 and SW480 were first incubated with 1 µM of LatA (Cayman Chemical)  for 2 hr, before 
imaging on a phase contrast microscope (VWR IT404 - 630-1575) using a 40x objective. 
Figure 5.1a shows an image of HL60 cells after treatment with LatA compared to untreated 
cells. The images show a change in morphology of the treated cells, they are generally less 
rounded and have more protrusions. This shape change was quantified by measuring the 
circularity 𝐷𝑐 (introduced in section 3.5.3). Figure 5.1b shows histograms of the 𝐷𝑐 of treated 
and untreated cells which show a log normal distribution, density scatter plots of 𝐷𝑐 as a 
function of cell diameter are also included. These show that treatment with LatA led to an 
increase in 𝐷𝑐 which indicates they are less round. The average diameter and 𝐷𝑐 for treated 
and untreated cells are shown in Figure 5.1c, which shows no significant change in cell 
diameter but a ~1.3 times increase in 𝐷𝑐 of treated cells.  
 
Figure 5.1 Measurement of the size and shape of HL60 cells compared to those treated with 1 µM of 
LatA: (a) Phase contrast images of HL60 and HL60 LatA cells taken with a 40x objective. (b) 
Histograms of the circularity 𝐷𝐶  of HL60 and HL60 LatA, and density scatter plots of 𝐷𝐶  as a function 
of diameter of HL60 and HL60 LatA. (c) A table summarising the average diameter and 𝐷𝐶  of HL60 




Comparatively, Figure 5.2a shows images of SW480 cells treated LatA and untreated cells. 
Here, the images show no immediate change in morphology. This was then quantified by 
measuring 𝐷𝑐 of treated and untreated SW480 (Figure 5.2b). The histograms of 𝐷𝑐 show a log 
normal distribution and show an increased shift in the peak of 𝐷𝑐 of treated cells. The increase 
can also be seen in the density scatter plots. Finally, the averaged cell diameter and 𝐷𝑐 of 
treated and untreated SW480 (Figure 5.2c) show no significant change in diameter and a ~1.2 
x increase in 𝐷𝑐. 
Both HL60 and SW480 show no change in diameter due to incubation with 1 µM of LatA, 
and both show similar increases in 𝐷𝑐. However, the phase contrast images clearly show a 
more obvious change in morphology in HL60 than SW480. This suggests that our image 
analysis and use of the circularity 𝐷𝑐 may not be sensitive enough to discern the protrusions 
seen in Figure 5.1a. The protrusions in HL60 could be related to the fact the cells are initially 
non-adherent, whereas SW480 were detached from a surface.  
 
Figure 5.2 Measurement of the size and shape of SW480 cells compared to those treated with 1 µM of 
LatA: (a) Phase contrast images of SW480 and SW480 LatA cells taken with a 40x objective. (b) 
Histograms of the circularity 𝐷𝐶  of SW480 and SW480 LatA, and density scatter plots of 𝐷𝐶  as a 
function of diameter of SW480 and SW480 LatA. (c) A table summarising the average diameter and 𝐷𝐶  
of SW480 and SW480 LatA.  
Confocal fluorescence of live cells was used to visualise the actin structure of HL60 and 
SW480 cells treated with varying concentrations of LatA. Concentrations of 0.01 µM, 0.1 µM 




fluorescent stains for 2 hours before imaging. F-Actin was stained using a live cell fluorogenic 
labelling probe based on Silicon-Rhodamine (Sir) (Spirochrome, Cytoskeleton Inc.), using a 
final concentration of 1 µM. DNA was stained using the dye Hoechst 3342 (Thermo Fisher 
Scientific) at a final concentration of 0.5 µg/ml. 
Figure 5.3 shows fluorescent images of HL60 at different concentrations of LatA, with actin 
shown in red and DNA shown in blue. The images do not show obvious changes in the actin 
structure, the 0.1 µM and 1µM samples show a less uniform actin structure compared to the 
0.01 µM and control sample. Comparatively, Figure 5.4  shows SW480 treated with different 
concentrations of LatA whilst adhered to a surface and Figure 5.5 shows detached SW480 
treated with different concentrations of LatA. Both adhered and attached samples show a clear 
disruption of actin filaments as a function of concentration. Untreated SW480 show a defined 
actin cortex, especially compared to untreated HL60 (Figure 5.3) which is an expected result 
as these cells are more deformable. As LatA concentration increases the cortex begins to break 
down and the structure is more dotted. 
 
Figure 5.3 Confocal fluorescence images of control HL60 cells and HL60 treated with 0.01 µM, 0.1 
µM and 1 µM of LatA, stained for actin (red) and DNA (blue). Images were taken using a 40 x objective, 





Figure 5.4 Confocal fluorescence images of control SW480 cells and SW480 treated with 0.01 µM, 0.1 
µM and 1 µM of LatA. Cells were adhered to a surface and stained for actin (red) and DNA (blue). 
Images show that with increased LatA concentration the actin cortex is less pronounced due to the drug 
inhibiting actin polymerisation. Scale bar 20 µm.  
 
Figure 5.5 Confocal fluorescence images of control SW480 cells and SW480 treated with 0.01 µM, 0.1 
µM and 1 µM of LatA. Cells were detached and have a rounded morphology, and were stained for actin 
(red) and DNA (blue). Images show that with increased LatA concentration the actin cortex is less 
pronounced due to the drug inhibiting actin polymerisation. Scale bar 20 µm.  
The fluorescent images were also used to measure the diameter of the nuclei (𝐴𝑛𝑢𝑐𝑙𝑒𝑢𝑠) of 
HL60 and SW480 treated with LatA compared to untreated cells. Figure 5.6 shows histograms 
of  𝐴𝑛𝑢𝑐𝑙𝑒𝑢𝑠 of HL60 and SW480 treated with 1 µM of LatA compared to control samples. 




show no significant change in nuclear diameter due to the effects of LatA, and that SW480 
had a significantly bigger nucleus than HL60 (~1.2 x bigger).  
Overall, results confirm that a 2 hr incubation of 1 µM of LatA leads to changes in cell 
morphology and actin structure of HL60 and SW480 cells, without affecting the whole cell of 
nucleus diameter.  
 
Figure 5.6 The nuclear diameter of HL60 and SW480 cells was measured using confocal fluorescence 
images with DNA staining. Histograms were plotted of the nuclear diameters 𝐴𝑛𝑢𝑐𝑙𝑒𝑢𝑠 of HL60 and 
SW480 treated with LatA and compared to control samples. Plots are fitted with a Gaussian function.  
5.1.2 Deformation Cytometry in the shear regime 
DC experiments on LatA treated cells were done at a concentration of 1 µM and an incubation 
time of 2 hr. Cells were microfluidically deformed over a range of flow rates whilst suspended 
0.5% PBS-MC buffer (µ~33 cP), whilst maintaining a constant concentration of LatA 
throughout the measurement period. Measurements were taken over a range of flow rates, 
collecting 10s-100s of cell events for each condition. Experiments were repeated N=3 to 
calculate an average and standard error for the deformation index DI. 
Figure 5.7a shows the DI of HL60 cells treated with LatA as a function of flow rate in the 
shear regime, compared to a control sample. For 𝑄 < 20 μ𝑙/𝑚𝑖𝑛, the treated cells showed 
increased deformability compared to the control cells. For 𝑄 > 20 μ𝑙/𝑚𝑖𝑛, the treated and 
untreated cells show no significant change in DI. Both datasets are fitted with an exponential 
function, used to extrapolate the maximum deformation index 𝐷𝐼𝑚𝑎𝑥. For the treated cells 
𝐷𝐼𝑚𝑎𝑥 = 2.25 ± 0.05 and for the untreated cells 𝐷𝐼𝑚𝑎𝑥 = 2.35 ± 0.05, showing that the 





Figure 5.7 (a) The deformation index DI of HL60 cells treated with 1 µM of LatA as a function of flow 
rate, compared to a control sample. Cells were deformed in a shear-dominant regime where 𝜇 ≅ 33 𝑐𝑃. 
Both datasets are fitted with an exponential function. (b) The DI ratio of HL60 cells treated with Lat A 
compared to untreated cells (DIHL60LatA/DIHL60), which is fitted with an exponential function.  
The change in DI due to LatA can be quantified using the DIratio, which equates to 
𝐷𝐼𝐿𝑎𝑡𝐴/𝐷𝐼𝑐𝑜𝑛𝑡𝑟𝑜𝑙. Where 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 1 indicates no change due to treatment with LatA, and 
𝐷𝐼𝑟𝑎𝑡𝑖𝑜 > 1 indicates increased deformability due to LatA. Figure 5.7b shows the DIratio of 
HL60 as a function of flow rate, the trend shows an exponential decay which is fitted in red. 
Results show 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 > 1 for 𝑄 < 30 𝜇𝑙/𝑚𝑖𝑛, for 𝑄 > 30 𝜇𝑙/𝑚𝑖𝑛 values of the DIratio ~1. 
Results show that DC can be used in the shear regime to detect increased deformability of 
HL60 cells, and that a low-strain regime (i.e. low flow rates) is most sensitive to these changes. 
On the other hand, higher strains (using higher flow rates) were not sensitive to any changes 
due to treatment with LatA. 
Figure 5.8a shows the DI of SW480 cells treated with 1 µM of LatA as a function of flow rate, 
compared to an untreated control sample. Both datasets are fitted with an exponential decay 
function tending to a maximum deformation index 𝐷𝐼𝑚𝑎𝑥. The plot shows a general increase 
in the DI of treated cells compared to untreated cells, where 𝐷𝐼𝑚𝑎𝑥 = 1.70 ± 0.02 for treated 
cells and 𝐷𝐼𝑚𝑎𝑥 = 1.62 ± 0.04 of untreated cells. Further, Figure 5.8b shows the DIratio as a 
function of flow rate which shows an exponential decay and is fitted in red. Here, 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 > 1 
for the majority of flow rates apart. from the highest flow rate used (𝑄 = 100 𝜇𝑙/𝑚𝑖𝑛) which 





Figure 5.8 (a) The deformation index DI of SW480 cells treated with 1 µM of LatA as a function of flow 
rate, compared to an untreated sample. Cells were deformed in a shear-dominant regime where 𝜇 ≅
33 𝑐𝑃. Both datasets are fitted with an exponential decay function. (b) The DI ratio of SW480 cells 
treated with Lat A compared to a control sample (DISW480LatA/DISW480), which is fitted with an 
exponential decay function.  
Overall, both HL60 and SW480 showed increased deformability when treated with LatA. This 
is the expected result as LatA prevents actin polymerisation and the actin cortex is known to 
provide the cell with mechanical rigidity. In the shear-regime, lower flow rates (which impart 
smaller strains) were most sensitive to changes due to LatA. At higher flow rates, treated HL60 
could no longer be distinguished from untreated HL60, and the 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 of SW480 was also 
reduced and tended to ~1. Treated SW480 could still be distinguished from untreated SW480 
for 𝑄 < 100 𝜇𝑙/𝑚𝑖𝑛 whereas HL60 could only be distinguished for 𝑄 < 30 𝜇𝑙/𝑚𝑖𝑛. This 
could be due to the fact HL60 are more deformable than SW480, the 𝐷𝐼𝑚𝑎𝑥 of HL60 is ~ 1.5 
times larger than SW480. At 𝑄 = 30 𝜇𝑙/𝑚𝑖𝑛 HL60 have 𝐷𝐼 = 1.90 ± 0.06, and at 𝑄 =
100 𝜇𝑙/𝑚𝑖𝑛 SW480 have 𝐷𝐼 = 1.64 ± 0.09. This corroborates that a low-strain regime is 
more sensitive to changes due to LatA prohibiting actin polymerisation. 
So far only the average DI values of treated and untreated cells have been investigated. 
However, as cells are heterogeneous due to the process of the cell cycle different cells may 
respond differently to treatment with LatA. This was investigated by looking at histograms of 
DI of treated and untreated cells. Figure 5.7 and Figure 5.8 showed that SW480 showed the 
biggest change in deformability due to LatA at the lowest flow rate 𝑄 = 10 𝜇𝑙/𝑚𝑖𝑛. Whereas, 
at the highest flow rate 𝑄 = 100 𝜇𝑙/𝑚𝑖𝑛, showed a smaller relative difference. Figure 5.9 
shows histograms of the DI of untreated and treated SW480 deformed at 𝑄 = 10 𝜇𝑙/𝑚𝑖𝑛 and 





Figure 5.9  Histograms of the DI of SW480 treated with 1 µM of LatA compared to an untreated sample. 
(a) Cells were deformed at 𝑄 = 10 𝜇𝑙/𝑚𝑖𝑛 in the shear-dominant regime (𝜇 ≅ 33 𝑐𝑃). The control 
cells are fitted with a single Gaussian peak. The LatA treated cells are fitted with two Gaussian peaks 
and the cumulative peak is also shown. (b) Cells deformed at 100 µl/min in the same flow regime, both 
graphs are fitted with a single Gaussian peak.  
 Figure 5.9a shows that untreated SW480 deformed at 10 µl/min show a normal distribution 
of DI which is fitted with a Gaussian function. The peak value is at 𝐷𝐼 = 1.23 ± 0.01 and the 
FWHM is 𝑤 = 0.17 ± 0.01. The treated SW480 show a distribution of DI with a large peak 
at 𝐷𝐼 = 1.43 ± 0.06 and a smaller peak with 𝐷𝐼 = 1.75 ± 1.29. The cumulative peak is also 
shown which has a peak value of 𝐷𝐼 = 1.45 ± 0.01, showing that the larger peak dominates 
the average of the distribution. The FWHM of the cumulative peak is 𝑤 = 0.33 ± 0.03, which 
is ~2 x greater than the untreated sample. These results show that treatment with LatA 
increased the average cell deformability, and also the spread of deformability’s increases. This 
could be due to some cells being more susceptible to the effects of LatA. Additionally, a 
smaller population of cells had a bigger increase in deformability as shown by the second 
peak. 
Figure 5.9b shows histograms of the DI of treated and untreated SW480 deformed at 100 
µl/min. Both plots show a normal distribution and are fitted with single Gaussian peaks. The 
untreated sample has a peak value of 𝐷𝐼 = 1.52 ± 0.01 and a FWHM of 𝑤 = 0.34 ± 0.01, 
the treated sample of 𝐷𝐼 = 1.63 ± 0.01 and a FWHM of 𝑤 = 0.36 ± 0.02. The FWHM of 
untreated SW480 deformed at 100 µl/min is ~2x larger than when deformed at 10 µl/min. This 
shows that imparting high-strains leads to larger spread of responses compared to low strains, 
therefore high-strains may be more sensitive to initial sample heterogeneity. Results show that 




error of each other. Thus, a high-strain regime is much less sensitive to changes in actin 
structure due to LatA when investigated by averaging and using SCA. 
5.1.3 Deformation Cytometry in the inertial regime 
Deformation Cytometry experiments on LatA treated cells were also performed in a inertia-
dominant flow regime, at a concentration of 1 µM and an incubation time of 2 hr. Cells were 
microfluidically deformed over a range of flow rates whilst suspended in cell media (µ~1 cP), 
whilst maintaining a constant concentration of LatA throughout the measurement period. 
Measurements were taken for a range of flow rates, collection 10s-100s of events for each 
condition. Experiments were repeated N=3 and used to calculate an average and standard error 
for the deformation index DI. 
Figure 5.10a shows the average DI HL60 cells treated with LatA as a function of flow rate in 
the inertia-dominant regime, compared to a control sample. As discussed in section 4.2.2, Q =
400 μl/min is associated with the cells apparent “yield stress” with a change in behaviour 
seen above and below this condition. A linear slope is fitted to data below the yield stress with 
a lower gradient than a linear slope fitted to data points above the yield stress. Figure 5.10b 
shows the DIratio of treated and untreated HL60 cells, where the majority of datapoints are 
within error of 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 1 which suggests no changes in deformability due to treatment with 
LatA. A linear slope is fitted to the data with a fixed slope of 0, resulting in an intercept value 
of 𝑦0 = 1.08 ± 0.02. Figure 5.10 shows no changes in DI of HL60 cells when treated with 
LatA for the entire range of flow rates. Comparatively, Figure 5.7 shows that in the shear-
regime there was an increase in DI of the treated cells when probed at low strains (𝐷𝐼 < 1.9) 
similar to those probed in the inertia-dominant regime but below the yield stress. 
 
Figure 5.10 (a) The deformation index DI of HL60 cells treated with 1 µM of LatA as a function of flow 
rate, compared to a control sample. Cells were deformed in an inertia-dominant regime where 𝜇 ≅
1 𝑐𝑃. Both datasets are fitted with linear fits for 𝑄 > 300 𝜇𝑙/𝑚𝑖𝑛 and 𝑄 > 300 μ𝑙/𝑚𝑖𝑛. (b) The DI 
ratio of HL60 cells treated with Lat A compared to untreated cells (DIHL60LatA/DIHL60), which is fitted 




 Figure 5.11a shows a plot of the DI of SW480 cells treated with LatA deformed over a range 
of flow rates in the inertia-dominant regime, compared to an untreated sample. Here, a change 
in behaviour is seen at 𝑄 = 300 𝜇𝑙/𝑚𝑖𝑛 corresponding the associated yield stress of the cells. 
Linear slopes are fitted separately to the datasets above and below the yield stress (𝑄 =
300 𝜇𝑙/𝑚𝑖𝑛 ), with the gradients of the slopes increasing above the yield stress. Results show 
an increase in DI of treated cells for 𝑄 < 300 𝜇𝑙/𝑚𝑖𝑛, whereas for 𝑄 > 300 𝜇𝑙/𝑚𝑖𝑛 there is 
no significant change in DI due to LatA. Figure 5.11b shows the DIratio of treated SW480 
compared to untreated cells, which shows that 𝑄 > 400 𝜇𝑙/𝑚𝑖𝑛 results in 𝐷𝐼𝑟𝑎𝑡𝑖𝑜~1 (this 
area is shaded in blue).  
In the inertia-dominant regime, high-strain deformations cannot be used to distinguish 
between SW480 treated with LatA and a control. The effects of LatA could not be detected 
when the deformation index of the control sample was DI>1.6, which occurred at 𝑄 >
300 𝜇𝑙/𝑚𝑖𝑛. Similarly, in the shear-dominant regime any changes due to LatA were not 
detected for 𝑄 > 100 𝜇𝑙/𝑚𝑖𝑛 where the deformation index was also DI>1.6. 
 
Figure 5.11 (a) The deformation index DI of SW480 cells treated with 1 µM of LatA as a function of 
flow rate, compared to an untreated sample. Cells were deformed in an inertia-dominant regime where 
𝜇 ≅ 1 𝑐𝑃. Both datasets are fitted with linear fits for 𝑄 > 300 𝜇𝑙/𝑚𝑖𝑛 and 𝑄 > 300 μ𝑙/𝑚𝑖𝑛. (b) The 
DI ratio of SW480 cells treated with Lat A compared to a control sample (DISW480LatA/DISW480).  
Overall, in the shear-dominant regime both HL60 and SW480 became more deformable due 
to treatment with LatA (Figure 5.7 and Figure 5.8). The 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 also showed that the relative 
increase in deformability was highest for low-strains, and decreased exponentially for high-
strains and tending towards no detectable change (𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 0). In the inertia-dominant 
regime no changes in the deformability of HL60 due to LatA could be detected at low or high 
strain deformation (Figure 5.10). For SW480, in the inertial regime, increased deformability 
due to LatA was detected in the low strain regime (below the yield stress) but not at high 




flow regime is the most sensitive to deformability changes induced by disruption of the actin 
cytoskeleton. SW480 previously showed a more defined actin cortex than HL60 (Figure 5.3 
and Figure 5.5), which could explain why they showed a larger change in deformability due to 
LatA which could be detected in both flow-regimes. Actin destabilisation at high strains could 
contribute to why a low strain regime shows most sensitivity when measuring deformability 
changes due to LatA. 
5.1.4 Deformation traces and SCA 
The strain 𝜀 (equation (3.2)) of SW480 treated with LatA was tracked as cells deformed and 
recovered through the SP of an extensional flow junction and compared to a control sample. 
Treated cells were incubated with 1 µM of LatA for 2 hr. A shear-dominant flow regime was 
used (μ ≅ 33 𝑐𝑃), at a flow rate of 5 𝜇𝑙/𝑚𝑖𝑛. These conditions were chosen because 
measurement of DI at low strain in the shear-regime proved to be most sensitive to changes in 
LatA Figure 5.8.  
The averaged strain traces of treated (N=56) and untreated (N=30) SW480 are shown by 
Figure 5.12, which can be used to extract multiple characteristic parameters. These include; 
the initial strain 𝜀0, the maximum strain 𝜀𝑚𝑎𝑥, the deformation time 𝜏𝑑, the relaxation time 𝜏𝑟 
and the final strain 𝜏∞. The deformation and relaxation times were found by fitting exponential 
functions to the deformation region of the graph (as the cell moves toward to SP) and the 
recovery region of the graph (as the cells moves away from the SP). The final strain was found 
by extrapolation of the exponential fit to the recovery region. Further, the different parameters 
are summarised in Table 5.1. This confirms that the LatA treated cells are more deformable 
than the control sample, as they have a larger εmax. The initial strain 𝜀0 of treated and untreated 
cells are within error of each other. However, the final strain 𝜀∞ of the treated cells is ~6 times 
bigger than of the control cells. The results show that the LatA treated cells have a relaxation 
time twice as fast as the untreated cells but they recover to a higher strain value than the 
magnitude of the initial strain (𝜀∞ > 𝜀0). Whereas, for the control cells the initial and final 
strains were within error of each other (𝜀0 = 𝜀∞). 
Figure 5.13 shows the average velocity profiles of treated and untreated SW480 as they pass 
through the extensional flow junction, which were fitted with sine functions (shown in red). 
This was used to fit the Kelvin-Voigt model (described in section 2.3.4) to the strain traces 
(shown in red). From this, the elastic modulus of SW480 was found to be 𝐸 = 542 ± 66 𝑃𝑎 
and SW480 treated with LatA was 𝐸 = 419 ± 54 𝑃𝑎. This corrobates the results shown by 





Figure 5.12 The averaged strain trace for SW480 (N = 56) and SW480 treated with 1 µM LatA  (N = 
30) as a function of time, with the standard error shown by the shaded areas. Q was 5 µl/min, and the 
suspension medium viscosity was 33 cP. The recovery is fitted with an exponential function and the 
dashed lines represent the extrapolated final strain 𝜀∞ for both samples.  
 
Figure 5.13 Strain traces of SW480 and SW480 treated with LatA fitted with the Kelvin voigt model, 
accompanied by velocity profiles fitted with a sine function. (a) The average strain trace of N=56 
SW480 cells, the Kelvin-Voigt model was fitted, shown in red. The average velocity profile of the same 
56 cells is shown and fitted with a sine function, shown in red. (b) Strain and velocity profiles for N=30 
SW480 cells treated with 1 µM of LatA. Cells were deformed in a shear-dominant regime where 𝑄 =
5 𝜇𝑙/𝑚𝑖𝑛 and 𝜇 ≅ 33 𝑐𝑃.  
Multiple parameters extracted from the averaged strain traces showed that εmax, τr, ε∞ and E 
were able to distinguish between the two samples, whereas τd and ε0 could not. However, as 
discussed in section 2.1.5 cell populations are heterogeneous and their mechanical properties 
depend on their stage in the cell cycle. Bulk measurements can often miss any subpopulations 




SW480 cells and the N=30 SW480 cells treated with LatA. SCA analysis was performed in 
the same manner described in results section 4.4.1. 
Table 5.1 compares the different parameters extracted from the “Averaged Strain Trace” and 
from averaging values found using SCA. Firstly, the values of 𝜀𝑚𝑎𝑥 found using both methods 
are within error of each other. The values of 𝜀0 are also comparable, and show the cells have 
relatively negligible initial strain compared to the applied strain at the SP (𝜀𝑚𝑎𝑥). The values 
of 𝜀∞ from both methods confirm that the SW480 recover back to their initial strain, whereas 
the treated cells recover to a higher strain (𝜀∞ > 𝜀0). The values for relaxation time 𝜏𝑟  for the 
treated cells are within error or each other, however the 𝜏𝑟 calculated from the averaged strain 
trace is ~1.5 times greater than the SCA value. This suggests some outliers may skew the value 
from the averaged trace and shows the importance of investigation at the single cell level. 
Table 5.1 Multiple characteristic parameters extracted from the strain traces of N=56 SW480 cells and 
N=30 SW480 cells treated with LatA. Including the initial cell diameter A, the initial strain ε0, the final 
strain ε∞, the maximum strain εmax, the deformation time τd, the relaxation time τr and the elastic modulus 
E. Two analysis methods were used and the resulting values were compared: 1. the strain traces were 
averaged and values were extracted, “Averaged Strain Trace” and 2. Single cell analysis was used 
“SCA” then averaged with ±SE.
 Averaged Strain Trace SCA 
 SW480 SW480-LatA SW480 SW480-LatA 
A (µm) N/A N/A 15.1±0.3 15.0±0.4 
𝜀𝑚𝑎𝑥 0.08±0.01 0.11±0.01 0.09±0.01 0.12±0.01 
𝜏𝑟 (ms)  1.36±0.06 0.67±0.09 0.89±0.11 0.79±0.14 
𝜏𝑑 (ms)  1.19±0.20 0.78±0.24 
N/A N/A 
𝐸 (𝑃𝑎) 542±66 419±54 N/A N/A 
𝜀0 -0.012±0.006 -0.007±0.014 -0.012±0.003 -0.003±0.013 
𝜀∞ +0.010±0.003 +0.059±0.001 +0.018±0.005 +0.053±0.001 
 
The statistical significance of the different parameters to classify the treated and untreated cell 
was investigated further using two sample t-tests. A t-test uses the difference between the 
mean values from two data sets, the standard deviation of the datasets and the sample size, to 
measure how significant differences between the datasets are. This is measured by the “p-
value” found from the t-test. Smaller p-values indicate a higher significance between 
differences measured by the t-test. A p-value ≤ 0.05 suggests strong evidence that the two 
datasets show significant differences, p-values ≥ 0.05 suggest no significant difference. 
Figure 5.14 shows bar graphs of the average A, εmax, ε∞, τr and ε0 of the two sample and the 
level of significance is labelled: where p>0.05 is not significant (ns), 0.01<p<0.05 is 
significant (*), 0.001<p<0.01 is very significant (**), 0.0001<p<0.001 is extremely significant 




no significant difference in A, τr and ε0 when SW480 cells are treated with LatA. However, 
εmax and ε∞ show a significant difference between treated and untreated cells and these 
parameters can potentially be used to classify these cell types. 
 
Figure 5.14 SCA was performed on strain traces of SW480 treated with LatA and a control sample to 
extract multiple parameters. The plots show the average values of the cell diameter A, maximum strain 
𝜀𝑚𝑎𝑥, initial strain 𝜀0, the relaxation time 𝜏𝑟 and the final strain 𝜀∞. The error bars denote the standard 
error SE and statistical t-tests were done to determine the level of significance, where ns indicates “no 
significance”.  
The heterogeneity of the two samples was explored by plotting histograms of parameters of 
interest. Table 5.1 and Figure 5.14 showed that LatA had no effect on the A or ε0 of SW480 cells 
using bulk averaging and SCA, therefore the histograms were not included. Figure 5.15 shows 
histograms of εmax, ε∞ and τr of the treated and untreated samples. The histograms of εmax both 
show a normal distribution, fitted with a Gaussian peak, with a shift in the peak position of 
the treated cells indicating an increase in deformability. The histogram for ε∞ of the control 
sample shows that most cells have ε∞=0, indicating their full recovery after deformation. The 
treated sample shows a peak of ε∞=0 and also a significant peak at ε∞~0.06, resulting in the 
non-zero average shown in Table 5.1. The histogram gives more information than using 
averages, suggesting that treatment with LatA leads to two populations with some cells 
recovering their initial shape and some having a “plastic deformation”. It is worth noting that 




distributions (Figure 5.14). However, t-tests can still be performed on large enough sample 
sizes and thus the p-values are still significant. Finally, the histograms of τr both show a normal 
distribution, fitted with a Gaussian, with similar peak positions ~0.3                                                                                                                                                                                                                                        
ms. Both datasets show some outliers with a relaxation time ~10 times greater than the peak 
position, this may explain the differences in τr found between the averaged strain trace and 
SCA Table 5.1. 
 
Figure 5.15 Histograms showing the maximum strain 𝜀𝑚𝑎𝑥, final strain 𝜀∞ and relaxation time 𝜏𝑟 of 
SW480 treated with LatA (N=30), compared to an untreated control sample (N=56). 
5.1.5 Discussion 
The deformability of HL60 and SW480 cells treated with LatA was probed using deformation 
cytometry. An increase in cell deformability was detected in both cell lines when deforming 
cells in the shear-dominant regime. For HL60 treated with LatA, an increase in deformability 
was only detectable at low applied strains (Q<30 µl/min). Increased deformability was 
detected at both low and high strains in the treated SW480 cells; however, the relative increase 
was more apparent at lower strains. The inertia-dominant regime was not sensitive to the 
effects of LatA in the HL60 cells. An increase in deformability was detected in SW480 but 
only for low applied strains below the yield stress (Q<300 µl/min). 
LatA binds strongly to actin monomers which precludes polymerisation of actin filaments and 
prevents actin recycling. Many studies have shown that treating cells with LatA leads to a 
reduction in cell stiffness, measurable over a wide range of techniques including; AFM, 
micropipette aspiration and optical stretching [8], [195]–[198]. Cytochalasin D is another drug 
which destabilises actin by capping the plus ends of filaments, leading to similar measurable 
decreases in cell stiffness [8], [199]–[201]. These techniques are classically high-accuracy and 
low-throughput and impart relatively small deformations. Therefore, actin filaments 




Microfluidic assays have also been used to measure deformability of cells treated with LatA 
and CytoD [22], [50], [174], [202]. Adamo et al. 2012 used microfluidic constriction channels 
to measure the transit time of HeLa cells treated with LatA. They showed that the treated cells 
had a ~26% faster transit time, which is equivalent to a decrease in cell stiffness allowing them 
to more easily deform through the channel. Kim et al. 2018 also used microfluidic constriction 
channels to measure the deformability of cells treated with LatA [203]. They compared the 
deformability of the malignant breast cancer cell line MCF7 to the non-malignant epithelial 
breast cell line MCF7-10A, when treated with LatA. Both cell lines showed increased 
deformability due to LatA, however MCF7 were more affected. They theorize that this may 
be due to initial F-actin content in the two cell lines. Similarly, we tested two cell lines and 
saw that SW480 were more affected than HL60. Confocal fluorescence images also showed 
that SW480 had an initially more defined F-actin structure. 
Golfier et al. 2017 studied deformability changes in HL60 due to disrupting the actin structure 
using the drug CytoD [50]. This was done using RT-DC where cells experience a fluid-
induced deformation due to shear confinement in a channel (Re<0.1). HL60 cells showed 
increased deformability due to treatment with CytoD, and their maximal relative deformation 
was ~1.5. Using LatA we showed a maximal deformation ratio ~1.1. This suggests that CytoD 
reduces the stiffness more than LatA. However, RT-DC imparts much smaller strains than 
Deformation Cytometry which may also indicate that lower-strains are more sensitive to 
cytoskeletal changes. Ahmmed et al. (2018) used a similar microfluidic deformation method 
and showed increased deformability of MCF7 cells treated with LatA [44]. 
Gossett et al. 2012 used an inertia-dominant extensional flow in a microfluidic device to 
deform 3T3 fibroblasts and HeLa cells treated with LatA (Re>>40) [27]. No significant 
changes in the deformation index of treated and control cells were seen for both cell lines. 
This technique deforms at high strains and high strain rates (~105 𝑠−1). They noted that these 
conditions are likely more sensitive to changes in the cytoplasmic viscosity and cell chromatin 
structure, whereas actin is known to fluidise at high-strains [83]. Our study showed that HL60 
and SW480 deformed in the inertial regime above the yield stress showed no significant 
change in DI due to LatA. Notably, the median deformability of T3T cells in Gossett et al. 
2012 was 𝐷𝐼 ≅ 1.8 which is above strains which could not distinguish HL60 (𝐷𝐼 ≅ 1.5) and 
SW480 (𝐷𝐼 ≅ 1.4) in this flow regime.  
Kubitschke et al. 2018 used a microfluidic cell stretcher to study the deformability of cells 
treated with LatA deformed at low and high strains [198]. Small deformations were defined 
as <5% the initial cell diameter, and large strains as >5% the initial cell diameter, no 




cells treated with LatA. This differs from our results using the shear-dominant regime, where 
cells deformed at low-strains were more effected by LatA leading to an increased relative 
deformation. However, the study in [198] showed that for small strains there was up to 75% 
increased deformability and for high strains there was up to 65% deformability. This result 
may also be indicative of small-strain deformation being more sensitive to actin changes. 
Additionally, the “high strains” defined here are relatively small compared to those in Gossett 
et al. 2012 and also in our study above the yield stress. Therefore, strains 0-20% may not be 
a sufficient range to fully study sensitivity to LatA at low and high strain. Strain-rate may also 
be a factor toward LatA sensitivity as the optical traps deform at a strain rate of seconds 
compared to inertia-dominant microfluidics which deforms at 10−5𝑠. 
An elastic modulus of SW480 treated with LatA was found from strain traces of cells 
deforming in the shear-dominant regime, using the Kelvin-Voigt model. Treated cells had an 
elastic modulus of 𝐸 = 419 ± 54 𝑃𝑎 compared to control cells which had 𝐸 = 542 ± 66 𝑃𝑎 
control cells were ~1.3 times stiffer. Abidine et al. 2015 used optical trap indentation of 200 
nm to find the elastic modulus of T24 human urinary bladder cancer cells to be 𝐸 = 100 ±
10 𝑃𝑎 compared to control cells 𝐸 = 29 ± 4 𝑃𝑎, a ~3.4 times decrease in stiffness [197]. 
Nawaz et al. 2012 used micropipette aspiration to deform MCF7 cells and found the elastic 
modulus to be 𝐸 = 441 ± 65 𝑃𝑎 which reduced to 𝐸 = 225 ± 41 𝑃𝑎 when treated with 
LatA, a ~2 times decrease in stiffness [196]. This is further evidence toward low strain and 
strain rate techniques being most sensitive to F-actin structure. 
The strain traces were also used to extract multiple deformation and relaxation parameters, 
and SCA was used to perform t-tests to quantify the significant of these parameters. Results 
showed that LatA and control SW480 initially had the same size A and shape 𝜀0. As expected, 
there was a significant increase in the maximum deformation 𝜀∞ of the treated cells. 
Additionally, the final strain of the treated cells did not recover over the time period whereas 
the control cells did. This suggests that actin disruption leads to some plastic deformation and 
changes the relaxation process of the cells. Kubitschke et al. (2017) tracked the recovery of 
MCF7 cells after a step force deformation using optical trapping. They found that cells treated 
with LatA did not recovery their original shape as much as control cells, also indicating that 
LatA induces more plasticity in cells [198]. 
5.2 Treating cells with Combretastatin A4 
Combretastatins are a group of natural products related to the tubulin-binding agent colchicine 
[204]. Combretastatin A4 (CA4) belongs to this group and has a strong binding affinity to 
tubulin, which inhibits microtubule polymerisation and leads to morphological changes of the 




in cancer treatments. CA4 is a drug of interest for treating cancer due to its abilities to disrupt 
tubulin and prevent cell proliferation, including being able to rapidly shut down established 
tumour vasculature [207]. The previous section showed that disruption to the actin 
cytoskeleton leads to changes in cell deformability. Here, CA4 was used to investigate whether 
changes in microtubule structure could be sensed using DC in shear and inertia-dominant flow 
regimes.  
The effects of CA4 on microtubule structure can be seen within 2-4 hr of incubation with the 
drug, and different studies report different concentrations being required for complete 
microtubule destabilisation. Mico et al. (2017) incubated SVR mouse pancreatic islet 
endothelial cells with 40-100 nM of CA4 for 2 hrs and saw complete destabilisation using 
fluorescence microscopy. Greene et al. (2010) incubated K562 and HL60 cells with 50 nM of 
CA4 for 4 hours. The effects of CA4 can be reversible below a critical concentration if the 
drug is removed, however above this concentration and long incubation times (>24 hr) induce 
cell apoptosis [208]. 
HL60 and SW480 were previously used to study the effects of actin disruption using LatA, 
these cell lines showed different responses to LatA which may relate to their differing initial 
morphologies and functionalities. Therefore, the same cell lines were used to study the effects 
of tubulin disruption using CA4. Probing both cell types in different flow regimes will 
elucidate more the importance of microtubules to cell deformability. 
5.2.1 Drug treatment and observations 
HL60 and SW480 cells were treated with CA4 and imaged using phase contrast microscopy 
and confocal fluorescence microscopy. This was to investigate whether the drug affected cell 
size and morphology and to visualise changes to the microtubule structure. 
HL60 cells were incubated with 100 nM of CA4 for 2 hr and imaged using a phase contrast 
microscope (VWR IT404 - 630-1575) with a 40x objective (Figure 5.16a). A control sample 
of HL60 show a rounded morphology and the CA4 treated cells show a less rounded 
morphology. This was quantified using the circularity deformation parameter 𝐷𝐶, where 𝐷𝐶 =
0 represents a perfect circle and 𝐷𝐶 > 0 deviates from a perfect circle. Figure 5.16b shows 
histograms of 𝐷𝐶 of treated and untreated HL60 cells, both datasets are fitted with a Lognormal 
distribution. The peak position of the untreated sample was 𝐷𝐶 = 0.075 ± 0.001 and for the 
treated sample was 𝐷𝐶 = 0.121 ± 0.005. The standard deviation of the lognormal curves was 





Figure 5.16 Measurement of the size and morphology of HL60 treated with 100 nM of CA4, compared 
to a control sample: (a) Phase contrast images of HL60 and HL60 CA4 cells taken with a 40x objective. 
(b) Histograms of the circularity 𝐷𝐶  of HL60 and HL60 CA4, fitted with Lognormal functions. (c) 
Density scatter plots of 𝐷𝐶  as a function of diameter of HL60 and HL60 CA4.  
These results show that cells treated with CA4 change their cell morphology, the average 𝐷𝐶 
increased ~1.6 times compared to the control sample. The standard deviation of the results 
increased ~2.2 times for the treated cells, which could suggest that cells have a range of 
susceptibilities to the drug leading to a wide range in morphological changes. Figure 5.16c 
shows density scatter plots of 𝐷𝐶 as a function of diameter for treated and untreated cells. It 
corroborates that treatment with CA4 leads to a change in circularity of HL60 cells. It also 
shows that the cell diameter does not change, the average diameter of untreated cells was 
𝐴𝑐𝑜𝑛𝑡𝑟𝑜𝑙 = 12.04 ± 0.09 𝜇𝑚 and of treated cells was 𝐴𝐶𝐴4 = 12.24 ± 0.09 𝜇𝑚. 
The same treatment protocol was repeated using SW480 cells, which were first detached into 
a single cell suspension. Figure 5.17a shows phase contrast images of CA4 treated cells 
compared to a control sample, showing no obvious changes in morphology. Figure 5.17b 
shows histograms of 𝐷𝐶 of both samples, which are fitted with Gaussian functions. The peak 
position for the control sample was 𝐷𝐶 = 0.323 ± 0.013 and for the treated sample was 𝐷𝐶 =
0.322 ± 0.010, which confirms no change in SW480 morphology due to CA4. Figure 5.17c 
shows density scatted plots of 𝐷𝐶 as a function of cell diameter, this shows a larger spread of 
𝐷𝐶 of SW480 compared to HL60 cells (Figure 5.16c) which may relate to the fact SW480 
were detached from a surface whereas HL60 are naturally non-adherent. It also shows the size 
of SW480 is not changed by treatment with LatA, the control sample had an average diameter 





Overall, analysis of phase contrast images show that treatment with 100 nM of CA4 for 2 hr 
lead to no changes in the diameter of HL60 and SW480 cells. Changes to morphology were 
measured using 𝐷𝐶 which showed that HL60 cells become less rounded when treated with 
CA4, whereas SW480 do not change shape. This could indicate that HL60 were more effected 
by treatment with CA4. 
 
Figure 5.17 Measurement of the size and morphology of SW480 cells treated with 100 nM of CA4, 
compared to a control sample: (a) Phase contrast images of SW480 and S2480 CA4 cells using a 40x 
objective. (b) Histograms of the circularity 𝐷𝐶  of SW480 and SW480 CA4, fitted with Gaussian 
functions. (c) Density scatter plots of 𝐷𝐶  as a function of diameter of HL60 and HL60 CA4.  
Live cell confocal fluorescence images were taken to visualise the microtubule structure of 
HL60 and SW480 cells treated with CA4. Concentrations of 10 nM, 50 nM and 100 nM were 
compared to a control sample. Cells were incubated with CA4 and the fluorescence stains for 
2 hr before imaging occurred. Tubulin was stained using a live cell fluorogenic labelling probe 
based on Silicon-Rhodamine (Sir) (Spirochrome, Cytoskeleton Inc.) at a final concentration 
of 1 µM. The dye Hoechst 3342 (Thermo Fisher Scientific) was used to stain the DNA, at a 
final concentration of 0.5 µg/ml. 
Figure 5.18 shows fluorescent images of HL60 treated with the different concentrations of 
CA4. In the image of the control sample there is a defined microtubule structure, with 
microtubules protruding radially from centrosomes (the main organelle of the microtubule 
organising centre). Cells treated with 10 nM of CA4 also show clear microtubule filaments, 
however there are notably less of them and they appear generally shorter in length. By a 
concentration of 100 nM of CA4 there are no defined microtubules, instead there is a diffuse 
background of tubulin and stronger fluorescence of what remains at the centrosome. Figure 




HL60, the control sample shows a defined microtubule structure which is highly disrupted for 
concentrations of CA4 >50 nM.  
 
Figure 5.18 Confocal fluorescence images of control HL60 cells and HL60 treated with 10 nM, 50 nM 
and 100 nM of CA4, stained for tubulin (red) and DNA (blue). Images were taken using a 40 x objective, 
scale bar 20 µm.  
 
Figure 5.19 Confocal fluorescence images of control SW480 cells and SW480 treated with 10 nM, 50 
nM and 100 nM of CA4, stained for tubulin (red) and DNA (blue). Images were taken with a 40x 
objective, scale bar 20 µm.  
The microtubules of HL60 cells looked more defined than for the SW480 cells (Figure 5.18 
and Figure 5.19). This may be because SW480 have a bigger nucleus compared to HL60, 




fluorescence images were also used to measure the nuclear diameter of HL60 and SW480 
treated with 100 nM of CA4. 
Figure 5.20 shows histograms of the nuclear diameter of HL60 and SW480 treated with CA4, 
compared to control samples. The nuclear diameter of HL60 was 𝐴𝑛𝑢𝑐𝑙𝑒𝑢𝑠 = 8.98 ± 0.04 
which is within error of HL60 treated with CA4, 𝐴𝑛𝑢𝑐𝑙𝑒𝑢𝑠 = 8.43 ± 0.13. The nuclear 
diameter of SW480 was 𝐴𝑛𝑢𝑐𝑙𝑒𝑢𝑠 = 10.66 ± 0.13, which was also within error of the treated 
sample 𝐴𝑛𝑢𝑐𝑙𝑒𝑢𝑠 = 10.59 ± 0.11. These results show that CA4 has no effect on the nucleus 
size of HL60 and SW480. 
 
Figure 5.20 DNA stained images were used to measure the nuclear diameter of HL60 and SW480 
treated with CA4. Histograms were plotted of the nuclear diameters 𝐴𝑛𝑢𝑐𝑙𝑒𝑢𝑠 of HL60 (a) and SW480 
(b) treated with CA4 and compared to control samples. Plots are fitted with a Gaussian function.  
5.2.2 Deformation Cytometry in the shear regime 
Deformation Cytometry was performed on HL60 and SW480 cells which were incubated with 
100 nM of CA4 for 2 hr. Cells were deformed microfluidically over a range of flow rates 
whilst suspended in 0.5% PBS-MC buffer (𝜇 ≅ 33 𝑐𝑃). A constant concentration of CA4 was 
maintained throughout the measurement period. For each flow rate, the DI of 10s-100s of cell 
events were measured. Experiments were repeated N=3 and the averaged DI and standard 
error in DI were calculated from this. 
Figure 5.21a is a plot of the DI of HL60 cells treated with CA4 as a function of flow rate in 
the shear-dominant regime, compared to a control sample. Results show a decrease in DI for 
the cells treated with CA4 for the entire range of flow rates. An exponential function was fitted 




sample 𝐷𝐼𝑚𝑎𝑥 = 2.5 ± 0.1 and for the treated sample 𝐷𝐼𝑚𝑎𝑥 = 2.3 ± 0.1, indicated a 
decrease in deformability measured even at high strains.  
The 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 was used to quantify the changes in DI induced by treated with CA4, where 
𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 𝐷𝐼𝐶𝐴4/𝐷𝐼𝑐𝑜𝑛𝑡𝑟𝑜𝑙. 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 1 equates to no change in deformability due to 
treatment with CA4, and 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 < 1 represents decreased deformability due to CA4. Figure 
5.21b shows the 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 of HL60 treated with CA4 as a function of flow rate, where the red 
dashed line is used highlight 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 1. This shows that for the entire range of flow rates 
𝐷𝐼𝑟𝑎𝑡𝑖𝑜 > 1, and that the values are within error of each other indicative of a systematic 
change in deformability. The average 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 was 0.86±0.01, showing a 14% drop in 
deformability due to CA4. These results are the opposite of the expected result. CA4 disrupts 
the microtubule network (Figure 5.18) which we would intuitively expect to make the cell 
softer, however these results indicate the cells became stiffer. 
 
Figure 5.21 (a) The deformation index DI of HL60 cells treated with 100 nM of CA4 as a function of 
flow rate, compared to a control sample. Cells were deformed in a shear-dominant regime where 𝜇 ≅
33 𝑐𝑃. Both datasets are fitted with an exponential decay function. (b) The DI ratio of HL60 cells 
treated with CA4 compared to untreated cells (DIHL60CA4/DIHL60).  
Individual cells may respond differently to treatment with CA4. This was investigated by 
comparing histograms of the DI of HL60 cells treated with CA4 and compared to a control 
sample. This is shown in Figure 5.22 for a flow rate of 60 µl/min as this flow condition had 
the largest number of events, and the 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 was the same for all flow rates. Both datasets 
show a normal distribution with a single peak, and are fitted with a Gaussian function. The 
central peak position of the control sample was 𝐷𝐼 = 2.46 ± 0.01 and of the treated sample 
was 𝐷𝐼 = 2.09 ± 0.01. The FWHM of the curves were 𝑤 = 1.00 ± 0.02 for the control 
sample and 𝑤 = 1.01 ± 0.03 for the untreated sample. Results show that treatment with CA4 
leads to a shift in the peak position and that the spread of the data remains the same. This 
suggests that CA4 has a similar effect on the entire sample, as opposed to creating 





Figure 5.22 Histograms of the DI of HL60 treated with 100nM of CA4 (N=890) and a control sample 
(N=853), cells were deformed at 60 µl/min in a shear dominant regime (𝜇 ≅ 33 𝑐𝑃). Both datasets are 
fitted with a Gaussian function.  
Figure 5.23a shows a plot of DI as a function of flow rate for SW480 cells treated with CA4 
and deformed in the shear regime, compared to a control sample. Results show no significant 
change in DI between the treated and untreated cells for the entire range of flow rates. The 
maximum deformation 𝐷𝐼𝑚𝑎𝑥 of the treated sample was 𝐷𝐼𝑚𝑎𝑥 = 1.74 ± 0.06 and for the 
control sample was 𝐷𝐼𝑚𝑎𝑥 = 1.66 ± 0.04, which are within error of each other. Further, 
Figure 5.23 shows the deformation ratio where 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 𝐷𝐼𝐶𝐴4/𝐷𝐼 𝑐𝑜𝑛𝑡𝑟𝑜𝑙. This shows that 
𝐷𝐼𝑟𝑎𝑡𝑖𝑜 ≅ 1 for all flow rates, corroborating that the shear regime is not sensitive to any 
mechanical changes induced by CA4 in SW480 cells. 
Figure 5.18 and Figure 5.19 showed that CA4 inhibits polymerisation of microtubules in both 
SW480 and HL60 cells, and a concentration of 100 nM leads to complete destabilisation of 
microtubules. Deformation cytometry in the shear regime was used to measure deformability 
changes of the cells due to microtubule disruption. Interestingly, HL60 become less 
deformable whereas no changes were measured in SW480. Confocal fluorescence imaging 
also showed that HL60 have a smaller nucleus and nuclear ratio compared to SW480, making 
their microtubule filaments able to pervade more of the cytoplasm. This could mean that the 
mechanical rigidity of HL60 is more affected by microtubule filaments than SW480, where 
the mechanical properties of the nucleus may dominate instead. Additionally, untreated HL60 
are naturally much softer than SW480 (𝐷𝐼𝑚𝑎𝑥 of HL60 Is ~1.5 times that of SW480). This 
means SW480 may also become stiffer due to CA4 but deformation cytometry in this regime 




HL60 becoming stiffer due to treatment with CA4 is counter-intuitive. Destabilising 
microtubules, part of the cell cytoskeleton, would suggest an increase in deformability. CA4 
is also known to be cytotoxic and can induce apoptosis after ~24 hr of incubation. Cells in the 
early stages of apoptosis become stiffer [48], therefore is it important to separate whether the 
decrease in stiffness is due to microtubule changes, apoptosis, or other subcellular changes. 
This is investigated in subsequent sections.  
 
Figure 5.23 (a) The deformation index DI of SW480 cells treated with 100 nM of CA4 as a function of 
flow rate, compared to a control sample. Cells were deformed in a shear-dominant regime where 𝜇 ≅
33 𝑐𝑃. Both datasets are fitted with an exponential decayfunction. (b) The DI ratio of SW480 cells 
treated with CA4 compared to untreated cells (DISW480CA4/DISW480). 
5.2.3 Deformation Cytometry in the inertial regime 
Deformation cytometry was also performed on HL60 and SW480 cells treated with CA4 in 
the inertia-dominant flow regime. Cells were incubated with 100 nM of CA4 for 2 hr and then 
deformed microfluidically whilst suspended in cell media (µ~1 cP). A constant concentration 
of CA4 was maintained throughout the measurement period. Cells were deformed over a range 
of flow rates (Q≤600 µl/min), 10s-100s of events were collected for each flow conditions. 
Experiments were repeated N=3 and the average DI and standard error were found. 
Figure 5.24a shows DI as a function of flow rate for HL60 cells treated with CA4 and 
deformed in the inertia-dominant flow regime. Both datasets are fitted with an exponential 
decay function and follow similar trends. Both datasets shows the previously discussed yield 
stress behaviour at 𝑄 ≅ 400 𝜇𝑙/𝑚𝑖𝑛 corresponding to a larger increase in DI. Figure 5.24b 
shows the 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 𝐷𝐼𝐶𝐴4/𝐷𝐼𝑐𝑜𝑛𝑡𝑟𝑜𝑙 as a function of flow rate, with  𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 1 equivalent 
to no deformability change induced by CA4. This shows that for the majority of flow rates 
𝐷𝐼𝑟𝑎𝑡𝑖𝑜 ≅ 1. Results show that no deformability changes could be detected in HL60 in the 





Figure 5.24 (a) The deformation index DI of HL60 cells treated with 100 nM of CA4 as a function of 
flow rate, compared to untreated cells. Cells were deformed in an inertia-dominant regime where 𝜇 ≅
1 𝑐𝑃. Both datasets are fitted with an exponential decay function. (b) The DI ratio of HL60 cells treated 
with CA4 compared to untreated cells (DIHL60CA4/DIHL60).  
Figure 5.25a is a plot of DI as a function of flow rate for SW480 cells treated with CA4 and 
deformed in the inertia-dominant flow regime, compared to a control sample. Results show 
that DI of the treated sample and the control sample are within error of each other across the 
range of flow rates. The datasets exhibit yield stress behaviour at 𝑄 ≅ 300 𝜇𝑙/𝑚𝑖𝑛, and are 
fitted with linear functions above and below this value. The gradient of the fits increases 
significantly for 𝑄 > 300 𝜇𝑙/𝑚𝑖𝑛. Figure 5.25b shows the 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 𝐷𝐼𝐶𝐴4/𝐷𝐼𝑐𝑜𝑛𝑡𝑟𝑜𝑙 as a 
function of flow rate. For the majority of flow rates 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 1, showing that there was no 
change in the deformability of SW480 due to CA4. 
These results show that no significant change in deformability could be detected in HL60 or 
SW480 treated with CA4 when using deformation cytometry in the inertia-dominant flow 
regime. No changes were observed at low strains (below the yield stress) or at high strains 






Figure 5.25(a) The deformation index DI of SW480 cells treated with 100 nM of CA4 as a function of 
flow rate, compared to untreated cells. Cells were deformed in a inertia-dominant regime where 𝜇 ≅
1 𝑐𝑃. (b) The DI ratio of SW480 cells treated with CA4 compared to untreated cells (DISW480CA4/DISW480).  
5.2.4 Viability Assays 
Apoptosis had been shown to increase cell stiffness [188]. Lam et al. 2007 used AFM to show 
that the chemotherapy drug daunorubicin caused cell death leading to an increase in cell 
stiffness [200]. The stiffness increase was detected in early (~1 hr) and late stage apoptosis 
(>2 hr incubation). CA4 has shown cytotoxic effects and is being researched as a 
chemotherapy drug due to its ability to cause cell death, apoptosis is generally induced after 
24-48 hr of incubation [208]. Figure 5.21 and Figure 5.30 showed that HL60 cells treated with 
CA4 became stiffer. This suggests that the mechanical changes could be due to early stage 
apoptosis as opposed to inhibited microtubule organisation, even though incubation times 
were kept low to avoid this (2 hr). This was investigated by performing viability assays on 
both HL60 and SW480, particularly over the incubation and measurement time (>4 hr) and 
the expected time to induce late stage apoptosis (~48 hr). 
Trypan blue exclusion assays were first performed (described in section 3.6.5) on HL60 cells. 
The cells were treated with 10 nM, 50 nM and 100 nM of CA4 and incubated for a period of 
48 hr. The viability was measured after 2 hr, 24 hr and 48 hr and compared to a control sample 
which was not exposed to CA4. Additionally, the effects of CA4 are known to be reversible 
below a critical concentration. Therefore, samples were compared that were incubated with 
CA4 for 2 hr and then the drug was removed and replaced with fresh media. These samples 
are referred to as “washed” samples. Figure 5.26 shows bar graphs of the viability of HL60 
treated with CA4 over a 48 hr period for samples washed after 2 hr incubation compared to 
unwashed samples (incubated with CA4 for the 48 hr period). 
Figure 5.26a shows that HL60 cells treated with 10 nM of CA4 remained viable (>95%) over 




drop in viability (~10% viability), showing apoptosis was induced. Cells incubated with 10 
nM for 2 hr and then washed also remained viable, showing that the effects of CA4 are 
reversible at this concentration. Figure 5.26b shows cells treated with 50 nM of CA4 also 
remained viable for 24 hr (>90%). Cells incubated with 50 nM for 48 hr had a significant drop 
in viability (~10% viable), cells washed after 2 hr also had a significant viability drop (~25% 
viable). This shows that 50 nM induces apoptosis after 48 hr and the effects are non-reversible 
after a 2 hr incubation period. Figure 5.26c shows cells treated with 100 nM of CA4 behaved 
the same as those treated with 50 nM. Cells had viability >95% after 2 hr incubation, which 
dropped to ~90% after 24 hr. After 48 hr the viability dropped to ~10% viability and treatment 
with CA4 was non-reversible. 
 
Figure 5.26 The viability of HL60 cells treated with CA4 was tested up to 48 hr of incubation with the 
drug. The reversibility of the drug was tested by also incubating samples with CA4 for 2 hr before 
removing the drug and replacing with fresh media, described as “washing” the cells. This was done 
for three concentrations of CA4: (a) 10 nM, (b) 50 nM and (c) 100 nM.  
Phase contrast images of HL60 were also taken after different incubation times with 10 nM 
and 100 nM CA4, these images were used to measure the circularity of the cells using 𝐷𝑐. 
Figure 5.27a shows density scatter graphs of HL60 treated with 10 nM of CA4 over 48 hr, 




𝐷𝑐 after the 2 hr incubation period from 𝐷𝑐 = 0.13 ± 0.02 to 𝐷𝑐 = 0.25 ± 0.01, cells were 
previously shown to become less rounded after incubation with CA4 (Figure 5.16). After 48 
hr, 𝐷𝑐 decreased again to 𝐷𝑐 = 0.15 ± 0.02  which is within error of the control sample. 
Figure 5.27b shows density scatter graphs of cells treated with 100 nM of CA4 over 48 hr, 
where cells were washed of the drug after 2 hr. Results show the cells become less rounded 
after the 2 hr incubation and increase in 𝐷𝑐 increased from 𝐷𝑐 = 0.13 ± 0.01 to 𝐷𝑐 = 0.23 ±
0.01. 𝐷𝑐 continued to increase to a value of 𝐷𝑐 = 0.44 ± 0.01  over 48 hr, showing the cells 
do not recover after the drug is removed. Figure 5.27c shows a phase contrast image of cells 
treated with 100 nM of CA4 for 48 hr compared to a control sample and cells incubated for 2 
hr. After 48 hr the cells show signs of deterioration, are more polydisperse in size and shape 
and have less contrast.  
DC was performed on HL60 incubated with 100 nM of CA4 for 2 hr. Results show that cells 
remained viable at this concentration for 24 hr, significantly later than the measurement period 
of 4 hr. The effects of CA4 were also non-reversible and significant apoptosis was induced 
after 48 hr leading to a viability of ~10%. These results initially suggested that the decrease in 
deformability of HL60 treated with CA4 was not due to apoptotic effects. However, trypan 






Figure 5.27 The circularity of HL60 cells treated with CA4 was measured using 𝐷𝑐  up to 48 hr of 
incubation with the drug. Samples were incubated with CA4 for 2 hr before removing the drug and 
replacing with fresh media, described as “washing” the cells. Density scatter plots of 𝐷𝑐  as a function 
of cell diameter, for two concentrations of CA4: (a) 10 nM and (b) 100 nM. (c) Phase contrast images 
of HL60 cells after incubation with CA4 for 2 hr, which was then removed and images were also taken 
after 48 hr.  
The viability of SW480 treated with CA4 was also tested using the trypan blue assay. Cells 
were incubated with 100 nM of CA4 for a 48 hr period. Figure 5.29a shows that cell viability 
was >95% even after 48 hr incubation, whereas HL60 cells had a significant viability drop 
after 48 hr. The concentration of cells was also monitored over 48 hr, and treated and untreated 
SW480 cells were compared (Figure 5.28b). The control sample showed an increase in cell 
concentration after 48 hr, indicating proliferation. The CA4 treated cells showed a decrease in 
concentration. This shows that CA4 stops proliferation (due to inhibiting microtubule 
function) and the drop indicates some cells have died during this time. As SW480 are adherent 
cells they were detached for viability and concentration measurements. The washing steps 
may have washed away any late stage apoptotic cells which would already have detached, 
leaving only the viable cells and resulting in a high viability measurement. Phase contrast 
images of adhered cells treated with CA4 for 48 hr showed no morphological changes 
compared to a control sample seeded on the same day, however the control samples are clearly 




These results indicate that CA4 inhibits proliferation in SW480 cells, however after 48 hr the 
initial cells were still viable using a trypan blue assay. SW480 also did not show any 
mechanical changes due to CA4 (Figure 5.23). This could suggest that CA4 takes longer to 
induce apoptosis in SW480 compared to HL60, where increased cell stiffness was detected 
after 2-4 hr. 
 
Figure 5.28 (a) The viability of SW480 cells after incubation with 100 nM of CA4 for 2 hr and 48 hr 
was measured using a Trypan blue assay. (b) The concentration of SW480 cells after 2 hr and 48 hr 
incubation with 100 nM of CA4 is compared to a control sample of SW480, results are normalised to 
the initial measurement.  
Another assay was also used to measure the viability of HL60 and SW480 incubated with 
CA4 over a period of 4 hr, which encompasses the 2 hr initial incubation and additional time 
where deformation measurements were taken (<1 hr). The Alamar Blue Assay (protocol 
described in section 3.6.5) measures the reducing potential of cells. Initially non-fluorescent, 
the reagent is reduced in living cells and becomes highly fluorescence. This fluorescence 
intensity was measured using a well plate reader and used to quantify viability. Alamar Blue 
may be able to detect early stages of apoptosis whereas Trypan blue may not, the metabolic 
activity of living cells is likely altered before the cell membrane is significantly compromised 
for measurement using the trypan blue exclusion method. 
Figure 5.29a shows the normalised fluorescence intensity of HL60 cells incubated with 
different concentrations of CA4 for 4 hr, using Alamar Blue. The average fluorescence 
intensity was averaged from n=5 wells, and normalised to a control sample which was not 
treated with CA4. Results show that the viability was >95% for concentrations ≤10 nM. For a 
concentration of 100 nM the viability was still ~93%. Figure 5.29b shows the normalised 
fluorescence intensity of SW480 cells treated with CA4 at different concentrations for 4 hr. 
Results show that for all concentrations the viability was >90%, and at 100 nM the viability 




These results suggest that treatment with CA4 over 4 hr did not induce a significant viability 
drop in HL60 or SW480 cells. Which is in accordance with results using the Trypan blue 
assay. 
 
Figure 5.29 The normalised fluorescence intensity of SW480 and HL60 using an AlamarBlue 
assay after 4 hr incubation with different concentrations of CA4. For each condition, the 
average fluorescence was found from n=5 wells and a standard error was calculated (scale 
bars). Values were normalised using the control sample, where no CA4 was added.  
5.2.5 Deformation traces and SCA 
Deformation cytometry was also used to track the strain ɛ of HL60 cells treated with CA4 and 
was compared to a control sample. Cells were treated with 100 nM of CA4 for 2 hr and 
deformed in the shear-dominant regime (μ ≅ 33 𝑐𝑃) at 5 µl/min. These conditions were 
chosen as HL60 cells treated with CA4 and deformed in the shear-regime previously showed 
decreased deformability (Figure 5.21) whereas the inertial regime showed no changes in 
deformability due to CA4 (Figure 5.23 and Figure 5.24). 
Figure 5.30 shows the averaged strain traces of N=56 HL60 cells, and N=38 HL60 cells treated 
with CA4. These traces were used to extract multiple deformation and relaxation parameters, 
summarised in Table 5.2. The deformation time 𝜏𝑑 and relaxation time 𝜏𝑟 were found by fitting 
exponential functions to the deformation and recovery regions of the strain traces (shown in 
black in Figure 5.30). The exponential fit of the relaxation was also used to extrapolate the 
final strain 𝜀∞. The results in Table 5.2 confirm that CA4 decreases the deformability of HL60 
as the 𝜀𝑚𝑎𝑥 of the control cells is ~1.4 x larger than the CA4 treated cells. The initial strains 
𝜀0 of both samples are within error of each other, whereas the final strain of the treated cells 




initial shape (𝜀0 = 𝜀∞) whereas the treated sample does not (𝜀0 < 𝜀∞). The 𝜏𝑑 of both samples 
are within error of each other, however the 𝜏𝑟 shows that the treated cells relax ~4x quicker 
than the control cells. Therefore, the CA4 treated cells relax more quickly after deformation 
but have an apparent permanent strain because 𝜀0 < 𝜀∞. 
Figure 5.31 shows the average velocity profile of N=38 HL60 cells treated with CA4 (the 
average velocity profile of untreated HL60 was shown in section 4.1.3), which is fitted with a 
sine function (shown in red). This allowed the Kelvin-Voigt model (described in section 2.3.4) 
to be fitted to the averaged strain trace (shown in red in Figure 5.31). The elastic modulus of 
HL60 treated with CA4 was found to be 𝐸 = 598 ± 66 𝑃𝑎, the elastic modulus of HL60 was 
previously found to be 𝐸 = 301 ± 29 𝑃𝑎 (section 4.4.1). This shows that HL60 become 
approximately twice as stiff when treated with CA4. 
 
Figure 5.30 The averaged strain trace for HL60 (N = 50) and HL60 treated with 100 nM LatA (N = 
30) as a function of time, with the standard error shown by the shaded areas. Flow rate was 5 µl/min, 
and the suspension medium viscosity was 33 cP. The deformation and recovery are fitted with an 





Figure 5.31 The averaged strain trace of N=38 HL60 cells treated with CA4, the Kelvin-Voigt model 
was fitted, shown in red. The average velocity profile of the same 38 cells is shown and fitted with a 
sine function, shown in red. Cells were deformed in a shear-dominant regime where 𝑄 = 5 𝜇𝑙/𝑚𝑖𝑛 and 
𝜇 ≅ 33 𝑐𝑃.  
As previously discussed, bulk averaging can miss subpopulations within a sample and offers 
less information than single cell analysis. SCA was also performed on the individual traces of 
HL60 treated with CA4 (N=38). This was performed using the method previously described 
in section 4.4.1. Table 5.2 shows the parameters found from the “Averaged Strain Trace” and 
compares them to values averaged from SCA. The values found of 𝜀𝑚𝑎𝑥 and 𝜀0 are within 
error of each other. The relaxation time 𝜏𝑟 of both samples is ~1.25 times bigger using the 
averaged strain trace compared to SCA. This suggests outliers may skew the averaged trace 
and indicates the importance of investigation at the single cell level. Both methods show that 
HL60 recover their initial strain (𝜀∞ = 𝜀0), whereas the treated cells show an apparent 
“permanent strain” (𝜀∞ > 𝜀0). However, the 𝜀∞ calculated for treated HL60 was ~1.3 times 
greater using the averaged strain trace compared to SCA. This difference is likely carried 
through from the differences in 𝜏𝑟 as these values are extrapolated from the same fit. 
Statistical t-tests were used to classify the level of significance between the parameters 
measured using SCA on control and treated HL60 populations. Figure 5.32 shows bar graphs 
of the average A, εmax, ε∞, τr and ε0 of both samples found by SCA, where the level of 
significance was measured by calculation of the p-value. The raw p-values are also included 
in a table shown in Figure 5.32. Results show no significant difference in A and ε0 due to 
treatment of HL60 with CA4. Significant differences (*) were shown using 𝜀𝑚𝑎𝑥 and 𝜀∞, and 




size and strain could not be used to distinguish the two samples but deformation and relaxation 
parameters could. This demonstrates the ability of mechano-phenotyping on the single cell 
level to accurately classify changes in cells due to treatment with a drug. 
Table 5.2 Multiple characteristic parameters extracted from the strain traces of N=50 HL60 cells and 
N=38 HL60 cells treated with CA4. This includes the initial cell diameter A, the initial strain ε0, the 
final strain ε∞, the maximum strain εmax, the deformation time τd, the relaxation time τr and the elastic 
modulus E. Values were found from the “Averaged Strain Trace” and also using single cell analysis 
“SCA”  of individual traces which were then averaged with ±SE.
 Averaged Strain Trace SCA 
 HL60 HL60-CA4 HL60 HL60-CA4 
A (µm) N/A N/A 12.3±0.2 12.9±0.2 
𝜀𝑚𝑎𝑥 0.18±0.01 0.13±0.02 0.18±0.01 0.13±0.02 
𝜏𝑟 (ms)  3.52±0.14 0.83±0.1 3.04±0.15 0.70±0.08 
𝜏𝑑 (ms)  1.04±0.05 1.10±0.10 
N/A N/A 
𝐸 (𝑃𝑎) 301±29 598±66 N/A N/A 
𝜀0 -0.012±0.005 -0.02±0.02 -0.012±0.005 -0.01±0.02 
𝜀∞ +0.030±0.004 +0.075±0.01 +0.030±0.004 +0.06±0.01 
 
 
Figure 5.32 SCA performed on strain traces of HL60 treated with CA4 and a control sample. The plots 
show the average values of the cell diameter A, maximum strain 𝜀𝑚𝑎𝑥, initial strain 𝜀0, the relaxation 
time 𝜏𝑟 and the final strain 𝜀∞. The error bars denote the standard error SE. Statistical t-tests were 
done to determine the level of significance, where p>0.05 is not significant (ns), 0.01<p<0.05 is 
significant (*), 0.001<p<0.01 is very significant (**), 0.0001<p<0.001 is extremely significant (***) 




Mechanical changes on the single cell level were further explored by plotting histograms of 
parameters which showed significant changes. Figure 5.33 shows histograms of εmax, τr and ε∞ 
of both datasets. For εmax, both histograms show a normal distribution fitted with a single 
Gaussian peak. There is a shift in the peak position of the treated cells, showing the decrease 
in average deformability. The histograms of τr also show a normal distribution, fitted with a 
Gaussian. The peak position for the treated cells is shifted which shows that the treated cells 
relax quicker after being deformed. For the control sample, the histogram of ε∞ shows the 
majority of cells have ε∞=0.025 which is within error of the initial strain ε0 shown in Table 
5.2. The treated sample shows a peak at ε∞=-0.01, showing that some of the treated cells 
recover their original strain (𝜀0 = 𝜀∞). There is also a second significant peak at ε∞=0.06, 
resulting in the non-zero average in ε∞ in Table 5.2. The histograms offer more information 
than the reported averages. Figure 5.33 indicates that treatment with CA4 affects some cells 
differently resulting in two populations, with some cells recovering their initial shape and 
some showing signs of a “plastic deformation”. 
 
Figure 5.33 Histograms showing the maximum strain 𝜀𝑚𝑎𝑥, relaxation time 𝜏𝑟 and final strain 𝜀∞ of 
HL60 treated with CA4 (N=38), compared to an untreated control sample (N=50). 
5.2.6 Discussion 
HL60 and SW480 cells were treated with CA4 to investigate changes in cell stiffness due to 
microtubule destabilisation. DC was used in both shear-dominant and inertia-dominant flow 
regimes, confocal fluorescence confirmed that CA4 fully destabilised microtubules at 100 nM. 
No changes in deformability were detected for SW480 in either flow regime. No deformability 
changes were detected in HL60 in the inertia-dominant regime, a decrease in deformability 
was seen across the entire range of flow rates in the shear dominant regime (1.4<DI<2.5). 





Martinez Vazquez et al. 2015 measured the pressure gradient required to deform cells through 
a constriction channel [209]. The pressure required to squeeze single cells through the 
constriction was measured, higher pressures were correlated to increased deformability due to 
deformable cells having higher contact area and adhesion to channel walls. Cells were treated 
with various cytoskeletal altering drugs; CA4 and nocodazole which disrupt microtubules, and 
paclitaxel which enhances microtubules. They found that CA4 and nocodazole made the cells 
softer and required an increased pressure to pass through the constriction, paclitaxel made the 
cells stiffer and required a decreased pressure. Their CA4 results show the opposite result to 
those by deformation cytometry.  
CA4 has been shown to cause shutdown of tumour vasculature and eventual tumour death 
[210]. Severe destabilisation of tubulin causes a time-dependent cytotoxic and 
antiproliferation effect [211]. Cells become stuck in the G1/S phase of the cell cycle due to 
failure to complete mitosis, and thus cell death can occur due to mitotic catastrophe as well as 
apoptotic pathways [212]. Trypan blue and Alamar Blue assays showed that CA4 induced 
apoptosis in HL60 over a 48-hr incubation period. The viability did not decrease in SW480 
however proliferation stopped over this time-period (indicating mitotic catastrophe). Green et 
al. 2010 studied an analogue of CA4, CA423, which displayed similar antiproliferation and 
cytotoxic effects [208].  HL60 cells treated with CA423 showed no increase in apoptosis over 
an 8 hr incubation period, after 48 hr >75% of cells were apoptotic. This agrees with the trypan 
blue and alamar assay results (section 5.2.4). HL60 treated with 100 nM of CA4 for 16 hr also 
showed that 75% of cells were in the G2M phase. Cells in this phase are known to be stiffer 
[96], [213]. However, after 4 hr there was a <5% increase in cells in the G2M which is the 
maximum measurement period used in our deformation cytometry study. These results 
suggest the increased stiffness of HL60-CA4 found using shear-dominant deformation 
cytometry is not due to apoptosis or mitotic catastrophe. 
Kubitschke et al. 2017 investigated how microtubule structure influences cell elasticity and 
recovery under small (<5%) and large strains (5-20%), using optical stretching. The drug 
nocodazole was used to disassemble microtubules. This lead to no changes in cell 
deformability at small strains and an increase in deformability at large strains. They theorise 
that the actin scaffold dominates cell elasticity at small strains, also shown in our results using 
the actin depolymerising drug LatA. However, individually microtubules are mechanically 
stiffer than microfilaments and actin fluidises under high strains, therefore high strains may 
be required to probe microtubules [198].   
Comparatively, our results on HL60 treated with CA4 showed that at high strains in the 




affect was found. Kubitschke et al. 2017 also found some counter-intuitive changes to cell 
deformability using the microtubule enhancing drug paclitaxel. No changes were seen at small 
strains, however concentration dependent changes were seen at high strains. For high-
concentrations (>200 nM) the cell stiffened which is the intuitive result. For low 
concentrations (<200 nM) the cells softened, which suggests that the microtubule 
enhancement leads to secondary mechanisms activating in the cell. Danowski et al. 1989 
showed that stabilising microtubules inhibits acto-myosin contractions which leads to 
softening [214].  
Golfier et al. 2017 used RT-DC to deform HL60 cells treated with various drugs to perturb 
the cytoskeletal structure [50]. They also showed counter-intuitive results, cells treated with 
Nocodazole became stiffer and those treated with Paclitaxel became softer over a range of 
concentrations. They argued that F-actin assembly occurs to compensate the loss of 
microtubules. Verin et al. 2001 found that disrupting microtubules initiates specific signalling 
pathways with microfilaments leading to myosin light chain phosphorylation which enables 
cell contraction [215]. Tsai et al. 1998 treated neutrophils with colchicine (a microtubule 
disruptor) and paclitaxel and measured deformability using micropipette aspiration. High 
concentrations of colchicine lead to increased actin polymerisation and cell rigidity, low 
concentrations had no effect on either and Paclitaxel did not influence actin and mechanical 
changes were not detected [216]. Paclitaxel is a chemotherapy drug which arrests cells in the 
mitosis stage of the cell cycle and stops proliferation. Similarly to CA4, it eventually induces 
apoptosis in cells.  
Our results confirmed that over the measurement period cells were not yet apoptotic, 
indicating that the stiffening was not due to apoptosis and likely a secondary mechanism due 
to microtubule destabilisation. Confocal fluorescence images of HL60 treated with CA4 with 
an actin stain are shown by Figure 5.34, and are compared to a control. The treated cells show 
signs of a more defined actin cortex and additional protrusions containing actin filaments. This 
may indicate that destabilisation of HL60 microtubules by CA4 leads to enhancement of 





Figure 5.34 Confocal fluorescence images of control HL60 cells and HL60 treated with 100 nM of CA4, 
stained for actin (red) and DNA (blue). Images were taken using a 10x (above) or a 40 x (below) 
objective, scale bar 20 µm.  
Gossett et al. 2012 used inertia-dominant deformability cytometry to deform HeLA and 
fibroblast cells treated with nocodazole. They showed no significant changes in deformability 
due to nocodazole, which contradicts the work by Kubitschke et al. 2017 who suggested high-
strain deformations were more sensitive to microtubule disruption [27], [198]. However, the 
strains in this work were still relatively low compared to deformability cytometry. 
Additionally, the strain rates used in optical stretching are on the second timescale whereas 
deformation cytometry works at 105𝑠−1. Gossett argues that the high strains and strain-rates 
in deformability cytometry are not sensitive to cytoskeletal changes and measurements are 
dominated by cytoplasmic properties and nuclear structure. This corroborates our work as both 
SW480 and HL60 treated with CA4 showed no deformability changes in the inertia-dominant 
regime at high strains. 
Kubitschke et al. 2017 also measured cell recovery after deformation and treatments with both 
nocodazole and paclitaxel [198]. Nocodazole lead to a lack of relaxation indicating increased 
plasticity. Similarly, we found that HL60 treated with CA4 did not recover their original shape 
also indicating a plastic deformation. Paclitaxel also showed an increased plasticity even 
though it enhances microtubules. This is further evidence that microtubule alterations lead to 
further changes in the cell which effects both cell elasticity and recovery. 
Overall, previous works suggest that actin is the dominant cytoskeletal component of cell 




used to disrupt or enhance microtubules trigger changes in actin and myosin within the cell 
which can lead to surprising changes in cell deformability. CA4 leads to cell stiffening using 
a shear-dominant deformation cytometry assay, suggesting secondary mechanisms may alter 
the substructure. Additionally, CA4 treated cells also did not recovery after deformation 
suggesting some plasticity is induced due to removal of prestressed microtubules.  
5.3 Treating cells with Trichostatin A 
The cell nucleus is the largest and stiffest organelle, its mechanical properties influence whole 
cell deformability. The nucleus rigidity is defined by nuclear lamina and chromatin structure. 
Chromatin structure is regulated by proteins including histones, which organise chromatin into 
a condensed structure. TSA is a drug which induces hyper-acetylation of histone tails leading 
to increased negative charges, thus electrostatic forces drive chromatin decondensation [217]. 
HL60 cells were used to study the effects of chromatin decondensation using TSA, these cells 
were previously used to study the effects of actin disruption using LatA and microtubule 
disruption using CA4. Cells were probed using deformation cytometry in shear-dominant and 
inertia-dominant flow regimes to compare how whole cell deformability is affected by nuclear 
changes compared to cytoskeletal perturbations. 
5.3.1 Drug treatment and observations 
HL60 cells were treated with the drug Trichostatin A (TSA), to test the sensitivity of DC to 
nuclear structural changes. Firstly, treated cells were imaged using phase contrast and confocal 
fluorescence microscopy to visualise TSA induced changes to cell morphology and 
substructure. 
Figure 5.35a shows phase contrast images of HL60 incubated with 1 µM of TSA for 2 hr and 
compared to a control sample. The treated sample shows a generally less rounded morphology 
compared to the control sample, with some cells showing blebbing and protrusions. The 
morphological changes were quantified by measuring the circularity 𝐷𝐶. Figure 5.35b shows 
histograms of 𝐷𝐶 for the treated sample compared to the control sample. The control sample 
is fitted with a lognormal distribution with a single peak, the centre of the peak was 𝐷𝐶 =
0.07 ± 0.01 and the curve had a standard deviation of 𝑤 = 0.02 ± 0.01. The treated sample 
shows a large peak at 𝐷𝑐 = 0.07 ± 0.01  with a standard deviation of 𝑤 = 0.04 ± 0.01, this 
is within error of the peak position of the control sample. There is a second peak at position 
𝐷𝑐 = 0.38 ± 0.01  with a ~6 times larger standard deviation of  𝑤 = 0.25 ± 0.03. This is 
likely the cells which experience blebbing and may indicate that a subpopulation of the cells 
are more effected by TSA than others. Figure 5.35c shows density scatter plots of 𝐷𝐶 as a 
function of cell diameter for both samples. This highlights that treatment with TSA leads to a 




diameter of control cells was found to be 𝐴 𝑐𝑜𝑛𝑡𝑟𝑜𝑙 = 13.6 ± 0.1 μ𝑚 and of treated cells was 
𝐴 𝑇𝐴 = 14.6 ± 0.1 μ𝑚. This shows that the treated cells had a small increase in size (~1.1 
times). 
 
Figure 5.35 Measurement of the size and shape of HL60 cells compared to those treated with 1 µM of 
TSA: (a) Phase contrast images of HL60 and HL60 TSA cells taken with a 40x objective. Scale bars are 
20 µm. (b) Histograms of the circularity 𝐷𝐶  of HL60 and HL60 TSA, with peak fitting. (c) Density 
scatter plots of 𝐷𝐶  as a function of diameter of HL60 and HL60 TSA.  
Confocal fluorescence images were taken of HL60 cells treated with TSA for concentrations 
of 0.1 µM, 1 µM and a control sample, which encompasses ranges previously used to 
destabilise chromatin [49], [87], [88]. Cells were incubated with the drug and fluorescent 
stains for 3 hr before imaging occurred. DNA staining was done using the dye Hoechst 3342 
(Thermo Fisher Scientific) at a concentration of 0.5 µg/ml. Tubulin was stained using a live 
fluorogenic labelling probe (Sir) (Spirochrome, Cytoskeleton Inc.) at a final concentration of 
1 µM. 
Figure 5.36 shows fluorescent images of HL60 control cell and those treated with TSA, DNA 
staining is shown in blue and tubulin staining is shown in red. The control cells and those 
treated with 0.1 µM TSA show a defined microtubule structure, with filaments arranged 
radially originating at centrosomes. Cells treated with 1µM show disrupted microtubule, 
instead showing a diffuse background with a fluorescent spot remaining at the centrosome. 
The DNA staining of the control sample shows a defined nucleus in each cell with similar size 
and a rounded morphology, this can also be seen in the 0.1 µM TSA sample. Treatment with 
1 µM of TSA shows obvious differences in the morphology of the nucleus of HL60. The 
nucleus appears less uniform and shows a larger diffuse background with bright spots of DNA, 





Figure 5.36 Confocal fluorescence images of control HL60 cells and HL60 cells treated with 0.1 µM 
and 1 µM of TSA, stained for DNA (blue) and tubulin (red). Images were taken using a 40 x objective, 
scale bar 20 µm.  
5.3.2 Deformation Cytometry in the shear regime 
Deformation Cytometry was performed on HL60 cells treated with 1 µM of TSA for 2 hr. 
Cells were deformed on-chip over a range of flow rates whilst suspended in 0.5% PBS-MC 
buffer (𝜇 ≅ 33 𝑐𝑃). The concentration of TSA was maintained over the measurement period. 
The DI of 10s-100s of cells was measured for each flow rate, experiments were repeated N=3 
to acquire an average and standard error of DI. 
Figure 5.37a shows a plot of DI as a function of flow rate for cells treated with TSA in the 
shear-dominant flow regime and compared to a control sample. Results show no change in 
deformability due to treatment with TSA for any of the flow rates. Both data sets are fitted 
with an exponential decay function which was used to extrapolate DImax. The control sample 
had 𝐷𝐼𝑚𝑎𝑥 = 2.64 ± 0.11 and the treated sample had 𝐷𝐼𝑚𝑎𝑥 = 2.79 ± 0.38, also indicating 
no changes in deformability. The 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 was also used to quantiy if any changes in DI 
occurred due to treatment with TSA, where 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 𝐷𝐼𝑇𝐴/𝐷𝐼𝑐𝑜𝑛𝑡𝑟𝑜𝑙 and 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 1 
indicates no change. Figure 5.37b is a plot of 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 as a function of flow rate, where 




within error of 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 ≅ 1. This confirms no deformability changes, due to TSA, are observed 
using deformation cytometry in the shear-dominant regime. 
 
Figure 5.37(a) The deformation index DI of HL60 cells treated with 1 µM of TSA as a function of flow 
rate, compared to a control sample. Cells were deformed in a shear-dominant regime where 𝜇 ≅ 33 𝑐𝑃. 
Both datasets are fitted with an exponential function. (b) The DIRATIO of HL60 cells treated with TSA 
compared to untreated cells (DIHL60TA/DIHL60) in the shear regime.  
5.3.3 Deformation Cytometry in the inertial regime 
Deformation Cytometry was also performed on HL60 treated with TSA in the inertia-
dominant flow regime, where cells were incubated with 1 µM of TSA for 2 hr. Cells were 
deformed whilst suspended in cell media (µ~1 cP) and a constant concentration of TSA was 
maintained throughout the measurement period. For a range of flow rates, 10s-100s of 
deformation events were collected. This was repeated N=3 to acquire an average and standard 
error in DI. 
Figure 5.38a shows DI as a function of flow rate for HL60 cells treated with TSA, compared 
to a control sample. Both datasets are fitted with an exponential and show the previously 
discussed yield stress behaviour occurring at ≅ 400 𝜇𝑙/𝑚𝑖𝑛 , and a general increase in 
deformability of cells treated with TSA. The 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 was used to quantify the increase in DI 
due to the effects of TSA, where 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 > 1 indicated increased deformability. Figure 5.38b 
is a plot of 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 as a function of flow rate. This shows that below the yield stress there is a 
small increase in deformability due to TSA (𝐷𝐼𝑟𝑎𝑡𝑖𝑜 ≅ 1.1). At the yield stress the increase in 
deformability is more apparent 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 = 1.34 ± 0.10. At 𝑄 = 600 𝜇𝑙/𝑚𝑖𝑛 the 𝐷𝐼𝑟𝑎𝑡𝑖𝑜 is 
within error of 1 indicating that no deformability changes can be distinguished here. Flow 
rates 𝑄 > 600 𝜇𝑙/𝑚𝑖𝑛 lead to a on-chip cell destruction and this was previously labelled the 
failure point (discussed in section 4.2.2). Therefore, this indicates the maximum strain of 






Figure 5.38 (a) The deformation index DI of HL60 cells treated with 1 µM of TSA as a function of flow 
rate, compared to untreated cells. Cells were deformed in a inertia-dominant regime where 𝜇 ≅ 1 𝑐𝑃. 
Both datasets are fitted with an exponential function. (b) The DI ratio of HL60 cells treated with TSA 
compared to untreated cells (DIHL60TA/DIHL60).  
The heterogeneity in the response of HL60 to TSA was investigated by plotting histograms of 
DI. Figure 5.39a shows histograms of DI of treated and control cells deformed at 300 µl/min 
(below the yield stress), 400 µl/min (at the yield stress) and 600 µl/min (at the failure point). 
Histograms are fitted with log-normal functions and the peak values DIpeak and standard 
deviation w are summarised in Table 5.3. 
Figure 5.39a shows that at 300 µl/min, both datasets have a single peak which is fitted with a 
log-normal function. The control dataset has a peak at 𝐷𝐼𝑝𝑒𝑎𝑘 = 1.38 ± 0.01 and the standard 
deviation of the curve is 𝑤 = 0.09 ± 0.01. The TSA treated dataset has a peak at 𝐷𝐼 = 1.59 ±
0.01 and a standard deviation of 𝑤 = 0.16 ± 0.01. This shows that there was an increase in 
average deformability due to TSA, with the peak DI increasing ~1.2 fold. Also, the spread of 
the data increased as the standard deviation was ~1.8 times greater for the treated cells. The 
datasets for 400 μl/min show similar results (Figure 5.39b) and are both fitted with a 
lognormal function. The peak position of the control is 𝐷𝐼𝑝𝑒𝑎𝑘 = 1.75 ± 0.01 and the 
standard deviation 𝑤 = 0.22 ± 0.01, for the treated sample 𝐷𝐼𝑝𝑒𝑎𝑘 = 2.06 ± 0.02 and 𝑤 =
0.34 ± 0.01. The peak DI increased ~1.2 fold and the standard deviation ~1.5 fold. 
Figure 5.39c shows histograms of cells deformed at 600 µl/min. The control dataset is fitted 
with a lognormal function, with a peak at 𝐷𝐼𝑝𝑒𝑎𝑘 = 2.32 ± 0.01 and a standard deviation of 
𝑤 = 0.23 ± 0.01. The dataset of the treated cells has a main peak fitted with a lognormal 
function, where 𝐷𝐼𝑝𝑒𝑎𝑘 = 2.71 ± 0.13 and 𝑤 = 0.60 ± 0.04. There is a second smaller peak 
fitted with a Gaussian function, with peak position at 𝐷𝐼𝑝𝑒𝑎𝑘 = 7.35 ± 0.29 and a FWHM of 
𝑤 = 0.29 ± 0.09. The main peak of the treated cells ~1.2 fold bigger than the control, and the 




failure point. These smaller second peak occurs at strains ~3 times bigger than the main peak. 
This may represent a population of cells which rupture on-chip and lose all mechanical 
structure-acting more like a liquid. In the control sample, a small quantity of cells also have 
these high strains (>8). TSA makes cells more deformable hence more “ruptures” occur at this 
flow rate compared to the control. 
The histograms show an increase in average DI of the treated cells for all the flow rates. The 
spread of the data also increased which is indicative of heterogeneous effects of TSA. 
Additionally, a sub-population was seen in the TSA treated cells at the failure point where 
cells achieved much higher strains (~DI=7). This suggests there is a critical strain of HL60 
cells, after which cell rupture occurs. 
 
Figure 5.39 Histograms of DI of HL60 at various flow rates, comparing cells treated with 1 µM of TSA 
to a control sample. Flow rates used include (a) 300 µl/min, (b) 400 µl/min (c) 600 µl/min. Samples 
were deformed in the inertia-dominant regime (𝜇 ≅ 1 𝑐𝑃).  
Table 5.3 Summary of DI results w between untreated HL60 cells and those treated with TSA. Including 
the peak values (DIpeak) and standard deviations (w) of log-normal fits to histograms of SW480 cells 
deformed at different flow rates in the inertia-dominant regime.
 
300 µl/min 400 µl/min 600 µl/min  
w DIpeak w DIpeak w DIpeak 
Control 0.09±0.01 1.38±0.01 0.22±0.01 1.75±0.01 0.23±0.01 2.32±0.01 
LatA 0.16±0.01 1.59±0.01 0.34±0.02 2.06±0.02 0.60±0.04 2.71±0.13 
 
5.3.4 Discussion 
HL60 cells were treated with TSA to investigate changes in cell deformability due to 
chromatin decondensation. Phase contrast and confocal fluorescence microscopy confirmed a 
small increase in cell size and changes in nuclear morphology due to treatment with TSA. DC 




The inertial-regime showed increased deformability in treated cells, which was more apparent 
above the cell yield stress. 
Decondensation of chromatin has been shown to reduce nuclear stiffness [49], [87], [88]. 
Chalut et al. 2000 combined optical stretching and fluorescence recovery after photobleaching 
(FRAP) to study the differentiation of embryonic stem cells. Embryonic cell states associated 
with a more condensed chromatin structure, were also found to have softer nuclei, treatment 
with TSA was also shown to soften cells. Krause et al. 2013 combined AFM and confocal Z-
stacks to visualise nuclear deformations of cells treated with TSA [88]. AFM measurements 
were specifically chosen over the cell nucleus and stiffness was measured to be 0.2-2.5 kPa. 
TSA induced nuclear softening up to 50%. For a contact force of 2 nN the control cells had 
maximal compression of 80% compared to 95% for treated cells. 
Masaeli et al. 2016 used inertia-dominant deformability cytometry to study the deformation 
of cells treated with TSA over a 3 day period [48]. After 1 day, two subpopulations emerged 
with the dominant group having increased size and deformability and a smaller group with 
decreased size and deformability. After 3 days all cells merged into the smaller group having 
decreased size and deformability compared to a control. TSA is commonly researched as a 
cancer therapy drug as it induces apoptosis. The time-dependent study shows that initial 
decondensation of chromatin leads to increased deformability, however after a day apoptosis 
was induced which decreased deformability. Hodgson et al. 2017 measured the nuclear 
deformability of fluorescently labelled cells deformed through constriction channels and 
treated with TSA [49]. They found that treatment with TSA decreased the stiffness of the 
nucleus. 
Golifer et al. 2017 used real-time deformability cytometry to deform HL60 cells treated with 
TSA [50]. They saw no change in deformability due to TSA for all concentrations tested (<10 
µM). This indicates that the small shear-dominant strains used in RT-DC are not sensitive to 
the effects of chromatin decondensation. Under these flow conditions, changes in nuclear 
structure may be masked by the cytoskeleton [218]. These results are in agreement with our 
deformation cytometry results. No changes were detected in shear-dominant and low-strain 
regimes, and this regime was shown to be sensitive to actin cytoskeletal changes (section 5.1). 
Cell softening was most apparent in the high-strain inertia-dominant regime, also used by 
Masaeli et al. 2017. 
Confocal fluorescence images showed that HL60 treated with 1 µM of TSA lead to 
destabilised microtubules as well as changes in chromatin structure. Ninios et al. 2010 found 
that HL60 showed decreased α tubulin as a function of incubation time with TSA [219], and 




al. 2015 used fluorescent microscopy to image the actin and microtubule structure of HeLa 
cells treated with TSA [221]. After 48 hr incubation they showed disruption of microfilaments 
and microtubules, which is indicative of cell cycle arrest. The deformability cytometry results 
indicate that changes in deformability due to TSA derive from the decondensation of 
chromatin and not secondary cytoskeletal changes. Section 5.1 showed that DC is most 
sensitive to actin disruption at a low-strain and high-shear regime, whereas changes in TSA 
was most apparent in a high-strain and inertia-dominant regime. Section 5.2 indicated that 
microtubule disruption alone did not lead to cell stiffening and this is likely a secondary 
mechanism. 
5.4 Chapter Overview 
Changes in cell deformability due to cytoskeletal perturbations were studied using 
deformation cytometry in shear-dominant and inertia-dominant regimes. Results found that 
deformation cytometry is sensitive to cytoskeletal and nuclear changes, dependent on flow 
regime.  
Actin filaments were disrupted using Latrunculin A, which increased the deformability of 
HL60 and SW480 cells. A low-strain and shear-regime showed the largest relative increase in 
deformability. Additionally, high-strains above the yield stress in the inertial-regime showed 
no significant changes in deformability which may indicate breakdown of the actin network 
under these conditions. Nuclear chromatin was decondensed using Trichostatin A, this showed 
increased deformability of HL60 cells only in the inertia-dominant regime with the largest 
increase above the yield stress. These results indicate that the cytoskeleton dominates cell 
response at shear-dominant and low-strains and may shield any nuclear changes, whereas 
high-strains may disrupt the cytoskeleton and nuclear changes dominate here.  
Microtubules were destabilised using Combretastatin A4, this showed a counter-intuitive 
response as HL60 cells became stiffer when probed in the shear-dominant regime. These 
results suggest that microtubule disruption may trigger secondary mechanisms in the cells 
resulting in a stiffening affect. Previous works show that microtubule disruption can cause 
enhancement of microfilaments, which may explain why stiffening was observed only in the 
shear-dominant regime. 
Strain traces of cells showed that both deformation and recovery parameters are affected by 
changes in the cytoskeleton, and can be used to distinguish treated and untreated samples. 
Treatment with both LatA and CA4 showed that cells did not recover their original shape after 
deformation, suggesting that disruption of microfilaments and microtubules leads to increased 
cell plasticity. SCA also showed significant changes in multiple measured parameters and 




however processing times limited the number of events. Even so, deformation cytometry 
shows promise for mechanical phenotyping single cells and identifying that subcellular 




6 Changes to mechanical phenotype with colorectal cancer 
progression 
This chapter discusses the use of DC to examine the mechanical properties of different 
colorectal cancer (CRC) cell lines. Which includes: the primary tumour cell line SW480, the 
more advanced primary tumour cell line HT29 and the lymph node secondary tumour cell line 
SW620. These three cell lines offer a model system of CRC cancer progression (introduced 
in greater detail in section 2.2.3). Results were also compared to the mechanical phenotype of 
the leukaemia cell line HL60, presented in chapters 4 and 5, as their mechanical properties 
were expected to differ. DC was performed in the shear-dominant and inertia-dominant flow 
regime, inducing low to high strain deformations. Cell deformation and recovery were also 
tracked as a function of time in order to perform multiparameter single cell analysis. This 
allowed investigation into how well the cell types could be classified based on deformation 
and relaxation parameters, and how the mechanical phenotype changes with disease 
progression. 
6.1 Colorectal cancer cell lines 
6.1.1 Initial morphology 
Cell size and morphology varies between cell lines. The three CRC cell lines are naturally 
adherent, phase contrast images of their morphology are shown by Figure 6.1. This is also 
compared to the non-adherent leukaemia cell line HL60. HT29 have an epithelial-like 
morphology, their shape is more polygonal. SW480 have two morphologies in their adherent 
state, the majority have an epithelial-like morphology however some cells have a rounded 
morphology [222]. SW620 have a fibroblast-like morphology, these are more elongated 
compared to SW480 and HT29.  
 
Figure 6.1 Phase contrast images of HL60, SW480, HT29 and SW620 in cell culture flasks to show 




6.1.2 Nucleus size 
Confocal fluorescence imaging was used to visualise the actin and nuclear structure of live 
detached SW480, HT29 and SW620 cells. Cells were detached by incubation with TrypleE 
(procedure described in section 3.6.2) and incubated with fluorescent dyes for ~30 mins. Actin 
was stained using the fluorogenic labelling probe based on Silicon Rhodamine (Sir) 
(Spirochrome, Cytoskeleton Inc.), using a final concentration of 1 µM, DNA staining used the 
dye Hoechst 3342 (Thermo Fisher Scientific) at a final concentration of 0.5 µg/ml. 
Figure 6.2 shows example fluorescent images of SW480, HT29 and SW620 with actin (red) 
and DNA (blue) stained. Fluorescence and corresponding bright field images were used to 
measure the whole cell diameter and apparent nuclear diameter of the three cell lines. 
Histograms are plotted of the whole cell diameter, using both a bright field image and using 
the actin cortex, and the nuclear diameter (Figure 6.2). Results show that bright field and actin 
cortex size measurements resulted in the same value for the cell diameter for SW480 and 
HT29. SW620 show a slight decrease in diameter using actin cortex compared to bright field. 
This may suggest a less structured actin cortex, a more diffuse fluorescence can also be seen 
in the accompanying fluorescent image. The distributions of the nuclear diameter of SW480 
and HT29 show a normal distribution and are fitted with Gaussian function. The distribution 
of SW620 nuclear diameter is unclear and suggests a higher population is needed to accurately 
characterise the size. These differences may be related to the fact SW480 and HT29 adhere in 





Figure 6.2 Confocal fluorescence images of detached (a) SW480, (b) HT29 and (c) SW620 
cells, stained for DNA (blue) and actin (red). Also included are corresponding histograms of 
the cell diameter found from bright field images (red graph) and the actin cortex diameter 
(blue graph), also the nuclear diameter using the DNA stain (green). Scale bars are 20 µm.  
From the datasets shown in Figure 6.2, the average nuclear diameter was found for the three 
CRC cell lines. These are shown in Table 6.1 and also compared to the nuclear diameter of 
HL60 cells (first presented in section 5.1.1). From this, the nuclear ratio 𝐴𝑛𝑢𝑐𝑙𝑒𝑢𝑠/𝐴𝑐𝑒𝑙𝑙 of the 




cell. The nuclear ratio is also presented as a bar graph for the four cell lines (Figure 6.3). This 
shows that HL60 has a low nuclear ratio compared to the three CRC cell lines, SW480 has the 
largest nuclear diameter and HT29 and SW620 have comparable nuclear diameters. 
Table 6.1 The average nuclear diameter of HL60, SW480, HT29 and SW620 cells (measured using 
confocal images), and the nuclear ratio of each cell line (Anucleus/Acell).
 Nuclear Diameter (µm) Nuclear Ratio 
HL60 8.9±0.1 0.55±0.02 
SW480 11.2±0.1 0.72±0.01 
HT29 11.0±0.1 0.63±0.01 
SW620 9.2±0.1 0.67±0.06 
 
Figure 6.3 Bar graph showing the Nuclear Ratio of HL60, SW480 and SW620 cells (Anucleus/Acell). Bright 
field images were used to measure Acell and fluorescent images were used to measure Anucleus.  
6.2 Deformation Cytometry 
6.2.1 Shear-dominant regime 
The three colorectal cancer cell lines were deformed in a cross-slot microfluidic device at the 
SP of an extensional flow junction. The cells were deformed over a range of flow rates Q in a 
shear-dominant flow regime (suspension buffer viscosity was µ≈33 cP and Re<6). 
Deformability was characterised using the deformation index DI. For each condition, 10s-
100s of cell events were collected and experiments were then repeated N=3. An average value 
and standard error of the DI was found. 
Figure 6.4 shows DI as a function of Q for SW480, HT29 and SW620 cells. The three datasets 
increase asymptotically as a function of Q toward a maximum value 𝐷𝐼𝑚𝑎𝑥. The plot shows 
that SW480 and SW620 cannot be distinguished by DI over the entire range of flow rates. 




values of 𝐷𝐼𝑚𝑎𝑥 were all within error of each other; 𝐷𝐼𝑚𝑎𝑥(𝑆𝑊480) = 1.71 ± 0.02, 
𝐷𝐼𝑚𝑎𝑥(𝐻𝑇29) = 1.68 ± 0.06, 𝐷𝐼𝑚𝑎𝑥(𝑆𝑊620) = 1.72 ± 0.10. 
 
Figure 6.4 DI of SW480, HT29 and SW620 cell lines over a range of flow rates Q (µl/min). The flow 
regime was shear dominant (µ≈33 cP). 𝐷𝐼 ± 𝑆𝐸 was averaged from multiple cell events combined from 
N=3 repeats. The total number of events measured was: 93<n<931 for SW480, 160<n<596 for HT29 
and 280<n<734 for SW620.  
To further investigate the heterogeneity of CRC cell deformation, histograms of DI were 
plotted. This was first done for low strain deformation at 𝑄 = 5 𝜇𝑙/𝑚𝑖𝑛, shown by Figure 6.5 
a-c. Each histogram shows a normal distribution and is fitted with a Gaussian function, the 
central peak value is also shown b. Results show that b of SW480 and SW620 are within error 
of each other, whereas b of HT29 shows a small increase (~1.1 fold). 
A two sample t-test was also used to measure the level of significance between these datasets 
(introduced in section 4.4.1). Figure 6.5d shows a bar graph of the average DI of SW480, 
HT29 and SW620 with the levels of significance denoted using the p-value. Results confirm 
that the DI of HT29 compared to SW480 and SW620 shows a significant difference 






Figure 6.5 Histograms of the DI of the CRC cells lines deformed at 5 µl/min in a shear-dominant regime 
(µ≈33 cP). Where (a) is SW480, (b) is HT29 and (c) is SW620. Each dataset is fitted with a Gaussian 
function. (d) Shows a bar graph of the average DI of  the CRC cell lines. The error bars denote the 
standard error SE and statistical t-tests were done to determine the level of significance. HT29 shows 
extremely significant difference to SW480 (𝑝 = 7.5 ∙ 10−6) and SW620 (𝑝 = 5.5 ∙ 10−4), whereas 
SW480 and SW620 showed no significant difference (p=0.058).  
Histograms of DI were also plotted for high strain deformation at 𝑄 = 80 𝜇𝑙/𝑚𝑖𝑛, shown by 
Figure 6.6 a-c. Each histogram shows a normal distribution and is fitted with a Gaussian 
function. Results show that b of HT29 and SW620 are similar, whereas b of SW80 shows a 
slight decrease (~1.1 fold). However, Figure 6.6d shows a bar graph of the average DI of the 
three cell lines. Consequently, this shows the average DI of SW480 to be within error of the 
DI of SW620 and HT29. Two sample t-tests confirm no significance between SW480 with 






Figure 6.6 Histograms of the DI of the CRC cells lines deformed at 80 µl/min in a shear-dominant 
regime (µ≈33 cP). Where (a) is SW480, (b) is HT29 and (c) is SW620. Each dataset is fitted with a 
Gaussian function. (d) Shows a bar graph of  the average DIof  the CRC cell lines. The error bars 
denote the standard error SE and statistical t-tests were done to determine the level of significance. 
HT29 shows a significant difference to SW620 (𝑝 = 0.02). Whereas SW480 and SW620 showed no 
significant difference (p=0.09), as did SW480 and HT29 (p=0.72).  
Overall, Figure 6.4 shows that the DI of SW480, HT29 and SW620 are largely 
indistinguishable from each other. This suggests that DI alone is not sensitive enough to 
characterize and separate the three CRC cell lines. Additional analysis was done at the lowest 
and highest strains, as we’ve previously shown that a low-strain and shear-dominant regime 
is more sensitive to cytoskeletal changes (section 5.1). These results showed that the low-
strain datasets could significantly distinguish HT29 from SW480 and SW620, however neither 
low nor high strain could distinguish between SW480 and SW620 using DI. 
Section 6.1.1 showed that the initial diameter of the three cell lines are different. Therefore, 
the values of DI were next normalized by initial size A (DI/A). This is a better representation 
of relative change in stiffness with metastatic progression, it better accounts for size-
dependent difference in applied stress [48], [174]. Figure 6.7 is a plot of DI/A as a function of 
Q for the three CRC cell lines, with each dataset fitted with an exponential function. Here, 
SW620 shows a systematic increase in DI/A compared to SW480 which indicates that SW620 
are in fact more deformable. At low flow rates, HT29 display properties similar to those of 




closer to those of SW480 (𝑄 ≥ 40 𝜇𝑙/min ). DI/A increased asymptotically toward a 
maximum deformation value (𝐷𝐼/𝐴)𝑚𝑎𝑥. For SW480 (𝐷𝐼/𝐴)𝑚𝑎𝑥 = 0.101 ± 0.004 which is 
within error of HT29 where (𝐷𝐼/𝐴)𝑚𝑎𝑥 = 0.106 ± 0.007. SW620 had (𝐷𝐼/𝐴)𝑚𝑎𝑥 =
0.119 ± 0.002 which is significantly higher than SW480 and HT29. 
 
Figure 6.7 The initial size normalised deformation index DI/A of three colorectal cancer cell lines over 
a range of flow rates Q (µl/min), 𝐷𝐼/𝐴 ± 𝑆𝐸 was averaged from multiple cell events combined from 
N=3 repeats. The flow regime was shear dominant (µ≈33 cP).  
6.2.2 Inertia-dominant regime 
The three colorectal cancer cell lines were also deformed over a range of flow rates Q in a 
inertia-dominant flow regime (suspension buffer viscosity was µ≈1 cP and Re<40). For each 
condition, 10s-100s of cell events were collected and experiments were then repeated N=3. 
An average value of the deformation index DI was found with standard error.  
Figure 6.8 shows DI as a function of Q for SW480, HT29 and SW620. An abrupt change in 
behaviour can be seen at 𝑄 = 400 𝜇𝑙/𝑚𝑖𝑛, which is equivalent to the previous described yield 
stress and is associated with the disruption of the cytoskeleton (section 4.2.2). For each dataset 
there is a linear relationship between DI/A and Q for 𝑄 < 300 𝜇𝑙/𝑚𝑖𝑛. A linear trend is also 
seen for   𝑄 ≥ 400 𝜇𝑙/𝑚𝑖𝑛, with an associated gradient increase for both SW480 and SW620. 
Below the yield stress, DI is unable to distinguish between any of the cell lines. Above the 
yield stress, HT29 and SW620 remain indistinguishable whereas SW480 has a relative 





Figure 6.8 DI of SW480, HT29 and SW620 cell lines over a range of  flow rates Q (µl/min). The flow 
regime was inertia dominant ( µ≈1 cP). 𝐷𝐼 ± 𝑆𝐸 was averaged from multiple cell events combined 
from N=3 repeats. The dashed line represents the “yield stress” behaviour, the datasets are fitted with 
separate linear fits before and after this value.  
Histograms of DI were also plotted for inertial regime deformations of SW480, HT29 and 
SW620. This was first done for a low strain, below the yield stress, at 𝑄 = 300 𝜇𝑙/𝑚𝑖𝑛. The 
plots are shown by Figure 6.9a-c and each histogram shows a log-normal distribution function, 
the central peak value is denoted on the plots as b. Figure 6.9d shows a bar graph of the average 
DI of the three cell lines. Results show that HT29 and SW620 have DI within standard error, 
whereas SW480 has a lower DI. However, two sample t-tests confirm that all three datasets 
show a significant difference (p<0.05). Particularly SW480 and HT29 are shown to have an 
extremely low p-value (p<0.0001). 
Histograms of DI were also plotted for high strain deformations, above the yield stress, at 
Q=600 μl/min, shown by Figure 6.10 a-c. Each histogram is fitted with a log-normal function. 
Results show that b of HT29 and SW620 are within error of each other, whereas b of SW80 
shows a ~1.2 fold increase. Figure 6.10d shows a bar graph of the average DI of the three cell 
lines, which shows the DI of HT29 to be within error of the DI of SW620. Here, SW480 has 
decreased DI which is the opposite result to below the yield stress (Figure 6.9d). Two sample 
t-tests confirm no significance between HT29 with SW620 (p>0.05). SW480 shows an 






Figure 6.9 Histograms of the DI of the CRC cells lines deformed at 300 µl/min in the inertia-dominant 
regime (µ≈1 cP). Where (a) is SW480, (b) is HT29 and (c) is SW620. Each dataset is fitted with a 
Lognormal function. (d) Shows a bar graph of the average DI of  the CRC cell lines. The error bars 
denote the SE and statistical t-tests determined the level of significance. HT29 shows extremely 
significant difference to SW480 (𝑝 = 2.26 · 10−5) and a significant different to SW620 (𝑝 = 0.03), 
SW480 and SW620 also showed a significant difference (p=0.008).  
 
Figure 6.10 Histograms of the DI of the CRC cells lines deformed at 600 µl/min in the inertia-dominant 
regime (µ≈1 cP). Where (a) is SW480, (b) is HT29 and (c) is SW620. Each dataset is fitted with a 
Lognormal function. (d) Shows a bar graph of the average DI of  the CRC cell lines. The error bars 
denote the SE and statistical t-tests determined the level of significance. HT29 showed an extremely 
significant difference to SW480 (𝑝 = 1.25 ∙ 10−6) and no significant different to SW620 (𝑝 = 0.592). 




Figure 6.11 shows the DI values normalised by the initial size of the cells (DI/A), to give a 
better relative representation of stiffness. Here, for 𝑄 < 400 𝜇𝑙/𝑚𝑖𝑛 (below the yield stress) 
the cell lines show systematic changes with SW620 having the highest DI/A followed by HT29 
and then SW480 having the lowest. For, 𝑄 ≥ 400 𝜇𝑙/𝑚𝑖𝑛 the cell lines are less 
distinguishable from each other. These results show a distinct behavioural change above and 
below the apparent yield stress of the cells (Q≈300 µl/min). 
 
Figure 6.11 DI/A of three colorectal cancer cell lines over a range of flow rates (µl/min), in an inertia 
dominant regime (µ≈1 cP). 𝐷𝐼/𝐴 ± 𝑆𝐸 was averaged from multiple cell events combined from N=3 
repeats. The total number of events measured was: 30<n<603 for SW480, 47<n<619 for HT29 and 
30<n<450 for SW620.  
6.2.3 Cell width and height 
Previously, the deformation index DI was used to characterise the maximum “cell squeezing” 
which occurs at the SP of the cross-slot devices. During these deformations, the cell width W 
decreases compared to initial cell diameter A whereas cell height H increases. In the shear-
regime (Figure 6.7) we see a maximum cell deformability as DI tends to 𝐷𝐼𝑚𝑎𝑥 as a function 
of flow rate. By looking at W and H separately more information about the cell stretching can 
be elucidated, such as whether these individual parameters reach a minimum/maximum at the 
same rate.  
Figure 6.12 shows W and H plotted as a function of flow rate for HL60, SW480, HT29 and 
SW620 cells deformed in the shear-dominant regime. Results show that for the four cell lines 
W decreases as an exponential decay and is fitted accordingly. The nuclear diameter (Table 
6.1) is marked in a dashed line, this shows that the minimum W does not surpass the nuclear 
diameter. A general increase in H as a function of flow rate is seen for the four cell lines. 




fitted with a linear fit. The initial cell diameter A is also marked with a dashed line. The plots 
show that cell deformation shows relatively larger change to H than to W. 
 
Figure 6.12 Cells were deformed at the SP of a cross-slot device, the width (W) and (height) of the cell 
were measured at their maximum deformed state at the SP (µ≈ 33 cP). Here, graphs are plotted of W 
and H of four cell lines under deformation as a function of flow rate. Measurements were taken in the 
shear-dominant regime. The initial cell diameter (before deformation) and nucleus diameter (from 
fluorescence imaging) are marked by dashed lines.  
Several parameters can be extracted from the exponential fits shown in Figure 6.12. Including 
the exponential decay constants for W as a function of flow rate (𝜏𝑊), and H as a function of 
flow rate (𝜏𝐻). These values are summarised in Table 6.2. Additionally, the exponential fit to 
W can be extrapolated to find the minimum deformed width of the cell (𝑊𝑀𝐼𝑁). Table 6.2 also 
shows the difference between 𝑊𝑀𝐼𝑁 and the diameter of the nucleus (WMIN - ANucleus). The 𝜏𝑊 
of HL60 and SW480 are within error of each other, HT29 and SW620 have lower 𝜏𝑊 values 
which shows they tend to 𝑊𝑀𝐼𝑁 at a faster rate. The values of 𝜏𝐻 are generally larger than 𝜏𝑊, 
however their associated errors are also larger (>50%). HT29 do not have a value for 𝜏𝐻 as a 
linear fit was more applicable. The three CRC cell lines show similar values for WMIN - ANucleus, 
HT29 and SW620 are within error of each other and SW480 shows a slight increase (~1.1 
fold). Comparatively, HL60 show a ~2 fold decrease in WMIN - ANucleus compared to the CRC 




compared to the other cell lines. This may be indicative of HL60 being more deformable than 
the CRC cell lines, and potentially having a softer nucleus. 
Table 6.2 Summary of parameters associated with cell width W and H during deformation at the SP 
over a range of flow rates. 
 𝜏𝑊 𝜏𝐻 WMIN - ANucleus 
HL60 20.8±7.9 53.3±50.3 1.07±0.02 
SW480 25.8±4.4 61.5±34.9 2.30±0.03 
HT29 4.3±2.4 N/A 2.10±0.02 
SW620 15.0±2.6 109.89±159.3 2.11±0.02 
 
 
Figure 6.13 Cell were deformed at the SP of a cross-slot device, the width (W) and (height) of the cell 
were measured at their maximum deformed state at the SP (µ≈ 1 cP). Here, graphs are plotted of W 
and H of four cell lines under deformation as a function of flow rate. Measurements were taken in the 
inertia-dominant regime. The initial cell diameter (before deformation) and nucleus diameter (from 
fluorescence imaging) are marked by dashed lines.  
Similarly, Figure 6.13 shows W and H plotted for the four cell lines deformed in the inertia-
dominant regime as a function of flow rate. Results show negligible change in W as a function 
of flow rate for SW480, HT29 and SW620. HL60 shows a small decrease in W for 𝑄 >
500 𝜇𝑙/𝑚𝑖𝑛. HL60 shows linear relationships between H and flow rate, with a distinct 
increase in gradient at 𝑄 > 300 𝜇𝑙/𝑚𝑖𝑛 which coincides with the previously discussed yield 




gradient, however the standard error values suggest no significant change in H over this flow 
range. For 𝑄 > 300 𝜇𝑙/𝑚𝑖𝑛, the H of SW620 increases significantly and has a linear fit (also 
suggesting yield stress behaviour. SW480 shows no significant changes in H for flow rates 
𝑄 > 400 𝜇𝑙/𝑚𝑖𝑛, then a linear increase for 𝑄 < 400 𝜇𝑙/𝑚𝑖𝑛 suggesting yield stress 
behaviour. Differently, HT29 show a linear trend encompassing the entire range of flow rates 
suggesting no yield stress behaviour. 
For all four cell lines, even at the highest flow rate the minimum W does not surpass the nuclear 
diameter (marked with a dashed line). The yield stress associated behavioural change is 
dominated by H in the calculation of DI. The lack of change in W of the yield stress could 
indicate that nuclear rupture is yet to occur and this change is likely associated with filament 
rupture of the cytoskeleton, leading to further extension of the cytosol in H. 
6.3 Deformation and Recovery 
6.3.1 Strain trace multiparameter analysis 
The strain ε of the three CRC cell lines was tracked as cells deformed and recovered through 
the SP of an extensional flow junction. Measurements were taken in the shear-dominant 
regime (µ≅33 cP) at Q=5 µl/min. This high-shear and low-strain regime was previously 
shown to be most sensitive to changes in the actin cytoskeleton (section 5.1). 
Figure 6.14 shows the averaged strain traces of N=56 SW480 cells (previously shown in 
section 5.1), N=49 HT29 cells and N=50 SW620 cells. The results for the HL60 cell lines 
(first discussed in chapter 4) are also included as a comparison. The strain traces were used to 
extract multiple characteristic parameters, including; the initial strain 𝜀0, the maximum 
strain 𝜀𝑚𝑎𝑥, the deformation time 𝜏𝑑, the relaxation time 𝜏𝑟 and the final strain 𝜀∞. The 
associated time constants (𝜏𝑑 and 𝜏𝑟) were found by fitting exponential decay functions to the 
deformation region (cell approach to the SP) and relaxation region (cell moving away from 
the SP) of the graph. The final strain 𝜀∞ was also found by extrapolation of the same fit used 
to find the relaxation time. As the inlet channels are perpendicular to the outlet channels some 
values of 𝜀0 are slightly below 0 (this is due to small deformations induced by shear channel 
confinement, which are relatively small compared to deformation at the SP). Thus, if cells 
recover their original shape post deformation the magnitude of final strain should match initial 
strain (|𝜀0| = |𝜀∞|). The areas shaded in pink in Figure 6.14 have a width of 2|𝜀0|, therefore 
if the final strain (denoted by a dashed line) falls within this vicinity then the cell recovers its 





Figure 6.14 Strain ε was tracked for SW480, HT29 and SW620 cells as a function of time, with the SE 
shown by the shaded areas. The flow rate was 5 µl/min and the suspension medium viscosity was 33 
cP. The final strain is marked by dashed lines (𝜀∞), found by extrapolation of a exponential fit to the 
relaxation (red line). (a) The averaged deformation trace of N=56 SW480 cells. (b) The averaged 
deformation trace of N=49 HT29 cells. (c) The averaged deformation trace of N=50 SW620 cells.  
The averages of all the mentioned parameters are summarised in Table 6.3. Results show that 
the initial strain 𝜀0 and deformation time 𝜏𝑑 of the four cell lines are within error of each other. 
The maximum strain of HT29 and SW620 are within error of each other, and SW480 has the 
lowest maximum strain of all the cell lines. The leukaemia cell lines HL60 is shown to be 
highly deformable compared to the three tumour originating cell lines, the maximum strain 
𝜀𝑚𝑎𝑥 is ~2.2 times larger than SW480 cells. HL60 are expected to be more deformable due to 
their original cellular function as a blood cell, which requires movement through blood 
vessels, whereas the CRC cell lines derive from a stationary tumour environment. HL60 also 
have the slowest relaxation time 𝜏𝑟 out of the four cell lines, HT29 relax at a rate 4-fold faster 
than HL60. Interestingly, even though SW480 deformed to a lower 𝜀𝑚𝑎𝑥 its relaxation time 
was slower than both HT29 and SW620. 
Table 6.3 and Figure 6.14 also show that the final strain 𝜀∞ of HL60 and SW480 is within 
error of the initial strain (|𝜀0| = |𝜀∞|), demonstrating that these cell types undergo complete 
initial shape recovery after deformation. Comparatively, both HT29 and SW260 show 
incomplete shape recovery as their final strain 𝜀∞ is significantly larger than the initial strain 








Table 6.3 Multiple characteristic parameters extracted from the strain traces of N=56 SW480 cells, 
N=49 HT29 and N=50 SW620 cells. The strain traces were averaged in order to extract the initial 
strain ε0, the final strain ε∞, the maximum strain εmax, the deformation time τd, the relaxation time τr, 
with ±SE.
 HL60 SW480 HT29 SW620 
𝜀𝑚𝑎𝑥 0.18±0.01 0.08±0.01 0.12±0.01 0.11±0.01 
𝜏𝑟 (ms)  3.52±0.14 1.36±0.06 0.89±0.05 1.04±0.05 
𝜏𝑑  (ms)  1.04±0.05 0.89±0.10 0.76±0.10 1.15±0.20 
𝐸 (𝑃𝑎) 301±29 542±66 309±50 372±98 
𝜀0 -0.012±0.004 -0.012±0.006 -0.004±0.007 -0.007±0.007 
𝜀∞ +0.03±0.009 +0.010±0.003 +0.056±0.001 +0.049±0.001 
Figure 6.15 a-c show the averaged cell velocity as a function of time through the extensional 
flow junction for SW480, HT29 and SW620, which were fitted with sine functions (shown in 
red). Alongside this are the strain traces which could then be fitted with the Kelvin-Voigt 
model (described in section 2.3.4), also shown in red. From this fit, the Elastic modulus of the 
three CRC cell lines was found. These values are also included in Table 6.3. Figure 6.16 is a 
bar graph of the elastic moduli of SW480, HT29, SW620 and also HL60. Results show that 
HL60 are the softest cell, HT29 and SW620 have similar stiffness within error of each other, 
and SW480 are the stiffest of the four cell types. 
 
Figure 6.15 The average strain trace of  SW480, HT29 and SW620 cells fitted with the Kelvin-Voigt 
function accompanied by the velocity profile fitted with a sine function (shown in red). (a) N=56 
SW480 cells, (b) for N=49 HT29 cells and (c) N=50 SW620 cells. For all datasets Q was 5 µl/min 





Figure 6.16 A bar graph of the Elastic moduli of HL60, SW480, HT29 and SW620 cells. This was found 
by fitting the Kelvin-Voigt model to strain traces of single cells deforming in an extensional flow.  
6.3.2 Single Cell Analysis 
As discussed in the previous results chapters, single cell analysis can offer additional insight 
into the heterogeneity of mechanical responses of a cell sample. Thus, SCA was also 
performed on individual strain traces of SW480, HT29 and SW620 in order to extract multiple 
parameters and perform additional statistical tests. The SCA procedure was identical to that 
described for HL60 cells in section 4.1.1. SCA was successfully used to extract 𝜀𝑚𝑎𝑥, 𝜀0, 𝜀∞, 
𝜏𝑟 and also the initial cell diameter A.  
Table 6.4 Characteristic parameters of HL60, SW480, HT29 and SW620 cell lines, found using single 
cell analysis of cells deforming at the stagnation point of an extensional flow at 5 µl/min in the shear-
dominant regime (µ≈33 cP). The mean value of each parameter is given with the associated standard 
error, the coefficient of variation is also given as a percentage where CV=mean/SD.
   HL60 SW480 HT29 SW620 
 Mean ± SE CV  Mean ± SE CV  Mean ± SE CV  Mean ± SE CV  
A (µm) 12.3±0.21 12 15.2±0.25 13 14.5±0.20 9 11.5±0.14 9 
𝜀𝑚𝑎𝑥 0.18±0.01 27 0.09±0.01 54 0.12±0.01 39 0.11±0.01 42 
𝜏𝑟 (ms)  3.04±0.15 34 1.11±0.14 82 1.15±0.24 141 0.96±0.10 86 
𝜀0 -0.012±0.004 52 -0.012±0.006 281 -0.005±0.006 155 -0.005±0.006 201 
𝜀∞ +0.03±0.004 87 +0.018±0.003 129 +0.047±0.006 80 +0.047±0.006 86 
 
The average of these values are shown in Table 6.4 with their standard error, the HL60 dataset 
first shown in section 4.4.1 is also included as a comparison. Histograms of the 5 parameters 
for the four cell lines can be found in the appendix (Figure S4-S8), the distributions follow the 
same trends as described for HL60. Table 6.4 also shows the coefficient of variation CV of 




and offers a measure of dispersion. Thus, CV can be used to compare the heterogeneity of the 
parameters between the cell lines. 
Two sample t-tests were performed on the 5 parameters to quantify their individual use for 
distinguishing between the four cell types. Figure 6.17 shows a bar graph of the average 
A, 𝜀𝑚𝑎𝑥, 𝜀∞, 𝜏𝑟 for HL60, SW480, HT29 and SW620 cells, with the level of significance 
labelled using the p-value. Where, p>0.05 is not significant (ns), 0.01<p<0.05 is significant 
(*), 0.001<p<0.01 is very significant (**), 0.0001<p<0.001 is extremely significant (***) and 
p<0.0001 is extremely significant (****). The raw p-values are summarised in Table 6.5, we 
note that the values for initial strain 𝜀0 showed no significant between any cell lines (an 
expected result as the cells should have near 0 strain). 
 
Figure 6.17 Multiparameter analysis of HL60, SW480, SW620 and HT29 cell populations using 
statistical t-tests were done to determine the level of significance, where the error bars denote the 
standard error SE,  (a) Initial cell diameter,  (b) The maximum strain 𝜀𝑚𝑎𝑥, (c) the final strain 𝜀∞ and 
(d) the relaxation time 𝜏𝑟 were extracted from deformation traces of single cells deforming at 5 µl/min 
in a shear dominant regime ( ~33 cP).  
Figure 6.17a shows that the initial diameter A shows statistical significance in separating all 
the cell lines, apart from SW480 and HT29 showing a non-significant p-value (p>0.05). Figure 




(p<0.05), whereas HT29 and SW620 show no significance (p>0.05). Interestingly, this shows 
that even though SW480 and HT29 are non-distinguishable by their initial size, the maximum 
strain can be used to separate the populations. Results also corroborate that SW620 and HT29 
have similar deformability (Figure 6.16). 
Figure 6.17c indicates that the final strain 𝜀∞ of SW480 shows an extremely significant p-
value compared to the other two CRC cell lines (p<0.0001), whereas SW620 and HT29 show 
no significance via 𝜀∞ (p>0.05). This corroborates the previously discussed result that SW480 
completely recovers its initial shape, whereas HT29 and SW620 do not (Figure 6.14). 
Additionally, these results continue to show a trend that SW480 are mechanically different to 
the later stage CRC cell lines which show similar deformation and relaxation behaviour. The 
HL60 cell line also shows a significant difference to all of the CRC cell lines (p<0.05). Finally, 
Figure 6.17d compares the relaxation time 𝜏𝑟 of the four cell lines. Results show no 
significance from the 𝜏𝑟 datasets between any of the CRC cell lines (p>0.05). However, the 
𝜏𝑟 of HL60 shows extreme significant compared to each of the CRC cell lines (p<0.0001). 
HL60 were highly deformable compared to the CRC cell lines and their average relaxation 
time was ~3 fold larger. 
Overall, Figure 6.17 shows that no single parameter is statistically significant when comparing 
the four cell types, and demonstrates the need for multiple parameter analysis for accurate 
classification of different cell types. 
Table 6.5 Summary of p-values comparing properties of HL60, SW480, SW620 and HT29 cell 
populations  using; initial cell diameter A, the initial strain 𝜀0, the maximum strain 𝜀𝑚𝑎𝑥,  the final 
strain 𝜀∞and the relaxation time 𝜏𝑟.
  
A (µm)    𝜺∞     𝜺𝒎𝒂𝒙    𝝉𝒓   𝜺𝟎    
  
p-value Sig. p-value Sig. p-value Sig. p-value Sig. p-value Sig. 
HL60 SW480 2.77E-13 **** 0.01074 * 4.23E-17 **** 7.03E-18 **** 9.78E-01 ns 
HL60 HT29 5.09E-12 **** 1.44E-02 * 3.78E-09 **** 2.09E-19 **** 0.33807 ns 
HL60 SW620 0.0022 ** 2.35E-02 * 2.10E-11 **** 7.38E-10 **** 0.35094 ns 
SW480 HT29 0.07687 * 1.44E-05 **** 7.03E-04 *** 5.93E-01 ns 0.38193 ns 
SW480 SW620 1.35E-20 **** 3.66E-05 **** 1.90E-02 * 8.92E-01 ns 3.94E-01 ns 
SW620 HT29 1.43E-22 **** 9.05E-01 ns 2.80E-01 ns 5.19E-01 ns 9.84E-01 ns 
 
6.3.3 Linear Discriminant Analysis 
Linear Discriminant analysis was next used on the multiparameter datasets of HL60, SW480, 
HT29 and SW620 to test their abilities to accurately classify the different cell types. LDA is 
a supervised multivariate method which obtains linear combinations of the parameters able to 
best separate the different cell lines. This method is trained with a subset of the sample, where 




by Julia Gala De Pablo and used on Raman Spectroscopy data for classifying cell lines, 
including SW480, HT29 and SW620 [2], [223]. 
The method was trained on a 4-class dataset (4 cell types), where each linear discriminant 
(LD) maximises the separation of a pair of classes. Then using all the LD scores to provide a 
final classification. A k-fold validation test was then applied to the data. This involves a 
random fraction of the data being first used to train the LDA model. The model is then used 
on the remaining data which assesses the models ability to correctly classify the cell types 
from the given parameters. Here, a 5-fold validation test was applied and the loadings and 
scores of the LDs are presented in Figure 6.18 and the confusion matrix is shown by Table 
6.6. Figure 6.18 shows that LD1, LD3 and LD5 result in the best separation of HL60 compared 
to the CRC cell types, with individual scores shown in Figure 6.18 B1, 3 and 5. The 
discriminants generally correspond to 𝜀𝑚𝑎𝑥, 𝜀0 and 𝜏𝑟. Between the CRC cell lines, LD2 and 
LD6 showed the best separation of SW480 from HT29 and SW620. These correspond to the 
initial diameter A and 𝜀∞. Comparing SW620 to either SW480 or HT29 shows the best 
separation by LD4 and LD6, mainly classified by their smaller diameter. 
 
Figure 6.18 Linear discriminant analysis of 5 parameter datasets for HL60, SW480, HT29 and SW620 
Where the bar plot (left) indicates the loadings for each of the linear discriminants (LD), and the box-
plots/beeswarm plots (right) on the right correspond to the scores on each of the LDs. Analysis was 
performed by Julia Gala De Pablo.  
Using the 5-fold LDA classification, summarised by the confusion matrix Table 6.6, we found 
that 82% of the HL60, 71% of SW480 and 85% of SW620 cells were correctly classified by 
the model. Comparatively, only 36% of HT29 were correctly classified with 39% incorrectly 




classification rate of the 4-class dataset was ~69%. These results show that >70% 
classification rate of SW480 and SW620, indicating significant differences detected from 
deformation and relaxation parameters. However, HT29 (the intermediate step of the CRC 
model) is generally harder to distinguish from the other CRC cell lines. This may be indicative 
of it having intermediate properties between the two. 
Table 6.6 k-fold validation tests to classify the four cell lines (5-fold). Shows that 82% of the HL60 can 
be classified correctly as HL60, that 71% of SW480 were classified correctly and that 85% of SW620 
were classified correctly. HT29 harder to classify (36%), the average classification of the four cell lines 
was 69±1%. The rows represent the actual cell type and the columns represent the predicted cell type.
 HL60 SW480 HT29 SW620 
HL60 82 ± 3 2 ± 1 5 ± 1 10 ± 2 
SW480 9 ± 1 71 ± 3 15 ± 2 5 ± 1 
HT29 5 ± 2 39 ± 3 36 ± 3 20 ± 3 
SW620 8 ± 2 2 ± 1 6 ± 1 85 ± 2 
6.4 Discussion and Chapter Overview 
Three CRC cell lines were used as a model system to study how mechanical phenotype 
changes with disease progression. Each cell line represents a different cancer stage: SW480 
originate from a primary adenocarcinoma (Dukes stage B), HT29 originate from a more 
advance primary tumour (Dukes stage C), and SW620 are from a metastasis to the local 
lymphatic system (Dukes stage C). Cells were deformed in shear-dominant and inertia-
dominant flow regimes as a function of flow rate (Figure 6.4 and Figure 6.8). In the inertial 
regime (Figure 6.11), for 𝑄 < 300 𝜇𝑙/𝑚𝑖𝑛 the deformation index normalized by initial size, 
DI/A, was largest for SW620 cells and lowest for SW480 cells (HT29 was intermediate). 
For 𝑄 ≥ 300 𝜇𝑙/𝑚𝑖𝑛, cell lines could not be distinguished by DI/A. This behavior suggests 
that 𝑄≅400𝜇𝑙/𝑚𝑖𝑛 represents the apparent cell yield stress (introduced in section 4.2.2). In 
chapter 5, we showed that disruption of the actin cytoskeleton using LatA lead to cell softening 
only at flow rates below the yield stress of SW480 cells [1]. Therefore, the CRC results suggest 
that cytoskeletal changes associated with progression, and actin breakdown above the yield 
stress results in no measurable changes to deformability under these flow conditions. 
In the shear regime, the DI/A of SW620 was largest for the entire range of flow rates and 
SW480 was the lowest (Figure 6.7). The DI/A of HT29 was more similar to those of the 
SW620s for low flow rates, but the values approached those of SW480 cells for higher flow 




secondary tumour cells (SW620) being softer than the primary tumour cells (SW480) has been 
reported in previous works [117], [222]. Several papers report that SW620 cells have up-
regulated genes associated with cytoskeletal alterations particularly related to actin structure. 
Which in turn, accompanies higher proliferation, increased motility, enhances invasive 
potential and reduced adhesion compared to SW480 [111]–[115]. 
It should be noted that characterising using deformation index, without adjusting for cell size, 
generally resulted in no significant differences between the cell types in either flow regime 
(Figure 6.4 and Figure 6.8). In the shear regime, the mean values of DI were within standard 
error of each other for all flow rates above 5 µl/min. Statistical t-tests showed a significant 
difference (p<0.0001) between HT29 and SW480 and SW620 for the DI at 5 µl/min (Figure 
6.5). Whereas SW480 compared to SW620 showed no significance (p>0.05). In the inertial 
regime, for 𝑄 > 400 μ𝑙/𝑚𝑖𝑛 the SW480 cells had increased DI compared to HT29 and 
SW480. However, SW480 cells have the largest initial diameter which could make them 
appear more deformable above the yield stress where cytoskeletal rupture may occur. These 
results indicate that other deformation and relaxation parameters may better characterise and 
separate the different CRC cell lines. 
Mechanical changes in the CRC model system were also studied by collecting single cell strain 
traces to perform multiparameter analysis (Figure 6.14), including fitting the Kelvin-Voigt 
model to averaged traces to find elastic modulus values (Figure 6.15). Table 6.3 showed that 
SW480 have a higher elastic modulus and a lower maximum strain 𝜀𝑚𝑎𝑥 compared to SW620, 
indicating that the secondary SW620s are softer. Palmieri et al. 2015 used AFM to measure 
the elastic modulus of SW480 and SW620 [117]. They also noted that SW480 have two 
appearances in culture, an epithilial-type (E-type) and rounded morphology. They found the 
elastic modulus of E-type SW480 to be 1060 Pa and R-type to be 580 Pa. The R-type value is 
within error of the reported value using microfluidic strain traces and the Kelvin-Voigt model. 
The mechanical properties of adhered cell types compared with detached can differ 
significantly, due to adhered cells containing stress-fibers and focal adhesions. Thus, the 
mechanical properties found using detached microfluidic deformation would intuitively be 
more similar to a cultured rounded morphology compared to epithelial-like. Additionally, they 
reported SW620 to have a lower elastic modulus, also indicating they are softer, also within 
error of our reported value. Therefore, SW620 still being softer than SW480 post-detachment 
suggests additional structural changes, not only stress fibers, occur within the cells with 
disease progression.  
Tsrikitis et al. 2015 used AFM to measure the elastic modulus of SW480 and SW620, finding 




morphologies of SW480. Boccaccio et al. 2017 combined nanoindentation results with finite 
element models to study the hyperelastic behaviour of SW480 and SW620 [224]. They 
discussed that previously measured differences are purely a result of initial morphology as 
opposed to intrinsic structural changes. SW380R and SW620 showed comparable hyperelastic 
parameters whereas SW480E were stiffer. Tomita et al. 1992 found that SW480R and SW620 
continue growth without anchorage (i.e. without attachment to a surface), whereas SW480E 
did not, which is indicative of lower stiffness [225]. 
SW620 cells have a smaller initial diameter compared to SW480 and HT29, however the 𝜀𝑚𝑎𝑥 
and elastic modulus of SW620 and HT29 are comparable whereas SW480 is different. This 
suggests that as CRC progresses from Duke stage B (SW480) to stage C (HT29), where cells 
migrate toward the outer lining of the bowel, the cells undergo sub-structural changes leading 
to increased deformability. The similar mechanical properties between HT29 and SW620 may 
indicate that as cells metastasise from the outer lining to a secondary site (lymph node), 
changes to the cell structure are less essential. 
Cell shape recovery after deformation was investigated using the final strain 𝜀∞. SW480 and 
HL60 cells recovered their original shape post-deformation (𝜀0 ≅ 𝜀∞). Comparatively, HT29 
and SW620 only recovered to a final strain of 𝜀∞ > 0.04 which is significantly higher than 
their initial strain (𝜀0 ≅ 0). Incomplete shape recovery may be indicative of a slower 
relaxation process occurring over a timescale longer than out experiment captures. 
Additionally, it could be a “permanent” deformation associated to “plastic” deformation 
(introduced in section 4.4). Cells commonly show a viscoelastic response to applied stress, 
however permanent plastic deformations have been seen to occur due to rupture of cytoskeletal 
bonds [86], [155]. SW620 and HT29 also have a shorter relaxation time 𝜏𝑟 compared to 
SW480, which may reflect a more active cytoskeleton. 
Single cell analysis was also performed on individual strain traces of N=56 SW480 cells, 
N=49 HT29 cells, N=50 SW620 cells and also compared to N=50 HL60 cells. Two sample t-
tests were used to measure the level of significance when using different parameters to 
characterise cell types, these included; A, 𝜀𝑚𝑎𝑥, 𝜀∞, 𝜏𝑟 and 𝜀0. p-values were obtained for each 
parameter between each cell type and summarised in Table 6.5 and Figure 6.6. The initial 
strain 𝜀0 of the four cell lines are within error of each other and show no significance (p>0.05), 
additionally 𝜏𝑑 values were previously shown to be within error of each other (Table 6.3) and 
thus were not studied using SCA. Figure 6.17a shows statistical significance (p<0.05) for 
separation of all cell lines using initial diameter A, apart from HT29 and SW480 which showed 
no significance (p>0.05). Comparatively, using 𝜀𝑚𝑎𝑥 results in a significant p-value (p<0.05) 




HT29 cannot be distinguished by initial size, they can be better identified using deformation 
parameters. These results also verify previous discussions that SW620 and HT29 show similar 
mechanical responses. 
Cell recovery was fitted with an exponential function used to extrapolate the final strain 𝜀∞, 
with averages and p-values summarised in Figure 6.17c. Here, 𝜀∞ shows an extremely 
significant difference between SW480 and the other CRC cell lines (p<0.0001), whereas 
SW620 and HT29 show no significance (p>0.05). This furthers the trend that SW480 are 
mechanically different compared to later stage CRC cell lines HT29 and SW620. HT29 and 
SW620 show similar deformation and relaxation characteristics. 
Figure 6.17d showed that 𝜏𝑟 is unable to distinguish between any of the CRC cell lines 
(p>0.05). However, there is an extremely significant difference in 𝜏𝑟 between HL60 and each 
of the CRC cell lines (p<0.0001). HL60 are a non-adherent leukaemia cell line and are softer 
than the CRC cell lines, and their relaxation time 𝜏𝑟 is ~3 fold longer. However, other 
deformation and relaxation parameters could distinguish the CRC cell lines (𝜀𝑚𝑎𝑥  𝑎𝑛𝑑 𝜀∞). 
Mechanical changes between SW480 and SW620 have previously been attributed to changes 
in actin structure [117], [226]. This could suggest that 𝜏𝑟 is less sensitive to cytoskeletal 
changes and could be dominated by nuclear mechanics instead. The nuclear diameter and 
nuclear ratio (Anucleus/Acell) of the four cell lines was shown by Table 6.1. The nucleus is the 
largest organelle and is known to by stiffer than the rest of the cell [84], [90]. Compared to the 
CRC cell lines HL60 have a smaller nucleus and nuclear diameter, which may factor towards 
its increased deformability and longer relaxation time. However, coupling between 𝜏𝑟 and 𝜀∞ 
makes it likely that response is more complex. HL60 and SW480 recovered their initial shape 
whereas HT29 and SW620 did not (|𝜀∞| ≠ |𝜀0|), suggesting longer relaxation processes may 
also be in play. Overall, the statistical t-tests showed that no individual parameter can 
significantly distinguish between all the cell lines. Thus, multiparameter analysis is necessary 
for accurate classification. 
LDA was used to perform a 5-fold validation test on the four datasets (Table 6.6) which 
showed that HL60, SW480 and SW620 had reasonable classification rates (<71%) . Only 36% 
of HT29 were correctly classified, 39% were incorrectly classified as SW480 and 20% as 
SW620. This result is likely due to HT29 and SW480 having a similar initial diameter, shown 
to be a dominant parameter in their classification (Figure 6.18). Additionally, multiparameter 
analysis and t-tests showed HT29 and SW620 have similar deformation and relaxation 
properties hence their difficulty to classify. As HT29 are the intermediate stage of the CRC 
system, their difficulty to classify against SW480 and SW620 may be indicative of this. The 




In practice 1000s of cell events can be captured for a sample, however limiting factors due to 
data processing of collection and analysis of high speed videos prevented this. However, even 
using relatively small sample size the average classification rate was still ~69% for the four 
cell types. Therefore, larger datasets combined with multiparameter analysis is ideal for 
accurately classify different cell types. 
Results in this chapter have shown that mechanical parameters can be used to distinguish 
between three CRC cell lines. Particularly, that cells tend to become softer with disease 
progression. Primary adenocarcinoma cell line SW480 have a similar cell size to advanced 
primary HT29 cells, however the deformation and relaxation properties of HT29 are more 
similar to further advanced cells SW620 (lymph node metastasis). Interestingly, relaxation 
time of the CRC cells did not significantly distinguish the CRC cell lines even though it 
showed an extreme difference to HL60 cells (non-adherent leukemia). Additionally, 
incomplete shape recovery was seen only in HT29 and SW620 suggesting additional 
relaxation processes of a permanent deformation due to internal filament rupture. 
These results are the first example of using a mechanical microfluidic assay to distinguish 
between non-metastatic and metastatic CRCs, supporting the expectation that further 
advanced cells are more deformable due to cytoskeletal changes. Further, it was found that 
multiple physical parameters were required to distinguish between the four tested cell types. 
Single cell analysis has potential beyond bulk measurements for studying heterogeneity, for 
instance to identify a diseased population in a mixed sample. Results show that a high-
throughput single cell technique combined with multiparameter analysis is necessary to 





7 Other applications of Deformation Cytometry 
7.1 Non-Endocytic uptake of Quantum Dots 
This chapter discusses the use of microfluidic cell deformations towards increasing non-
endocytic uptake of Quantum Dots (QDs) into MCF7 cells. Cell deformation in microfluidic 
devices has been shown to create transient membrane pores allowing passage of 
macromolecules and nanoparticles across cell membranes by passive diffusion [61], [68], 
[227]. This topic was introduced in more detail in section 1.4.3.  
The redox state of cells is regulated by redox couples (a reducing species and its corresponding 
oxidizing form), which are vital for many cellular processes. The ratio of redox couples can 
be an indicator of disease states, such as cancer. For example, the ratio of the redox pair 
Nicotinamide Adenine Dinucleotide (reduced, NADH; oxidised NAD+) is known to be shifted 
in breast cancer cell line MCF7 to a high ratio of NADH/NAD+. Thus, methods to measure 
the redox potential of cells have diagnostic applications. Ubiquinone-modified ligands in 
conjugation with QDs were reported to sense NADH [228]. Where the electron acceptor 
ubiquinone ligand reduces the NADH, and subsequently the QD emission is quenched. As 
such, an appealing use of QDs is their redox sensing abilities. A more detailed description of 
QDs for redox sensing can be found in the thesis of Harvie 2018 [229]. A hurdle in using QDs 
for redox sensing is that cells typically uptake QDs via endocytosis. QDs trapped inside 
endosomes are subject to a different chemical environment to the cytosol and thus cannot 
measure the true cell redox potential. For use as redox sensors a technique is needed to 
efficiently deliver QDs to the cell cytoplasm.  
Here, DC was investigated as a method to achieve non-endocytic uptake of ~5 nm core-shell 
CdTe/CdS QDs into MCF7 cells. MCF7 were chosen as they display a particularly reduced 
redox state [230]. Both shear and inertial regimes were tested to investigate if a particular flow 
regime achieved more efficient delivery. Figure 7.1 is a schematic showing the concept of the 
method, deformation at the SP of a cross-slot may generate transient membrane pores allowing 
passive diffusion of QDs into the cell’s cytoplasm. This work is in collaboration with the 
Critchley group in the Molecular and Nanoscale Physics department at the University of 
Leeds. Abiral Tamang synthesised and provided quantum dots and participated in deformation 
cytometry experiments, as well as developing and performing confocal fluorescence imaging 





Figure 7.1 Schematic describing the passive diffusion of quantum dots through transient membrane 
pores in cells, due to deformation at the stagnation point of a cross-slot microfluidic device. 
7.1.1 Shear Regime 
The uptake of CdTe/CdS core/shell QDs was studied after cross-slot deformation in a shear-
dominant regime (µ≈33 cP) over a range of flow rates. Section 3.7.2 outlines the microfluidic 
uptake protocol. This involved suspending the MCF7 cells with QDs at a final concentration 
of 100 nM before passing them through the microfluidic device. After collection, samples 
were left to incubate for ~20 mins to allow passive diffusion of QDs through any transient 
membrane pores. Excess QDs were then washed by centrifugation, and QD uptake was 
measured using confocal fluorescence microscopy. 
 The deformation index DI was measured over the range of flow rates which is shown by 
Figure 7.2. Here, no velocity threshold was applied as all cells passed through the device were 
used for subsequent fluorescence measurements. The dataset is fitted with an exponential 
function (shown in red) which tends towards a maximum deformation index of 𝐷𝐼𝑚𝑎𝑥 =





Figure 7.2 The deformation index DI of MCF7 cells as a function of flow rate in a shear-dominant 
regime (𝜇 ≅ 33 𝑐𝑃), fitted with an exponential function.  
The amount of QD uptake was quantified by taking confocal fluorescence images of samples 
measuring the fluorescence intensity of each cell, the image analysis was done as described in 
section 3.7.3. The total intensity was measured for samples over the range of flow rates, the 
experiment was then repeated (N=3) to obtain the mean average fluorescence per cell. Figure 
7.3a shows a plot of mean fluorescence per cell as a function of flow rate which shows a linear 
trend, thus uptake increases as a function of flow rate. Comparatively, the deformation index 
as a function of flow rate was fitted with an exponential (Figure 7.2), and DI remained 
approximately constant for flow rates ≥ 75 μ𝑙/𝑚𝑖𝑛. Interestingly, fluorescence intensity 
continued to increase linearly for > 75 μ𝑙/𝑚𝑖𝑛. This suggests that even at maximum stretch 
increasing the flow rate continues to improve uptake, suggesting that more transient pores are 
formed or bigger or longer lasting pores are formed. 
Figure 7.3b shows that cell viability is >80% for flow rates up to <125 µl/min. However, a 
significant viability drop occurs for flow rates >125 µl/min with only 62.4% viability for 175 
µl/min. Thus, 100 µl/min was able to achieve most uptake without a resulting significant drop 





) comparing the incubated control sample (i) with the sample deformed at the 
optimum condition 100 µl/min (ii). The incubated control (i) shows a linear relationship 
between fluorescence intensity and cell size and is fitted with a straight line (black line). The 
deformed sample shows deviation from the initial linear fit (shown in black), with the majority 
of the population having increased fluorescence intensity, and a general increase in scattering 
can be seen. A linear fit to the deformed sample (shown in red) further highlights the increased 
uptake due to microfluidic deformation. The majority of the deformed cell population shows 




efficiency. Such that, if efficiency was low we may expect to see a subpopulation similar to 
the distribution shown by the incubated control (i). 
 
Figure 7.3 QD uptake analysis of MCF7 cells microfluidically deformation whilst suspended with 100 
nM of QDs in a shear-dominant regime (µ≈33 cP). (a) The average fluorescence emission per cell as 
a function of flow rate.(b) The cell viability after deformation and incubation with QDs as a function of 
flow rate using an MTT assay. (c) Density scatter plots of fluorescence emission of uptaken QDs in 
cells for (i) a control sample which was not deformed (0 µl/min) and (ii) a sample deformed at 100 
µl/min. Data was acquired and analysed by Abiral Tamang who provided these figures.  
Examples of confocal fluorescence images of MCF7 are provided in Figure 7.4. This includes 
a sample that was deformed in the shear regime at 100 µl/min whilst incubated with 100 nM 
of QDs, compared to a control sample which was not treated by the microfluidic device but 
was also incubated with 100 nM of QDs for the same length of time. The images show a 
general increase in fluorescence intensity for the deformed sample. Additionally, fluorescence 
in the control sample is localised to small “dots” which is indicative of uptake occurring via 
endocytosis. Comparatively, the deformed sample shows more distributed fluorescence 
throughout the cells which is indicative of cytosolic uptake. 
Overall, image analysis showed an increase in the average fluorescence intensity per cell as a 
function of flow rate indicating that microfluidic deformation in the shear-dominant regime 




increased uptake is due to QDs within the cytoplasm due to the formation of transient 
membrane pores, in addition to any endocytotic processes. 
 
Figure 7.4 Confocal fluorescence images of MCF7 cells with QD uptake, showing QD emission in red 
overlayed onto bright field images. Comparing a sample which was microfluidically deformed at 100 
µl/min in the presence of QDs (100 nm), and a control sample which was not deformed but was 
incubated with QDs. Scale bars 100 µm.  Images were provided by Abiral Tamang.  
7.1.2 Inertial Regime 
Cross-slot deformation in the shear-dominant regime showed increased cytosolic uptake of 
QDs. Uptake was also studied in the inertia-dominant regime at four different flow rates. 
Based on our previous inertial regime deformation studies (HL60, SW480, HT29, SW620 in 
sections 4.2.2 and 6.2.2) the apparent yield stress of cells occurs at ~300-400 µl/min. Thus, 
for this study flow rates below (100 µl/min), at (400 µl/min) and above (500 and 600 µl/min) 
were chosen to test cytosolic QD uptake. Figure 7.5 shows the deformation index DI as a 
function of Q. Results follow the behaviour observed in the inertial regime for HL60 and CRC 
cell lines, with no significant change in DI above 500 µl/min. This suggests the maximum 
deformation has been reached and cells could be near to their failure point. The DI at 600 






Figure 7.5 The deformation index DI of MCF7 cells as a function of flow rate. Cells were deformed in 
an inertia-dominant regime where 𝜇~1 𝑐𝑃.  
Microfluidic uptake experiments in the inertia-dominant regime were conducted as described 
in section 4.2.2. Confocal fluorescence was used to collect both bright field and fluorescence 
images of the cells after incubation with QDs and treatment with on-chip deformation. Uptake 
was measured by calculating the mean and median fluorescence per cell for deformations at 
four flow rates and a control sample (same QD incubation time without microfluidic 
deformation treatment). The median was measured to highlight any skew that may be caused 
by a small proportion of cells with extremely high fluorescence (i.e. due to dead cells with 
highly compromised cell membranes). The experiment was repeated (n=3) and the average of 
the mean and median values were plotted as a function of flow rate, shown by Figure 7.6. 
Both the mean average (Figure 7.6a) and median average (Figure 7.6b) fluorescence per cell 
are essentially constant as a function of flow rate, both graphs are fitted with a linear fit with 
the gradient set at 0 (shown in red). These results suggest that inertia-dominant deformation 
of MCF7 did not increase cytosolic uptake of QDs, and that uptake was dominated by 
endocytosis. Comparatively, the shear-dominant regime did show increased cytosolic uptake 
as a function of flow rate, which may indicate shear forces and deformation at lower strain 
rates is more efficient at forming transient membrane pores. 
Figure 7.7a shows example density scatter plots of the fluorescence intensity per cell as a 
function of cell area, for MCF7 microfluidically deformed at 500 µl/min compared to the 
purely incubated control sample. Both graphs show a linear relationship between uptake and 
cell size, similar to in the shear regime (Figure 7.2), and linear fits are shown in red. The 
control sample shows more scatter and higher number of outliers with high fluorescence. This 
is partly due to the larger sample size for the control compared to the deformed sample (>4 




amount of the QDs, the 500 µl/min condition may have destroyed these cells during treatment 
with the microfluidic device. The slope of the control sample was 46.9 ± 1.9 and of the 
deformed sample was 45.0 ± 2.0. Further, both fluorescence intensity datasets are plotted as 
histograms which show a single peak and are fitted with Lognormal functions (𝑅2 ≈ 0.97). 
The peak of the control sample was 2577±21 and of the deformed sample was 2644±26. This 
data corroborates that microfluidic deformation in the inertial regime did not significantly 
increase QD uptake in MCF7 cells. 
 
Figure 7.6 Uptake of QDs in MCF7 cells deformed in a cross-slot device whilst suspended in media 
(µ~1 cP) with 100 nM QDs, the fluorescence of each cell was then measured to quantify QD uptake as 
a function of deformation. (a) The experiment was repeated n=3 and an average of the mean values for 
each experiment was plotted as a function of flow rate. (b) For the same datasets the median 






Figure 7.7 Analysis of uptake of MCF7 cells deformed in a cross-slot whilst suspended with 100 nM of 
QDs (µ≈1 cP). (a) Density scatter plots of fluorescence intensity in cells due to QD uptake for a control 
sample which was not deformed (0 µl/min) and a sample deformed at 500 µl/min.(b) Histograms of the 
fluorescence intensity per cell for a control sample and a sample deformed at 500 µl/min.  
7.1.3 Constriction channel control 
The cross-slot geometry used throughout the thesis was described in detail in section 3.2.1, 
before deforming at the SP cells travel through a channel with a width of 35 µm. At higher 
flow rates in the shear-regime, shear forces due to confinement in the channel can induce 
bullet-like cell deformations (similar to those used by the Guck group in RTDC [33]). An 
example image of this can be found in Figure 7.8bi. Additionally, increased cytosolic uptake 
of QDs has been seen for constriction channel geometries (where channel width is smaller 
than initial cell diameter) [65]. Thus the cytosolic uptake seen in the shear-regime may be 
partly due to the bullet-like deformations before/after extensional flow junction. Also, 
deformation at the SP did not lead to cytosolic uptake in the inertial-regime which suggests 
shear forces dominate transient pore membrane formation.  
To decouple shear-induced deformation by confinement and extensional flow deformation at 
the SP, a serpentine channel was designed to replicate our devices without the extensional 
flow junction. This device was described in detail in section 3.2.2, cells travel through a 
serpentine with the same inlet/outlet dimensions of the cross-slot including being the same 
length. This device was then used to measure QD uptake at three flow rates compared to a 
control (incubated without microfluidic device treatment). Considering the initial cross-slot 




extensional flow junction, the equivalent volumetric flow rates set on the syringe driver were 
half for the serpentine compared to the cross slot. For example, the largest flow rate tested on 
the serpentine was 75 µl/min which is equivalent to using 150 µl/min on the cross-slot device 
to achieve the same flow velocity. 
The deformations in the serpentine channel were measured using high speed imaging at three 
flow rates. As deformations were asymmetrical, deformability was characterised by two 
parameters the deformation index DI and the circularity DC. These were first introduced in 
section 3.5.3 and are also shown in schematics in Figure 7.8a. Figure 7.8b shows DI at a 
function of flow rate and is fitted with an exponential function. This suggests that stretching 
in the direction of flow tends to a maximum value. Figure 7.8b shows DC as a function of flow 
rate, which is fitted with a linear fit. This shows that even though stretching has reached a 
maximum the circularity continues to deviate over this flow range. This is likely due to the 
bullet-like shape, at higher flows the back of the cell can become concave which would further 
increase Dc. 
 
Figure 7.8 Shape analysis of cells deformed in a constriction channel. (a) Diagrams showing how the 
deformation due to shear in a constriction channel was quantified. Using both deformation index and 
the circularity. (b) A graph of DI at a function of flow rate for MCF7 cells deformed by shear in a 
constriction channel (µ≈33 cP). (i) An example of image of the bullet-like deformation. (c) A graph of 




Uptake experiments using the serpentine device were conducted following the same protocols 
as the cross slot device. Cells treated microfluidically and a control sample were then imaged 
using confocal fluorescence microscopy, and a customised Matlab code measured the 
fluorescence of individual cells (section 3.7.3). The mean and median fluorescence per cell 
was measured, the experiment was repeated (n=3) and the average of the mean and median 
values was calculated and plotted as a function of flow rate (Figure 7.9). 
The mean average (Figure 7.9a) and the median average (Figure 7.9b) show no significant 
change in fluorescence per cell as a function of flow rate. Both graphs are fitted linearly with 
the slope fixed at 0 (shown in red). These results suggest that bullet-like deformations due to 
shear confinement are not sufficient to increase cytosolic uptake of quantum dots. Thus, it is 
the extensional flow induced deformation of the cross-slot which led to increased cytosolic 
uptake in the shear-dominant regime (Figure 7.3). 
Figure 7.10a shows density scatter plots of the fluorescence intensity per cell as a function of 
cell size, for cells microfluidically deformed in a serpentine channel at 75 µl/min compared to 
an undeformed control sample. Both graphs show a linear relationship between intensity and 
cell size, with no noticeable changes or increase in uptake for the deformed sample. The 
fluorescence intensity datasets are also plotted as histograms (Figure 7.10b), which are both 
fitted with a single peak Lognormal. The peak center of the control sample was 499.9±1.6 and 
the deformed sample was 430±1.5. These results also indicate no significant improvement in 
uptake due to constriction deformation using a high viscosity buffer (µ≈33 cP).  
 
Figure 7.9 Uptake of QDs into MCF7 cells deformed in a constriction channel (µ≈33 cP) with 100 nM 
QDs, the fluorescence of each cell was then measured to quantify QD uptake as a function of 
deformation. (a) The experiment was repeated (n=3) and an average of the mean values was plotted as 
a function of flow rate. (b) The median fluorescence per cell was also found, then the average of the 





Figure 7.10 Analysis of uptake of QDs in MCF7 cells deformed in a constriction channel whilst 
suspended with 100 nM of QDs (µ≈33 cP). (a) Density scatter plots of fluorescence intensity in cells 
due to QD uptake for a control sample which was not deformed (0 µl/min) and a sample deformed at 
75 µl/min.(b) Histograms of the fluorescence intensity per cell for a control sample and a sample 
deformed at 75 µl/min.  
7.1.4 Uptake by incubation 
Sections 7.1.1 and 7.1.2 presented results for QD uptake as a function of flow rate in shear-
dominant and inertia-dominant regimes in a cross-slot device. These results were compared 
to undeformed control samples which were suspended in the high viscosity PBS-MC buffer 
(µ≈33 cP) for the shear regime or suspended in media for the inertial regime (µ~1 cP). It was 
noticed from these that the control sample in the shear regime appeared more fluorescent than 
the control for the inertial regime. This effect was further investigated. MCF7 were incubated 
in media or PBS-MC with 100 nM of QDs for 20 mins. Cell suspensions were then washed 
by repeated centrifugation at 100 g for 5 mins (n=3) to remove excess QDs, as described in 
section 3.7.2. Samples were then imaged using confocal fluorescence and the fluorescence per 
cell was measured, similar to the procedure in 7.1.1 and 7.1.2. The sample originally incubated 
in media will be referred to as the inertial control, and the sample incubated in PBS-MC 
referred to as the shear control. 
Figure 7.11 a(i) and b(i) show low magnification fluorescent images of QD uptake in the shear 
control and inertial control. These images show a large number and were taken using the same 




shear control shows increased fluorescent intensity compared to the inertial control. Figure 
7.11 a(ii) and b (ii) show higher magnification images of both samples where the fluorescent 
images are overlayed onto bright field images. Fluorescence in the inertial control image is 
mostly showed as bright dots which is indicative of QDs localised in endosomes. The shear 
control image also shows bright dots but also some more diffuse fluorescence is present which 
may represent QDs in the cytoplasm. 
 
Figure 7.11 Confocal images of QD uptake in MCF7 cells of the inertial and shear controls.(a i) A low 
magnification fluorescent image of QD uptake in the inertial control sample. Scale bar is 100 µm. (ii) 
An overlayed fluorescent image of uptake in the inertial control sample, the bright spots are indicative 
of endocytic uptake. Scale bar is 20 µm. (b i) A low magnification image of uptake in the shear control 
sample (scale bar 100 µm). (ii) An overlayed fluorescent image of uptake in the shear control sample, 
bright spots indicating endocytic uptake are present but also some diffuse fluorescence more likely to 
be cytosolic uptake.  
The fluorescence per cell was measured from low magnification fluorescence images of the 
inertial control and the shear control. Statistical measurements were done to quantify any 
significant changes in QD uptake between the samples, including histograms and boxplots 
(Figure 7.12). Experiments were repeated to obtain mean average and median average values 
of fluorescence per cell (N=4 for the inertial control) and (N=3 for the shear control). Figure 
7.14a shows histograms of both samples which are fitted by Lognormals. The peak center of 
the inertial control was 2794±14 and of the shear control was 3160±51, showing a ~1.1 fold 




showed a wider distribution as the standard deviation of the fit was 𝑤 = 0.473 ±
0.014 compared to 𝑤 = 0.361 ± 0.004 for the inertial control. 
Figure 7.12b shows a box-plot of the fluorescence per cell of the inertial control and shear 
control. Here, the box extends the 25th to 75th percentiles and the whiskers extend the 10th-90th 
percentile. The line through box shows the mean fluorescence per cell and the square shows 
the median value. The box-plot shows a small increase in the median value of the shear control 
and a much larger increase in the mean value. It also shows a much wider distribution for the 
shear control, which is skewed towards much higher values of fluorescence per cell. This can 
be seen in the fluorescent images as a small number of cells appear significantly brighter in 
the shear control (Figure 7.11). Figure 7.12b (i) shows a table of mean average and median 
average values of fluorescence per cell taken from the experimental repeats of the inertial 
control (N=4) and shear control (N=3). The mean average of the shear control shows a ~2.1 
fold increase compared to the inertial control, and the median also shows a ~1.3 fold increase. 
Overall, the consensus shows that the shear control has higher fluorescence indicating 
increased uptake of QDs. 
 
Figure 7.12 (a) Histograms of the fluorescence per cell for the inertial control and the shear control, 
showing the distribution of QD uptake in MCF7 cells. (b) A boxplot of the fluorescence per cell for the 
inertial control and the shear control. Where the box extends the 25th to 75th percentile with a line 
representing the mean and square representing the median, the whiskers extend the 10th to 90th 
percentiles. (i) Shows the mean and median average fluorescence per cell from the experimental repeats 
of the inertial control (N=4) and the shear control (N=3).  
Increased uptake in the shear control likely indicates that additional stresses on the cells 
during the incubation and washing steps leads to formation of transient membrane pores and 




experience increased shear forces during the centrifugation steps for washing and from gentle 
pipetting to resuspend the cells after pelleting. Figure 7.6 showed that microfluidic 
deformation using the cross-slot can lead to a further ~1.8 fold increase in the mean 
fluorescence per cell.  
7.1.5 Discussion 
Microfluidic deformation was investigated as a method to increase cytosolic uptake of QDs 
into MCF7 cells. Delivery of QDs into the cytosol, as opposed to endosomes, is important for 
the development of QDs as redox sensors which has potential applications in cancer diagnosis. 
Firstly, cells were deformed using a cross-slot device in a shear-dominant regime (µ≈33 cP) 
and this showed a linear increase in uptake as a function of flow rate (Figure 7.3). Confocal 
fluorescence images suggest QDs located in the cytosol after cell deformation, whereas 
controls incubated with QDs showed them to be localised to endosomes (Figure 7.4). A flow 
rate of 100 µl/min proved optimum as it induced the most uptake without significantly 
decreasing cell viability. Measurements of the deformation index showed that even through 
𝐷𝐼𝑚𝑎𝑥 was reached for flow rates ≥ 75 𝜇𝑙/𝑚𝑖𝑛, QD uptake continued to increase linearly up 
to 150 𝜇𝑙/𝑚𝑖𝑛. Thus, continued increase of the flow rate further increases the stress on the 
cell which either creates more pores or increases the size of the pores regardless of the cell 
being at maximum stretch (𝐷𝐼𝑚𝑎𝑥).  
For the optimum condition of 100 µl/min the mean fluorescence emission per cell was ~1.7 
fold greater than for the control sample. Density scatter plots (Figure 7.3c) show the majority 
of the population of deformed cells show increased emission compared to the control sample, 
indicative of high efficiency of cytosolic uptake. However, more robust methods are needed 
to accurately quantify uptake efficiency. Lee et al. 2012 used constriction channels (W<A) to 
achieve cytosolic delivery of QDs into cells. They engineered a nanoparticle which changed 
emission profile when interacting with the reducing environment of the cytosol, and used this 
to quantify uptake efficiency. Using flow cytometry they found ~35% of the cells deformed 
through the constriction channels had successful cytosolic delivery. 
The same group delivered a range of materials into 11 cell types, and showed that increased 
cell speeds, reduced constriction dimensions, and repeating constrictions lead to increased 
uptake efficiency [66], [67]. They also elucidated the mechanism of uptake by adding 3 kDa 
dextran beads at varying time points after microfluidic treatment, showing 70-90% of delivery 
occurs within the first minute, supporting that transient membrane pores allow passive 
diffusion of material. Further tests were done to support that membrane disruption leads to 
material exchange both in and out of the cell. Bi-directional transport was investigated by 




presence of dextran and then washed, which showed net diffusion of dextran into the cells. 
Next, the same cells were microfluidically treated without the presence of dextran in the 
suspension media which showed a net reduction of dextran out of the cells. Finally, the cells 
were treated a third time again in the presence of dextran which again showed net uptake. A 
2D diffusion COMSOL model was used to replicate these experimental results. Passive 
diffusion across a porous membrane with a set membrane diffusivity showed good agreement 
with the three-cycle test. However, this model offers no insight into pore size, number of pores 
or pore lifetime, additionally the stress on a constrained cell is not homogeneous which may 
cause heterogeneity in pore location. 
The use of a constriction channel (where channel width is less than initial cell size) also 
resulting in 50-90% of the initial number of cells recovered after microfluidic treatment, 
contributed by cell sticking and clogging within the device. Additionally, even though 
increasing constriction length and decreasing width led to increased uptake efficiency it also 
reduced the number of recovered cells. Therefore, using hydrodynamic deformation does not 
require such dramatic cell confinement and would likely improve recovery and reduce 
clogging. 
No significant increase of QD uptake into MCF7 cells was seen using a constriction channel 
(wider than the initial cell size) in a shear-dominant regime (Figure 7.9). This result suggests 
that the shear stress due to confinement is not sufficient to generate pores for passive diffusion 
of material, converse to extensional deformation at the cross-slot. Physical confinement was 
shown to increase uptake of QDs [65], likely due to imparting larger membrane deformations 
but could also be due to additional friction between the cell membrane and channel walls. 
The inertia-dominant regime in the cross-slot device also showed no significant improvements 
to the uptake of QDs into MCF7 cells. This is in disagreement with other studies which show 
improved uptake of various macromolecules and nanoparticles using highly inertial 
microfluidic deformation. Chungs lab developed the inertial microfluidic cell stretcher 
(iMCS), where cells are deformed using a T-junction and endure direct contact with the 
channel wall (Re>100) [54]. Uptake efficiency was increased further with the addition of a 
sharp-tip located where the cell deforms [68]. The use of high-flow speeds and direct contact 
with the solid channel likely imparts more stress compared to hydrodynamic deformation at 
the SP. However, more recently this group have opted for a cross-slot device in an inertial 
flow regime (as introduced by Di Carlo et al. [27]) referred to as a Hydroporator [231]. The 
Hydroporator study achieved delivery of a range of macromolecules to 10 cell types, 
including MCF7, with up to 90% delivery efficiency. This included delivery of 2000 kDa 




showed correlation between cell deformability and delivery efficiency, and out of the 10 cell 
lines tested MCF7 proved least deformable and had lowest uptake efficiency of 3-5 kDa beads 
(~25%). Additionally, surface chemistry of NPs likely affects delivery efficiency and QD 
uptake has not previously been reported in studies using inertial microfluidics. 
Finally, incubated controls of MCF7 with QDs using low viscous cell media (inertial control) 
and high viscosity PBS-MC (shear control) showed an increase in QD emission for the shear 
control (Figure 7.12). This result suggested that during incubation, washing and resuspension 
steps, in a high viscosity environment, additional stresses may lead to passive diffusion of 
material via transient pores. Centrifugation of the cell samples imparts drag forces whist the 
cells sediment into a pellet, the drag force and sedimentation rate can be estimated and 
compared for the inertial control and the shear control. 
The drag force 𝐹𝑑𝑟𝑎𝑔 on a sphere can be calculated using Stokes law equation 7.1, which was 
used to estimate the shear forces on a cell being centrifuged at 100 g. 𝐹𝑑𝑟𝑎𝑔 is proportional to 
the sedimentation velocity 𝑣 shown by equation 7.2, when A is the cell diameter, 𝜌𝑐𝑒𝑙𝑙 is the 
cell density, 𝜌𝑚𝑒𝑑𝑖𝑎 is the media density, 𝜇 is the viscosity and g is the gravitational force. For 
the inertial control 𝜌𝑚𝑒𝑑𝑖𝑎 = 1000 𝑘𝑔/𝑚
3 and 𝜇 = 1 𝑐𝑃, and for the shear control 𝜌𝑚𝑒𝑑𝑖𝑎 =
1005 𝑘𝑔/𝑚3 and 𝜇 = 33 𝑐𝑃. The diameter of MCF7 was estimated as 18 µm and the cell 
density as 𝜌𝑐𝑒𝑙𝑙 ≈ 1080 𝑘𝑔/𝑚
3 (estimated to be the same as HeLa cells [232]). Thus, the drag 
force on an MCF7 cell centrifuged at 100 g for the inertial control was 𝐹𝑑𝑟𝑎𝑔 = 0.24 𝑛𝑁 and 
for the shear control was 𝐹𝑑𝑟𝑎𝑔 = 0.22 𝑛𝑁. Thus, a similar drag force is experienced in both 
regimes due to the relatively small change in the density of the medium. However, as 
sedimentation rate is inversely proportional to viscosity and proportional to the change in 
density the cells in the inertial regime sediment ~35 times faster than those in the shear regime. 
This means that for a cell to fall ~1 cm from the top of a sample in an Eppendorf to pellet at 
the bottom would take ~7 s for the inertial control compared to ~4 min for the shear control. 
Thus, the cells in the shear control are subject to drag forces for a longer time allowing more 
opportunity for passive diffusion of the QDs through transient membrane pores. 





This theory could be investigated further by quantifying QD uptake in cells centrifuged as a 
function of; medium viscosity, centrifugation force and centrifugation time. Additionally, 
altering sedimentation distance whilst maintaining viscosity would further confirm the theory. 




time, ease of operation and potential for bulk volumes to be tested. However, as cells would 
be initially suspended throughout the sample the sedimentation time would always be 
distributed which may affect uptake efficiency. Thus, microfluidics offers a controlled force 
environment for each individual cell and has shown potential for high efficiency cytosolic 
uptake (>90%) [231]. 
To conclude, the use of a cross-slot microfluidic device in the shear-dominant regime showed 
increased QD uptake into MCF7 cells with evidence that QDs entered through transient 
membrane pores and were present throughout the cytosol of cells. Comparatively, these 
studies showed that a constriction channel geometry and cross-slot inertial-regime did not 
significantly improve QD uptake. Deformation cytometry for cytosolic uptake is 
advantageous compared to traditional techniques (such as electroporation, sonoporation or 
microinjection) due to being; high throughput, label-free, maintaining high viability and 
requiring no external fields of ultrasound. Further studies are needed to quantify uptake 
efficiency (such as flow cytometry), however the method shows potential for the study of QDs 
for measuring redox potential in cells.  
7.2 DC for probing the mechanoresponse of Piezo1 
Cell membranes contain protein ion channels which are activated under certain stimuli, 
forming temporary pores allowing ions to pass across the membrane. Mechanical deformation 
is one such stimuli, and an example of a mechanosensitive ion channel (MSC) is Piezo1 which 
is a ~286 kDa transmembrane protein. Piezo1 can be stimulated by mechanical force, 
including membrane tension and actomyosin contractile forces [233], [234], activated Piezo1 
are permeable to Na+, K+, and Ca2+. Figure 7.13 shows a simplified schematic of Piezo1 
activation. Pathological significance has been noted in Piezo1, including mutations linked to 
haemolytic anaemia [235] and autosomal recessive congenital lymphatic dysplasia [236], as 
well as contributing to metastases by facilitating cell escape from a monolayer [237]. Piezo1 
can be studied by the agonist Yoda1 (discovered in 2015 [186]), which provides a chemical 






Figure 7.13 Simplified shematic showing the mechanosensitive ion channel Piezo1 which resides in the 
cell membrane. Mechanical stimulation, via membrane tension or cytoskeletal contractile forces, 
activates the channel which opens the pore allowing influx of ions.  
The previous results sections of the thesis have described the use of deformation cytometry 
for mechano-phenotyping and increased cytosolic uptake of QDs. This included adapting the 
technique to probe at low and high strains in two distinct flow regimes (shear and inertia 
dominant). Thus, this technique may be applicable for studying Piezo1 activation by 
mechanical force. The applied force can be tailored using flow rate and suspension buffer 
viscosity, which could potentially infer information on the required forces for activation. This 
section presents preliminary results for using deformation cytometry to study the MSC Piezo1. 
The two cell lines used to investigate Piezo1 activation will be referred to as HEK293 T-REx 
and Piezo1 T-REx, and were introduced in section 3.6.4. Piezo1 T-REx is a HEK293 cell line 
with stably incorporated tetracycline-inducible human Piezo1 expression, and show Piezo1 
expression after being induced with tetracycline but not without induction. As a control, 
normal HEK293 T-REx cells (with no incorporated Piezo1) show no response with or without 
induction by tetracycline. These cells were provided by Elizabeth Evans and the David Beech 
group (University of Leeds, Faculty of Biological Sciences). 
HEK293 cells are an adherent cell line with an epithelial morphology. Figure 7.14a shows 
phase contrast images of adhered HEK293 T-REx and Piezo1 T-REx, which show no apparent 
changes in their morphology. For deformation assays and subsequent fluorescence 
measurements for detecting Piezo1 activation, cells were detached into a rounded 
morphology. Figure 7.14b includes histograms of the diameter of detached HEK293 T-REx 




Gaussian peak of HEK293 T-REx was 16.5 ± 0.2 μm and of Piezo1 T-REx was 16.4 ±
0.1 μm, showing no significant change in size between the two cell lines. 
Strain traces were also collected for HEK293 T-REx and Piezo1 T-REx to investigate whether 
incorporation of Piezo1 into the cell membrane affects the mechanical properties or HEK293 
cells. 
 
Figure 7.14 (a) Phase contrast images of HEK293 T-REx and Piezo1 T-REx cell lines adhered to a 
culture flask, scale bars are 20 µm. (b) Histograms of the diameter of HEK293 T-REx and Piezo1 T-
REx cell lines when detached into a rounded state, showing normal distributions fitted with Gaussians.  
7.2.1 Yoda1 activation 
The system was initially tested using the drug Yoda1 to activate Piezo1 and the ratiometric 
fluorescent dye Fura-2 for detection. A detailed protocol of how cells were loaded with Fura-
2 can be found in section 3.6.4. Both cell lines were incubated with 0.1 µg/ml of tetracycline 
for 24 hr before measurements occurred, tetracycline should induce Piezo1 expression in the 
Piezo1 T-Rex cell line but not the control cell line. After cells were loaded with Fura2, samples 
were arranged in a 96 well plate (Costar 96 clear U bottom) with 200 µl/well and ~50,000 
cells per well. Different concentrations of Yoda1 were added to the wells, with five repeating 
wells for each condition, and a platereader (SpectraMax ® M2) was then used for fluorescence 
measurements. 
Cells were suspended in SBS (Standard Barths Solution) which contains calcium ions, once 
Piezo1 is activated calcium ions can pass the cell membrane into the cell. Unbound Fura-2 
excites at 380 nm but ones bound to calcium excite at 340 nm. Both excitation wavelengths 
emit at 510 nm. Thus, the addition of Yoda1 should activate Piezo1 allowing the passage of 
Calcium ions resulting in increased emission when using 340 nm excitation and reduced 




380/510 nm (Lm2), and the ratio Lm1/Lm2 was used to quantify increased activation of 
Piezo1 ion channels. 
This protocol was based off the work by Evans et al. 2018 who tested Yoda1 analogues using 
these cell lines and the Fura2 ratiometric fluorescence measurements [186]. Their protocol 
including seeding the cells in the well plate such that they were adhered when Yoda1 was 
applied. However, for microfluidic deformation the cells are required to be detached and 
rounded. Therefore, the Yoda1 control was conducted for a range of concentrations on both 
cell lines in their detached and adhered morphologies. 
Figure 7.15 is a graph of fluorescence response Lm1/Lm2 as a function of Yoda1 
concentration, where an increase in Lm1/Lm2 indicates increased Piezo1 activation. Results 
are baseline normalised using Lm1/Lm2 well plate measurements taken before addition of 
Yoda1. Firstly, results indicate no significant difference in response due to cells being adhered 
or detached. The Piezo1 T-Rex datasets are fitted with an exponential function, this behaviour 
is expected as a saturation point will eventually be reached if all Piezo1 channels are fully 
open. The HEK293 T-Rex datasets show a linear relationship between Yoda1 and Lm1/Lm2, 
however response is significantly less than the Piezo1 T-REx. HEK T-REx should 
theoretically not express Piezo1 and so increase in Lm1/Lm2 would be expected due to 
addition of Yoda1. The presence of endogenous Piezo1 in HEK293 cells is a source of debate 
and discussed in Dubin et al. 2017 [238], thus the data presented by Figure 7.15 would support 








Figure 7.15 The drug Yoda1 was used to activate the mechanosensitive ion channel Piezo1. Activation 
of Piezo1 allows calcium ions into the cell which then bind to the pre-loaded dye Fura2. Fura2 excites 
at 340 nm when bound with emission at 510 nm (Lm2), unbound Fura2 excites at 380 nm and also emits 
at 510 nm (Lm1). Lm1/Lm2 is a measure of Piezo1 activation as fluorescence at Lm1 should increase 
and Lm2 should decrease. This method was tested on HEK293 T-REx and Piezo1 T-REx cell lines as a 
function of Yoda1 concentration. This method was also tested on cells adhered to to the well surface 
and detached to a rounded state. Fluorescence intensity was measured across 5 wells for each 
datatpoint and averaged.  
7.2.2 Shear Regime Deformation 
DC experiments were performed on HEK293 T-REx and Piezo1 T-REx in the shear-dominant 
regime (µ≈33 cP). Cells were deformed on-chip using a range of flow rates, collecting 10s-
100s of events for each condition. Experiments were repeated N=3 to calculate the average 
deformation index DI. Cells were deformed between 20 µl/min and 200 µl/min, the same range 
used for trying to detect Piezo1 activation due to mechanical force. 
Figure 7.16 shows the DI of HEK293 T-REx and Piezo1 T-REx as a function of flow rate, 
both datasets are fitted with an exponential function. The majority of data points are within 
error of each other, including the lowest and highest flow rate. This suggests that the 





Figure 7.16 The deformation index DI of HEK293 T-REx and Piezo1 T-REx as a function of flow rate. 
Cells were deformed in a shear-dominant regime (where 𝜇 ≅ 33 𝑐𝑃) and both datasets are fitted with 
an exponential function (n=3).  
The same protocol as described in the previous section was used, however instead of activating 
Piezo1 using Yoda1 cells were passed through a cross-slot device at different flow rates. This 
was to test whether the mechanical force imparted on cells at the SP would activate Piezo1. 
As before, both cell lines were incubated with 0.1 µg/ml of tetracycline 24 hr in advance and 
then cells were preloaded with Fura2. The cells were passed through the device until a 300 µl 
sample was collected, this was then separated into 100 µl into three wells in a 96 well plate. 
The initial cell density was 5 ∙ 105 𝑐𝑒𝑙𝑙𝑠/𝑚𝑙, to end up with 50,000 cells per well. Fluorescent 
measurements of Lm1 (380/510 nm) and Lm2 (340/510 nm) were then immediately recorded 
and the ratio Lm1/Lm2 was used to indicate increased uptake of calcium into the cells. The 
experiment was repeated three times and from this an average Lm1/Lm2 was found for each 
flow condition. Figure 7.17a shows Lm1/Lm2 as a function of flow rate for HEK293 T-REx 
and Piezo1 T-REx. Both cell lines show increased Lm1/Lm2 with flow rate suggesting that 
microfluidic deformation aids passage of calcium ions across the cell membrane, however 
Piezo1 T-REx have increased response for all flow rates. 
Both data sets are linearly fitted, the slope for HEK293 T-REx was (8.72 ± 0.51) ∙ 10−4 and 
for Piezo1 T-REx was (8.61 ± 0.30) ∙ 10−4 which are within error of each other, suggesting 
a systematic increase in response. This is further confirmed by Figure 7.17b which shows the 
Piezo1 T-REx dataset normalised by the HEK293 T-REx dataset. This is fitted with a linear 
fit with a set gradient of 0, and shows the Piezo1 T-REx dataset showed a ~1.4 fold increase 





Figure 7.17 (a) The fluorescence intensity Lm1/Lm2 of HEK293 T-REx and Piezo1 T-REx cell lines as 
a function of flow rate through a cross-slot microfluidic device. A higher ratio is indicative of calcium 
ions getting inside the cell and bonding with the pre-loaded dye Fura2, increasing the emission of Lm1 
and decreasing the emission of Lm2. Both data sets have a linear fit with a positive gradient. (b) The 
ratio of (𝐿𝑚1/𝐿𝑚2)𝐻𝐸𝐾293 𝑇−𝑅𝐸𝑥/(𝐿𝑚1/𝐿𝑚2)𝑃𝑖𝑒𝑧𝑜1 𝑇−𝑅𝐸𝑥  to show the relative change in 
fluorescence intensity between the cell lines. A ratio of ~1 would indicate no change.  
Figure 7.17 highlights that the control samples (no microfluidic deformation) also show a ~1.4 
fold increase in Lm1/Lm2 of the Piezo1 T-REx compared to HEK293 T-REx. This suggests 
that some Piezo1 activation occurs without any microfluidic deformation. As shown in the 
previous section, cells suspended in higher viscosity media showed increased QD uptake after 
centrifugation compared to cells suspended in low viscosity media (Figure 7.12). Similarly, 
in this instance the cells were resuspended in SBS with 0.5% methyl cellulose by 5 min 
centrifugation at 100 g before performing deformation cytometry. Additionally, during the 
protocol gentle mixing of the samples occurring by pipetting. These steps will impart some 
force onto the cells which could result in Piezo1 activation or transient pore formation, the 
~1.4 increase in Piezo1 T-REx compared to HEK293 T-REx response indicates that Piezo1 
activation must be at least partly responsible. 
These results remain inconclusive whether deformation cytometry increased Piezo1 
activation. The increase in Piezo1 T-REx response is systematic as a function of flow rate, 
suggesting Piezo1 activation occurred before microfluidic deformation. The increase in 
Lm1/Lm2 response as a function of flow rate is likely caused instead by transient pore 
formation, as previously seen for QD uptake in MCF7 cells. An additional artefact of the 
method is the time delay between deformation and fluorescent measurement. For instance, to 
collect 300 µl of sample at a flow rate of 20 µl/min takes 15 minutes. The Yoda1 results in 
Evans et al. 2018 show that after treatment the ion channels activate instantly and Lm1/Lm2 





7.2.3 Strain Traces 
The strain 𝜀 of HEK293 T-REx and Piezo1 T-REx was tracked as cells deformed and 
recovered through an extensional flow junction of a cross-slot device. A flow rate of 5 µl/min 
was used in a shear dominant flow regime (μ ≅ 33 𝑐𝑃). These conditions were used as a low 
strain shear-regime has previously shown to be most sensitive to cytoskeletal changes, and the 
addition of Piezo1 may affect the membrane which is coupled to the cytoskeleton. 
Figure 7.18 shows the averaged strain traces of N=95 HEK293 T-REx and N=60 Piezo1 T-
REx cells. These were used to extract multiple parameters including; the initial strain 𝜀0, the 
maximum strain 𝜀𝑚𝑎𝑥, the deformation time 𝜏𝑑, the relaxation time 𝜏𝑟 and the final strain 𝜏∞. 
Deformation and relaxation times were acquired by fitting of exponential functions to the 
deformation and recovery regions of the traces, and the final strain was then extrapolated by 
the exponential fit to the recovery region. These parameters are summarised in Table 7.1, 
showing that ε0, εmax and τd are within error of each other for the two cell lines. The Piezo1 
T-REx show a relatively small increase in τr compared to HEK293 T-REx, whereas there was 
a ~3 fold increase in ε∞ of HEK293 T-REx compared to Piezo1 T-REx. These results show 
that Piezo1 T-REx recovers its initial shape (𝜀0 = 𝜀∞) whereas HEK293 T-REx does not 
(𝜀∞ > 𝜀0). This is highlighted by the blue shaded region of the graph which is equivalent to 
|2𝜀0|, as 𝜀0 is a vector. 
Figure 7.19 shows the average velocity profiles of both cell lines as they traversed the 
extensional flow junction, both profiles are fitted with sine functions (shown in red). This was 
used to fit the Kelvin-Voigt model (section 2.3.4) to the average strain traces of HEK293 T-
REx (a)and Piezo1 T-REx (b), also shown in red. From this, the elastic modulus of HEK293 
T-REx was found to be E=144±18 Pa and of Piezo1 T-REx was found to be E=167±22 Pa. 
These values are within error of each other, which suggests that the incorporation of Piezo1 





Figure 7.18 The averaged strain trace for HEK293 T-REx (N = 95) and Piezo1 T-REx (N=60) as a 
function of time, with the standard error shown by the red and grey shaded areas. The flow rate was 5 
µl/min, and the suspension medium viscosity was 33 cP. The recovery is fitted with an exponential 
function and the dashed lines represent the extrapolated final strain 𝜀∞ for both samples.  
 
Figure 7.19 Averaged strain traces and velocity profiles of (a) N=95 HEK293 T-Rex cells and (b) N=60 
Piezo1 T-Rex cells. Strain traces are fitted with the Kelvin-Voigt model and velocity profiles fitted with 
a sine function. Cells were deformed in a shear-dominant regime where 𝑄 = 5 𝜇𝑙/𝑚𝑖𝑛 and 𝜇 ≅ 33 𝑐𝑃.  
As discussed in section 4.4.1 cell populations are heterogenous and bulk measurements can 
often miss information, such as subpopulations within a sample. Thus, single cell analysis 
(SCA) was also performed on the N=90 HEK293 T-REx cells and N=65 Piezo1 T-REx cells, 
in the same manner as described in results section 4.4.1. Table 7.1 compares the parameters 
extracted from the “Averaged Strain Trace” to those found by taking the mean average of 




The values of 𝜀0 are within error of each of for both cell lines using both analysis methods, as 
are the values of 𝜀𝑚𝑎𝑥. The relaxation times 𝜏𝑟 are within error of each other for each of the 
two cell lines using SCA, however both values are greater than their corresponding averaged 
strain trace values. This suggests outliers may skew the value reported for the averaged trace, 
showing the importance of investigations at the single cell level. The reported values of 𝜀∞ 
using SCA are also marginally higher than those from the averaged strain traces, which is 
likely coupled to the increase in 𝜏𝑟. 
Table 7.1 Multiple characteristic parameters extracted from the strain traces of N=95 HEK293 T-REx 
cells and N=60 Piezo1 T-REx cells. Including the initial cell diameter A, the initial strain ε0, the final 
strain ε∞, the maximum strain εmax, the deformation time τd, the relaxation time τr and the elastic modulus 
E. Values were found from the “Averaged Strain Trace” and also using single cell analysis “SCA”  of 
individual traces which were then averaged with ±SE.
  HEK293 T-REx   Piezo1 T-REx   
  Averaged trace SCA Averaged trace SCA 
A (µm) N/A 14.114.±0.2 N/A 13.1±0.2 
εmax 0.17±0.01 0.18±0.01 0.17±0.01 0.17±0.01 
ε0 0.0409±0.0005 0.0399±0.0042 0.0477±0.0003 0.0477±0.004 
𝜀∞ 0.099±0.001 0.086±0.005 0.033±0.003 0.027±0.004 
𝜏𝑑(ms) 1.35±0.49 N/A 0.75±0.14 N/A 
𝜏𝑟(ms) 1.25±0.08 1.77±0.38 1.46±0.11 2.37±0.78 
E (Pa) 144±18 N/A 167±22 N/A 
Two sample t-tests were used to measure the statistical significance between the different 
parameters of HEK293 T-REx and Piezo1 T-REx. This was measured using their p-values, 
where smaller p-values indicate a higher significance in difference between two datasets. 
Figure 7.20 shows bar graphs of the average A, εmax, ε∞, τr and ε0 acquired from SCA of the 
two cell lines. The level of significance is labelled on the graphs, and raw p-values are also 
shown in a table in Figure 7.20. 
Results show that there is no significant difference between εmax, τr and ε0 between HEK293 
T-REx and Piezo1 T-REx and some significance between the initial size A of the two datasets 
(**). The final strain ε∞ shows an extremely significant difference between the two cell lines 
(****), showing that the incomplete shape recovery of the HEK293 T-REx is the best physical 





Figure 7.20 SCA was performed on individual strain traces of HEK293 T-Rex and Piezo1 T-REx. The 
plots show the average values of the cell diameter A, maximum strain 𝜀𝑚𝑎𝑥, initial strain 𝜀0, the 
relaxation time 𝜏𝑟 and the final strain 𝜀∞. The error bars denote the standard error SE. Statistical t-
tests were done to determine the level of significance, where p>0.05 is not significant (ns), 0.01<p<0.05 
is significant (*), 0.001<p<0.01 is very significant (**), 0.0001<p<0.001 is extremely significant (***) 
and p<0.0001 (****). 
Figure 7.21 shows histograms of ε∞ for HEK293 T-REx and Piezo1 T-REx. The histogram of 
Piezo1 T-REx shows that most cells have ε∞=0, indicating full shape recovery after 
deformation. The histogram of HEK293 T-REx shows a single main peak at ε∞=0.095±0.003 
found from the peak centre of a fitted Gaussian curve, a smaller population of cells have ε∞=0 
and recover initial shape. The histograms provide more visual information than the averages, 
by showing the general shift in ε∞ for HEK293 T-REx as well as the small subpopulation 
which show similar behaviour to Piezo1 T-REx. 
Overall results indicate that the deformation properties (εmax, τd and E) were the same for 
HEK293 T-REx and Piezo1 T-REx, showing that incorporation of Piezo1 does not alter whole 
cell stiffness. However, incomplete shape recovery of HEK293 T-REx compared to Piezo T-
REx was identified by both averaged strain trace and SCA and further confirmed from 
Histogram plots and calculation of the p-value. This suggests that the recovery process of 





Figure 7.21 Histograms showing the final strain 𝜀∞ of HEK293 T-REx (N=95) and of Piezo1 T-Rex 
(N=60). 
7.2.4 Discussion 
Deformation cytometry was investigated as a potential method for studying activation of the 
MSC Piezo1 by mechanical force. This was done by deforming cells over a range of flow rates 
in the shear-dominant regime and measuring the fluorescence response Lm1/Lm2, where an 
increase is indicative of calcium ions entering the cells and bonding to the dye Fura2. The 
response of control HEK293 T-REx (no incorporated Piezo1) was compared to Piezo1 T-REx 
(tetracycline inducible expression of Piezo1). 
Results showed a linear relationship between fluorescence response and flow rate for both cell 
lines (Figure 7.17a), with a systematic increase in the Piezo1 T-REx including the control 
which was not treated microfluidically (Figure 7.17b). The gradients of the linear fits were 
within error, which suggests the increase in Lm1/Lm2 was due to pore formation (as discussed 
in section 7.1). We may expect a critical applied stress to activate Piezo1, thus the systematic 
increase between the control does not indicate any specific response due to Piezo1. This could 
indicate that the range of applied stresses are already too high and Piezo1 MSCs are fully 
activated, or that the dominant response is due to pore formation and the system is not sensitive 
enough to separate the purely Piezo1 response.  
Piezo1 MSCs open via direct gating on the microsecond timescale [239], which can happen 
via two methods; force transduction through cytoskeletal tethers, or force transduction through 
membrane tethers. Traditionally, MSC dynamics have been studied using patch clamp 
electrophysiology adapted for applying mechanical force. Typically, a tight electrical seal is 




applied to induce membrane tension. The electric potential across the membrane due to the 
ionic current across the ion channels is then measured. Piezo1 activation in HEK293 cells 
using this method showed a T50 (half maximal tension) value of 1.4 mN/m, showing Piezo1 
can be gated through membrane tension [234]. An alternate path clamp method involves 
indenting the top surface of the cell whilst measuring the current. Gottlieb et al. 2012 showed 
that actin cytoskeleton disruption using Cytochalasin D lead to a reduced current, this suggests 
the cytoskeleton also plays a role in transmitting mechanical stimuli to the Piezo1 channels 
[240]. Comparatively, Retailleau et al. 2015 knocked out filamin (which acts as a scaffold 
between actin and membrane proteins) and found this made the channel easier to activate, 
suggesting the presence of the cytoskeleton offers some mechoprotection [241]. Finally, 
Piezo1 activity has also been shown to occur in the absence of external mechanical stimuli 
suggesting that internal acto-myosin contractile forces can also induce activity, which was 
confirmed by inhibition of Myosin II resulting in reduced spontaneous Piezo1 activity [242]. 
Spontaneous Piezo1 activity due to acto-myosin may explain the increase in Lm1/Lm2 shown 
in our control (undeformed) sample for Piezo1 T-REx compared to HEK293 T-REx (Figure 
7.17). 
Many techniques are emerging to study Piezo1 activation due to mechanical stress, including 
the use of indentation, membrane stretch, shear flow and osmotic stress [239]. Gaub and 
Muiller 2017 used AFM to stimulate activation of Piezo1 under pushing and pulling 
conditions and with attachment of different ECM proteins to the cantilever [243]. They found 
Piezo1 activation at a pushing force of ~200 nN which was unchanged by altering ECM 
proteins. However, pulling was dependent on the ECM protein and was more sensitive and 
activated at ~33 nN. These results show that force directionality elicits different Piezo1 
responses. This may lend itself to the cross-slot system, as we can tailor a shear or compressive 
dominant force regime. Comparatively, we estimate the microfluidic force on cells in the shear 
regime to be on the 0.1-1.25 µN range (Figure 4.15). Thus, we may have covered a range of 
forces already eliciting maximum Piezo1 response and missing the critical range where we 
see Piezo1 “switch on”. Additionally, the whole cell deformation using a microfluidic cross-
slot may differently affect Piezo1 compared to localised AFM probing. 
A major artefact in this experimental set-up was the time delay between collection of the 
microfluidically deformed cells and subsequent fluorescent measurement, which was also 
affected by flow rate. A sample of 300 µl was required, which took 15 minutes using 20 µl/min 
but only 1.5 minutes using 200 µl/min. Fluorescence measurements were taken within 2-5 
minutes of sample collection. Evans et al. 2018 showed that Piezo1 is activated instantly by 
Yoda1 with Lm1/Lm2 reaching a maximum value within seconds which then decreases 




be acquired in real time. Figure 7.17 shows much larger errors for Piezo1 T-REx, particularly 
in the 25-50 µl/min, which may be indicative of the time-dependence of response due to 
Piezo1. 
Combining microfluidic fluorescence with high speed fluorescence could allow force to be 
applied and fluorescence to be measured on-chip at the point of applied force, and immediately 
after. Additionally, performing measurements on-chip would allow much lower stresses to be 
applied which may be able to activate Piezo1 without creating transient membrane pores. For 
example, in section 7.1.3 we showed that a constriction channel was not sufficient to increase 
QD uptake in to MCF7 cells, additionally Rosendahl et al. 2018 combined a similar 
deformation geometry with flow cytometry to simultaneously collect mechanical properties 
and 1D fluorescence data on the single cell level [69]. 
Strain traces were also collected for HEK293 T-REX and Piezo1 T-REx deformed in the 
shear-dominant regime (µ≈33 cP) at 5 µl/min. Results show no significant changes in the 
deformation parameters of the two cell lines, including deformation time 𝜏𝑑, maximum strain 
𝜀𝑚𝑎𝑥 and elastic modulus E. However, there were significant differences in the recovery 
parameters including the relaxation time 𝜏𝑟 and final strain 𝜀∞. The main finding was that 
HEK293 T-REx do not recover their initial shape whereas Piezo1 T-REx did. Incomplete 
shape recovery was seen in section 6.3.1, where HL60 and SW480 previously showed 
complete shape recovery whereas HT29 and SW620 did not. These results indicate that 
incorporation of Piezo1 into HEK293 can alter their recovery process post deformation, and 
that mechanophenotyping can be used to study these cell processes. 
Just as the cytoskeleton effects Piezo1 activation through tethered force transduction, current 
works are investigating a potential feedback mechanism where Piezo1 activity can also effect 
cytoskeletal structure. Mchugh et al. 2009 showed that knockdown of Piezo1 in Hela cells 
reduced activation of integrin B, where integrin is a membrane protein which facilities binding 
to the extracellular matrix [244], which resulted in reduced cell adhesion. The orientation of 
stress fibers of endothelial cells lining blood vessels, which tend to align in the direction of 
blood flow was also investigated [245], [246]. They found that in the absence of Piezo1 
activation, stress fibers did not reorient with shear slow and showed a thicker morphology. 
This feedback mechanism may be responsible for the changes in 𝜏𝑟 and 𝜀∞ shown in Piezo1 
T-REx which may have altered cytoskeletal structure compared to HEK293 T-REx. For 
instance, in results chapter 5 we showed that the relaxation dynamics of SW480 were affected 
by destabilisation of the actin using the drug Latrunculin A (LatA). Untreated SW480 




The study of Piezo1 also has diagnostic application as Piezo1 function has been recently linked 
to a number of cancers. Jiang et al. 2015 found that inhibiting Piezo1 reduced proliferation 
and invasion of osteosarcoma cells [247]. Li et al. 2017 reported upregulation of Piezo1 in the 
breast cancer cell lines MCF7 compared to normal epithelial cell line MCF-10A, and blocking 
of Piezo1 in MCF7 also lead to decreased motility [248]. Mchugh 2012 et al. proposed that 
depleted Piezo1 expression could increase migration and metastasis of small cell lung cancer 
[249]. Cells are known to change their mechanical properties with cancer progression 
(discussed in section 2.2.4 and chapter 6), thus mechanophenotyping of cells with and without 
expression of Piezo1 may offer more insight into their relation to cancer progression. 
Overall, microfluidics could offer a novel approach to the study of the response of Piezo1 to 
applied stress. Compared to techniques such as patch clamp physiology, and more recently 
AFM, microfluidics is high-throughput and requires no pre-selection of each cell. 
Additionally, the cross-slot device is capable of two distinct regimes where either shear or 
inertial forces dominate which may offer further insight into the force mechanisms which 
activate Piezo1. Preliminary results indicate that real-time fluorescence combined with 
microfluidic deformation would be more applicable, as fluorescence response is nearly 
instantaneous and may decrease drastically within minutes. Results also suggest that lower 
flow rates may be required to impart smaller stresses to ensure the critical activation force of 
Piezo1 is not missed. Gentler microfluidic deformations which do not cause pore formation 
should also be explored, to confirm that fluorescence response is significantly due to activation 
of Piezo1. Finally, comparison of strain traces between Piezo1 T-REx and control HEK293 
T-REx showed they could be distinguished by their recovery parameters including relaxation 
and shape recovery. This could be of huge interest as Piezo1 expression has been shown to be 
coupled to cytoskeletal structure and also is a biomarker of some cancers. Thus, 
mechanophenotyping of cells with and without Piezo1 could begin to identify structural 




8 Conclusions and Future Work 
8.1 Chapter by Chapter Overview 
Chapter 4 (page 70) detailed optimisation of a cross-slot microfluidic device for measuring 
the deformation and relaxation properties of single cells, including extracting multiple 
parameters and comparing bulk measurements with single cell analysis.  
HL60 cells were deformed in two distinct flow regimes; the shear-dominant regime and the 
inertia-dominant regime, which showed highly different mechanical responses. Cells 
deformed via cross-slot extensional flow experience a shear force due to the viscosity of the 
suspension fluid and a compressive force due to velocity of the fluid flow. By tailoring the 
fluid velocity and suspension viscosity a shear-dominant regime (typically low velocity and 
high viscosity) or inertia-dominant regime (typically high velocity and low viscosity) were 
achieved. This was also defined using the Reynolds number, where Re≈40 was defined as the 
end of the shear regime and the beginning of the inertial regime. Cells deformed in a shear-
dominant regime as a function of flow rate showed an increase in deformation index DI which 
then asymptotically tended towards a maximum value denoted 𝐷𝐼𝑚𝑎𝑥. In the inertia-dominant 
regime, for flow rates ≤400 μl/min the DI tended towards a plateau value 𝐷𝐼𝑚𝑎𝑥. For Q≥ 400 
μl/min, DI increased nonlinearly until Q=600 μl/min and above this cells began to rupture  and  
visibly  break  apart. The onset of the non-linear increase was defined as an apparent yield 
stress associated with internal breakdown of the subcellular structure (i.e. cytoskeleton), the 
onset of cell rupture was defined as the cell failure point. Viability measurements confirmed 
that cells remained viable post-deformation in both cell regimes, except beyond the failure 
point there was a significant drop in viability (<40%). Thus, cells mechanically phenotyped 
in a regime below the failure point could be used for further experiments such as chemical 
phenotyping or genotype measurements.  
Tracking cell deformation and recovery was used to collect individual “strain traces” of 50 
HL60 cells in a low-strain and shear-dominant regime, from these traces multiple 
characteristic parameters were extracted. These included the initial cell diameter A, initial 
strain before deformation 𝜀0 and the maximum strain at the SP 𝜀𝑚𝑎𝑥. An exponential was 
fitted to the deformation area of the strain trace (as the cell moves from the inlet to the SP) to 
extract the deformation time 𝜏𝑑, and an exponential was fitted to the recovery area (as the cell 
moves from the SP to the outlet) to extract a relaxation time 𝜏𝑟 and extrapolate the final strain 
𝜀∞. Comparison of initial strain to final strain allowed quantification of shape-recovery post 
deformation, where |𝜀0| = |𝜀∞| indicative cells recovered their original shape and |𝜀0| < |𝜀∞| 
showed a permanent deformation or secondary relaxation mechanism not identified over our 




recovery whereas a smaller population did not, an average value however showed |𝜀0| < |𝜀∞| 
which showed the importance of single cell measurements over bulk averaging. Finally, the 
Kelvin-Voigt model was fitted to the averaged strain trace to find the elastic modulus of HL60 
cells to be 𝐸 = 301 ± 29 𝑃𝑎. This value was on the same order of magnitude to those reported 
in the literature using AFM [34], [190], optical trapping [192] and microfluidic constrictions 
[34], [250]. 
The recovery of HL60 after high-strain deformations was also investigated in both shear and 
inertial regimes. This was done by measuring the average DI of cells before the SP, at the SP, 
and at various distances through the outlet post deformation. The cell recovery was fitted with 
an exponential to extrapolate the recovered 𝐷𝐼∞, showing incomplete shape recovery in shear 
and inertial regimes (𝐷𝐼∞ > 1) which is indicative of a permanent “plastic” deformation due 
to disruption of subcellular structure. Histograms identified multiple subpopulations of 𝐷𝐼∞ 
representing cells which did recover their initial shape and others which underwent an 
apparent “permanent” deformation, this again showed that single cell analysis is a more 
powerful tool to utilise.  
Chapter 5 (page 105) applied the optimised cross-slot conditions to test changes to the 
mechanical properties of cells treated with various drugs to alter the subcellular structure. This 
included Latrunculin A (LatA) to depolymerise actin filaments, Combretastatin A4 (CA4) to 
destabilise microtubules, and Trichostatin A (TA) to decondense nuclear chromatin. Actin 
changes were tested on HL60 cells and SW480 cells. LatA treated and untreated cells were 
deformed in shear and inertia-dominant flow regimes over a range of flow rates. In the shear-
regime, results showed that HL60 cells treated with LatA were significantly more deformable 
than those not treated at low-strain (low flow rates). At high strain (increasing flow rate) the 
LatA treated and untreated cells had a comparable deformation indices. SW480 cells treated 
with LatA showed increased DI for the range of flow rates, however the relative increase in 
DI decreased exponentially with flow rate. In the inertial regime, treated HL60 could not be 
distinguished from untreated cells at any flow condition. For SW480, the treated cells had 
increased DI again at low-strains below the yield stress. These results indicated that 
deformation cytometry is most sensitive to changes to the actin cytoskeleton in the low-strain, 
and shear dominant regime. Strain traces were also collected for SW480 and SW480 LatA in 
a low-strain, shear regime. From this, the elastic modulus of SW480 was found to be 𝐸 =
542 ± 66 and the LatA treated cells to be 𝐸 = 419 ± 54 confirming that disrupting the actin 
cytoskeleton reduces cell stiffness. Single cell multiparameter analysis showed that 𝜀𝑚𝑎𝑥 and 
𝜀∞ were the only parameters to significantly distinguish the samples. LatA treated cells 
showed incomplete shape recovery |𝜀0| < |𝜀∞|, whereas normal SW480 did recovery initial 




CA4 disrupts the microtubules. Both HL60 and SW480 cells treated with CA4 were studied 
in the shear-and inertia-dominant flow regimes. Treated and untreated SW480 showed no 
significant changes in DI as a function of flow rate. Similarly, no change in DI was seen for 
treated and untreated HL60 in the inertia-dominant regime. However, a systematic decrease 
in DI was seen for treated cells across all flow rates in the shear-dominant regime. This result 
was counter-intuitive such that we would expect destabilising the microtubules would make 
the cells softer. Strain traces were collected for HL60 treated with CA4 to extract multiple 
deformation and recovery parameters. The elastic modulus of the CA4 treated cells was 𝐸 =
598 ± 66 (a ~2-fold increase of that of the untreated cells) confirming that CA4 increased cell 
stiffness. Significant changes were also seen for 𝜀𝑚𝑎𝑥, 𝜀∞ and 𝜏𝑟. Interestingly, even though 
CA4 increased stiffness this was also accompanied by incomplete shape recovery. Viability 
tests confirmed that the increased stiffness was unlikely to be caused by cell apoptosis or 
mitotic catastrophe. Thus, changes are likely due to a secondary mechanism such as the cell 
overcompensating for microtubule destruction by enhancing the actin cytoskeleton [50], 
[214], [215]. 
TSA is known to decondense nuclear chromatin, and thereby reduce nuclear stiffness [49], 
[87], [88]. In the shear-dominant regime no significant changes in the DI of HL60 were seen 
across the entire range of flow rates. In the inertia-dominant regime, a small increase in DI 
was seen for flow rates below the yield stress (~1.1-fold increase in DI). For flow rates above 
the yield stress a larger relative increase in DI was seen (~1.3 fold at the yield stress), 
indicating that a high-strain and inertia-dominant flow regime is most sensitive to such nuclear 
changes. Previous results using LatA indicated that cytoskeletal breakdown occurs above the 
yield stress, thus at low-strain nuclear changes may be shielded by the mechanics of the 
cytoskeleton. Therefore, high strains are more useful for probing the nuclear properties which 
is in accordance with results by Gossett et al. 2012 [27]. 
Chapter 6 (page 154) used Deformation Cytometry to explore changes in mechanical 
properties of different colorectal cancer (CRC) cell lines, using three cell lines as a model of 
CRC progression. This included; primary tumour cell lines SW480, an advanced primary 
tumour cell line HT29, and the lymph node secondary tumour cell line SW620. The three cell 
lines were probed in the shear-dominant flow regime and inertia-dominant flow regimes over 
a range of flow rates. 
For these measurements, the deformation index was normalised by the initial size of the cell 
(DI/A) as this better accounts for size-dependence in applied stress [48]. Below the yield stress 
in the inertia-dominant regime, DI/A was largest for SW620 cells and lowest for SW480 cells 




showed significant differences in DI/A. The yield stress is thought to be associated with 
breakdown of the actin cytoskeleton. These results suggest that cytoskeletal changes 
associated with progression are apparent below the yield stress, however actin breakdown 
above the yield stress results in no changes to deformability under these flow conditions. The 
shear-dominant regime showed the largest DI/A for SW620 for the entire range of flow rates, 
and SW480 had the lowest. At low flow rates, the DI/A of HT29 was comparable to SW620 
but as flow rate increased the DI/A approached those of SW480. A larger DI/A is likely 
indicative of increased deformability, these results correlated previous works using AFM 
which showed the metastatic SW620 cells to be softer than the primary tumour SW480 cells 
[222], [251]. 
It was noted that using DI without adjusting for cell size, mostly resulted in no significant 
changes between cell types in either flow regime. This suggested that multiparameter 
measurements of deformation and relaxation may better characterise mechanical changes 
between the different CRC cell lines. Strain traces were found for the different cell types and 
the Kelvin-Voigt model was used to extract an elastic modulus, offering a mechanical 
parameter which accounts for initial cell size. The elastic modulus of SW480 was 𝐸 = 542 ±
66, of HT29 was 𝐸 = 309 ± 50 and of SW620 was 𝐸 = 372 ± 98. These results confirmed 
that SW620 (cells from later stages of disease progression) were softer than SW480, and that 
HT29 have comparable stiffness to SW620. 
The relaxation of the CRC cell lines showed that SW480 underwent complete shape recovery, 
whereas HT29 and SW620 did not suggesting a permanent induced deformation and increased 
plasticity. HT29 and SW620 showed similar deformation and relaxation properties, even 
though the initial size of HT29 and SW480 was similar compared to smaller SW620 cells. 
These results indicate that as CRC progresses from Dukes stage B (SW480) to stage C (HT29), 
which involves cells migrating to the outer lining of the bowel, sub-structural changes occur 
increasing cell deformability. Then as cells metastasis from the outer lining to a lymph node 
(secondary site), mechanical changes are less essential. Statistical t-tests were done on HL60, 
SW480, HT29 and SW620 using the parameters A, 𝜀𝑚𝑎𝑥, 𝜀0, 𝜏𝑟 and 𝜀∞ to quantify their 
significance for characterisation. Results showed that no single parameter could significantly 
distinguish all the cell types, highlighting the need for multiparameter mechanical 
phenotyping. Further, Linear Discriminant Analysis (LDA) was used on the datasets to 
perform k-fold validation tests. The resulting classification rates were; ~82% for HL60, ~71% 
for SW480, ~85% for SW620 and ~36% for HT29. HT29 had a significantly lower 
classification rate with ~39% incorrectly classified as SW480 and ~20% as SW620, this result 
may be indicative of HT29 showing intermediate properties between the other two CRC cell 




increased sample size would likely further enhance results (current datasets included 46<N<56 
strain traces). 
Chapter 7 (page 179) investigated other applications of Deformation Cytometry. Firstly, 
deformation cytometry tested toward increasing cytosolic uptake of quantum dots (QDs) into 
MCF7 cells through generating transient membrane pores through microfluidic deformations 
[227]. QDs have diagnostic potential for sensing redox potential which is a marker for disease 
[230], however this requires a method for non-endocytic delivery into cells. Cells were 
deformed with QDs in a cross-slot device using shear and inertial regimes, confocal 
fluorescence was then used to observe QD uptake. The shear-dominant regime showed a linear 
increase in uptake with flow rate, and confocal and TEM imagine confirmed increased 
cytosolic uptake. An optimum flow rate of 100 ul/min was found to offer most improved 
uptake whilst maintaining cell viability. Comparatively, deformation using an inertial regime 
did not show significant changes in uptake compared to an undeformed sample over a range 
of flow rates (up to 600 µl/min), with comparable deformation DI to the shear regime. This 
result is contradictory to reports of a cross-slot inertial regime for cytosolic uptake of various 
macromolecules and nanoparticles to the cytosol [68], [231]. Deformation using a constriction 
channel and high viscosity suspension buffer (µ≈33 cP) was also tested for increasing uptake, 
where the constriction channel was slightly wider than the cell size and induced bullet-like 
dimensions (similar to RT-DC [96]). The length and dimensions of the channel were 
comparable to the inlet and outlet of the cross-slot devices. This also showed no significant 
improvements to uptake over a range of flow rates comparable to the cross-slot shear-regime. 
The use of a constriction with dimensions smaller than initial cell size has been shown to 
increase cytosolic uptake of QDs into cells [65]. These results show that shear forces are more 
efficient for generating transient membrane pores, as is extensional deformation compared to 
constriction deformation. 
Deformation in a cross-slot device in a shear-dominant regime was also tested for activating 
the mechanosensitive ion channel Piezo1. The Piezo1 T-REx cell line was used (which has 
incorporated tetracycline inducuble Piezo1) was compared to control cell line HEK293 T-
REx. The mechanical properties of the two cell clines were compared, with mostly no changes 
between DI seen in the shear-regime across a range of flow rates. Strain traces collected for 
both cell lines also indicated no changes in the deformation properties (𝜀𝑚𝑎𝑥 and elastic 
modulus). However significant changes were seen for relaxation properties (𝜀∞ 𝑎𝑛𝑑 𝜏𝑟), 
Piezo1 T-REx showed complete shape recovery whereas HEK293 did not. Piezo1 is known 
to have pathological significance [236], [252] and its function has been recently linked to a 
number of cancers [247]–[249]. Additionally, Piezo1 activation is partially caused by tethers 




[245], [246], [249]. Thus, microfluidics shows potential for studied the response of Piezo1 to 
applied stress and how Piezo1 incorporation may alter mechanical phenotype which could 
potentially be correlated to disease state (discussed further in the next steps section 8.3.3). 
The ratiometric dye Fura2 was used to assess activation of Piezo1. Results showed increased 
fluorescence response as a function of flow rate for both cell lines, with a systematic increase 
in Piezo1 T-REx. However, the origin of this increase remained inconclusive (i.e. could also 
be due to pore formation), thus, further testing and improvements to the experimental method 
are needed which are discussed in the next steps section 8.3.  
8.2 MRC Project 
The work in this thesis was initially part of a joint project between the University of Leeds 
and Leeds Teaching Hospitals toward development of a microfluidic platform to integrate 
different phenotyping methods. These methods were first to be developed separately. Whilst 
this thesis developed the mechanical phenotyping method, another PhD student Julia Gala De 
Pablo worked towards chemical phenotyping of cells on-chip using Raman Spectroscopy. 
Some of her results of chemical phenotyping of CRC cell lines, including SW480, HT29 and 
SW620, were published in the Journal of Raman Spectroscopy (2018) [2].  Results showed 
that Raman spectra could distinguish cell lines with high confidence, with a 98.7% 
classification rate between SW480 and SW620 using principal component analysis combined 
with linear discriminant analysis. Thus, our results combined provide an overview of the 
mechanical (chapter 6) and chemical phenotype of CRC. A future aim is to combine the 
techniques into a joint microfluidic platform, allowing mechanical and chemical phenotype 
on a single cell level. 
Some comparisons can be made between the chemical and mechanical phenotypes of HL60, 
SW480, HT29 and SW620 cells. Firstly, measurement of the nuclear ratio (𝐴𝑟𝑎𝑡𝑖𝑜 =
𝐴𝑛𝑢𝑐𝑙𝑒𝑢𝑠/𝐴𝑐𝑒𝑙𝑙 showed that HL60 had the smallest nuclear diameter, followed by SW620, 
HT29 and SW480 respectively (Table 4.1). Raman results showed that the 782 𝑐𝑚−1 and 
810 𝑐𝑚−1 show the DNA contents of the cell followed a trend inverse to the nuclear ratio. 
This may indicate that these peaks are sensitive to how compressed the nuclear material is and 







Table 8.1 Confusion Matrix of PCA/LDA results from Raman spectra of the three CRC cell lines, where 
each column corresponds to the predicted members of a class, and each row corresponds to the actual 
membership of the class. Results adapted  from Julia Gala De Pablo’s PhD thesis [253].
 
SW480 HT29 SW620 
SW480 91.7±1.0 7.8±0.9 0.2±0.2 
HT29 9.0±1.0 90.0±1.0 0.5±0.2 
SW620 0.8±0.3 1.9±0.5 96.2±0.7 
Multiple parameters were extracted from strain traces of the CRC cell lines, and showed that 
HT29 (primary, Duke’s stage C) and SW620 (metastatic, Duke’s stage C) had similar 
deformation and recovery properties (including maximum strain, elastic modulus and final 
strain). Whereas SW480 showed different deformation and recovery and was generally stiffer 
than SW620 cells. These results suggested HT29 acquired a metastatic mechanical phenotype 
before leaving the primary tumour site. Interestingly, HT29 and SW480 cells appear to have 
more similar Raman signatures compared to SW620. The confusion matrix shown by Table 
8.1, adapted from the PhD thesis of Julia Gala De Pablo, shows a summary of this, ~8% of 
SW480 were incorrectly classified as HT29 and ~9% of HT29 as SW480. Comparatively, 
SW620 had the highest classification rate of ~96% [253]. Overall, results point towards HT29 
cells being an intermediate state between SW480 and SW620 cells, where the chemical 
phenotype matches the primary cells but the mechanical phenotype matches the metastatic 
cells. 
8.3 Next Steps 
8.3.1 Further optimisation  
Multiparameter analysis of strain traces showed promise for single-cell mechanical 
phenotyping and classification, however sample sizes were relatively low (50<N<100) 
compared to other microfluidic assays (N>1000). The current limiting factor is that strain 
traces require a larger field of view, compared to just measuring DI at the SP, which vastly 
increases the processing time required to save already large high-speed videos (N>10,000s of 
frames per sample). Theoretically, using a flow rate of 5 µl/min and a cell density of 1 ∙
106 𝑐𝑒𝑙𝑙𝑠/ 𝑚𝑙 is equivalent to a throughput of ~800 cells/s. Thus, implementation of real-time 
analysis or a more powerful operating system (capable of processing data at faster speeds), 
would allow utilisation of this throughput. This would lead to collection of larger sample sizes 
with more statistical significance.  
The  upper-end of the range of flow rates in both regimes was limited due to back-pressure in 
the device, thus the failure point of stiffer cells (i.e. the CRC cell lines) could not be measured. 




To accurately compare between samples, only cells which deformed at the SP were included 
in deformability measurements to ensure all cells deformed under the same applied stress. The 
velocity profile of cells was tracked, and a velocity threshold was defined to discard cells 




, a of ∆𝑣 ≥ 0.75 was found to be a sufficient threshold as further increasing 
the threshold did not alter the average DI of a sample.  
Further optimisation to the technique would be to implement a microfluidic focusing 
technique to ensure all cells enter the extensional flow junction centrally, this would mean no 
cells are discarded from calculations and further improve throughput. Sheath flows are 
commonly used to push particles into the channel centre, achieved by joining two outer 
flowing channels to the central channel [96]. However, this would add further complexity to 
the device requiring additional inlets and a second syringe pump to be used for measurements. 
Also, the addition of the sheath fluid essentially dilutes the sample which would reduce 
throughput. Sheath-less methods of focusing include, viscoelastic focusing [29] and inertial 
focusing [254]. Inertial focusing involves implementing curved channels to manipulate 
inertial forces acting on particles in flow (1<Re). Curving channels induce a secondary 
rotational flow due to the inertia of the fluid itself, known as Dean flow, which can change to 
equilibrium position of flowing particles. Di Carlo et al. 2007 used asymmetric curbing 
geometries to focus particles to a single central stream, which has since been implemented in 
the group deformation cytometry experiments [27], [165]. Although a highly accurate 
focusing method, it depends highly on coupling channel geometry and flow rate. Thus, our 
experiments worked to probe cell deformations across a wide range of flow conditions using 
the same cross-slot geometry and it would be time-consuming to alter the design for each flow 
rate to test.  
8.3.2 DC to study other subcellular alterations 
Chapter 5 investigated mechanical changes to cells treated with drugs which changed the 
structure of actin, microtubules and the nucleus, and these results were compared to other cell 
mechanics studies. However, currently significantly less work has been done on the role of 
intermediate filaments and how changes to their structure affects whole cell mechanics. 
Understanding the mechanobiology of intermediate filaments has many applications because 
their structural changes have been linked to various diseases such as cancer [255], and also 
drugs targeting intermediate filaments may offer new cancer therapies [256].  
Intermediate filaments are the least stiff of the three cytoskeletal filaments, however they can 
withstand much higher strains than microfilaments and microtubules [82]. In the thesis, we 




strains. Thus, a high strain inertia-dominant regime may be more sensitive to changes to 
intermediate filaments. This would differ from actin and microtubule changes which favoured 
a low-strain and shear-dominant regime. Gossett et al. 2012 used a compound to reorganise 
networks of the intermediate filament Keratin using deformability cytometry in a high strain 
inertial regime, results showed no significant change due to treatment [174]. The same group 
later reported an inertia-dominant pinched flow deformation, which was able to detect 
increased deformability of cells with disrupted vimentin intermediate filaments using 
Calyculin A [30]. Gladilin et al. 2014 used microfluidic optical stretching to show increased 
cell deformability due to vimentin disruption using  Withaferin A [257]. These results 
highlight that different types of intermediate filaments have different mechanical roles within 
the cell, and detecting these changes may require different strains, flow regime and 
multiparameter analysis of deformation and recovery profiles. Additionally, lamins are a type 
of intermediate filament which make up the nuclear lamina, which along with chromatin add 
mechanical integrity to the cell nucleus. The nucleus structure is mediated by lamins and loss 
of lamins has been coupled to cytoskeletal changes and shown reduced cell stiffness [89]. 
Various other subcellular changes could be probed using deformation cytometry, including 
inhibition of molecular motors. Various studies have studied mechanical changes of cells due 
to inhibition of the actin dwelling motor protein myosin II, using drugs such as blebbistatin 
[52], [174] or ML7 [44]. Chan et al. 2015 studied the deformability of multiple adherent and 
non-adherent cell lines deformed in a suspended state using microfluidic optical stretching, 
RT-DC and advection time through microcontrictions [52]. They found that cells showed 
increased stiffness with myosin II inhibition using the range of techniques. Comparatively, 
Ahmmed et al. 2018 showed decreased stiffness in MCF7 with myosin II inhibition using a 
similar microfluidic constriction induce deformation [44]. Thus, the role of myosin II and its 
relationship to mechanical integrity remains unclear in suspended cells. Additionally, changes 
to motor proteins could affect the cells ability to recovery post deformation and may show 
significant changes to relaxation time 𝜏𝑟 and final strain 𝜀∞. Mechanophenotyping cells with 
inhibition of microtubule motor proteins Kinesin and Dynein could also be of interest. 
Microtubule motor proteins are heavily involved in mitosis, thus alterations in their expression 
can lead to carcinogenesis [258].  
8.3.3 DC for studying Piezo1  
Future work could investigate using deformation cytometry to detect Piezo1 MSCs in cells 
and elucidate how activation is coupled to the cytoskeleton and whole cell mechanics. 
Currently unpublished work to be included in the PhD thesis of Judith Valluru (University of 
Leeds) investigated links between Piezo1 functionality in colorectal cancer cells lines. HT29 




with the agonist Yoda1. Piezo1 siRNA transfection was used to knockdown Piezo1, which 
was used to test the responses of the CRC cell lines with and without Piezo1 functionality. 
Results showed that Piezo1 knockdown reduced proliferation without cell death in both cell 
lines. A migration assay through a porous membrane towards a chemo-attractive substrate, 
showed that Piezo1 aids migration. Additionally, Piezo1 also showed increased G2M arrest 
and cell cycle stages are known to have distinct mechanophenotypes. These results imply 
mechanical changes may accompany Piezo1 knockdown in CRC cell lines, which could be 
studied using deformation cytometry. Our results in section 7.2 show that the recovery of 
HEK293 with incorporated Piezo1 was significantly different to a control without Piezo1. 
Additionally, our results showed mechanical differences between SW480 and the more 
advanced CRC cell lines HT29 and SW620 which could potentially be correlated to Piezo1 
functionality. 
8.3.4 DC and high speed fluorescence 
Results throughout the thesis showed that subcellular structural changes cause measurable 
changes to whole cell mechanical properties. Additionally, yield stress behaviour was noted 
and may be indicative of subcellular breakdown. Recent mechanophenotyping methods are 
working towards combining bright field and fluorescence measurements. The Guck group 
recently combined RT-DC with 1D fluorescence measurements, to try to match flow 
cytometry throughput, however this offers no 2D structural information [69]. Combined 
fluorescent labelling and bright field imaging during deformation would allow direct 
correlation between deformability changes and substructural changes (described by the 
schematics in Figure 8.1). For example, by staining the nucleus the nuclear deformability and 
whole cell deformability could be tracked. Also, at high-strains above the yield stress is may 
be possible to visualise cytoskeletal breakdown of nuclear rupture. Finally, real-time 
fluorescence imaging combined with microfluidics would be ideal for quantifying Piezo1 
activation as it is known to occur instantaneously after force is applied. The method could also 
be used to study transient pore formation and resealing after deformation at the SP, by loading 





Figure 8.1 Schematic showing structural information that could be gained from combining deformation 
cytometry and fluorescence imaging. Including visualising (a) the lipid membrane, actin cortex and 
nucleus. (b)-(d) show examples of how this could be regime dependent, including how high strains 
could elicit cytoskeletal breakdown and nuclear rupture.  
Development of high-speed fluorescence microscopes able to resolve cell structure when 
travelling at high speeds, have been limited by the fluorescence lifetime of fluorophores. The 
Goda research group developed the FDM (frequency division multiplexing) confocal 
microscope that achieved a frame rate higher than the limiting fluorescence lifetime [70]. 
Combined high speed confocal and light-sheet fluorescence can resolve cells travelling >1 m/s 
down a straight microfluidic channel, including using 2 fluorescent channels with a DNA stain 
[259]. This allowed multiple parameter analysis of physical parameters including whole cell 
and nuclear shape. Future work will collaborate with Goda’s lab to combine their fluorescence 
microscopy with deformation cytometry, allowing single-cell multiparameter analysis 
including direct relation to whole cell deformability and subcellular structure. Preliminary 
work successfully deformed cells in a cross-slot in the shear regime with two-channel 
cytoplasmic and nuclear staining, and current work is being done toward processing and 





COMSOL model from Chapter 4 
COMSOL Multiphysics simulates fluid flow by solving a set of equations for known boundary 
conditions including inlets, outlets and walls. The fluid velocity and pressure can be predicted 
for a given geometry by solving the Navier-Stokes (NS) equation (equation 2.14), which 
represents momentum conservation, and the continuity equation (equation 2.15), which 
represents conservation of mass. A model was built to calculate the flow velocity in the inlet 
and outlet channels of the cross-slot device, to compare to the measured velocity of beads and 
cells in flow (section 4.1.1) in the same device geometry. The Model Navigator below outlines 
how the model was built and how data was extracted from it. 
Model Navigator  
From the File menu, choose New.  
NEW  
1 In the New window, click Model Wizard.  
MODEL WIZARD  
1 In the Model Wizard window, click 3D.  
2 In the Select physics tree, select Fluid Flow >Single-Phase Flow >Laminar Flow. Click 
Add.  
3 Click Study.  
4 Click Done.  
PARAMETERS  
1 In the Global Definitions window, select Parameters.  
2 Add a Parameter labelled 𝐹𝑅 (flow rate) with an initial value of 5 𝜇𝑙/𝑚𝑖𝑛.  
GEOMETRY  
1 In the Model Builder window, under Component 1 (comp1) click Geometry 1.  
2 In the Settings window for Geometry, locate the Units section, from the length unit list, 
choose μm.   
3 On the Geometry toolbar, click Primitives and choose Rectangle. Set the Width to 500 and 
Height to 35.  
4 Go to Draw and select Extrude and extrude Work Plane 1 (wp1) by 25.  
5 On the Home toolbar, click Build All.  
MATERIALS  
1 In the Model Builder window, under Component 1 (comp1) right-click Materials and  




LAMINAR FLOW  
1 In the Model Builder window, under Component 1 (comp1) click Laminar Flow.  
2 Select All Domains. Select Equations from Study Controlled, Study 1 Stationary.  
3 Set Compressibility to incompressible fluid. 4 Under Fluid Properties, select both density 
𝜌 and viscosity µ as from Material.  
5 Under Wall 1 select domains 2, 3, 4 and 5.  
6 On the Laminar Flow toolbar, click Inlet 1. Select domain 1, Laminar inflow as the 
boundary condition and in the Flow Rate text field type FR.  
8 On the Laminar Flow toolbar, click Outlet. Select domain 6, select Pressure=0 as the 
Boundary Condition and select Suppress Backflow.  
MESH GENERATOR  
1 Select Physics Controlled Mesh and select Finer from the predefined mesh sizes list.  
2 Click the Initialize Mesh button in the toolbar to generate the mesh.  
STUDY  
1 In the Model Builder window, under Component 1 (comp1) click Study.  
2 Locate the Parametric Sweep section. Set Name of parameter to 𝐹𝑅 (flow rate) and List of 
parameter values to range (2.5 [µl/min], 5 [µl/min], 10 [µl/min], 25 [µl/min], 40[µl/min]).  
3 On the Home toolbar, click Compute.  
RESULTS  
1 In the Model Builder window, under Component 1 (comp1) click Results.  
2 On the Data Sets toolbar, click Cut Line. For Point 1 set: x=100, y=0, z=12.5. For Point 2 
set: x=100, y=35, z=12.5.  
3 On the Velocity toolbar, click and add Slice and select the x-y plane.   
4 On the Velocity toolbar, click and add Streamline and select uniform density and a 
separating distance of 0.01.  
5 Under 1D Group Plot select Cut Line 1, for Parameter Selection (FR) select All.  
6 Click Plot.  





Supplementary Figures for Chapter 4 
 
Figure S1 Viscosity data for PBS with different amounts of methyl cellulose (0.25%, 0.35% and 0.5% 
w/v). Viscosity was measured using a Rheometrics SR-500 Dynamic Stress Rheometer in the parallel 
plate configuration (diameter of 25 mm). The graph shows a plot of strain rate as a function of stress, 
each dataset has a linear fit where the gradient is equivalent to the viscosity. Rheometry measurements 
were taken by Matthew Hughes.  
 
Figure S2 The raw data of the N=50 strain traces of HL60 cells deformed in a shear-dominant regime 








Supporting Videos for Chapter 4 
Video 1: HL60 cells deforming in the shear-dominant flow regime (µ≈33 cP) at a flow rate 
of 80 µl/min. 
Video 2: HL60 cells deforming in the inertia-dominant flow regime (µ≈1 cP) at a flow rate 
of 200 µl/min, which is below the cells yield stress. 
Video 3: HL60 cells deforming in the inertia-dominant flow regime (µ≈1 cP) at a flow rate 
of 400 µl/min, which is equivalent to the cells yield stress. 
Video 4: HL60 cells deforming in the inertia-dominant flow regime (µ≈1 cP) at a flow rate 
of 600 µl/min, which above the cells yield stress and at the critical strain (flow rates above 
this surpass the cell failure point leading to on-chip cell rupture). 
Video 5: HL60 cells deforming in the shear-dominant flow regime (µ≈33 cP) at a flow rate 
of 5 µl/min. An example of the maximised field of view used to track cell deformation and 
relaxation and extract multiple parameters. 
Supplementary Figures for Chapter 5 
 
Figure S3 Phase contrast images of SW480 cells treated with 100 nM of CA4 for 24 hr compared to a 




Supplementary Figures for Chapter 6 
 
Figure S4 Histograms showing the initial diameter A of four cell lines. Found using image analysis as 
cells approached the SP of an extensional flow junction. The flow regime was shear-dominant (µ≈33 
cP, Q=5 µl/min).  
 
Figure S5 Histograms showing the maximum strain 𝜀𝑚𝑎𝑥 of four cell lines. Found using image analysis 
as deformed at the SP of an extensional flow junction. The flow regime was shear-dominant (µ≈33 cP, 





Figure S6 Histograms showing the initial strain 𝜀0 of four cell lines. Found using image analysis as 
cells approached the SP of an extensional flow junction. The flow regime was shear-dominant (µ≈33 
cP, Q=5 µl/min).  
 
Figure S7 Histograms showing the final strain 𝜀∞ of four cell lines. Found using image analysis as 
cells recovered after deformation at the SP of an extensional flow junction. The flow regime was shear-





Figure S8 Histograms showing the relaxation time 𝜏𝑟 of four cell lines. Found using image analysis as 
cells recovered after deformation at the SP of an extensional flow junction. The flow regime was shear-
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